Alan J. Wein, M.D. Ph.D.(hon.) · Royal Society of Medicine Sexual Medicine Society of North America, Inc. Sigma Xi Simon Foundation Société Internationale d’Urologie Société

Alan J. Wein, M.D. Ph.D.(hon.) Curriculum Vitae 2012 _____________________________

2

Faculty Appointments:

1967-1968 Assistant Instructor in Surgery, University of Pennsylvania School of Medicine, Philadelphia

1969-1971 Assistant Instructor in Urology (Surgery), University of Pennsylvania School of Medicine

1971-1972 Instructor in Urology (Surgery), University of Pennsylvania School of Medicine

1974-1976 Assistant Professor of Urology (Surgery), University of Pennsylvania School of Medicine

1976-1983 Associate Professor of Urology (Surgery, with tenure), University of Pennsylvania School of Medicine

1983- Professor of Urology (Surgery with Tenure), University of Pennsylvania 1990- Professor of Surgery (Urology) in Radiology 2007- Founders Professorship in Urology…formally known as…

The Alan J. Wein, M.D. Founders Professorship of Urology Perelman School of Medicine…previously known as… University of Pennsylvania School of Medicine

Hospital and Administrative Appointments:

1974-1979 Assistant Chief of Urology, Hospital of the University of Pennsylvania; 1974-1982 Chief of Urology, Veterans Administration Hospital, Philadelphia; 1974- Assistant Surgeon, Children’s Hospital of Philadelphia; 1974- Director, Urodynamics Evaluation Center, Division of Urology, University

of Pennsylvania School of Medicine; 1975-1977 Consultant in Urology, Philadelphia General Hospital; 1975- Director, Residency Program in Urology, Division of Urology, University

of Pennsylvania School of Medicine; 1976- Director, Program in Urologic Oncology, Division of Urology, University

of Pennsylvania School of Medicine; 1977- Associate Surgeon, Pennsylvania Hospital, Philadelphia; 1980-1997 Attending Urologist, Graduate Hospital, Philadelphia; 1979-1981 Acting Chief of Urology, Hospital of the University of Pennsylvania,

Acting Chairman, Division of Urology, University of Pennsylvania School of Medicine;

1981- Chairman, Division of Urology, Department of Surgery, University of Pennsylvania School of Medicine;

1981- Chief of Urology, Hospital of the University of Pennsylvania; 1982-1996 Attending Urologist, Veterans Administration Hospital, Philadelphia

Awards, Honors, and Memberships in Honorary Societies and By-Election Only 1962 Cum Laude, Princeton University 1962 Sigma Xi, Princeton University 1966 Alpha Omega Alpha, University of Pennsylvania 1969 Second Prize, Philadelphia Urological Society Essay Contest (The

Effects of Aminophylline on Ureteral Contractility) 1970 First Prize, Philadelphia Urological Society Essay Contest (The Effects

of Isuprel on Ureteral and Bladder Contractility)


3

1971 Third Prize, Philadelphia Urological Society Essay Contest (The

Adrenergic Innervation of the Dog Ureter) 1972 Second Prize, Philadelphia Urological Society Essay Contest (The

Effect of 6-Hydroxydopamine on Ureteral Contractility) 1984 American Association of Genitourinary Surgeons 1987 Second Prize, Lapides Essay Contest, American Urological Association

(Studies on the Biphasic Nature of Urinary Bladder Contraction and Function)

1988 Clinical Society of Genitourinary Surgeons 1990 Honorary Member, Southeastern Section, American Urological

Association 1990 Honorary Award for achievements in the field and contribution to

knowledge about IC, Presented by Interstitial Cystitis Association 1992 William P. Burpeau Award, New Jersey Academy of Medicine, Section

of Urology 1992 Lifetime Achievement Award, Urodynamics Society (now known as the

Society for Urodynamics and Female Urology 1993 American Surgical Association 1994 Société Internationale de Chirurgie 1995 Society of Surgical Oncology 1996 F. Brantley Scott Award, American Foundation for Urologic Disease, Inc. 1996 Ramon Guiteras Lecturer, American Urological Association, Inc. 1996 Best Doctors in America 1996 1997 Hugh Hampton Young Award, American Urological Association, Inc. 1997 American Urological Association Lecturer at the Société Internationale

d’Urologie 1999 British Journal of Urology Lecturer at British Association of Urological

Surgery Meeting 1999 Robert Dunning Dripps Memorial Teaching Award, University of

Pennsylvania School of Medicine 2000 Distinguished Service Award, American Urological Association, Inc.

for Education in Urology 2001 Distinguished Contribution Award, American Urological Association, Inc.

for Contributions to the Science and Practice of Urology 2001 America’s Top Doctors 2001 Recipient, Legion of Honor Gold Medallion from Chapel of Four

Chaplains, Valley Forge, PA 2001-2002 Best Doctors in America

2002 American Urological Association Lecturer at European Association of Urology

2003 America’s Top Doctors 2005 Honorary Ph.D. conferred by the University of Patras, Patras, Greece,

September 2005 2005 America’s Top Doctors for Cancer 2005 Philadelphia Top Doctors 2005-2006 Best Doctors in America 2006 America’s Top Doctors for Cancer 2007-2008 Best Doctors in America 2008 Distinguished Service Award for Outstanding Contributions to

Urodynamics, Female Urology and Voiding Dysfunction and Exemplary


4

Service, Society for Urodynamics and Female Urology 2008 The Class of “32 Distinguished Alumni Award, The Mercersburg

Academy, presented October 18, 2008 at the 50th Reunion of the Class of 1958

2008 America’s Top Doctors for Cancer 2008 Philadelphia Top Doctors 2009 18th Annual National Mature Media AwardsSM Honoring the Best in

Advertising, Marketing & Educational Materials for Older Adults for “Managing and Treating Urinary Incontinence 2nd Edition (honoring the Best in Advertising, Marketing & Educational Materials for Older Adults. Media/Book)

2009 America’s Top Doctors for Cancer 2009 The 2009 American Urological Association Education and Research,

Inc/Pfizer Visiting Professorship in Urology 2009-2010 Best Doctors in America 2010 America’s Top Doctors 2010 America’s Top Doctors for Cancer 2011 Ferdinand C. Valentine Award (New York Academy of Medicine)

April 2011 2012 Edward L. Keyes Medal – AAGUS Award Ceremony, April 2012 2012 University of Pennsylvania Division of Urology Paul Rodin Leberman

Teaching Award (Recognition of Excellence in Resident Education), June 2012

2012 Super Doctors 2012 2012-2013 Vice President, Clinical Society of Genitourinary Surgeons (CSGUS) 2013-2014 President, Clinical Society of Genitourinary Surgeons

Memberships in Professional and Scientific Societies: Local: American Urological Association, Mid-Atlantic Section College of Physicians of Philadelphia

Delaware Valley Society of Transplant Surgeons John Morgan Society Pennsylvania Medical Association Pennsylvania Society of Oncology Hematology Philadelphia Academy of Surgery Philadelphia County Medical Society Philadelphia Urologic Society Ravdin-Rhoads Surgical Society Urological Association of Pennsylvania

National and International:

Alpha Omega Alpha American Academy of Clinical Neurophysiology American Association for the Advancement of Science American Association for the Surgery of Trauma American Association of Clinical Urologists American Association of Genitourinary Surgeons American Cancer Society


5

American Clinical Neurophysiology Society (formerly the American Electroencephalographic Society)

American College of Surgeons American Fertility Society American Institute of Ultrasound in Medicine American Medical Association American Medical Foundation American Society for Pharmacology and Experimental Therapeutics American Society of Andrology American Society of Clinical Oncology American Surgical Association American Uro-Gynecologic Society American Trauma Society American Urological Association American Urological Association Allied Association for Academic Surgery Canadian Urological Association Clinical Society of Genito-Urinary Surgeons Eastern Cooperative Oncologic Group Endourological Society European Association of Urology International Continence Society International Society of Impotence Research Interstitial Cystitis Association National Association for Continence National Association of Veterans Administration Physicians National Kidney Foundation, Inc. Council on Urology New York Academy of Sciences Radiation Therapy Oncology Group Royal Society of Medicine Sexual Medicine Society of North America, Inc. Sigma Xi Simon Foundation Société Internationale d’Urologie Société Internationale de Chirurgie Society for Basic Urological Research Society for Minimally Invasive Surgery Society for the Study of Impotence Society for Sex Therapy and Research Society for Urodynamics and Female Urology-SUFU (Formerly the Urodynamics Society)

Society of Government Service Urologists Society of Pelvic Surgeons Society of Surgical Oncology Society of University Surgeons Society of University Urologists Society of Urology Chairs and Program Directors Society of Urologic Cryosurgeons Society of Urologic Oncology (Founding member) University Urologic Forum (now defunct) Urologic Investigators Forum (now defunct) Urologic Research Society Urologists Correspondence Club (now defunct)


6

Non-University Consultative and Committee Positions

1977-1990 Consultant, Committee on Drug Evaluation and Voiding, American Medical Association 1978-1980 Urology Consultant, Marion Laboratories, Inc. 1978-1981 Committee on Pharmacodynamics, Urodynamics Society 1978-1982 Surgical Committee, Philadelphia Professional Standards Review Organization 1979-1980 Program Committee, Combined Meeting, International Continence Society/Urodynamics Society (October 1980) 1979-1981 Task Force on Urodynamics Procedures, Urodynamics Society (SUFU) 1979-1982 Educational Materials Project Appraisal Panel, Association of American

Medical Colleges 1979-1983 Committee on Education, Mid-Atlantic Section, American Urological

Association; Chairman, 1982-83. 1979-1987 Mid-Atlantic Section Representative, Long Range Planning Committee Think Tank, American Urological Association 1979-1988 Program Committee, Annual Meeting, Mid-Atlantic Section, American

Urological Association 1980-1981 Committee on Classification, Urodynamics Society (SUFU) 1980-1990 Genitourinary Working Committee Radiation Therapy Oncology Group 1980- Executive Committee, Society of Urodynamics and Female Urology (SUFU) (formerly Urodynamics Society) 1981-1985 Chairman, Committee on Neurophysiology, Urodynamics Society

(SUFU) 1981-1985 Committee on Resident Education Standards, Urodynamics Society (SUFU) 1981-1985 Committee on Undergraduate Education, American Urological

Association 1982 Chairman, Mid-Winter Seminar, Mid-Atlantic Section, American Urological Association

1982-2004 Editor-in-Chief, Home Study Courses American Urological Association Office of Education 1983 Program Director, Annual Meeting, Urodynamics Society (SUFU) 1983 Program Committee, Combined Meeting, International Continence Society/Urodynamics Society (SUFU) 1983-1990 Urology Advisory Board, United States Pharmacopoeia 1983-1990 Course Chairman, Annual Meeting, American College of Surgeons 1983-2004 Consultant, Program Committee, Annual Meeting, American Urological

Association 1983- Coordinating Council, American Urological Association (Representative of Urodynamics Society (SUFU) 1984-1986 Vice President, Urodynamics Society (SUFU) 1984-1988 Member, Food and Drug Administration, General Medical Devices Panel, Gastroenterology/Urology Section 1984-1988 Ad Hoc Committee to Study Safety and Effectiveness of Percutaneous and Extracorporeal Stone Dissolution, American Urological Association 1984-1989 Examination Committee, American Urological Association, Chairman, Task Force A, 1988-1999 1984-1992 Executive Committee, Philadelphia Urological Society 1984- American Cancer Society Lecturer’s Bureau


7

1984-1990 Member, Ethicon Advisory Board 1984-1991 Genitourinary Steering Committee, Eastern Cooperative Oncology Group 1985 Chairman, Program Committee, Mid-Atlantic Section, American Urological Association 1985-1987 Co-Chairman, Practice Affairs Committee, Philadelphia Urological Society 1985-1987 Research Committee, Mid-Atlantic Section, American Urological Association 1985-1999 Research Committee, American Urological Association 1985-2000 Intersociety Relations Committee, Urodynamics Society (SUFU) 1985- Consultant in Urology, Blue Cross of Pennsylvania 1985- Consultant in Urology, Blue Shield of Pennsylvania 1986- Advisory Board, Simon Foundation for Incontinence 1986 Committee, Society for Sex Therapy and Research, Annual Meeting 1986-1988 President, Urodynamics Society (SUFU) 1986 Program Committee, Combined Meeting, Urodynamics Society

(SUFU)/International Continence Society 1986-1987 Chairman, NIH Sponsored Symposium on Interstitial Cystitis 1987-1991 Advisory Panel, Help for Incontinent People 1987-1989 Chairman, Ethicon Advisory Board 1987-1990 National Kidney and Urologic Diseases Advisory Board, National Institutes of Health, Member, First Steering Committee 1987-1991 Advisory Board, Counterpoints in Urology 1986- Medical Advisory Board, Interstitial Cystitis Association 1987-1989 Scientific Committee, International Continence Society 1988-1998 Diagnostic and Therapeutic Technology Assessment Panel, American Medical Association 1988-1992 Chairman, American Urological Association Ad Hoc Committee on Female Urology and Urodynamics 1988-1992 Editorial Committee, Mid-Atlantic Section, American Urological Association 1989 President (Meeting Chairman) Urological Research Society 1990- Consultant, American Urological Association Education Council 1989-1994 Measurement Committee, American Urological Association (AD Hoc Committee to Study Prostatectomy) 1989-1999 American Foundation for Urologic Disease (AFUD) – AUA Research Committee 1989-1999 NIDDK Coordinating Council to the American Urological Association Research Committee 1990-1996 President, Philadelphia Urologic Society 1990-1997 Trustee, American Board of Urology; Vice President, 1995-1996 1990-1991 Alternative Representative to the American Urological Association

Executive Committee from the Mid-Atlantic Section 1990-2005 Chairman, Bladder Advisory Council, American Foundation for Urologic

Disease 1990 Consultant, CDC Council on Incontinence 1991-1997 Residency Review Committee, Urology 1991-1997; ACGME and American Board of Urology, Vice Chairman 1993-1995; Chairman 1995-1997 1992-2000 Consultant, American Medical Association: Drugs Used in Urologic

Disorders 1993 Program Chairman, Urodynamics Society Meeting (SUFU) 1993 Program Chairman, Mid-Atlantic Section Meeting, American Urological Association 1993-1998 International Consultation on Benign Prostatic Hyperplasia, Subcommittee


8

on the Effects of Obstruction and Aging on the Lower Urinary Tract 1993-1999 Subcommittee (AUA) for the Evaluation of Clinical Trials in BPH (Reviewer of Products) 1993-1997 Secretary/Treasurer, Clinical Society of Genitourinary Surgeons 1994 Urinary Incontinence Update Panel, Agency on Health Care Policy and Research, Technical Specialist 1994-1997 Executive Committee, Mid-Atlantic Section, American Urological

Association 1994- Membership Chairman, Urodynamics Society (SUFU) 1995-2006 Advisory Committee, American Urological Association Office of Education 1995-1999 Consultant, American Urological Association Urology Work Force Committee 1995 Consultant, American Urological Association Strategic Planning Committee 1996-2000 Counselor, Society of University Urologists (SUU) 1996 Advisory Committee, American Medical Foundation 1996-1997 Technical Advisor, Clinical Practice Guidelines – Urinary Incontinence in Adults: Acute and Chronic Management, Agency for Health Care Policy and Research 1997-1999 NIDDK Coordinating Council Representative on AUA/AFUD Research

Committee 1997-1998 AUA Special Committee to Develop Guidelines for Ultrasound in Urology 1997-2002 Voiding Dysfunction Subcommittee, American Urological Association 1997- Co-Chairman Medical Advisory Board, Interstitial Cystitis Association 1997-1999 Committee Member, 4th International Consultation on BPH; Committee on Pathophysiology of Bladder Obstruction in Aging

1997- Co-Chairman, World Health Organization International Consultation on Incontinence (I, II, III, IV)

1997-2009 Member, Board of Appeals Panel Residency Review Committee for Urology 1997-2000 Course Director, American Urological Association Office of Education

Annual Review Course 1997 Co-Chairman Consensus Conference, The Overactive Bladder: From Basic Science to Clinical Management 1998-1999 Mid-Atlantic Section Representative, American Urological Association Nominating Committee 1998-1999 Member, Strategic Planning Committee, American Urological Association 1998-2000 American Urological Association Public Relations Advisory Board

1998-2009 Chairman, Committee on Residency Standards, Society of University Urologists 1998-2005 World Health Organization Committee Member, International Consultation

on Prostate Cancer, Committee on Diagnosis and Staging of Prostate Cancer 1999-2006 Terminology Subcommittee, International Continence Society

2000-2004 World Health Organization Member, 5th International Consultation on Benign Prostatic Hyperplasia; Committee on Initial Evaluation of BPH

2000-2001 Co-Chairman, 2nd World Health Organization International Consultation on Incontinence 2000-2002 Medical Advisory Board National Overactive Bladder Evaluation Project NOBLE 1998- Alumni Services Council, Princeton University

1999- Ambassador, Chapel of the Four Chaplains, Philadelphia, PA 2000-2001 President, Society of University Urologists (SUU) 2000-2009 Chairman, Residency Standards Committee, Society of University Urologists


9

2001-2002 President-Elect, Mid-Atlantic Section American Urological Association 2001-2005 Chairman, Education Council Committee, American Urological Association 2002-2003 President, Mid-Atlantic Section, American Urological Association

2002-2009 Advisory Council for Urology, American College of Surgeons 2002-2009 Special Society Governor of the American Association of Genitourinary Surgeons, Board of Governors-American College of Surgeons 2002-2003 Internet Advisory Committee, American Urological Association 2003 Co-Chair, International Panel on Consensus for Minimal Necessary Evaluation of Stress Urinary Incontinence 2003-2006 Nominating Committee (MA-AUA) Mid Atlantic-American Urological

Association 2004 Co-Chair Annual Advances in Genitourinary Health (Johns Hopkins, sponsor) 2005- Evidence Based Urology Task Force 2005- Mercersburg Academy, Board of Regents 2006-2008 EPIC-2 Study, Medical Advisory Board 2006- Nominating Committee Alternates (Mid-Atlantic Section, Rep – MAS REP),

American Urological Association (Term 2010) 2006-2009 Board of Governors’ Committee on Physician Competency and Health,

American College of Surgeons 2006-2008 Faculty of 1000 Medicine (F1000 Medicine Reports), Section Head for Lower

Urinary Tract: Dysfunction, Incontinence & Urodynamics 2006-2007 Education Council, American Urological Association (AUA) 2007 Nominating Committee, Board of Governors, American College of Surgeons 2007-2008 Education Council, American Urological Association (AUA) 2008 Nominating Committee, Board of Governors, American College of Surgeons 2008- Faculty of 1000 Medicine, Urology Advisory Board, F1000 Medicine Reports 2008-2009 Education Council, American Urological Association (AUA) 2009-2010 Education Council, American Urological Association (AUA) 2009-2010 President-Elect of the Society of University Urologists (SUU) 2010-2011 2nd Presidency, Society of University Urologists (1st Presidency 2009) 2010-2011 Education Council, American Urological Association (AUA) (acceptance 2009)

2010- Committee to Revise ICD 11 Terminology 2010- AUA Urodynamics Guidelines Panel 2010- Stress Urinary Incontinence Measures Development Panel (Joint Committee

of AUA and ACOG for the AMA The Physician Consortium for Performance Improvement)

2010- ICS Urodynamics Committee Managing Committee (Peter Rosier, chair) 2010-2012 AUA Nominating Committee 2011- Foundation for Men’s Health (FMH) Scientific Committee 2011- Education Council, American Urological Association (AUA) 2011- AUA Guidelines Committee Member, Use of Pelvic Ultrasound 2012 Program Planning Committee, AUA Annual Meeting 2012

University Committees and Elected Positions

1975-1983 Surgical Audit Committees, Veterans Administration Hospital, Philadelphia 1975-1983 Surgical Audit Committee, Hospital of the University of Pennsylvania 1977-1983 Operating Room Committee, Veterans Administration Hospital 1978- Operating Room Committee, Hospital of the University of Pennsylvania 1980-1983 Committee on Academic Freedom and Responsibility, University of


10

Pennsylvania School of Medicine 1979- Medical Board, Hospital of the University of Pennsylvania 1980-2000 Trauma Center Advisory Committee, University of Pennsylvania School of Medicine 1981-1999 Member, Clinical Smell and Taste Research Center, University of

Pennsylvania 1980- Executive Committee/Council of Chiefs, Department of Surgery, University of Pennsylvania School of Medicine 1981- Clinical Research Committee University of Pennsylvania Cancer Center 1983- Laser Subcommittee, Operating Room Committee, Hospital of the University of Pennsylvania 1984-1985 Committee to Review Emergency Services, Hospital of the University

of Pennsylvania 1987- Clinical Practices Executive Committee, University of Pennsylvania School of Medicine

1988-1999 Residency Review Committee, Hospital of the University of Pennsylvania 1989-1991 Ad Hoc Committee on Ambulatory Surgery, Hospital of the University

of Pennsylvania 2001- Chair, Department of Surgery Committee on Appointments and

Promotions (COAP), University of Pennsylvania School of Medicine 2008- Finance Committee, Department of Surgery, University of Pennsylvania

School of Medicine 2009-2010 Microsurgery Search Committee, Penn Medicine, University of Pennsylvania

Health System 2009- HUP PeriOp Robotic Advisory Committee

Editorial Positions

1978-1981 Editorial Board Assistant, Urological Survey 1978-1981 Editorial Board Consultant, Investigative Urology 1980-1985 Consultant Editor, Urodynamic Diagnosis of the Month, Urology Times 1980-1989 Assistant Editor, Journal of Urology 1981-1982 Editorial Consultant, Yearbook of Urology 1986-1987 (Articles on Neurourology) 1981-1985 Board of Editors, Investigative Urology (four year term) 1982-1983 Consultant Editor, World Urology Update Series 1982-2006 Associate Editor, Neurourology and Urodynamics 1982-2005 Editorial Board, World Journal of Urology 1982-1987 Assistant Editor, Urological Survey 1983-2006 Editorial Board, American Urological Association Update Series 1985- Ad Hoc Reviewer, Cancer 1985 Consulting Editor, Sexuality and Disability 1987- Editorial Board, Urological Survey Section, Journal of Urology 1980- Ad Hoc Reviewer, Clinical Section, Journal of Urology 1989-1994 Editorial Board, International Journal of Impotence Research: Basic and Clinical Studies 1989-1994 Editorial Board, Investigative Section, Journal of Urology 1991-1993 Editorial Board, Urology 1991- Editorial Board, Advances in Therapy 1992-2002 Associate Editor, Campbell’s Urology - 7th & 8th editions


11

1992-2002 Associate Editor, Campbell’s Urology-Review – 7th & 8th editions 1992- Associate Editor, Urology 1999- Editorial Board, Family Urology 1995-2002 Editorial Board, Journal of Pelvic Surgery 1999-2000 Editorial Board, British Journal of Urology International (BJUI) 1999-2004 Editorial Board, Contemporary Surgery 2000-2003 North American Editor, British Journal of Urology International 2000-2010 Editorial Board, Current Urology Reports 2002- Editorial Board, Current Opinion in Urology 2002 Guest Editor, Conversations in Neurology Newsletter, 1st Issue 2002- Editor-in-Chief, Campbell-Walsh Urology – 9th, 10th, 11th editions 2002- Editor-in-Chief, Campbell-Walsh Urology-Review - 9th, 10th, 11th editions 2002-2004 Editor-in-Chief, Timely Topics in Medicine, Urology 2003- Associate Editor, British Journal of Urology International 2004-2010 Editorial Board, International Urogynecology Journal 2005-2006 Associate Editor, Current Urology Reports 2005- Co-Editor in Chief, UroToday (Web Based) 2006 Editorial Board, Current Urology Reports 2006- Advisory Board, Nature Clinical Practice Urology 2006- Editorial Board, Current Bladder Dysfunction Reports 2007- Executive Committee, Neurourology and Urodynamics 2007- Editorial Board, Postgraduate Medicine (a peer-reviewed journal) 2009- Editorial Board, LUTS (Lower Urinary Tract Symptoms) 2010- Associate Editor, Therapeutic Advances in Urology 2010-2011 Editorial Board, Annals of Urology (accepted 2009) (defunct 2011)

Alan J Wein, M.D., Ph.D.(hon.) Curriculum Vitae 2012 _____________________________

12

RESEARCH FUNDING Veterans Administration, 1974-1979.

Post Fund Awards for Study of "Autonomic Factors in Lower Urinary Tract Function and Dysfunction" ($6,000).

Grant to Urology Research Fund ($20,000): "The Effect of Bethanechol Chloride on Bladder

Function." McCabe Research Fund, 1975-1982.

Awards to Urology Development Fund ($84,000): "Autonomic Factors in Lower Urinary Tract Function"; "The Effects of Pharmacologic Agents on Lower Urinary Tract Function and Dysfunction".

Marion Laboratories, 1976-1978.

Grant to Urology Development Fund ($40,000): "Autonomic Factors in Lower Urinary Tract Function"; "The Effect of Oxybutynin on Lower Urinary Tract Function Following Transurethral Surgery."

Eaton Laboratories, 1978-1980.

Grant to Urology Development Fund ($15,000): "Factors Involved in Urinary Infection Following Transurethral Surgery."

Merrell National Laboratories, 1979-1982.

Grant to Urology Development Fund ($31,000): "Autonomic Factors in Lower Urinary Tract Function"; "The Effect of Bentyl on the Smooth Musculature of the Lower Urinary Tract."

Sponsor, National Kidney Foundation Grant (Dr. John D. Bartges), 1978-1979.

"Viscoelastic Properties of Smooth Muscle of the Lower Urinary Tract" ($12,000). Veterans Administration, 1979, 1981.

Merit Review Grant (Principal Investigator): "Autonomic Factors in Lower Urinary Tract Function and Dysfunction" ($102,600).

Sponsor, National Kidney Foundation Grant (Dr. David Staskin), 1980-1981.

"Autonomic Factors in Lower Urinary Tract Dysfunction ($12,000). National Institutes of Health (NIAMDD) Research Grant No. ROI-AM-26508 (Co-Principal

Investigator), 1980-1983: "Autonomic Control of Lower Urinary Tract Function" ($201,021).

Merrell National Laboratories, 1980-1982.

Grant to Neurourology Fund ($24,000): "Placebo-Controlled Study of the Effect of Candicidin on Benign Prostatic Hypertrophy.”

Veterans Administration, 1981-1984.

Merit Review Grant (Principal Investigator): "Autonomic Factors in Lower Urinary Tract Function and Dysfunction" ($160,000).

Roche Laboratories, 1981. Grant to Urology Development Fund ($12,000): "Comparison of Midazolam with Diazepam for Urologic Endoscopy.”


13

Sponsor, National Kidney Foundation Grant (Dr. Keith N. Van Arsdalen), 1982-1983:

"Autonomic Factors in Lower Urinary Tract Dysfunction ($15,000). Smith Kline and French Laboratories, 1982.

Grant to Urology Development Fund ($24,000): "Evaluation of Phenoxybenzamine in the Management of Benign Prostatic Hypertrophy.”

Sponsor, National Kidney Foundation Grant (Dr. Bruce Malkowicz), 1983-1984.

"Autonomic Factors in Lower Urinary Tract Dysfunction" ($17,000). National Institutes of Health (NIAMDD) Research Grant No. ROI-AM-26508-05 (Co-

Principal Investigator), 1983-1988: "Autonomic Control of Lower Urinary Tract Function" ($213,000).

National Institutes of Health Research Grant #2 R01-AM26508 (Co-Principal lnvestigator),

1980-1983, 1983-1986, 1986-1989: "Autonomic Control of Lower Urinary Tract Function" ($240,000/3 years).

Veterans Administration, 1978-1982, 1982-1985, 1985-1988.

Merit Review Grant (Co-Principal Investigator): "Autonomic Factors in Urinary Tract Function and Dysfunction" ($240,000/3 years).

National Institutes of Health Research Grant No. I RO I AM33559 (Co-Principal

Investigator), 1984-1987: "Metabolic Control of Urinary Bladder Function" ($212,000/3 years)

National Institutes of Health Research Grant No. 1 RO-1-DK 39086-01 (CO-Principal

Investigator, 1987-1992: "Interstitial Cystitis: Human and Animal Studies" ($750,000/5 years).

SmithKline French Laboratories, 1986-1988.

Pharmaceutical Grant ($100,000/2 years): "Effect of SKF Compounds on Urinary Bladder Function".

Eli Lilly Laboratories, 1986-1988.

Pharmaceutical Grant ($120,000/2 years): “Effect of Lilly Compounds on Urinary Bladder Function".

Foundation for Interstitial Cystitis Grant, 1986-1987, $55,000.

To initiate research program in interstitial cystitis. Foundation for Interstitial Cystitis Grant, 1987-1988, $10,000.

To initiate research program in interstitial cystitis. McCabe Research Fund, 1987-1988.

Award to Urology Development Fund ($15,000): "Studies in Neurourology". National Institutes of Health Research Grant #1 P50 DK 39257-01 (Co-Principal

Investigator), 1987-1992. "The Study of Obstructive Uropathyl” ($110,000 per year/5 years)


14

National Institutes of Health Research Grant #23-1352685 (Co-Principal Investigator), 1987-1992. "In Vitro Studies on Obstructive Uropathy" ($278,191 per year/5 years).

National Institute of Health Research Grant (Co-Principal Investigator), 1987-1992

"Metabolic Regulation of Urinary Bladder Function" ($240,526 per year/5 years). National Institutes of Health Research Grant (Co-Principal Investigator) "Purinergic

lnnervation of the Rabbit Urinary Bladder", 1985-1988 ($37,500 per year/3 years). National Institutes of Health Research Grant (Co-Principal Investigator) 1987-1990,

"Interstitial Cystitis - Human and Animal Studies ($238,898 per year/3 years). Veterans Administration Merit Review Grant, (Principal Investigator) 1988-1992. "Autonomic

Factors in Urinary Tract Function and Dysfunction" ($240,000/3 years.) Veterans Administration Merit Review Grant, (Co-Principal Investigator), 1988-1992.

"Urinary Tract Infection: Factors Affecting Bacterial Adhesion" ($240,000/3 years). National Institutes of Health I RO I-DK33559 (Principal Investigator), 1988-1991. "Metabolic

Control of Urinary Bladder Function" ($412,000/3 years). ICI Pharmaceutical Company (Co-Principal Investigator), 1989-1991. "Development of

Animal Models of Urinary Urinary Incontinence" ($100,000/2 years). National Institutes of Health I P50 DK39257-03 (Co-Principal Investigator). Center for the

Study of Obstructive Uropathy ($81,722.00 annual direct cost) National Institutes of Health R01-DK26508-09 (Co-Principal Investigator). Autonomic

Control of Lower Urinary Tract Function ($212,014.00 annual direct cost). National Institutes of Health 3-PSO DK39250-03Sl (Principal Investigator), 1989-1991.

Interstitial cystitis database supplement. ($92,000.00 annual direct cost) University of Wisconsin (Subcontract). Effects of the Sensory Nerve System on Bladder

Function. ($19,000.00 annual direct cost) Eli Lilly Company, 1991

Grant to Urology Development Fund ($64,000.00). Effect of Potassium and Calcium Channel Agents on In-Vivo and In-Vitro Models.

Sterling Drug Company, 1991

Grant to Urology Development Fund ($54,000.00). Development of a Canine Model off Benign Prostatic Hyperplasia with Urethral Obstruction and Impaired Urodynamics.

National Institutes of Health 1 RO I DK 33559 (Co-Principal Investigator), 1991-1995.

Metabolic Control of Urinary Bladder Function. ($450,000.00/3 years) National Institutes of Health RO I DK 39740 (Principal Investigator). lntracellular Mechanism

for Urinary Bladder Function. Veterans Administration Merit Review Grant, (Co-Principal Investigator), 1991-1995.

"Autonomic Factors in Urinary Tract Function and Dysfunction". ($464,000/4 years)


15

National Institutes of Health 1-UO-I-DK 44998-02 (Principal Investigator). 1991-1996.

Interstitial Cystitis: Clinical Centers Database. ($385,000/5 years). National Institutes of Health Postdoctoral Training Program in Basic Urological Research,

(Principal Investigator), T32-DK07708-06, 1992-1996, $58,663/ year. National Institutes of Health Physician and Scientists Training in Urologic Research, T32-

DK-07708, 1994-1999, ($73,118 annual direct cost). National Institutes of Health, (Principal Investigator) Postdoctoral training program in basic

urological research, K-12-DK-02196, 1994-1999, ($61,495 annual direct cost). Zeneca Pharmaceuticals,1994-1995.

Grant to Urology Development Fund ($44,500). Study to determine the effect of experimental compound on hyperreflexia.

Wyeth-Ayerst Laboratories.

1994-1995.Grant to Urology Developmental Fund ($18,500). Study to determine the effect of experimental compound on hyperreflexia.

Hercules, 1994-1995.

Grant to Urology Development Fund ($35,000). Study of ureteral stents. Debat, 1994-1995. Grant to Urology Development Fund ($42,500). A study to determine

the effect of drug on outlet obstruction in the rabbit. Veterans Administration, 1995-2000

Merit Review Grant (Co-Investigator): Autonomic Factors in urinary tract function and dysfunction. ($114,000 per year to end 3-31-2000).

National Institutes of Health Research Grant No. T32-DKO-7644, (1994-1997) Postdoctoral

training program in basic urological research. ($58,663/3 years). National Institutes of Health Research Grant No. K 12-D K-02196, 1994-1999, Physician

and scientist training in urological research. ($643,464 total). National Institutes of Health Interstitial Cystitis Database Grant No. DK-44998-06 (Principal

Investigator) 1993-1999, $610,229/6 years

Pfizer, 1997-1999, Effects of zoloprestat on bladder dysfunction in diabetic rats. $120,000 total.

Pfizer, Effects of zoloprestat on bladder function in diabetic rabbits, 1997-1999 ($96,000). National Institutes of Health O’Brien Urology Research Center, Co-principal investigator:

Remodeling of Bladder Smooth Muscle in Outlet Obstruction. NIH P50 DK52620-01, 1998-2003. Current year $72,000, total support $3,625,000.

National Institutes of Health, Mechanisms for Altered Detrusor Contractility in Diabetes, Co-

principal investigator. NIH RO1 DK55042-01, 1998-2003. Current year $224,603, total support $984,251.


16

National Institutes of Health, Postdoctoral Training Program in Basic Urological Research (Principal Investigator). T32-DK07708-07, 1998-2003, $82,840/year. National Institutes of Health, Postdoctoral Training Program (for urologists) in Basic Urological Research, Principal Investigator. NIH K12-DKO2196-07, 1998-2004 ($252,182/yr.; total $1,260,900). National Institutes of Health, Research Grant No. DK-54138, Interstitial Cystitis Clinical Trials Group, 1999-2003 ($871,015 total). National Institutes of Health, Co-principal investigator, George M. O’Brien Urology Research Center: Remodeling of bladder smooth muscle in outlet obstruction. NIH P50 DK52620-06, 2003-2004. (Current year $725,000, total 43,625,000) National Institutes of Health, Postdoctoral Training Program (for Ph.D.) in Basic Urological Research, Principal Investigator NIH T32-DKO7708-07, 1998-2008 ($114,541/yr.; total $572,705). National Institutes of Health, Co-principal investigator, George M. O’Brien Urology Research Center: Remodeling of bladder smooth muscle in outlet obstruction. NIH P50 DK52620-06, 2003-2008. (Current year $894,250, total $4,471,250). National Institutes of Health, Co-principal investigator, George M. O’Brien Urology Research

Center: Bladder Wall Remodeling in LUTS. NIH 2P50DK052620-11. 1998-2013. (Direct plus Indirect = $1,222,416/year; Total 5 Year Support - 9/18/09 to 7/31/2013 = $6,112,080).


17

Medical College or Organizational Visiting Professorships or Invited Keynote Talks 1974-1975 Philadelphia College of Osteopathic Medicine 1975-1976 University of Eastern Virginia

Shore Medical Center Allentown Hospital 1976-1977 West Jersey Hospital 1977-1978 Newcomb Hospital

Chester Crozer Medical Center Hazleton State Hospital West Jersey Hospital 1978-1979 Abington Hospital

Salem Hospital Maryland Urologic Association Burlington County Memorial Hospital 1979-1980 University of Texas, Houston Abington Hospital Allentown Sacred Heart Hospital Texas Association of Genitourinary Surgeons Virginia Urologic Society Cook County Graduate School of Medicine West Jersey Hospital Riverview Hospital 1980-1981 West Virginia University Methodist Hospitals of Memphis McGill University Raleigh County Medical Society 1981-1982 Society of Government Service Urologists

Wilmington Medical Center Society of Uro-Radiology St. Luke’s Hospital, Bethlehem, PA

Mayo Clinic, Rochester, MN Beth Israel Medical Center, New York, NY 1982-1983 University of Toronto Medical College of Virginia New England Section, American Urological Association University of Cincinnati Cincinnati Urologic Society University of Missouri New York Section, American Urological Association University of Arkansas Arkansas Medical Society Wayne State University


18

1983-1984 Society of Government Service Urologists UCLA Harvard Programs in Urology Oregon Health Sciences University Long Island Jewish Medical Center 1984-1985 Spinal Cord Society Kaiser Foundation, Los Angeles State University of New York, Buffalo, NY Temple University 1985-1986 American Academy of Neurology University of Wisconsin University of Padua Medical College of Pennsylvania 1986-1987 Cleveland Urological Society Northeastern Ohio University Yale University 1987-1988 Brown University Ohio State University Baylor University 1988-1989 New York Section, American Urological Association University of Iowa Iowa State Urologic Society Pittsburgh Urologic Society University of Indiana Duke University

1989-1990 University of Colorado University of Texas, Dallas Southwestern University of South Florida Atlanta Urologic Society University of Florida, Gainesville, FL

Medical College of Ohio Northwest Ohio Urologic Society

1990-1991 University of Massachusetts Southeastern Section, American Urological Association

University of Missouri Cleveland Clinic University of Utah UCLA State University of New York, Syracuse, NY (OB/GYN)

1991-1992 Study Group for Frequency and Incontinence of the Elderly (Japan) American Urogynecologic Society University of California at San Diego Kaiser Permanente Group, Los Angeles, CA New Jersey Academy of Medicine Washington University School of Medicine


19

1992-1993 Beth Israel Hospital, New York

Northeastern and New England Sections (combined, American Urologic Association)

Bowman Gray School of Medicine (now Wake Forest) Harvard Medical School 1993-1994 University of Miami 1994-1995 New York Section AUA, London, England

Mercer Medical Center, Trenton, NJ 1995-1996 AUA Ramon Guiteras Lecture Temple University Department of Urology

AUA Office of Education, Charlottesville, VA 1996-1997 Johns Hopkins University Urotrend 2000, Monte Carlo New York Section, American Urological Association, Paris, France Columbia University, New York Northwestern University School of Medicine AUA Office of Education, Palm Springs, CA AUA Basic Science Course, Charlottesville, VA AUA Subject Oriented Seminar, Dallas, TX 1997-1998 Northwestern University Societe Internationale d’Urologie (AUA Lecture) 1998-1999 Canadian Urologic Society Shinshu University, Japan New York Hospital, Cornell Medical Center Italian Society of Urology British Association of Urological Surgeons (British Journal of Urology Lecture) 1999-2000 University of Alabama State University of New York, Stony Brook, NY Mayo Clinic, Jacksonville, FL 2000-2001 Tennessee Urological Society South Central Section, American Urological Association Loyola University New York University School of Medicine 2001-2002 University of Rochester

Puerto Rico Urological Association Canadian Urological Association 2002-2003 European Association of Urology, State of the Art AUA Lecture Charles J. Robson Visiting Professorship, University of Toronto Urological Association of Pennsylvania Vanderbilt University 2003-2004 Shinsu University


20

Keio University Tokyo University Osaka University 2004-2005 American College of Osteopathic Surgeons

University of California, Irvine New York University University of Maryland

2004-2005 Baylor University (Methodist Hospital) State University of New York at Stonybrook George Washington University School of Medicine Franco-American Urology Society State University of New York at Syracuse 2005-2006 Urologic Association of Pennsylvania Hellenic Urology Society Wake Forest University School of Medicine University of Patras, Greece University of Miami School of Medicine Atlanta Urology Mater Misericordia Hospital Center (Dublin, Ireland) 2006-2007 University of Wisconsin

University of Nebraska Tampa Urologic Society New York Section AUA, India (New Delhi, Agra, Jaipur)

University of Washington, Seattle WA

2007-2008 Beaumont Hospital, Troy, MI Botsford Hospital, Farmington Hills, MI Wayne State University School of Medicine, Detroit, MI Ohio State University, Columbus, OH Columbia University, NY University of Southern California North Shore Long Island Jewish Hospital, NY

2008-2009 Massachusetts General Hospital/Harvard Medical School, Boston, MA

New York University, Department of Urology, New York, NY 2010-2011 Cleveland Clinic/Glickman Urological & Kidney Institute, Cleveland, OH Beth Israel Medical Center, New York, New York 2012- Case Western Reserve School of Medicine, Dept of Urology, Cleveland, OH

Alan J Wein, M.D., Ph.D.(hon.) Curriculum Vitae 2012 ___________________________

21

PUBLICATIONS IN PRINT

1. Lisk RD. Wein AJ.: Neurological site of action of estradiol in eliciting estrous behavior in the spayed rat. Am. Zoologist, 2:304, 1962.

2. Wein, A.J., Perkins, J.H., Rohner, T.J., and Schoenberg, H.W.: Electrolyte determinations in

normal, denervated, and defunctionalized dog bladders. Invest. Urol., 4:608, 1967. 3. Gregory, J.G., Sansone, T.C., Wein, A.J., and Murphy, J.J.: Sympathetic control of rennin

release. Surg. Forum, 20:525, 1969.

4. Wein, A.J., Gregory, J.G., Sansone, T.C., Rohner, T.J., and Schoenberg, H.W.: Qualitative studies of the phosphorylase, succinic dehydrogenase, adenosine triphosphatase, and glycogen synthetase content of normal, neurogenic, and defunctionalized bladder muscle. Invest. Urol., 8:177, 1970.

5. Gregory, J.G., Wein, A.J., Sansone, T.C., and Murphy, J.J.: Bladder resistance to infection. J.

Urol., 105:220, 1971. 6. Rohner, T.J., Raezer, D.M., Wein, A.J., and Schoenberg, H.W.: Contractile responses of dog

bladder neck muscle to adrenergic drugs. J. Urol., 105:657, 1971.

7. Wein, A.J. Graham, W.P. III, and Royster, H.P.: Malignant change in chronic wounds. Indus. Med. Surg. 41:12, 1972.

8. Wein, A.J. Gregory, J.G. Sansone, T.C. and Schoenberg, H.W.: The effect of aminophylline on

ureteral and bladder contractility. Invest. Urol. 9:290, 1972.

9. Wein, A.J., Leoni, J.V., Schoenberg, H.W., and Jacobowitz, D.: A study of the adrenergic nerves

in the dog ureter. J. Urol., 108:232, 1972.

10. Wein, A.J. Leoni, J.V. Schoenberg, H.W. and Jacobowitz, D.: The effect of 6 hydroxydopamine on canine ureteral contractility: further evidence in favor of a non-neurogenic theory of ureteral function. J. Urol. 108:402, 1972.

11. Wein, A.J., and Murphy, J.J.: Experience in the treatment of prostatic carcinoma with cyproterone

acetate. J. Urol., 109:68, 1972.

12. Wein, A.J., and Schoenberg, H.W.: A review of 402 girls with recurrent urinary infection. J. Urol., 107:329, 1972.

13. Leoni, J.V. Wein, A.J. Raezer, D.M. and Schoenberg, H.W.: The effect of beta-adrenergic

stimulation on the contractile response of canine detrusor muscle. Invest. Urol.10:419, 1973.

14. Leoni, J.V. Wein, A.J. and Schoenberg, H.W.: The effects of lsuprel and aminophylline on detrusor muscle contractility in an organ bath apparatus. Invest. Urol. 10:458, 1973.

15. Murphy, J.J., and Wein, A.J.: Urological problems associated with diseases of the nervous system. In, Neurological Surgery, J.R. Youmans, ad. Philadelphia, W.B. Saunders Co., 1973, pp. 2931-2946.


22

16. Raezer, D.M. Wein, A.J. Jacobowitz, D. and Corriere, J.N. Jr.: Autonomic innervation of canine

urinary bladder: cholinergic and adrenergic contributions and interaction of sympathetic and parasympathetic nervous systems in bladder function. Urology. 2:211, 1973.

17. Wein, A.J., Gregory, J.G., Leoni, J.V., Corriere, J.N., Jr., and Jacobowitz, D.J.:Chemical

sympathectomy with 6-hydroxydopamine: a useful research tool. Surg. Forum, 24:560, 1973.

18. Wein, A.J., Gregory, J.G., Sansone, T.C., Rohner, T.J., and Schoenberg, H.W.: Glycogen accumulation in neurogenic bladder muscle: a reappraisal. Invest. Urol., 10:442, 1973.

19. Gregory, J.G., Wein, A.J., and Schoenberg, H.W.: A comparison of the action of Tofranil and

ProBanthine on the urinary bladder. Invest. Urol., 12:233, 1974.

20. Halpern, G.N., Kalies, D., Factor, S., and Wein, A.J.: Malacoplakia causing bilateral ureteropelvic junction obstruction: case report and review of the literature. Urology, 3:628, 1974.

21. Wein, A.J., Gregory, J.G., Cromie, W.J., Corriere, J.N., Jr., and Jacobowitz, D.J.: Sympathetic

innervation and chemical sympathectomy of canine bladder. Urology, 4:27-32, 1974.

22. Wein, A.J., and Halpern, G.N.: Morbidity following transrectal and transperineal prostatic needle biopsy. Proc. Kimbrough Urological Seminar, 7:90, 1974.

23. Wein, A.J., Raezer, D.M., Benson, G.S., and Murphy, J.J.: At home intermittent catheterization in

the treatment of patients with neuromuscular bladder dysfunction. Proc. Kimbrough Urological Seminar, 8:41, 1974.

24. Benson, G.S., Raezer, D.M., Wein, A.J., and Corriere, J.N., Jr.: The effect of muscle length on

adrenergic stimulation of the canine detrusor. Urology, 5:769, 1975.

25. Wein, A.J., Gadbois, W.F., Raezer, D.M., Benson, G.S., Jacobowitz, D.M. and Corriere, J.N., Jr.: The effect of long-term chemical sympathectomy on the function of the canine urinary tract. Urology, 6:200, 1975.

26. Wein, A.J., Leoni, J.R., Raezer, D.M., Corriere, J.N., Jr., and Jacobowitz, D.J.: The effect of acute

chemical sympathectomy on the competency of the canine ureterovesical junction. Urol. Res., 3:95, 1975.

27. Benson, G.S., Jacobowitz, D.M., Raezer, D.M., Corriere, J.N., Jr., and Wein, A.J.: Adrenergic

innervation and stimulation of canine urethra. Urology, 7:337, 1976.

28. Benson, G.S., Wein, A.J., Raezer, D.M., and Corriere, J.N., Jr.: Adrenergic and cholinergic stimulation and blockade of the human bladder base. J. Urol., 116:174, 1976.

29. Lipshultz, L.I., Wein, A.J., Arger, P., and Murphy, J.J.: Post-transplantation lymphocyst: the use of

ultrasound as an adjunct in its diagnosis. Urology, 8:624, 1976.

30. Raezer, D.M., Greenberg, S., Jacobowitz, D.M., Benson, G.S., Corriere, J.N., Jr., and Wein, A.J.:

The innervation of the trigonal area of the urinary bladder. Urology, 7:369, 1976.

31. Shrom, S.H., Donaldson, M.H., Duckett, J.W., Jr., and Wein, A.J.: Formalin treatment for


23

intractable hemorrhagic cystitis. Cancer, 38:1785, 1976.

32. Wein, A.J., Benson, G.S., Raezer, D.M., and Mulholland, S.G.: Oral methylene blue and dissolution of renal calculi. J. Urol, 116:140, 1976.

33. Wein, A.J., Raezer, D.M., and Benson, G.S.: Management of neurogenic bladder dysfunction in

the adult: a review. Urology, 87:432, 1976.

34. Benson, G.S., Sarshik, S.A., Raezer, D.M., and Wein, A.J.: Comparative effects and mechanisms of action of atropine, propantheline, flavoxate, and imipramine on bladder muscle contractility. Urology, 9:31, 1977.

35. Carpiniello, V.L., Hanno, P.M., Malloy, T.R., and Wein, A.J.: Management of simple

ureterolithotomy closure: review of 89 cases. Urology, 103:10, 1977.

36. Greenberg, S.H., Lipshultz, L.I., and Wein, A.J.: Use of the Doppler stethoscope in the evaluation of varicoceles. J. Urol., 117:296, 1977.

37. Greenberg, S.H., Wein, A.J., Pertoff, L.J., and Barker, C.F.: Ureteropyelostomy and

ureteroneocystostomy in renal transplantation: Postoperative urological complications. J. Urol., 118:17, 1977.

38. Lipshultz, L.I., Greenberg, S.H., and Wein, A.J.: A systematic approach to the diagnosis and

treatment of the subfertile male. Proc. Kimbrough Urological Seminar, 10:102, 1977.

39. Lipshultz, L.I., Greenberg, S.H., Morganroth, J., and Wein, A.J.: The use of the Doppler stethoscope in the evaluation of varicoceles. In, Techniques of Human Andrology, E.S.E. Hafez, ed. New York, North Holland Publishing Co., 1977, pp. 450-453.

40. Raezer, D.M., Benson, C.S., Wein, A.J., and Duckett, J.W., Jr.: The functional approach to the

management of the pediatric neuropathic bladder: a clinical study. J. Urol. 117:649, 1977.

41. Wein, A.J., Arger, P.H., and Murphy, J.J.: Controversial aspects of blunt renal trauma. J.Trauma, 17:622, 1977.

42. Wein, A.J., and Benson, G.S.: The treatment of urethral condyloma acuminatum with 5-

fluorouracil cream. Urology, 9:413, 1977.

43. Wein, A.J., Benson, G.S., and Raezer, D.M.: A pharmacologic approach to the management of neurogenic bladder dysfunction. Proc. Kimbrough Urological Seminar, 10:22, 1977.

44. Wein, A.J., Carpiniello, V.L., Mulholland, S.G., and Murphy, J.J.: Partial nephrectomy: a review of

80 cases with special emphasis on its role in the management of localized renal stone disease. Urology, 10: 1 93, 1977.

45. Wein, A.J., Hanno, P.M., and Benson, G.S.: The variability of carbon dioxide cystometry. Surg.

Forum, 28:557, 1977.

46. Wein, A.J., and Leberman, P.R.: Prostatitis. In, Current Diagnosis, H.F. Conn, ed., 5th edition. Philadelphia, W.B. Saunders Co., 1977, pp. 874-875.

47. Wein, A.J., Leoni, J.V., Sansone, T.C., Mulholland, S.G., and Bogash, M.: Two-stage


24

urethroplasty for urethral stricture disease. J. Urol., 118-392, 1977.

48. Wein, A.J., Murphy, J.J., Mulholland, S.G., Chait, A.W., and Arger, P.H.: A conservative approach to the management of blunt renal trauma. J. Urol., 117:425, 1977.

49. Wein, A.J., and Shrom, S.G.: The use of intravesical formalin in the treatment of exsanguinating

bladder hemorrhage. - Proc. K imbrough Urological Seminar, 10: 1 8, 1977.

50. Freiman, D.B., Ring, E.J., Oleaga, J.A., Carpiniello, V.L., and Wein, A.J.: Thin--needle biopsy in the diagnosis of ureteral obstruction with malignancy. Cancer, 42, 714, 1978.

51. Gefter, W.B., Arger, P.H., Mulhern, C.B., Pollack, H.M., and Wein, A.J.: Computed tomography of

circumcaval ureter. Am. J. Roentgenol., 131:1086, 1978.

52. Greenberg, S.H., Lipshultz, L.I., and Wein, A.J.: Experience with 425 subfertile male patients. J. Urol., 119:507, 1978.

53. Hanno, P.M., Fritz, R., Wein, A.J., and Mulholland, S.G.: Heparin as antibacterial in rabbit

bladder. Urology, 12:411, 1978.

54. Lipshultz, L.I., and Wein, A.J.: Septic shock. In, Urology in Practice, C.J. Devine, Jr., and J.F. Stecker, Jr., eds. Boston, Little Brown & Co., 1978, pp. 525-536.

55. Malloy, T.R., and Wein, A.J.: The etiology, diagnosis, and surgical treatment of erectile

impotence. J. Reprod. Med., 20:183, 1978.

56. Oleaga, J.A., Wein, A.J., Freiman, D.B., Husted, J.W., and Ring, E.J.: Renal venography: applications in a variety of pathological conditions. Urology, 12:609, 1978.

57. Wein, A.J.: Neurogenic obstruction at the level of the urethral smooth musculature. In,

Bibliography in Urology, American Urological Association, 1978.

58. Wein, A.J., Carpiniello, V.L., and Murphy, J.J.: A simple technique for partial nephrectomy Surg. Gynec. Obstet., 146:620, 1978

59. Wein, A.J., Hanno, P.M., Dixon, D.O., Raezer, D., and Benson, G.S.: The reproducibility and

interpretation of carbon dioxide cystometry. J. Urol., 120:205, 1978. 60. Wein, A.J., Hanno, P.M., Raezer, D.M., and Benson, G.S.: Effect of oxybutynin (Ditropan) on

bladder spasm after transurethral surgery. Urology, 12:184, 1978.

61. Wein, A.J., and Malloy, T.R.: Urodynamics, controversies, limitations, applications. Proc.

Kimbrough Urological Seminar, 11:50, 1978.

62. Wein, A.J. , Hanno, P.M. , Dixon, D.O. , Raezer, D.M. , Benson, G.S. : The effect of oral bethanechol chloride on the cystometrogram of the normal male adult. J. Urol. 120:330, 1978.

63. Arger, P.H., Mulhern, C.B., Pollack, H.M., Banner, M.P., and Wein, A.J.: Ultrasonic assessment

of renal transitional cell carcinoma: preliminary report. Am. J. Roentgenol., 132:407, 1979.


25

64. Greenberg, S.H., Lipshultz, L.I., and Wein, A.J.: A preliminary report on "subclinical varicocele": diagnosis by Doppler ultrasonic stethoscope examination and initial results of therapy. J. Reprod. Med., 22:77, 1979.

65. Greenberg, S.H., Ring, E.J., Oleaga, J., and Wein, A.J.: Gonadal venography for preoperative

localization of nonpalpable testes in adults. Urology, 13:453, 1979.

66. Hanno, P.M., Wein, A.J., Shofer, F.S., Fritz, R., and Mulholland, S.G.: Urinary tract infection in men: antimicrobial sensitivities of 6,749 bacterial isolates. Proc. Kimbrough Urological Seminar, 12:90, 1979.

67. Katz, M.E., Grosbach, A.B., Wein, A.J., and Glick, J.H.: Testicular germ cell tumors: diagnosis,

management and the potential for cure. Clin. Cancer Trials, 1:274, 1979.

68. Levin, R.M. and Wein, A.J.: Distribution and function of adrenergic receptors in the urinary bladder of the rabbit. Molec. Pharmacol., 16:441, 1979.

69. Levin, R.M. and Wein, A.J.: Quantitative analysis of alpha- and beta-adrenergic receptor densities

in the lower urinary tract of dog and rabbit. Invest. Urol., 17:75, 1979.

70. Malloy, T.R., Wein, A.J., and Carpiniello, V.L.: Further experience with the inflatable penile prosthesis. J. Urol., 122:478, 1979.

71. Pahira, J.J., Wein, A.J., Barker, C.F., Banner, M.P., Arger, P.H., Mulhern, C., and Pollack, H.M.:

Bilateral complete ureteral obstruction secondary to abdominal aortic aneurysm with perianeurysmal fibrosis: diagnosis by computed tomography. J. Urol., 121:103, 1979.

72. Shrom, S.H., Lief, H.I., and Wein, A.J.: A clinical profile of experience with 130 "impotent" men.

Urology, 13:511, 1979.

73. Wein, A.J.: Diagnosis and evaluation of neurogenic bladder dysfunction. Weekly Urology Update, 2(4):1-8, 1979.

74. Wein, A.J.: Medical treatment of neurogenic bladder dysfunction. Weekly Urology Update, 1(4):1-

8, 1979. 75. Wein, A.J.: Pharmacologic approaches to the management of neurogenic bladder dysfunction. J.

Cont. Educ. Urol., 18:17, 1979.

76. Wein, A.J., Benson, G.S., and Jacobowitz, D.M.: Lack of evidence for adrenergic innervation of

the external urethral sphincter. J. Urol., 121:324-326, 1979.

77. Wein, A.J., Hanno, P.M., Carpiniello, V.L., Mulholland, S.G., and Murphy, J.J.: Enterocystoplasy to augment bladder capacity. Proc. Kimbrough Urological Seminar, 12:35, 1979.

78. Wein, A.J., and Levin, R.M.: Adrenergic receptor density in the human urinary bladder as

compared to that of the dog and the rabbit. Surg. Forum, 30:576, 1979.

79. Wein, A.J., Malloy, T.R., Hanno, P.M., and Raezer, D.M.: The reproducibility and significance of carbon dioxide urethral profilometry. J. Urol., 122:651, 1979.

80. Wein, A.J., and Raezer, D.M.: Physiology of micturition. In, Clinical Neurourology R.J. Krane and


26

M.B. Siroky, eds. Boston, Little, Brown & Co., 1979, pp. 1-33.

81. Wein, A.J., Ring, E.A., Carpiniello, V.L., Oleaga, J.A., Freiman, D.B., Banner, M.P., and Pollack, H.M.: Applications of thin-needle biopsy in urology. J. Urol., 121:626, 1979.

82. Wein, A.J., Levin, R.M.: Comparison of adrenergic receptor density in the urinary bladder in man,

dog, and rabbit. Surg. Forum 30:576, 1979.

83. Englestein, M.E., Carpiniello, V.L., Malloy, T.R., and Wein, A.J.: Urological tumors presenting as neurosurgical masses. Urology, 16:55, 1980.

84. Glick, J.H., Wein, A.J., Padavic, K., Negendank, W., Harris, D., and Brodovsky, H.: Tamoxifen in

refractory metastatic carcinoma of the prostate. Cancer Treat. Rep., 64:813, 1980.

85. Glick, J.H., Wein, A.J., Torri, S., Alavi, J., Harris, D., and Brodovsky, H.: Phase 11 study of tamoxifen in patients with advanced renal cell carcinoma. Cancer Treat. Rep., 64:343, 1980.

86. Greenberg, S.H., Wein, A.J., and Levin, R.M.: Sperm motility analysis: comparison of routine

visual techniques with turbidimetric measurement. Surg. Forum, 31,567, 1980.

87. Grossman, I.C., Carpiniello, V.L., Malloy, T.R., Greenberg, S.H., and Wein, A.J.: Staging pelvic lymphadenectomy for carcinoma of the prostate. J. Urol., 124:632, 1980.

88. Hanno, P.M., Shofer, F., Fritz, R., Mulholland, S.G., and Wein, A.J.: Antimicrobial sensitivities in

urinary tract infections in men. Urol. Nephrol., 12:283, 1980.

89. Levin, R.M., Shofer, F.S., and Wein, A.J.: Cholinergic, adrenergic and purinergic response of sequential strips of rabbit urinary bladder. J. Pharmacol. Exp. Ther., 21 2:536-541, 1980.

90. Levin, R.M., Shofer, F.S., and Wein, A.J.: Estrogen-induced alterations in the autonomic

responses of the rabbit urinary bladder. J. Pharm. Exp. Ther., 215:614, 1980.

91. Levin, R.M., and Wein, A.J.: Adrenergic alpha receptors outnumber beta receptors in human penile corpus cavernosum. Invest. Urol., 18:225, 1980.

92. Malloy, T.R., and Wein, A.J.: Penectomy and groin dissection for carcinoma of the penis. Clin.

Androl., 2:215, 1980.

93. Malloy, T.R., and Wein, A.J.: Peyronie's disease. Weekly Urol. Update, 33(2):2, 1980.

94. Malloy, T.R., and Wein, A.J.: Surgery for sex reversal. In, Urology, L. Karafin and Kendall, ads. Hagerstown, MD., Harper and Row, 1980, pp. 1-14.

95. Malloy, T.R., Wein, A.J., and Carpiniello, V.L.: Comparison of the inflatable penile prosthesis with

the Small-Carrion prosthesis in the surgical treatment of erectile impotence. J. Urol., 123:678, 1980.

96. Malloy, T.R., Wein, A.J., and Carpiniello, V.L.: Transpubic urethroplasty for prostatomembranous

urethral disruption. J. Urol. 124:359, 1980.

97. Raezer, D.M., Wein, A.J., and Duckett, J.W., Jr.: A clinical experience with the Scott Genitourinary Sphincter in the management of urinary incontinenece in the pediatric age group. J. Urol., 123:546, 1980.


27

98. Rosen, R.M., McLean, G.K., Freiman, D.B., Oleaga, J.A., Wein, A.J., and Ring, E.J.: Obstructed

ureteroileal conduits: antegrade catheter drainage. Am. J. Roentgenol., 135:1201, 1980.

99. Wein, A.J.: Drug therapy of neurogenic and non-neurogenic bladder dysfunction. Current Urologic Therapy. J.J. Kaufman, ed. Philadelphia, W. B. Saunders Co., pp. 248-255.

100. Wein, A.J.: Pharmacology of the bladder and urethra. In, Surgery of Female Incontinence,

Stanton and E.A. Tanagho, eds. Berlin and New York, Springer-Verlag, 1980, pp. 185-199.

101. Wein, A.J., Greenberg, S.H., and Levin, R.M.: Quantitative assays of alpha and beta adrenergic receptor density in human penile corpus cavernosum. Surg. Forum, 31:577, 1980.

102. Wein, A.J., and Leberman, P.R.: Prostatitis. In, Current Diagnosis H.F. Conn and R.B. Conn, Jr.,

eds. Philadelphia, W. B. Saunders, 1980, pp. 826-827.

103. Wein, A.J., and Malloy, T.R.: Simple omental mobilization for genitourinary surgery. Urology, 16:515, 1980.

104. Wein, A.J., Malloy, T.R., Carpiniello, V.L., and Murphy, J.J.: Vesicovaginal fistula repair by a

suprapubic transvesical approach. Surg. Gynec. Obstet. 150:57, 1980.

105. Wein, A.J., Malloy, T.R., Greenberg, S.H., Carpiniello, V.L., and Murphy, J.J.: Omental transposition as an aid in genitourinary reconstructive procedures. J. Trauma, 20:473, 1980.

106. Wein, A.J., Malloy, T.R., Shofer, F.S., and Raezer, D.M.: The effects of bethanechol chloride on

urodynamic parameters in normal women and in women with significant residual urine volumes. J. Urol., 124:397-399, 1980.

107. Wein, A.J., Raezer, D.M., and Malloy, T.R.: Failure of the bethanechol supersensitivity test to predict improved voiding after subcutaneous bethanechol administration. J. Urol., 123:202, 1980.

108. Arger, P.H., Mulhern, C.B., Coleman, B.G., Pollack, H.M., Wein, A.J., Koss, J., Arenson, R.J.,

and Banner, M.: Prospective analysis of the value of scrotal ultrasound. Radiology, 141:763, 1981.

109. Barrett, D.M., and Wein, A.J.: Flow evaluation and simultaneous external sphincter

electromyography in clinical urodynamics. J. Urol., 125:538, 1981.

110. Greenberg, S.H., Freiman, D.B., Ring, E.J., Oleaga, J.A., and Wein, A.J.: Antegrade ureteral catheterization prior to complicated ureteral surgery. Urol. Radiol., 2:99, 1981.

111. Greenberg, S.H., Ring, E.J., Pollack, H.M., and Wein, A.J.: The falsely positive gonadal

venogram: presence of a pampiniform plexus without a gonad. J. Urol., 125:887, 1981.

112. Grossman, I.C., Cromie, W.J., Wein, A.J., and Duckett, J.W.: Renal hypertension secondary to ureteropelvic junction obstruction: an unusual presentation and new therapeutic modality. Urology, 17:69, 1981.

113. Guerriero, W., Peters, P., Wein, A., and Cass, A.: Genitourinary Trauma. Home Study Course, American Urological Association, Inc., 1981.

114. Hanno, P.M., Fritz, R.W., Mulholland, S. G., and Wein, A.J.: Heparin: an examination of the

antibacterial properties. Urology, 18:273, 1981.


28

115. Hanno, P.M., Fritz, R., Wein, A.J., and Mulholland, S.G.: The effect of pre-existing bacteriuria on

bladder resistance to superinfection in the rabbit. Urol. Res., 9:99, 1981.

116. Hanno, P.M., and Wein, A.J.: Management of septic shock. AUA Update Series, American Urological Association, Inc., 1(3):3-8, 1981.

117. Harshman, M.W., Cromie, W.J., Wein, A.J., and Duckett, J.W., Jr.: Urethral stricture disease in

children. J. Urol., 126:650, 1981.

118. Hennessy, W.T., Pollack, H.M., Banner, M.P., and Wein, A.J.: Radiologic evaluation of anuric patient: systematized approach. Urology, 18:435, 1981.

119. Jacobs, J.A., Ring, E.J., and Wein, A.J.: New indications for renal infarction. J. Urol., 125:243,

1981.

120. Koss, J.C., Arger, P.H., Coleman, G.B., Mulhern, C.B., Pollack, H.M., and Wein, A.J.: CT staging of bladder carcinoma. Am. J. Roent., 137:359, 1981.

121. Levin, R.M., Amsterdam, J.D., Winokur, A., and Wein, A.J.: Effects of desmethylimipramine and

lithium on human sperm motility. Surg. Forum, 32:598, 1981.

122. Levin, R.M., Amsterdam, J.D., Winokur, A., and Wein, A.J.: Effects of psychotropic drugs on human sperm motility. Fertil. Steril., 36-503, 1981.

123. Levin, R.M., Greenberg, S.H., and Wein, A.J.: Clinical use of the turbidimetric analysis of sperm motility: comparison with visual techniques. Fertil. Steril., 35-332, 1981.

124. Levin. R.M., Greenberg, S.H., and Wein, A.J.: Quantitative analysis of the effects of caffeine on

sperm motility and cyclic AMP phosphodiesterase. Fertil. Steril., 36:798, 1981.

125. Levin, R.M., Jacobowitz, D., and Wein, A.J.: Autonomic innervation of the rabbit urinary bladder following estrogen administration. Urology, 17:449, 1981.

126. Levin, R.M., Jacoby, R., and Wein, A.J.: Effect of adenosine triphosphate on contractility and

adenosine triphosphatase activity of the rabbit urinary bladder. Mol. Pharmacol., 19:525, 1981.

127. Levin, R.M., Malkowicz, S.B., Jacobowitz, D., and Wein, A.J.: The ontogeny of the autonomic innervation and contractile response of the rabbit urinary bladder. Pharmacol. Exp. Ther., 219:250, 1981.

128. Levin, R.M., Shofer, J., Wein, A.J., and Greenberg, S.H.: ATP concentration of human

spermatozoa: lack of correlation with sperm motility. Andrologia, 13:468, 1981.

129. Levin, R.M., and Wein, A.J.: The effect of vasoactive intestinal peptide on the contractility of the rabbit urinary bladder. Urol. Res., 9:217, 1981.

130. Levine, M.S., Arger, P.H., Coleman, B.G., Mulhern, C.B., Pollack, H.M., and Wein, A.J.: Detecting

lymphatic metastases from prostatic carcinoma: superiority of CT. Am. J. Roent., 137:207, 1981.

131. Malloy, T.R., Wein, A.J., and Carpiniello, V.L.: Advanced Peyronie's disease treated with the inflatable penile prosthesis. J. Urol., 125:327, 1981.


29

132. Staskin, D.R., Parsons, K.F., Levin, R.M., and Wein, A.J.: Bladder transaction: a functional,

neurophysiological, neuropharmacological and neuroanatomical study. Br. J. Urol., 53:552, 1981.

133. Staskin, D.R., Parsons, K.F., Levin, R.M., and Wein, A.J.: A new technique for chronic catheterization of female dogs. Invest. Urol., 19:109, 1981.

134. Wein, A.J.: Classification of neurogenic voiding dysfunction: a review. J. Urol.,25:605, 1981.

135. Wein, A.J.: Female incontinence - clinical trials. In, Female Incontinence, N.R. Zinner and A.M.

Sterling, eds. New York, Alan Liss, Inc., 1981, pp. 39-44.

136. Wein, A.J.: Neuropharmacologic manipulation in the patient with neurogenic bladder dysfunction. Urol. Rounds, 2(l):18, 1981.

137. Wein, A.J.: Urinary incontinence management: drug therapy. Dialogues Pediat. Urol., 4(3), 1981.

138. Wein, A.J., Fishkin, R., Carpiniello, V.L., and Malloy, T.R.: Expansion without significant rigidity

during nocturnal penile tumescence testing: potential source of misinterpretation. J. Urol., 126:343, 1981.

139. Wein, A.J., Shrom, S.H., and Malloy, T.R.: Surgical management of male impotence: current status. In, Sexual Problems in Medical Practice, H.I. Lief, ed. Monroe, Wisconsin, American Medical Association, 1981, pp. 354, 359.

140. Wein, A.J., Staskin, D.R., and Levin, R.M.: Contractile and metabolic responses of the rabbit

urinary bladder to acute overdistention. Surg. Forum, 32:628, 1981.

141. Blaivas, J.G., Awad, S.A., Bissada, N., Khanna, O.P., Krane, R.J., Wein, A.J., and Yalla, S.: Urodynamic procedures: recommendations of the Urodynamics Society. Procedures that should be available for routine urologic practice. Neurourol.Urodyn., 1:51, 1982.

142. Glick, J.H., Wein, A.J., Pdadvic, K., Negendank, W., Harris, D., and Brodovsky, H.:Phase 11 trial

of tamoxifen in metastatic carcinoma of the prostate. Cancer, 49:1367, 1982.

143. Grossman, I., Pollack, H.M., Banner, M.P., and Wein, A.J.: Endoscopic removal of intrarenal foreign body using Dormia Stone Basket. Urology, 20:458, 1982.

144. Harshman, M.W., Pollack, H.M., Banner, M.P., and Wein, A.J.: Conservative management of

ureteral obstruction secondary to suture entrapment. J. Urol., 127:121, 1982.

145. Levin, R.M., Einstein, R., and Wein, A.J.-. Phosphodiesterase activity of the lower urinary tract. J. Urol., 128:615, 1982.

146. Levin, R.M., High, J.J., and Wein, A.J.: Metabolic and contractile effects of anoxia on rabbit

urinary bladder. J. Urol., 128:194, 1982.

147. Levin, R.M., Staskin, D.R., and Wein, A.J.: The muscarinic cholinergic binding kinetics of the human urinary bladder. Neurourol. Urodyn., 1:221, 1982.

148. Levin, R.M., and Wein, A.J.: Response of the in-vitro whole bladder (rabbit) preparation to

autonomic agonists. J. Urol., 128:1087, 1982.


30

149. Malloy, T.R., Wein, A.J., and Carpiniello, V.L.: Improved mechanical survival with revised model inflatable penile prosthesis using rear top extenders. J. Urol., 128:489, 1982.

150. Malloy, T.R., Wein, A.J., and Carpiniello, V.F.: Surgical results with artificial urinary sphincter.

Urology, 19:602, 1982.

151. Wein, A.J.: Pharmacologic management of lower urinary tract storage failure. In, Pharmacology of the Urinary Tract and Male Reproductive System, A. Finkbeiner, Barbour, and N. Bissada, eds. New York, Appleton Century-Crofts, 1982, pp.

152. Levin, R.M., Wein, A.J.: Direct measurement of the anticholinergic activity of a series of

pharmacological compounds on the rabbit and canine urinary bladder. Urol., 128:395, 1982.

153. Levin, R.M., Jacoby, R., Wein, A.J.: Radioligand binding of 3 H-ATP to membranes derived from rabbit urinary bladder: A preliminary report. Neurourol. Urodyn. 1:227-232, 1982.

154. Wein, A.J., and Barrett, D.M.: Etiologic possibilities for increased pelvic floor electromyographic activity during cystometry. J. Urol., 127:949-952, 1982.

155. Banner, M.P., Pollack, H.M., Ring, E.J., and Wein, A.J.: Catheter dilatation of benign ureteral

strictures. Radiology, 147:427, 1983.

156. Becker, J.M., Arger, P.M., Wein, A.J., and Kendall, A.R.: Inclusion cyst of the tunica albuginea: demonstration by ultrasound. Urol. Radiol., 5:123, 1983.

157. Hanno, P.M., and Wein, A.J.: Anesthetic techniques for cystoscopy in men. J. Urol., 130:1105,

1983.

158. Levin, R.M., Brendler, K., and Wein, A.J.: Comparative pharmacological response of in-vitro whole bladder preparation (rabbit) with response of isolated smooth muscle strips. J. Urol., 130:377, 1983.

159. Levin, R.M., Brendler, K., Van Arsdalen, K.N., and Wein, A.J.: Functional response of the rabbit

urinary bladder to anoxia and ischemia. Neurourol. Urodyn., 2:233, 1983.

160. Levin, R.M., Jacoby, R., and Wein, A.J.: High affinity divalent ion specific binding of 3H-ATP to homogenate derived from rabbit urinary bladder. Mol. Pharmacol., 23:1, 1983.

161. Levin, R.M., Staskin, D.R., and Wein, A.J.: Analysis of the anticholinergic and musculotropic

effects of desmethylimipramine on the rabbit urinary bladder. Urol., Res., 11:259, 1983.

162. Levin, R.M., Staskin, D.R., and Wein, A.J.: The effects of acute overdistention of the rabbit urinary bladder. Neurourol. Urodyn., 2:63, 1983.

163. Malloy, T.R., and Wein, A.J.: Inflatable penile prosthesis. In, Biomaterials in Reconstructive

Surgery, L. R. Rubin, ed. St. Louis, C. V. Mosby Co., 1983, pp. 929-935.

164. Malloy, T.R., and Wein, A.J.: Penile flaccidity due to vascular insufficiency. Med. Asp. Hum. Sexual., 17:211, 1983.

165. Malloy, T.R., Wein, A.J., and Carpiniello, V.L.: Revised surgical technique to improve survival of

penile cylinders for inflatable penile prostheses. J. Urol., 130:1105, 1983.


31

166. Malloy, T.R., Wein, A.J., and Gross, P.: Scrotal and penile lymphedema: surgical considerations

and management. J. Urol., 130:263, 1983.

167. Malloy, T.R., Weiss, J., and Wein, A.J.: Congenital urologic disorders: unsuspected sources of sexual discomfort. Med. Asp. Hum. Sexual., January:32, 1983

168. Murphy, J.J., and Wein, A. J.: Evaluation of genitourinary function. In, The Spinal Cord, G.

Austin, ed. New York, lgaku-Shoin Co., 1983, pp. 667-676.

169. Murphy, J.J., and Wein, A.J.: Neuroanatomy and neurophysiology of the genitourinary system. In, The Spinal Cord, G. Austin, ed. New York, Igaku-Shoin Co., 1983, pp. 664-666.

170. Murphy, J.J., and Wein, A.J.: Urologic management. In, The Spinal Cord, G. Austin, ed. New York, Igaku-Shoin Co., 1983, pp. 677-696.

171. Nesi, M.H., Malloy, T.R., Carpiniello, V.L., and Wein, A.J.: A comparison of morbidity following

transrectal and transperineal prostatic needle biopsy. Surg. Gynec. Obstet., 156:464, 1983.

172. Schultz, R.E., Hanno, P.M., Wein, A.J., Levin, R.M., Pollack, H.M., and Van Arsdalen, Percutaneous ultrasonic lithotripsy: choice of irrigant. J. Urol., 130:858, 1983.

173. Van Arsdalen, K.N., Levin, R.M., and Wein, A.J.: Cholinergic receptor and functional muscular

changes in the canine urinary bladder after spinal cord injury. Surg. Forum, 34:660, 1983.

174. Van Arsdalen, K.N., Malloy, T.R., and Wein, A.J.: Erectile physiology, dysfunction, and evaluation. I. Physiology of erection. Monographs in Urology, 4:137, 1983.

175. Van Arsdalen, K.N., Malloy, T.R., and Wein, A.J.: Erectile physiology, dysfunction, and

evaluation. II. Etiology and evaluation of erectile dysfunction. Monographs in Urology, 4:165, 1983.

176. Van Arsdalen, K.N., Wein, A.J.: A critical review of diagnostic tests used in the evaluation of the

impotent male. World J. Urol., 1:218, 1983.

177. Van Arsdalen, K.N., Wein, A.J., and Levin, R.M.: Contractile and metabolic effects of acute ischemia on rabbit urinary bladder. J. Urol., 130:180, 1983.

178. Wein, A.J.: Nonsurgical treatment of lower urinary tract dysfunction. In, Female Urology, S. Raz,

ed. Philadelphia, W.B. Saunders, 1983, pp. 161-188.

179. Wein, A.J.: Principles for evaluation of pharmacologic agents. In, Benign Prostatic Hypertrophy, F. Hinman, Jr., ed. New York and Berlin, Springer-Verlag, 1983, pp. 414-418.

180. Wein, A.J., Van Arsdalen, K.N., and Levin, R.M.: Adrenergic corporal receptors. In, Male Sexual

Dysfunction, R.J. Krane, M.B. Siroky, and I. Goldstein, eds. Boston, Little Brown & Co., 1983, pp. 33-36.

181. Wein, A.J., Van Arsdalen, K.N., and Malloy, T.R.: Nocturnal penile tumescence. In, Male Sexual

Dysfunction, R.J. Krane, M.B. Siroky, and I. Goldstein, eds. Boston, Little Brown & Co., 1983, pp. 203-212.

182. Weinerman, P.M., Arger, P.H., Coleman, B.G., Pollack, H.M., Banner, M.P., and Wein, A.J.:


32

Pelvic adenopathy from bladder and prostate carcinoma: detection by rapid sequence computed tomography. Am. J. Roent., 140:95, 1983.

183. Weiss, J., Wein, A.J., Jacobs, J., and Hanno, P.M.: Use of nitrofurantoin crystals after

transurethral prostatectomy. J. Urol., 130:479, 1983.

184. Hanno, P.M., and Wein, A.J.: Urologic trauma. Emer. Med. Cl. N. Am., 2:283, 1984.

185. Levin, R.M., Goldman, M., and Wein, A.J.: Effect of isoproterenol and EGTA on the volume-pressure relationship of the in-vitro whole bladder preparation. Neurourol. Urodyn., 3:133, 1984.

186. Levin, R.M., High, J., and Wein, A.J.: The effect of short-term obstruction on urinary bladder function in the rabbit. J. Urol., 132:789, 1984.

187. Levin, R.M., High, J., and Wein, A.J.: Evidence against the presence of spare muscarinic

receptors in the rabbit urinary bladder. Neurourol. Urodyn., 2:317, 1984.

188. Levin, R.M., Malkowicz, S.B., and Wein, A.J.: Laboratory models for neuropharmacologic studies. World J. Urol., 2:222, 1984.

189. Levin, R.M., and Wein, A.J.: Comparative effects of five tricyclic compounds on the rabbit urinary

bladder. Neurourol. Urodyn., 3:127, 1984.

190. Malloy, T.R., and Wein, A.J.: Laser technology in urology. AUA Update Series, Vol. 3, Lesson 27. American Urological Association, Inc., 1984, pp. 3-7.

191. Malloy, T.R., and Wein, A.J.: Urologic neodymium:Yag laser surgery. Surg. Cl. Am., 64:905,

1984.

192. Spera, J.A., Pollack, H.M., Banner, M.P., Brennan, R.E., and Wein, A.J.: Metastatic melanoma mimicking renal cell carcinoma. J. Urol., 131:740,

193. Stephenson, T.P., and Wein, A.J.: The interpretation of urodynamics. In, Urodynamics:

Principles, Practice and Application. A.R. Mundy, T.P. Stephenson, and A.J. Wein, eds. New York and London, Churchill Livingstone, 1984, pp. 93-115.

194. Van Arsdalen, K.N., Pollack, H.M., and Wein, A.J.: Ureteral stenting. Seminars in Urology, 2:180,

1984.

195. Van Arsdalen, K.N., and Wein, A.J.: Drug-induced sexual dysfunction in older men. Geriatrics, 39:63, 1984.

196. \Van Arsdalen, K.N., and Wein, A.J.: Drug Treatment of Voiding Dysfunction. Home Study

Course, American Urological Association, 1984.

197. Levin, R.M., Hypolite, J.A., Wein, A.J.: Clinical use of the turbidimetric analysis of sperm motility: an Update. Andrology, 16:434, 1984.

198. Van Arsdalen, K.N., and Wein, A.J.: Drugs and sexual dysfunction. AUA Update Series, Volume

3, Lesson 34. American Urological Association, 1984, pp. 1-8.

199. Van Arsdalen, K.N., Wein, A.J., Hanno, P.M., and Malloy, T.R.: Erectile failure following pelvic trauma: a review of pathophysiology, evaluation, and management, with particular reference to


33

the penile prosthesis. J. Trauma, 24:579, 1984.

200. Wein, A.J.: Applied pharmacology. In, Clinical Gynecologic Urology, S. L. Stanton, ed. St. Louis, C.V. Mosby Co., 1984, pp. 441-461.

201. Wein, A.J.: Classification of voiding dysfunction: a simple approach. In, Controversies in Neuro-Urology. D.M. Barrett and A.J. Wein, eds. New York and London, Churchill Livingstone, 1984, pp. 239-250.

202. Wein, A.J.: Pharmacologic and surgical management of unstable bladder: pharmacologic management. Dialog. Pediat. Urol., 7(9):1, 1984.

203. Wein, A.J.: Pharmacological treatment of non-neurogenic voiding dysfunction. In, The

Pharmacology of the Urinary Tract, M. Caine, ed. Berlin and New York, Springer-Verlag, 1984, pp. 100-134.

204. Wein, A.J.: Pharmacology of the bladder and urethra. In, Urodynamics: Principles, Practice and

Application. A.R. Mundy, T.P. Stephenson, and A.J. Wein, eds. New York and London, Churchill Livingstone, 1984, pp. 26-41.

205. Wein, A.J.: The pitfalls of urodynamics. In, Urodynamics: Principles, Practice and Application,

A.R. Mundy, T.P. Stephenson, and A.J. Wein, eds. New York and London, Churchill Livingstone, 1984, pp. 150-153.

206. Wein, A.J., Malloy, T.R., Lief, H.T., Hanno, P.M., and Van Arsdalen, K.N.: Evaluation of the

impotent man: University of Pennsylvania approach. In, Controversies in Neuro-Urology, D.M. Barrett and A.J. Wein, eds. New York and London, Churchill Livingstone, 1984, pp. 481-488.

207. Wein, A.J., Van Arsdalen, K.N., and Malloy, T.R.: Evaluation and treatment of impotence: the

urologist's viewpoint. In, Sexual Arousal: New Concepts in Basic Sciences, Diagnosis and Treatment, M. Ficher, R.E. Fishkin, and J.A. Jacobs, eds. Springfield, Il, Charles Thomas, Co., 1984, pp. 101-115.

208. Toolin, E. , Pollack, H.M. , McLean, G.K. , Banner, M.P. , Wein, A.J.: Ureteroarterial fistula: a

case report. J Urol. 132:553, 1984.

209. Wein, A.J., Van Arsdalen, K.N., and Reilly, N.: Treatment of voiding dysfunction in spinal cord injured patients. In, Controversies in Neuro-Urology, D.M. Barrett and A.J. Wein, eds. New York and London, Churchill Livingstone, 1984, pp. 453-470.

210. Weiss, J.P., Wein, A.J., and Hanno, P.M.: Sigmoidocystoplasty to augment bladder capacity.

Surg. Gynec. Obstet., 159-377, 1984.

211. Malkowicz, S.B., Brendler, K., Wein, A.J., Levin, R.M.: The effect of diltiazem on in-vitro rabbit bladder function. Pharmacology, 31:24, 1985.

212. Carpiniello, V.L., Malloy, T.R., and Wein, A.J.: Stenting techniques. Urology, 15:74, 1985.

213. Carpiniello, V.L., Malloy, T.R., and Wein, A.J.: Toward bloodless nephrotomy during Gil-Vernet

pyelolithotomy. Urology, 25:187, 1985.

214. Levin, R.M., Malkowicz, S.B., and Wein, A.J.: Recovery from short-term obstruction of rabbit urinary bladder. J. Urol., 134:388, 1985.


34

215. Levin, R.M., Van Arsdalen, K.N., , Thomas, T., and Wein, A.J.: Effect of dinitrophenol on bladder metabolism and contraction. Neurourol. Urodyn., 4:61, 1985.

216. Malkowicz, S.B., Atta, M.A., Elbadawi, A., Wein, A.J., and Levin, R.M.: Effect of parasympathetic decentralization on feline urinary bladder. J. Urol., 133:521, 1985.

217. Malkowicz, S.B. and Wein, A.J.: The pharmacologic treatment of voiding dysfunction. Sieber and

McIntyre, Inc., 1985, pp. 2-9.

218. Malkowicz, S.B., Wein, A.J., and Levin, R.M.: Calcium antagonist affinity for adrenergic and cholinergic receptors in rabbit urinary bladder. Neurourol. Urodyn., 4:143, 1985

219. Schlecker, B.A., Siegel, A., Weiss, J., and Wein, A.J.: Epidermoid cyst of the testis: a surgical

approach for testicular preservation. J. Urol., 1 33:610, 1985.

220. Siegel, A.L., Muller, J.L., Wein, A.J., and Hanno, P.M.: Technique which eliminates need for assistant during prostatic needle biopsies. Urology, 25:404, 1985.

221. Staskin, D., Malloy, T.R., Carpiniello, V.L., Schwartz, I., and Wein, A.J.: Urological complications

secondary to contraceptive diaphragm. J. Urol., 134:142, 1985.

222. Wein, A.J.: Pharmacological treatment of lower urinary tract dysfunction. Cl. Obstet. Gynec., 12(2):379, 1985.

223. Wein, A.J.: Pharmacologic treatment of lower urinary tract dysfunction in the female patient. Urol.

Cl. N. Am., 12(2):259, 1985.

224. Orland, S.M. , Hanno, P.M. , Wein, A.J.: Prostatitis, prostatosis and prostatodynia. Urology 25:439, 1985.

225. Schultz, R.E. , Varello, M.A. , Tsou K.C. , Wein, A.J. , Murphy, J.J.: Simultaneous flow

cystometric deoxyribonucleic acid and acid phosphatase analysis of benigh and malignant lesions of the prostate. J. Urol. 134:1133, 1985.

226. Wein, A.J., and Van Arsdalen, K.N.: Lower urinary tract: pharmacology. In, Textbook of

Genitourinary Surgery. H.N. Whitfield and W. F. Hendry, eds. London and New York, Churchill Livingstone, 1985, pp. 361-369.

227. Wein, A.J. and Van Arsdalen, K.N.: Non-surgical management of neuropathic voiding

dysfunction. Seminars in Urology, 3:216-237, 1985.

228. Wein, A.J. and Van Arsdalen, K.N.: Upper urinary tract: pharmacology.In, Textbook in Genitourinary Surgery, H. N. Whitfield and W. F. Hendry, eds. London and New York, Churchill Livingstone, 1985, pp. 286-289.

229. Weiss, J.P., Schlecker, B. A., Wein, A.J., Hanno, P.M.: Preservation of periprostatic autonomic

nerves during total perineal prostatectomy by intrafascial dissection. Urology, 26:160, 1985.

230. Levin, R.M., Clayton, R., Strong, G., Brenman, H., and Wein, A.J.: Rectal electro-stimulation of erection in Macaca fascicularis primates. Neurourol. and Urodyn., 4:239, 1985.


35

231. Van Arsdalen, K.N., and Wein, A.J.: Sexuality in the elderly. In, Geriatric Nephrology and Urology, E.T. Zawada, Jr., and D. A. Sica, eds. PSG Publishing Co., Littleton, Mass., 1985, pp. 513-532.

232. Wein, A.J.: Drug therapy for detrusor hyperactivity: where are we? Neurourol. and Urodyn.,

4:337, 1985.

233. Malloy, T.R., and Wein, A.J.: Surgery for Sexual Reversal in Urology, Karafin, L., and Kendall, R. (eds.), Harper and Row, Philadelphia, Volume 2, Chapter 23B, pp. 15-16, 1985.

234. Van Arsdalen, K. N., Wein, A. J.: Bladder diverticula in adults. In: Resnick, M.I., Caldamone,

A.A., Spirnak, J.P. (eds) Decision Making in Urology, B.C. Decker, Inc., Toronto, Philadelphia, 1985, pp. 152-154.

235. Van Arsdalen, K.N., Wein, A.J.: Stress urinary incontinence. In: Resnick, M.I., Caldamone, A.A.,

Spirnak, J.P. (eds) Decision Making in Urology. B. C. Decker, Inc., Toronto, Philadelphia, 1985, pp. 156-158.

236. Wein, A.J., Van Arsdalen, K.N.: Neurogenic bladder. In: Resnick M.I., Caldamone, A.A., Spirnak,

J.P. (eds) Decision Making in Urology, B. C. Decker, Inc., Toronto, Philadelphia, 1985, pp. 160-162.

237. Malloy, T.R., Wein, A.J.: Surgery of the penis. In: Campbell's Urology, P.C. Walsh, R.F. Gittes,

A.D. Perlmutter, T.A. Stamey (eds) W. B. Saunders Co., Philadelphia and London, 1986, pp. 2888-2914.

238. Wein, A.J.: Drug therapy for neurogenic and non-neurogenic voiding dysfunction. In Current

Urologic Therapy, J.J. Kaufman, ed., W. B. Saunders Co., Philadelphia and London, 1986, pp. 265-271.

239. Hanno, P.M., and Wein, A.J.: Female urethra diverticula, AUA Update, Lesson 3, Volume 5,

American Urological Association Office of Education, 1986, pp. 1-8.

240. Malloy, T.R., Schultz, R.E., Wein, A.J., Carpiniello, V.L.: Renal preservation utilizing neodymium:YAG laser. Urology, 27:99, 1986.

241. Levin, R.M., Ruggieri, M.R., Wein, A.J.: Functional effects of the purinergic innervation of the

rabbit urinary bladder. J. Pharmacol. Exptl. Therapy. 236:452, 1986.

242. Tomaszewski, J.E., Korat, O.C., LiVolsi, V.A., Connor, M., Wein, A.J.: Paget's disease of the

urethral meatus following transitional cell carcinoma of the bladder. J. Urol., 135:368, 1986.

243. Wein, A.J.: Pharmacology of the bladder and urethra. In, Stanton, S.L. and Tanagho, (eds). Surgery of Female Incontinence (2nd edition), Springer-Verlag, Berlin and New York, 1986, pp. 229-250.

244. Orland, S.M., Schlecker, B.A., Wein, A.J.: Benign diseases of the testicle and paratesticular tissues. AUA Update Series, American Urological Association, Inc., Lesson 24, Volume 1986, pp. 1-8.

245. Levin, R.M., Ruggieri, M.R., Hypolite, J., Wein, A.J.: Beta adrenergic stimulation of cyclic AMP


36

production in the rabbit urinary bladder. Neurourol. and Urodyn., 1986.

246. Malloy, T.R., and Wein, A.J.: Lasers in urology. Home Study Course, American Urological Association, Inc., 1986.

247. Siegel, A.L., Tomaszewski, J.E., Wein, A.J., Hanno, P.M.: lnvasive carcinoma of the prostate

presenting as rectal cancer. Urology, 27:162, 1986.

248. Levin, R.M., Memberg, W., Ruggieri, M.R., Wein, A.J.: Functional effects of in-vitro obstruction on rabbit urinary bladder. J. Urol., 135:847, 1986.

249. Hanno, P.M., and Wein, A.J.: Practical Guide to the Use of Antibiotics in Urology. Ken Payne and

Company, Greenwich, CT, 1986.

250. Van Arsdalen, K.N., and Wein, A.J.: Micturition and bladder dysfunction. In, Asbury, A.K., Mclchann, G.N., McDonald, W.I. (eds), Diseases of the Nervous System, W.B. Saunders Co., Philadelphia and William Heinemann Ltd., London, 1986, pp. 618-625.

251. Levin, R.M., Ruggieri, M.R., Hypolite, J., and Wein, A.J.: Beta adrenergic stimulation of cyclic

AMP production in the rabbit urinary bladder. Neurourol. and Urodyn., 5:227, 1986.

252. Levin, R.M., and Wein, A.J.: Experimental models of urinary bladder outlet obstruction. Neurourol. and Urodyn., 5:241, 1986.

253. Levin, R.M., Ruggieri, M.R., Velagapudi, S., Gordon, D., Altman, B. and Wein, A.J.: Relevance of

spontaneous activity to urinary bladder function: in-vitro and in-vivo study. J. Urol., 136:517, 1986.

254. Wein, A.J., Van Arsdalen, K.N., Hanno, P.M., and Levin, R.M.: Physiology of male sexual

function. In, RA.J.fer, J. (ed.), Urologic Endocrinology, W. B. Saunders Co., Philadelphia, PA, 1986, pp. 249-273.

255. Van Arsdalen, K.N., Malloy, T.R., and Wein, A.J.: Male sexual dysfunction. In, Rajfer, J. (ed.),

Urologic Endocrinology, W. B. Saunders Co., Philadelphia, PA, 1986, pp. 274-289.

256. Malloy, T.R., Van Arsdalen, K.N., and Wein, A.J.: Transsexualism. In, Rajfer, J. (ed.), Urologic Endocrinology, W. B. Saunders Co., Philadelphia, PA, 1986, pp. 357-361.

257. Levin, R.M., Latimore, J., Wein, A.J., Van Arsdalen, K.N.: Correlation of sperm count with

frequency of ejaculation. Fertil. Steril. 45:732, 1986.

258. Schwartz, I., Wein, A.J., Malloy, T.R., Glick, J.H.: Prostatic cancer after prostatectomy for benign disease. Cancer 58:994, 1986.

259. Levin, R.M., Wein, A.J.: Spontaneous activity and urinary bladder function. Surg. Forum 37:645,

1986.

260. Carpiniello, V., Sedlacek, T., Cunnane, M., Schlecker, B., Malloy, T., Wein, A.: Magnified penile surface scanning in diagnoses of penile condyloma. Urology 28:190, 1986.

261. Wein, A.J.: Classification of voiding dysfunction. American Urological Association Update Series,

Volume 6, Number 4, 1987, pp. 1-8.


37

262. Wein, A.J.: Physiology of micturition. Clinics Geriatric Med. 2(4):689, 1986.

263. Levin, R.M., Strong, G., Brenman, H., Hayes, L., Memberg, W., O'Brien, C.P., Ternes, J., Wein, A.J.: Effect of opiate dependence on erectile function in primates. Neurourol and Urodyn. 5:397, 1986.

264. Malkowicz, S.B., Wein, A.J., Elbadawi, A., Van Arsdalen, K., Ruggieri, M.R., Levin,: Acute

biochemical and functional alteration in partially obstructed rabbit urinary bladder. J. Urol. 136:1324, 1986.

265. Orland, S.M., Stewart, A.F., LiVolsi, V.A., Wein, A.J.: Detection of hypercalcemic hormone of

malignancy in adrenal cortical carcinoma. J. Urol. 136:1000, 1986.

266. Malloy, T.R., Wein, A.J., Carpiniello, V.L.: Reliability of AMS M700 inflatable penile prosthesis. Urology 28:385, 1986.

267. Wein, A.J.: Pharmacology of the bladder and urethra. In: Surgery of Female Incontinence,

Stanton, S.L. and Tanagho, E.A. (eds), Springer Verlag, Berlin and New York, 1986.

268. Wein, A.J., Hanno, P.M.: Carcinoma of the genitourinary tract. In: Hanno, P.M., Wein, A.J. (eds) A Clinical Manual of Urology. Appleton-Century-Crofts, Norwalk, CT, 1987, pp. 281-352.

269. Wein, A.J., Hanno, P.M.: Voiding function and dysfunction. In: Hanno, P.M., Wein, A.J. (eds) A

Clinical Manual of Urology, Appleton-Century-Crofts, Norwalk, CT, 1987, pp. 383-410.

270. Hanno, P.M., Wein, A.J.: Male sexual dysfunction. In: Hanno, P.M., Wein, A.J. (eds) A Clinical Manual of Urology. Appleton-Century-Crofts, Norwalk, CT, 1987, pp. 411-432.

271. Hanno, P.M., Wein, A.J.: Interstitial Cystitis (Parts 1 and 2), American Urological Association

Update Series, Lessons 9 and 10, Volume 6, Houston, TX, 1987.

272. Malloy, T.R., Wein, A.J.: Laser treatment of bladder carcinoma and genital condylomata. Urol. Clin. N. A. 14 (1):121, 1987.

273. Hanno, P.M., Wein, A.J.: Medical treatment of interstitial cystitis (other than RIMSO-5O/Elmiron).

Urology, Supplement on Interstitial Cystitis, 29:22-26,1987.

274. Levin, R.M., Haugaard, N., Ruggieri, M.R., Wein, A.J.: Biochemical characterization of the rabbit urinary bladder base and body. Neurourol. and Urodyn. 6:57, 1987.

275. Haugaard, N., Wein, A.J., Levin, R.M.: In vitro studies of glucose metabolism of rabbit urinary

bladder. J. Urol. 137:782, 1987.

276. Wein, A.J.: Lower urinary tract function and pharmacologic management of lower urinary tract dysfunction. Urol. Cl. N.A. 14 (2):273-296, 1987.

277. Torosian, M.H., Wein, A.J.: Liposarcoma of the spermatic cord: case report and review of the

literature. J. Surg. Onc., 34:179-181, 1987.

278. Goldwasser, B., Barrett, D.M., Wein, A.J.: Surgery of neuropathic bladder, Libertino, J.A. led), Pediatric and Adult Reconstructive Urologic Surgery (2nd edition), Williams and Wilkins, Baltimore and London, 1987, pp. 419-443.


38

279. Levin, R.M., Ruggieri, M.R., Hypolite, J.A., Malkowicz, S.B., Wein, A.J.: Surface spectrofluorometry of the rabbit urinary bladder. Neurourol. and Urodyn. 6:109, 1987.

280. Wein, A.J.: Vesicovaginal Fistula. Resnick, M.I., Kursh, E. (eds). Current Therapy in

Genitourinary Surgery. B. C. Decker, Inc., Toronto and Philadelphia, 1987, pp. 209-212.

281. Phillips, M.E., Kressel, H.Y., Spritzer, C.E., Arger, P.H., Wein, A.J., Axel, L., Gefter, W.B., Pollack, H.M.: Normal prostate and adjacent structures: MR Imaging at 1.5T. Radiology, 164:381, 1987.

282. Phillips, M.E., Kressel, H.Y., Spritzer, C.E., Arger, P.H., Wein, A.J., Marinelli, D., Axel, L., Gefter,

W.B., Pollack, H.M.: Prostatic disorders: imaging at 1.5T. Radiology 164:386, 1987.

283. Levin, R.M., Wein, A.J., Lee W., Ruggieri, M.R.: Effect of chronic atropine administration on muscarinic receptor density in the rat. Surg. Forum 39:659, 1987.

284. Ruggieri, M.R., Bode, D.C., Levin, R.M., Wein, A.J.: Muscarinic receptor subtypes in human and

rabbit bladder. Neurourol. and Urodynamics 6:119, 1987.

285. Levin, R.M., Ruggieri, M.R., Wein, A.J.: Receptor subtypes in the rabbit and human urinary bladder. Surg. Forum 38:654, 1987.

286. Wein, A.J., Malloy, T.R., Hanno, P.M.: Intracavernosal injection programs: their place in the

management of erectile dysfunction. Problems in Urology, 1(3), 496, 1987.

287. Malkowicz, S.B., Wein, A.J., Ruggieri, M.R., Levin, R.M.: Comparison of calcium antagonist properties of antispasmodic agents. J. Urol. 138:667, 1987.

288. Levin, R.M., Ruggieri, M.R., Gill, H.S., Haugaard, N., Wein, A.J.: Studies on the biphasic nature

of urinary bladder contraction and function. Neurourol. and Urodyn. 6:339, 1987.

289. Batra, A.K., Wein, A.J., Ruggieri, M.R., Levin, R.M.: Comparative response of smooth muscle strips of bladder and bowel to various pharmacological agents. Neurourol. and Urodyn. 6:351, 1987.

290. Wein, A.J., Levin, R.M., Barrett, D.M.: Voiding function: relevant anatomy, physiology,

pharmacology. In: Gillenwater, J.Y., Grayhack, J.T., Howards, S.S., Duckett, J.W. (eds) Adult and Pediatric Urology. Year Book Medical Publishers, Chicago, London, Boca Raton, 1987;pp. 800-862.

291. Barrett, D.M., Wein, A.J.: Voiding dysfunction: diagnosis, classification and management. In: Gillenwater, J.Y., Grayhack, J.T., Howards, S.S., Duckett, J.W. (eds) Adult and Pediatric Urology. Year Book Medical Publishers, Chicago, London and Boca Raton, 1987, pp. 863-962.

292. Ruzich, J.V., Gill, H.S., Wein, A.J., Van Arsdalen, K.N., Hypolite, J., Levin, R.M.: Objective assessment of the effect of caffeine on sperm motility and velocity. Fertility Sterility 48:891, 1987.

293. Hanno, P.M., Wein, A.J.: Interstitial cystitis. J Urol. 138:595, 1987.

294. Gillenwater, J.Y. , Wein, A.J.: Summary of National Institute of Arthritris, Diabetes, Digestive and

Kidney Diseases Workshop on Interstitial Cystitis. National Institutes of Health, Bethesda, MD, August 28-29, 1987. J. Urol. 140:203, 1988.

295. Wein, A.J., Van Arsdalen, K.N.: Drug induced male sexual dysfunction. Urol. Clin. North Am.,

15(1), 1988, 23-32.


39

296. Spera, J.A., Whittington, R., Littman, P., Solin, L.J., Wein, A.J.: A comparison of preoperative

radiotherapy regimens for bladder carcinoma. The University of Pennsylvania experience. Cancer 61:255, 1988.

297. Levin, R.M., Ruggieri, M.R., Lavkar, R.M., Hanno, P.M., Wein, A.J.: Effect of chronic

nitrofurantoin on rabbit urinary bladder. J. Urol. 139:400, 1988.

298. Chun, A.L., Wallace, L.J., McGeraid, M.D., Levin, R.M., Wein, A.J.: Effect of age on in-vivo urinary bladder function in the rat. J. Urol. 139:625, 1988.

299. Levin, R.M., Ruggieri, M.R., Gill, H.S., Haugaard, N., Wein, A.J.: Effect of bethanechol on

glycolysis and high energy phosphate metabolism of rabbit urinary bladder. J. Urol. 139:646, 1988.

300. Levin, R.M., Malkowicz, S.B., Wein, A.J.: Basic research models and methods in neuromuscular

studies of the lower urinary tract. In: Yalla, S.V., McGuire, E.J., Elbadawi, A., Blaivas, J.G. (eds). Neurourology and Urodynamics: Principles and Practice, Macmillan Co., New York, 1988, pp. 122-147.

301. Wein, A.J.: Clinical neuropharmacology of the lower urinary tract. In: Yalla, S.V., McGuire, E.J.,

Elbadawi, A., Blaivas, J.G. (eds). Neurourology and Urodynamics: Principles and Practice, Macmillan Co., New York, 1988, pp. 377-399.

302. Wein, A.J.: Drug treatment of voiding dysfunction Part I (Evaluation of drugs; treatment of

emptying failure) and Part 2 (Drug treatment of storage failure). American Urological Association Update Series, Lesson 14, Volume 7, pp. 106-119, Houston, Texas (AUA Office of Education), 1988.

303. Batra, A.K., Wein, A.J., Ruggieri, M.R., Gill, H.S., Levin, R.M.: Effect of ileocystoplasty on

contractile response of the bladder ileum and cystoplastic ileal segment. Neurourology and Urodynamics 6:363, 1988.

304. Levin, R.M., Ruggeri, M.R., Barasha, B., Kraman, D., Wein, A.J.: Comparison of the in vitro isolated

strip methodology with the superfused technique. Neurourology and Urodynamics 6:381,1988.

305. Hanno, P.M., Lopez, R., Wein, A.J.: Trazodone induced priapism. Brit. J. Urol. 61:94, 1988.

306. Strauss, K.L., Littman, P., Wein, A.J., Whittington, R., Tomaszewski, J.E.: Treatment of bladder cancer with interstitial iridium-1 92 implantation and external beam irradiation. lnt. J. Radiation Oncology Biol. Phys. 14:265, 1988.

307. Wein, A.J.: Voiding dysfunction: neurogenic or non-neurogenic? American Urological Association Update Series, Lesson 23, Volume 7, pp. 178-183, Houston, TX (AUA Office of Education), 1988.

308. Lin, A.T., Wein, A.J., Gill, H.S., Levin, R.M.: Functional effect of chronic ischemia on the rabbit

urinary bladder. Neurourology and Urodynamics 7:1, 1988.

309. Wein, A.J.: Receptor function and drug action in the lower urinary tract. Sem. Neurol. 8:121, 1988.

310. Wein, A.J.: Evaluation of complex neurogenic and anatomic conditions affecting bladder function.

In: McCullough, D.L. (ed.), Difficult Diagnoses in Urology, Churchill Livingstone, New York and London, 1988, pp. 179-206.


40

311. Kato, K., Wein, A.J., Kitada, S., Haugaard, N., Levin, R.M.: The functional effect of mild outlet

obstruction on the rabbit urinary bladder. J. Urol. 140:880, 1988.

312. Shapiro, M.J., Banner, M.P., Amendola, M.A., Gordon, R.L., Pollack, H.M., Wein A.J: Balloon catheter dilation of ureteroenteric strictures: long term results. Radiology 168:385, 1988.

313. Zderic, S. A., Carpiniello, V.L., Malloy, T.R., Wein, A.J.: The diagnosis and management of

genital infections with the human papilloma virus. American Urological Association Update Series, Lesson 34, Volume 7, pp. 266-271, AUA Office of Education, Houston, TX, 1988.

314. Bezzi, M., Kressel, H.Y., Allen, K.S., Schiebler, M.L., Altman, H.G., Wein, A.J., Pollack, H.M.:

Prostatic carcinoma: staging with MR imaging at 1.5T. Radiology 169:339, 1988.

315. Grover, R., Wein, A.J., Ruggieri, M.R., Levin, R.M.: Functional effects of imipramine in the rabbit urinary bladder: an in vitro study. Pharmacology 37:148, 1988.

316. Zderic, S.A., Carpiniello, V.L., Malloy, T.R., Wein, A.J., Rando, R.F.: Human papilloma virus

typing using DNA probes for the diagnosis of genital condyloma. Surg. Forum 39:671, 1988.

317. Levin, R.M., Ruggieri, M.R., Wein, A.J.: Identification of receptor subtypes in rabbit and human bladder by selective radioligand binding. J. Urol 139:844, 1988.

318. Levin, R.M., Ruggieri, M.R., Lee, W., Wein, A.J.: Effect of chronic atropine administration on rat

urinary bladder. J. Urol. 139:1347, 1988.

319. Gill, H.S., Monson, F.C., Wein, A.J., Ruggieri, M.R., Levin, R.L.: Effect of short term in vivo ischemia on contractile function of rabbit urinary bladder. J. Urol. 1 39:1 350, 1988.

320. Kato, K., Wein, A.J., Kitada, S., Haugaard, N., Levin, R.M.: Functional effect of mild bladder outlet

obstruction on rabbit urinary bladder. J. Urol. 140:880, 1988. 321. Monson, F.C., Goldschmidt, M.H., Zderic, S.A., Ruggieri, M.R., Levin, R.M., Wein, A.J.: Use of a

previously undescribed elastic lamina of the serosa to characterize connective tissue hypertrophy of the bladder wall following partial outlet obstruction. Neurourology and Urodynamics 7:385, 1988.

322. Ruzich, J.V., Wein, A.J., Keating, M.A., Ruggieri, M.R., Levin, R.L.: Effect of urinary bladder outlet obstruction on the rabbit ureter. Neurourology and Urodynamics 7:483, 1988.

323. Malloy, T.R., Wein, A.J., Carpiniello, V.L.: Carcinoma of penis treated with neodymium YAG

laser. Urology 31:26, 1.988.

324. Schoenberg, M., Kelly, A., Siegel, A., Hanno, P., Wein, A.J., The Kelly scrotal bridge. Urology 31:521, 1988.

325. Levin, R.M., Chun, A.L., Kitada, S., Garber, B.B., Wein, A.J.: Effect of contractile activity on

muscarinic receptor density and the response to muscarinic agonists. J. Pharmacol. Exptl. Therap., 247(2):624-629, August 8, 1988.

326. Levin, R.M., Kitada, S., Wein, A.J.: Effect of uninhibited bladder contraction on muscarinic

receptor density and response to muscarinic stimulation. Surg. Forum, 1988.

327. Chun, A.L., Wallace, L.J., Gerald, M.C., Wein, A.J., Levin, R.M.: Effects of age on urinary bladder


41

function in male rat. J. Urol. 141:170, 1989.

328. Kitada, S., Wein, A.J., Kato, K., Levin, R.M.: Effects of acute complete obstruction on rabbit urinary bladder. J. Urol. 141:166, 1989.

329. Wein, A.J., English, W.S., Whitmore, K.E.: Office urodynamics. Urol. Clin. North America

15(4):609-624, 1988.

330. Hanno, P.M., Wein, A.J.: Trauma to the genitourinary tract. In, Conn's Current Therapy, Rakel, R.E. (ed.), W.B. Saunders Co., Philadelphia and London, 1989, pp. 616-621.

331. Wein, A.J.: The case against the use of urodynamic testing in the clinical setting. In,

Controversies in Urology. Carlton, C.E. Jr. (ed.), Yearbook Medical Publishers, Chicago, London, Boca Raton, 1989, pp. 159-163.

332. Chun, A.L., Ruzich, J.V., Wein, A.J., Levin, R.M.: Functional and pharmacologic effects of

ureteral diversion. J. Urol. 141:403, 1989.

333. Levin, R.M., Moore, D., Ruggieri, M.R., Haugaard, N., Wein, A.J.: Biochemical characterization of the rabbit urinary bladder II. Intracellular concentration of nucleotides. Neurourology and Urodynamics 8:63, 1989.

334. Chun, A.L., Wallace, L.J., Gerald, M.D., Wein, A.J., Levin, R.M.: Functional whole rat bladder

model. Neurourology and Urodynamics 8:73, 1989.

335. Elbadawi, A., Meyer, S., Malkowicz, S.B., Wein, A.J., Levin, R.M., Atta, M.: Effects of short term partial bladder outlet obstruction on the rabbit detrusor: an ultrastructural study. Neurourology and Urodynamics 8:89, 1989.

336. Meyer, S., Atta, M., Wein, A.J., Levin, R.M., Elbadawi, A: Morphometric analyses of muscle cell changes in the short term partially obstructed rabbit detrusor. Neurourology and Urodynamics 8:117, 1989.

337. Meyer, S., Levin, R.M., Ruggierl, M., Wein, A.J., Elbadawi, A.: Quantitative analysis of

intracelfular changes in the short term partially obstructed rabbit detrusor. Neurourology and Urodynamics 8:133, 1989.

338. Lin, A., Kato, K., Monson, F., Wein, A.J., Levin, R.M.: Pharmacological responses of rabbit

urinary bladder after subtotal cystectomy. J. Urol. 142:409, 1989.

339. Wein, A.J., Malkowicz, S.B. (ed): Cancer of the Prostate: Current Practice/Future Directions, Parts 1-4. Co-Med Communications, Philadelphia, PA, 1989.

340. Malkowicz, S.B., Wein, A.J.: Epidemiology and natural history of prostate cancer. In, Wein, A.J.,

Malkowicz, S.B. (eds), Cancer of the Prostate: Current Practice/Future Directions, Co-Med Communications, Philadelphia, PA, 1989, Part 1, pp. 4-11.

341. Kitada, S., Kato, K., Wein, A.J., Levin, R.M.: Experimental models of reflex contractile activity in

the rabbit bladder. Neurourology and Urodynamics 8:255, 1989.

342. Freedman, A.K., Wein, A.J., Whitmore, K.E., Levin, R.M.: In vitro effects of intravesical dimethylsuffoxide. Neurourology and Urodynamics 8:277, 1989.


42

343. Hanno, P.M., Buehler, J., Wein, A.J.: Use of amitryptyline in the treatment of interstitial cystitis. J. Urol. 141:846-848, 1989.

344. Malloy, T.R., Wein, A.J., Carpiniello, V.C.: Surgical success with AMS GU sphincter for male

incontinence. Urology 33:274, 1989.

345. Schiebler, M., Tomaszewski, J., Bezzi, M., Pollack, H., Kressel, H., Cohen, E., Altman, H., Geffen, W., Wein, A.J., Axel, L.: Prostatic carcinoma and benign prostatic hyperplasia: correlation of high resolution MR and histopathologic findings. Radiology 172:131, 1989.

346. Kato, K., Kitada, S., Chun, A., Wein, A.J., Levin, R.M.: In vitro intravesical instillation of

anticholinergic antispasmodic and calcium blocking agents (rabbit whole bladder model). J. Urol. 141:1471, 1989.

347. Pollack, H.M., Wein, A.J.: Imaging of renal trauma. Radiology 172:297, 1989.

348. Wein, A.J.: Voiding function and dysfunction: a coordinated overview. In, Barker, C., Daly, J.M.

(eds), Jonathan E. Rhoads Eightieth Birthday Symposium. Lippincott Co., Philadelphia, PA, 1989, pp. 411-417.

349. Sheline, M., Amendola, M., Pollack, H., Banner, M., Morenas, A., Wein, A.J.: Fluoroscopically guided retrograde brush biopsy in the diagnosis of transitional cell carcinoma of the upper urinary tract: results in 45 patients. Am. J. Roentgenol 153:313, 1989.

350. Gill, H.S., Wein, A.J., Ruggieri, M.R., Whitmore, K.E., Levin, R.M.: Functional and biochemical alterations in rabbit urinary bladder following ileocystoplasty. Urol. 142:860, 1989.

351. Garber, B.B., Wein, A.J.: Common urologic bleeding problems, Parts I and II, American

Urological Association Update Series, Lessons 33 and 34, pp. 258-271, Houston, Texas (AUA Office of Education), 1989.

352. Levin, R.M., Hypolite, J., Ruggieri, M.R., Longhurst, P.A., Wein, A.J.: Effects of muscarinic

stimulation on intracellular calcium in the rabbit bladder: comparison with metabolic response. Pharmacology 39:69-73, 1989.

353. Levin, R.M., Longhurst, P.A., Wein, A.J.: Correlation of intracellular free calcium with the

metabolic response of the rabbit urinary bladder to bethanechol. Surg. Forum XL:668, 1989.

354. Lin, A.T., Kato, K., Haugaard, N., Wein, A.J., Levin, R.M.: Effect of chronic ischemia in glucose metabolism of rabbit urinary bladder. J. Urol. 142:1127, 1989.

355. Chun, A.L., Gill, H.S., Wein, A.J., Levin, R.M.: Pharmacological comparison of the isolated whole

urethra model to urethral strip methodology. Pharmacology 39:192, 1989.

356. Lipman, P.A., Cavalieri, S., Wein, A.J., Miller, W.T.: Whole lung tomography in urologic malignancy. Urology 34:227, 1989.

357. Wein, A.J.: Urinary incontinence: classification and therapeutic guidelines. Seminars in Urology

7:59-65, 1989.

358. Hypolite, J.A., Haugaard, N., Wein, A.J., Ruggieri, M.R., Levin, R.M.: Comparison of palmitic and glucose metabolism in the rabbit urinary bladder. Neurourology Urodynamics 8:599, 1989.


43

359. Malloy, T.R., Wein, A.J.: Current status of penile prostheses. lnt. J. lmpot. Res. 3/4:153, 1989.

360. Wein, A.J.: Neuromuscular Disorders (Neurourology) (Associate Editor), in: Pollack, H.M. led.),

Clinical Urography W.B. Saunders Co., Philadelphia, London, 1990, pp. 1926-2075.

361. Wein, A.J.: Overview of voiding function and dysfunction: relevant anatomy, physiology, pharmacology, classification, definition. In: Pollack, H.M. (ed.), Clinical Urography W.B. Saunders Co., Philadelphia and London, 1990, 1926-1935.

362. Wein, A.J.: Overview. Needle vesicourethral suspension and periurethral polytetrafluoroethylene

(Polytef) injection. In: Whitehead, E.D. (ed.) Current Operative Urology, J.B. Lippincott Co., Philadelphia, 1990, pp. 67-72.

363. Levin, R.M., Longhurst, P.A., Monson, F.C., Kato, K., Wein, A.J.: Effect of bladder outlet

obstruction on the morphology, physiology and pharmacology of the bladder. The Prostate, suppl. 3:9, 1990. First published online July 20, 2006, The Prostate, DOI: 10.1002/pros.2990170503

364. Fantl, J.A., Wyman, J.F., Wilson, M., Elsenick, R.K., Bump, R.C., Wein, A.J.: Diuretics and urinary incontinence in community dwelling women. Neurourology Urodynamics 9:25, 1990.

365. Wein, A.J.: Pharmacology of the lower urinary tract. In: Scientific Foundations of Urology, Chisolm, G.O., Fair, W.R. (eds) Yearbook Medical Publishers, Chicago, 1990, pp. 299-308.

366. Hanno, P.M., Levin, R.M., Monson, F.C., Teuscher, C., Zhou, Z.Z., Ruggieri, M.R., Whitmore,

K.E., Wein, A.J.: Diagnosis of interstitial cystitis. J. Urol. 143:278, 1990.

367. Wein, A.J., Hanno, P.M., Gillenwater, J.Y.: Interstitial cystitis: an introduction to the problem. In: Hanno, P., Staskin, D., Krane, R.J., Wein, A.J. (eds.) Interstitial Cystitis, Springer Verlag, London, Berlin, New York, 1990, pp. 3-16.

368. Held, P.J., Hanno, P.M., Wein, A.J., Pauly, M.V., Cann, M.A.: Epidemiology of interstitial cystitis.

In: Hanno, P., Staskin, D., Krane, R.J., Wein, A.J. (eds.) Interstitial Cystitis, Springer Verlag, London, Berlin, New York, 1990, pp. 3-16.

369. Ruggieri, M.R., Monson, F.C., Levin, R.M., Wein, A.J., Hanno, P.M.: Interstitial cystitis: animal

models. In: Hanno, P., Staskin, D., Krane, R.J., Wein, A.J. (eds.) Interstitial Cystitis, Springer Verlag, London, Berlin, New York, 1990, pp. 49-62.

370. Hanno, P.M., Wein, A.J.: lntravesical therapy in interstitial cystitis. In: Hanno, P., Staskin, D.,

Krane, R.J., Wein, A.J. (eds.) Interstitial Cystitis Springer Verlag, London, Berlin, New York, 1990, pp. 147-152.

371. Chun, A., Wein, A.J., Gill, H.S., Levin, R.M.: Response of the whole bladder-urethra model

(rabbit) to autonomic drugs. Neurourology Urodynamics 9:165, 1990.

372. Longhurst, P., Wein, A.J., Levin, R.M.: In vivo bladder function in rats following prolonged diabetic and non-diabetic drugs. Neurourology Urodynamics 9:171, 1990.

373. Longhurst, P.A., Kang, J., Wein, A.J., Levin, R.M.: Length tension relationship of urinary bladder

strips from streptozotocin - diabetic rats. Pharmacology 40:1 10, 1990.

374. Kato, K., Wein, A.J., Radzinski, C., Longhurst, P., McGuire, E.J., Miller, L.F., Elbadawi, A., Levin,


44

R.M.: Short term functional effects of bladder outlet obstruction in the cat. J. Urol. 143:1020, 1990.

375. Chun, A.L., Wein, A.J., Harkaway, R., Levin, R.M.: Comparison of urinary bladder function in

sexually mature and immature male and female rats. J. Urol. 143:1267, 1990.

376. Levin, R.M., Wein, A.J., Whitmore, K., Monson, F.C., McKenna, B.A., Ruggieri, M.: Trypan blue as an indicator of urothelial integrity. Neurourology Urodynamics 9:269, 1990.

377. Malloy, T.R., Wein, A.J.: Complications of lasers in urology. In: Marshall, F.F. (ed.). Urologic

Complications. Mosby-Yearbook Co., St. Louis, Baltimore, Boston, 1990, pp. 411- 419.

378. Levin, R.M., Longhurst, P.A., Levin, S.S., Haugaard, N., Wein, A.J.: Creatine kinase activity of urinary bladder and skeletal muscle from control and streptozotocin-diabetic rats. Mol All Biochem 97:153, 1990.

379. Wein, A.J.: Pharmacologic therapy for incontinence. Urology (suppl 4):36, October 1990.

380. Barrett, D.M., Wein, A.J., Parulkar, B.G.: Surgery for neuropathic bladder. AUA Update Series, Lesson 38, Volume 9, pp. 298-303, American Urological Association, Inc., Houston, TX, 1990.

381. Keating, M.A., Duckett, J.W., Snyder, H.M., Wein, A.J., Potter, L., Levin, R.M.: Ontogeny of

bladder function in the rabbit. J. Urol 144:766, 1990.

382. Kato, K., Kitada, S., Longhurst, P.A., Wein, A.J., Levin, R.M.: Time-course alteration of bladder function following acetone-induced cystitis. J Urol 144:1272, 1990.

383. Zderic, S.A., Duckett, J.W., Wein, A.J., Snyder, H.M., Levin, R.M.: Developmental factors in the

contractile response of the rabbit bladder to both autonomic and nonautonomic elements. Pharmacology 41:119, 1990.

384. Zderic, S.A., Plzak, J.E., Duckett, J.W., Snyder, H.M., Wein, A.J., Levin, R.M.: Effect of

pregnancy on rabbit urinary bladder physiology: effects of extracellular calcium. Pharmacology 41:124, 1990.

385. Wein, A.J.: Evaluation of treatment response to drugs in benign prostatic hyperplasia. Urologic

Clinics North America 17(3):631, 1990.

386. Wein, A.J., Elkins, T.E.: Urinary fistulas: the diagnostic evaluation and repair of the vesico-vaginal fistula. Illustrated Medicine (Female Urology Series), volume number 2, 1990, pp. 2-16.

387. Zderic, S.A., Duckett, J.W., Snyder, H.M., Wein, A.J., Levin, R.M.: Ontogeny of bladder

compliance. Neurourology and Urodynamics, 9:595, 1990.

388. Kato, K., Wein, A.J., Longhurst, P.A., Haugaard, N., Levin, R.M.: The functional effects of long-term outlet obstruction on the rabbit urinary bladder. J. Urol. 143: 600, 1990.

389. Levin, R.M., Longhurst, P.A., Kato, K., McGuire, E.J., Elbadawi, A., Wein, A.J.: Comparative

physiology and pharmacology of the cat and rabbit urinary bladder.Urol. 143:848, 1990.

390. Longhurst, P.A., Kang, J., Wein, A.J., Levin, R.M.: Comparative length-tension relationship of urinary bladder strips from hamsters, rats, guinea pigs, rabbits, and cats. Comp. Biochem. Physiol. 96A:221, 1990.


45

391. Staskin, D.R., Wein, A.J., Andersson, K.E.: Urinary incontinence: classification and pharmacologic therapy. Ciba Foundation Symposium 151 (Neurobiology of lncontinence), 1990, pp. 289-306.

392. Levin, R.M., Zderic, S.A., Van Arsdalen, K.N., Duckett, J.W., Wein, A.J.: Developmental factors in

the contractile response to bethanechol: the role of calcium translocation. Surg Forum XLL:703, 1990.

393. Levin, R.M., Longhurst, P.A., Wein, A.J.: Neuropharmacologic investigations of the lower urinary

tract. World J Urol 8:180, 1990.

394. Hanno, P., Ruggieri, M., Wein, A.: Current status of interstitial cystitis. World J Urol, 8:212, 1990.

395. Wein, A.J.: Pharmacologic treatment of incontinence. J.Am. Geriatric Soc. 38:317, 1990.

396. Kato, K. , Lin, A.T. , Haugaad, N. , Longhurst, P. , Wein, A.J. , Levin, R.M.: Effects of outlet obstruction on glucose metabolism of the rabbit urinary bladder. J. Urol. 143:1020, 1990.

397. Longhurst, P.A., Kang, J., Wein, A.J., Levin, R.M.: The influence of intravesical volume upon

contractile responses of the whole bladder preparation from streptozocin diabetic rats. J. Gen. Pharmacol. 21:687, 1990.

398. Wein, A.J., Van Arsdalen, K.N.: Stress urinary incontinence. In: Resnick, M.I., Caldamone, A.A.,

Spirnak, J.P. (eds), Decision Making in Urology. Decker Publishing Co., Philadelphia and Hamilton, pp. 174-176, 1991,

399. Wein, A.J., Van Arsdalen, K.N.: Neurogenic bladder. In: Resnick, M.I., Caldamone, A.A.,

Spirnak, J.P. (eds), Decision Making in Urology. Decker Publishing Co., Philadelphia and Hamilton, 1991, pp. 178-180.

400. Van Arsdalen, K.N., Wein, A.J.: Bladder diverticula in adults. In: Resnick, M.I., Caldamone, A.A.,

Spirnak, J.P. (eds), Decision Making in Urology. Decker Publishing Co., Philadelphia and Hamilton, pp. 170-172, 1991.

401. Wein, A.J.: Evaluation of treatment response in benign prostatic hyperplasia. AUA Update

Series, Lesson 9, Volume 10, American Urological Association, Inc., Houston, TX, 1991, pp. 66-71.

402. Van Arsdalen, K.N., Wein, A.J.: Physiology of micturition and continence. In, Krane, R.J., Siroky,

M.B. (eds), Clinical Neuro-Urology, Little Brown Co., Boston and London, 1991, pp. 25-82.

403. Wein, A.J., Van Arsdalen, K.N., Levin, R.M.: Pharmacologic therapy. In Krane, R.J., Siroky, M.B. (eds), Clinical Neuro-Urology, Little Brown Co., Boston and London, 1991, 523-558.

404. Longhurst, P.A., Wein, A.J., Levin, R.M.: In vitro models of bladder contraction and function.

Neurourology and Urodynamics, 10:97, 1991.

405. Wein, A.J.: Practical uropharmacology. Urol Clinics of North America 18(2):269, 1991.

406. Levin, R.M., Ruggieri, M., Kato, K., Lin, A., Wein, A.J.: Correlation of in vitro pressure with urinary bladder function. Neurourology and Urodynamics 10:185, 1991.


46

407. Wein, A.J., Levin, R.M., Barrett, D.M.: Voiding function: relevant anatomy, physiology and pharmacology. In: Gillenwater, J.Y., Grayhack, J.T., Howards, S.S., Duckett, J.W. (eds) Adult and Pediatric Urology, Mosby-Year Book Publishers, St. Louis, Baltimore, Boston, Chicago, 1991, pp. 933-1000.

408. Barrett, D.M., Wein, A.J.: Voiding dysfunction: diagnosis, classification, and management. In:

Gillenwater, J.Y., Grayhack, J.T., Howards, S.S., Duckett, J.W. (eds) Adult and Pediatric Urolony. Mosby-Year Book Publishers, St. Louis, Baltimore, Boston, Chicago, 1991, pp. 1001-1 100.

409. Levin, R.M., Hypolite, J., Longhurst, P., Wein, A.J.: Comparison of the contractile and metabolic

effects of muscarinic stimulation with those of KCI. Pharmacology 42:142, 1991.

410. Zhou, Z., Zheng, Y., Monson, F., Wein, A., Ruggieri, M., Levin, R., Hanno, P., McKenna, B., Teuscher, C.: Immunohistochemical analysis of the urinary bladder: a comparative study of the cellular immune response of patients diagnosed as having interstitial cystitis, non-interstitial cystitis voiding dysfunctions and normal controls. Seminars in Urology 9:115, 1991.

411. Hanno, P.M., Wein, A.J.: Conservative therapy of interstitial cystitis. Seminars in Urology 9:143,

1991.

412. Monson, F.C., Wein, A.J., McKenna, B., Whitmore, K.E., Levin, R.M.: Indigo carmine as a quantitative indicator of urothelial integrity. J Urol 145:842, 1991.

413. Radzinski, C., McGuire, E., Smith, D., Wein, A., Levin, R., Miller, L., Elbadawi, A: Creation of

feline model of obstructive uropathy. J Urol. 145:859, 1991.

414. Hypolite, J.A., Wein, A.J., Haugaard, N., Levin, R.M.: Role of substrates in the maintenance of contractility of the rabbit urinary bladder. Pharmacology 42:202, 1991.

415. Wein, A.J., Van Arsdalen, K., Hanno, P.M., Levin, R.M.: Anatomy of male sexual function. In:

Jonas, U., Thon, W.F., Stief, C.G. (eds). Erectile Dysfunction.Springer-Verlag, Berlin, Heidelberg, New York, 1991, pp. 3-16.

416. Kato, K., Kondo, A, Saito, M., Miyake, K., Wein, A.J., Levin, R.M.: In vitro intravesical instillation

of anticholinergic antispasmodic and calcium blocking agents to decrease bladder contractility. Urol. lnt. 1991; 47 (suppl 1):36.

417. Levin, R.M., Haugaard N., Levin, S., Wein, A.J.: Creatine kinase activity in normal and

hypertrophied urinary bladder tissue (following partial outlet obstruction). Molec Cellul Biochem 1991; 106:143.

418. Kim, Y.S., Longhurst, P.A., Wein, A.J., Levin, R.M.: Effects of sensitization on female guinea pig

urinary bladder function: in vivo and in vitro studies. J. Urol., 1991; 146:454.

419. Malloy, T.R., Carpiniello, V.L., Wein, A.J., Payne, C.P., Wuchinuch, D.: Bladder outlet obstruction treated with transurethral ultrasonic aspiration: one year follow up on 59 patients. Urology, 1991; 37:512.

420. Malkowicz, S.B., Kimmel, B., Wein, A.J., Herlyn, M.: The selection and phenotypic

characterization of invasive variants of transitional cell carcinoma. Surg. Forum 1991; 42:700.


47

421. Cendron, M., Deserable, D., Malkowicz, S.B., Wein, A.J.: Urology crash box. J Urol. 1991; 146:389

422. Sigal, S.H., Tomaszewski, J.E., Brooks, J., Wein, A.J., LiVolsi, V.A.: Carcinosarcoma of bladder following long term cyclophosphamide therapy. Arch Pathol Lab Med 115:1049, 1991.

423. Pierce, L.J., Whittington, R., Hanno, P.M., English, W., Wein, A.J., Goodman, R.L.:

Pharmacologic erection with intracavernosal injection for men with sexual dysfunction following irradiation: a preliminary report. lnt. J Radiation Oncology Biol. Phys., 21:1331, 1991

424. Zderic, S.A., Wein, A.J., Monson, F.C., Levin, R.M.: The effects of infravesical obstruction on the

bladder. Problems in Urology 1991; 5(3):357.

425. Zderic, S.A., Hypolite, J., Duckett, J.W., Snyder, H., Wein, A.J., Levin, R.M.: Developmental aspects of bladder contractile function: sensitivity to extracellular calcium. Pharmacology 1991; 43:61.

426. Levin, R.M., Zderic, S.A., Ewalt, D.H., Duckett, J.W., Wein, A.J.: Effects of pregnancy on

muscarinic receptor density and function in the rabbit urinary bladder. Pharmacology 1991; 43:69.

427. Levin, R.M., Kitada, S., Hayes, L., Kau, S.T., Fromm-Freeck, S., Howe, B.B., Wein, A.J.

Experimental hyperreflexia: effect of intravesical administration of various agents. Pharmacology 1991; 42:54.

428. Zhao, Y., Wein, A.J., Bilgen, A., Levin, R.: The effect of anoxia on in-vitro bladder function.

Pharmacology 1991; 43:337.

429. Cendron, M., Wein, A.J., Schwartz, S.S., Murtagh, F., LiVolsi, V.A., Tomaszewski, J: Germ cell tumor of testis in a patient with von Hippel-Lindau disease. Urology 1991; 37:69.

430. Braren V., Vaughan, E.D. Jr. , Mostofi, F.K. , Pennington, R.D. , Salvatierra, O. , Wein, A.J.:

Long range plan of the Natiional Kidney and Urologic Diseases Advisory Board. J. Urol. 145:567, 1991.

431. Schoenberg, M.P., Van Arsdalen, K.N., Wein, A.J.: The management of transitional cell

carcinoma in solitary renal units. J Urol, 1991, 146:700; discussion 702.

432. Kim, Y.S., Levin, R.M., Wein, A.J., Longhurst, P.A.: Effects of sensitization on the permeability of urothelium in guinea pig urinary bladder. J Urol 1992, 147:270.

433. Wein, A.J., Hanno, P.M.: Interstitial cystitis. In Resnick, M.I., Kursh, E.D. (eds). Current Therapy

in Genitourinary Surgery, B.C. Decker, Mosby Yearbook, St. Louis, 1992, pp. 379-381.

434. Tong, Y.C., Wein, A.J., Levin, R.M.: Effects of acid-base changes on rabbit urinary bladder contractility. Neurourol. Urodynamics 1992 11:41.

435. Haugaard, N., Potter, L., Wein, A., Levin, R.: Effect of partial obstruction of the rabbit urinary

bladder on malate dehydrogenase and citrate synthase activity. J Urol, 1992; 147:1391.

436. Kang, J., Wein, A.J., Levin, R.: Bladder functional recovery following acute overdistention. Neurourol and Urodynamics, 1992;1 1:253.


48

437. Wein, A.J.: Neuromuscular dysfunction of the lower urinary tract. In Walsh, P.C., Retik, A.B.,

Stamey, T.A., Vaughan, E.D. (eds.), Campbell's Urology (6th edition), W.B. Saunders Co., Philadelphia, London, 1992, pp. 573-642.

438. Wein, A.J., Barrett, D.M.: Physiology of micturition and urodynamics. In Kelalis, P.P., King, L.R.,

Belman, AB (eds), Clinical Pediatric Urology (3rd edition), W.B. Saunders Co., Philadelphia, London, 1992, pp. 187-207.

439. Wein, A.J.: Neurourology: Pathophysiology, classification of dysfunctions, and treatment

guidelines. Problems in Urology, 1992; 6:591.

440. Tammela, T., Wein, A.J., Levin, R.M.: Effect of tetrodotoxin on the phasic and tonic responses of isolated rabbit urinary bladder smooth muscle to field stimulation. Urol., 1992; 148:1937.

441. Bilgen, A., Wein, A.J., Haugaard, N., Packard, D., Levin, R.M.: Effect of outlet obstruction on

pyruvate metabolism of the rabbit urinary bladder. Molecular Cellular Biochem 1991; 117:159.

442. Batra, A.K., Wein, A.J., Hanno, P.M.: Interstitial cystitis. AUA Update Series, volume 8, lesson 8, pp. 56-71, 1992.

443. Turek, P., Malloy, T.R., Cendron, M., Carpiniello, V.L., Wein, A.J.: KTP-532 laser ablation of

urethral strictures. Urology, 1992; 40:330.

444. Monson, F.C., McKenna, B.A., Wein, A.J., Levin, R.M.: Effect of outlet obstruction on 3H-Thymidine uptake and metabolism: a radiographic and biochemical study. Urol., 148:158, 1992.

445. Bilgen, A., Wein, A.J., Zhao, Y., Levin, R.M.: The effects of anoxia on the biphasic response of

isolated strips of rabbit bladder to field stimulation, bethanechol, methoxamine, and KCI. Pharmacol. 44:283, 1992.

446. Levin, R.M., Hays, L., Eika, B., McGuire, E.J., Elbadawi, A., Wein, A.J.: Comparative autonomic

responses of the cat and rabbit urinary bladder and urethra. J. Urol., 148:216, 1992.

447. Levin, R.M., Hayes, L., Zhao, Y., Wein, A.J.: The effect of pinacidil on spontaneous and evoked contractile activity. Pharmacol. 45:1, 1992.

448. Levin, R.M., Haugaard, N., Packard, D., Kaplan, M., Wein, A.J.: Effect of ryanodine on

mitochondrial function. Pharmacol. 45:117, 1992.

449. Samadzadeh, S., Tong, Y-C., Wein, A.J., Levin, R.M.: The influence of the bathing medium on the contractile response of the rabbit urinary bladder. Pharmacol. 45:136, 1992.

450. Levin, R.M., Longhurst, P.A., Barasha, B., McGuire, E.J., Elbadawi, A., Wein, A.J.: Studies on

experimental bladder outlet obstruction in the cat: long-term functional effects. J. Urol., 148:939, 1992.

451. Levin, R.M., Haugaard, N., Wein, A.J.: Metabolic alterations induced by obstructive hypertrophy

of the rabbit urinary bladder. Jap. J. Pharmacol. 58 Supp. 11, p.341, 1992.

452. Tong, Y-C., Wein, A.J., Levin, R.M.: Effects of pregnancy on adrenergic function in the rabbit urinary bladder. Neurourol and Urodyn, 11:525, 1992.


49

453. Charles, R.S., Wein, A.J. , Wilczynski, S. , Tomaszewski, J.E. , Hanno, P.M.: Cystic renal cell and squamous cell carcinoma of single kidney with concurrent transitional cell carcinoma of ipsilateral ureter and urinary bladder. Urology 39:470, 1992.

454. Greven, K.M. , Spera, J.A. , Solin, L.J. , Whittington, R. , Wein, A.J. , Hanks, G.E.: Secondary

malignant neoplasms in patients with bladder carcinoma. Urology 39:204, 1992.

455. Levin, R.M., Hypolite, J., Longhurst, P., Wein, A.J.: Energeti/cs of muscarinic stimulation of smooth muscle. Third International Symposium on Excitation-Contraction Coupling in Skeletal, Cardiac, and Smooth Muscle, (G.B. Frank, ed.) Plenum Press, New York, pp. 323-324, 1992.

456. Wein, A.J.: Non-surgical management of bladder dysfunction. In, Webster, G., Kirby, R., King, L.,

Goldwasser, B., (eds): Reconstructive Urology, Blackwell Scientific Publications, Boston and Oxford, 1993, pp. 403-420.

457. Levin, R.M., Longhurst, P.A., Monson, F.C., Haugaard, N., Wein, A.J.: Experimental studies in

bladder outlet obstruction. In, Lepor, H., Lawson, R.K. (eds), Prostate Diseases. W.B. Saunders Co., Philadelphia, London, Toronto, 1993, pp. 119-130.

458. Wein, A.J.: Criteria for assessing outcome following intervention for benign prostatic hyperplasia.

In, Lepor, H., Lawson, R.K. (eds), Prostate Diseases. W.B. Saunders Co., Philadelphia, London, Toronto, 1993, pp. 139-149.

459. Wein, A.J.: Assessing treatment results for benign prostatic hyperplasia. In, Romas, N.,

Vaughan, E.D. (eds): Alternate Methods in the Treatment of Benign Prostatic Hyperplasia. Springer-Verlag, Berlin and New York, 1993, pp. 45-6S.

460. Tammela, T., Wein, A.J., Levin, R.M.: Urothelial permeability of the isolated whole bladder.

Neurourol. Urodyn., 12:39, 1993.

461. Levin, R.M., Saito, M., Wein, A.J., Packard, D., Cohen, A., Haugaard, M.: Effect of partial outlet obstruction on choline acetyltransferase activity in the rat and rabbit. Neurourol. Urodyn. 12:255, 1993.

462. Longhurst, P.A., Wein, A.J., Levin, R.M.: Effect of potassium on the contractile response of the rat

detrusor muscle to field stimulation at increasing calcium concentrations. Gen. Pharmacol. 24:89, 1993.

463. Tammela, T., Longhurst, P.A., Wein, A.J., Levin, R.M.: The effect of furosemide induced diuresis

on rabbit micturition and bladder contractile function. J. Urol., 150:204, 1993.

464. Levin, R.M., Scheiner, S., Zhao, Y., Wein, A.J.: The effect of terodiline on hyperreflexia (in vivo) and the in-vitro response of isolated strips of rabbit bladder to field stimulation, bethanechol, and KCI. Pharmacol. 46:346, 1993.

465. Zhao, Y., Wein, A.J., Levin, R.M.: Role of calcium in mediating the biphasic contraction of the

rabbit urinary bladder. Gen. Pharmacol. 24:727, 1993.

466. Lee, J.G., Wein, A.J., Levin, R.M.: The effect of caffeine on the contractile response of the rabbit urinary bladder to field stimulation. Gen. Pharmac., 24:1007, 1993.


50

467. Wein, A.J., Barrett, D.M.: Practical urodynamics. AUA Update Series, volume 12, lesson 39, American Urological Office of Education, Houston, Texas, 1993, pp. 306-311.

468. D'Amico, A., Altschuler, M., Whittington, R., Kao, G., Malkowicz, S.B., Wein, A.J.: The use of

clinical parameters in an interactive statistical package to predict pathological features associated with local failure after radical prostatectomy for Prostate cancer. Clin. Perf. Qual. Health Care 1993; 1:219-222.

469. Saito, M., Longhurst, P.A., Tammela, T.L., Wein, A.J., Levin, R.M.: Effects of partial outlet

obstruction of the rat urinary bladder on micturition characteristics, DNA synthesis and the contractile response to field stimulation and pharmacological agents. J. Urol. 1993; 150:1045-51.

470. Levin, R.M., Zderic, S.A., Yoon, J.Y., Sillen, U., Wein, A.J.: Effect of ryanodine on the contractile

response of the normal and hypertrophied rabbit urinary bladder to field stimulation. Pharmacology 1993; 47:244-251.

471. Hypolite, J.A., Longhurst, P.A., Gong, C., Briscoe, J., Wein, A.J., Levin, R.M.: Metabolic studies

on rabbit smooth muscle and mucosa. Mol. Cellular Biochem 1993; 125:35-42.

472. Zderic, S.A., Sillen, U., Liu, G.H., Snyder, H. McC., Duckett, J.W., Wein, A.J., Levin, R.M.: Developmental aspects of bladder contractile function: evidence for an intracellular calcium pool. J. Urol. 1993; 150:623-625.

473. Levin, R.M., Zderic, S.A., Wein, A.J.: Effects of intravesical administration of calcium channel

inhibitors and potassium channel iospheres on experimental hyperreflexia. Dialogues in Pediatric Urology 1993; 16:4-7.

474. Schiebler, M.L., Schnall, M.D., Pollack, H.M., Lenkinski, R., Tomaszewski, J.E., Wein, A.J.,

Whittington, R., Rauschning, W., Kressel, H.Y.: Current role of MR imaging in the staging of adenocarcinoma of the prostate. Radiology 1993; 189: 339-352.

475. Saito, M., Wein, A.J., Levin, R.M.: Effect of partial outlet obstruction on contractility: comparison

between severe and mild obstruction. Neurourology and Urodynamics 1993; 12: 573:584.

476. Lee, J.G., Macarak, E., Coplen, D., Wein, A.J., Levin, R.M.: Distribution and function of the adrenergic and cholinergic receptor in the fetal calf bladder during mid-gestational age. Neurourology and Urodynamics 1993; 12:599-608.

477. Wein, A.J.: Pharmacologic management of non-BPH induced voiding dysfunction, parts I and 2,

Monographs in Urology 1993; 14:68-106.

478. Lee, J.G., Wein, A.J., Levin, R.M.: Effects of pregnancy on urethral and bladder neck function. Urology 1993; 42:747-752.

479. Haugaard, N., McKenna, B., Wein, A.J., Levin, R.M.: Effect of partial outlet obstruction in the rabbit on the incorporation of adenine into adenine nucleotides in bladder smooth muscle. Neurourology and Urodynamics 1993; 12:473-479.

480. Hale, T., Elbadawi, A., Horn, T., Homma, Y., Keuppers, F., Light, K., Lindstrom, S., Thuroff, J.,

Wein, A.: The effects of obstruction and aging on the function of the lower urinary tract. In, Cockett, A., Khoury, S., Aso, Y., Chatelain, C., Denis, L., Griffith, K., Murphy, G. (eds): The 2nd International Consultation on Benign Prostatic Hyperplasia, Scientific Communication International Ltd., 1993, pp. 85-128.


51

481. Saito, M., Wein, A.J., Levin, R.M.: Effect of partial outlet obstruction of the rat urinary bladder on

the response to alterations in the concentration of potassium and calcium. Gen. Pharmacol. 1993; 24:1495-1500.

482. Batra, A.K., Wein, A.J., Hanno, P.M.: Interstitial cystitis. AUA Update Series, American Urological

Association, Inc., Houston Texas, 1993, volume 12, lesson 8, pp. 66-71.

483. Wein, A.J., Broderick, G.A.: Voiding function and dysfunction. In, Hanno, P.M., Wein, A.J. (eds), Clinical Manual of Urology. 2nd edition, McGraw-Hill Inc., New York, 1994, pp. 305-378.

484. Wein, A.J.: Benign prostatic hyperplasia and other anatomic causes of bladder outlet and urethral

obstruction. In, Hanno, P.M., Wein, A.J. (eds), Clinical Manual of Urology, 2nd edition, McGraw-Hill Inc., New York, 1994, pp. 379-402.

485. Malkowicz, S.B., Wein, A.J.: Adult genitourinary cancer. In, Hanno, P.M., Wein, A.J. (eds),

Clinical Manual of Urology, 2nd edition, McGraw-Hill Inc., New York, 1994, pp. 419-480.

486. Batra, A.K., Wein, A.J., Hanno, P.M.: Male sexual dysfunction. In, Hanno, P.M., Wein, A.J. (eds), Clinical Manual of Urology, 2nd edition, McGraw-Hill Inc., New York, 1994, pp. 567-592.

487. Wein, A.J., Broderick, G.A.: Interstitial cystitis: current and future approaches to diagnosis and

treatment. Urol. Clinics North America 1994; 21:153.

488. Saito, M., Longhurst, P.A., Murphy, M., Monson, F.C., Wein, A.J., Levin, R.M.: 3 H-thymidine uptake by the rat urinary bladder after partial outflow obstruction. Neurourology and Urodynamics 1994; 13:63-69.

489. Monson, F.C., Wein, A.J., Eika, B., Murphy, M., Levin, R.M.: Stimulation of DNA synthesis in

rabbit wall after partial outlet obstruction and acute overdistention. Neurourology and Urodynamics 1994; 13:51-61.

490. Broderick, G.A., Wein, A.J.: Pharmacologic therapy for incontinence. In, O'Donnell, P.D. (ed):

Geriatric Urology. Little Brown and Co., Boston, 1994, pp. 285-300.

491. Wein, A.J.: Medical therapy for detrusor incontinence. In, Kursh,E.D., McGuire, E.J. (eds): Female Urology, J. B. Lippincott, Co., Philadelphia, 1994, pp. 103-118.

492. Lee, J.G., Wein, A.J., Levin, R.M.: Comparative pharmacology of the male and female rabbit

bladder neck and urethra: involvement of nitric oxide. Pharmacology; 48:250-259, 1994. 493. Lee, J.G., Coplen, D.G., Macarak, E., Wein, A.J., Levin, R.M.: Comparative studies on the

autogeny and autonomic responses of the fetal calf bladder at different stages of development: involvement of nitric oxide on field stimulated relaxation. Urol.; 151:1096-1101, 1994.

494. Berlin, J.W., Ramchandani, P., Banner, M.P., Pollack H.M., Nodine, C.F., Wein, A. J.: Voiding

cystourography after radical prostatectomy: normal findings and correlation between contrast extravasation and anastomotic studies. Am. J. Roentgen, 162:87-91, 1994.

495. Wein, A.J.: Diagnostic evaluation of neuromuscuiar disorders of the bladder.In, Seidmon, E.J.,

Hanno, P.M. (eds): Current Urologic Therapy, W.B. Saunders Co., Philadelphia, London, 1994, pp. 286-190.

496. Wein, A.J.: Drug therapy for neurogenic and non-neurogenic bladder dysfunction. In, Seidmon,


52

E.J., Hanno, P.M. (eds): Current Urologic Therapy, W.B. Saunders Co., Philadelphia, London, 1994, pp. 291-298.

497. Soulen, M.C., Faykus, M.H., Shlansky-Goldberg, R.D., Wein, A.J., Cope, C.: Elective

embolization for prevention of hemorrhage from renal angiomyolipomas. Vasc. Internat. Radiology, 5:587-591, 1994.

498. Ghoniem, G.M. , Wein, A.J.: Animal research. Neurol Urodyn 13:89, 1994.

499. Levy, J.B. , Jacobs, J.A. , Wein, A.J.: Combined abdominal and vaginal approach for bladder

neck closure and permanent suprapubic tube: urinary diversion in the neurologically impaired woman. J. Urol. 152 (6 Pt 1):2081, 1994.

500. Saito, M. , Broderick, G.A. , Wein, A.J. , Levin, R.M.: Effect of chronic ethanolconsumption on the

pharmacological response of the rabbit corpus cavernosum. Pharmacology 49:386-391, 1994.

501. Fogarty, K.T., Ayer, P.H., Shibutani, Y., Nodine, C., Tomaszewski, J.E., Coleman, B.G., Jacobs, J.E., Langer, J.E., Wein, A.J.: Follow up of benign hypoechoic peripheral zone lesion of the prostate gland. US characteristics and cancer prevalence. Radiology 191:69-74, 1994.

502. Malkowicz, S.B., Pressler, L., Robbins, S., Wein, A.J., Linnenbach, A.J.: Chromosome 9 LOH

analysis in transitional cell carcinoma. Surg. Forum, 805-808, 1994.

503. Schoor, R.A., Canning, D.A., Bellor, R.D., Broderick, G.A., Snyder, H.M., III, Duckett J.W., Jr., Krasnapolski, L, Wein, A.J., Levin, R.M.: Ultrasound diagnosis of bladder outlet obstruction in rabbits. Neurourology Urodynamics, 13:559-569, 1994.

504. D'Amico, A.V., Whittington, R., Malkowicz, S.B., Schnall, M., Tomaszewski, J., Schultz D, Kao,

G., Van Arsdalen, K., Wein, A.J.: A multivariable analysis of clinical factors predicting for pathological features associated with local failure after radical prostatectomy for prostate cancer. Int J Radiation Oncology Biol. Phys., 30:293-302, 1994.

505. Saito, J., Hypolite, J.A., Wein, A.J., Levin, R.M.: Effect of partial outflow obstruction on rat

detrusor contractility and intracellular free calcium concentration. Neurourology Urodynamics, 13:297-306, 1994.

506. Levin, R.M., Haugaard, N., Eika, B., Packard, D., McGuire, E.J., Elbadawi, A., Wein, A.J.: Comparative biochemical characteristics of the cat and rabbit urinary bladder. Neurourology Urodynamics, 13:307-314, 1994.

507. Levin, R.M., Monson, F.C., Longhurst, P., Wein, A.J.: Rabbit as a model of urinary bladder

function. Neurourology Urodynamics, 13:119-136, 1994.

508. Saito, M., Longhurst, P.A., Murphy, M., Monson, F.C., Wein, A.J., Levin, R.M: Effect on slow and rapid cystometry on in vitro rat urinary bladder DNA synthesis. Gen. Pharmac. 25:1021-1025, 1994.

509. Ramchandani, P., Banner, M.P., Berlin, J.W., Dannenbaum, M.S., Wein, A.J.: Vesicourethral

anastomotic strictures after radical prostatectomy: efficacy of balloon dilation. Radiology, 193:345-349, 1994.

510. Kao, G.D., Malkowicz, S.B., Whittington, R., D'Amico, A.V., Wein, A.J.: Locally advanced renal


53

cell carcinoma; low complication rate and efficacy of postnephrectomy radiation therapy planned with CT. Radiology, 193:725-730, 1994.

511. Levy, J.B., Ramchandani, P., Berlin, J.W., Broderick, G.A., Wein, A.J.: Vesicourethral healing

following radical prostatectomy: is it related to surgical approach? Urology, 44:888, 1994.

512. Saito, M., Wein, A.J., Levin, R.M.: Biphasic response of the rabbit detrusor muscle to changing the extracellular concentrations of potassium and calcium. Gen Pharmac 25:1101-1107, 1994.

513. Broderick, G.A., Longhurst, P.A., Juniewicz, I.E., Wein, A.J., Levin, R.M.: A novel canine model of

partial outlet obstruction secondary to prostatic hypertrophy. World J Urol 12:245-248, 1994.

514. Levin, R.M., Wein, A.J., Buttyan, R., Monson, F.C., Longhurst, P.A.: Update on bladder smooth muscle physiology. World J Urol, 12:226-232, 1994.

515. Levin, R.M., Levin, S.S., Zderic, S.A., Saito, M., Yoon, J., Wein, A.J.: Effect of partial outlet

obstruction of the rabbit urinary bladder on ryonodine binding to microsomal membranes. Gen Pharmac, 25:421-425, 1994.

516. Hsu, T.J., Levin, R.M., Wein, A.J., Haugaard, N.: Alterations of mitochondrial oxiodative

metabolism in rabbit urinary bladder after partial outlet obstruction. Mol Cell Biochem 141:21-26, 1994.

517. Roelof, M., Wein, A.J., Monson, F.C., Passerini-Glazel, G., Koteliansky, V.E., Sartore, S., Levin,

R.M.: Contractility and phenotype transitions in serosal thickening of obstructed rabbit bladder. J Appl Physiol, 78:1432-1441, 1995.

518. Wein, A.J.: Assessing treatment results in benign prostatic hyperplasia. Urologic Clinics of North

America, 22:345-355, 1995.

519. Levin, R.M., Monson, F.C., Haugaard, H., Buttyan, R., Hudson, A., Roelofs, M., Sartore, S., Wein, A.J.: Genetic and cellular characteristics of bladder outlet obstruction. Urologic Clinics of North America, 22:263-283, 1995.

520. D'Amico, A.V., Whittington, R., Schnall, M., Malkowicz, S.B., Tomaszewski, J.E., Shultz, D., Wein, A.J.: The impact of the inclusion of endorectal coil magnetic resonance imaging in a multivariate analysis to predict clinically unsuspected extraprostatic cancer. Cancer, 75:2368-2372, 1995.

521. Whittington, R., Malkowicz, S.B., Barnes, M.M., Broderick, G.A., Van Arsdalen, K., Dougherty,

M.J., Wein, A.J.: Combined hormonal and radiation therapy for lymph node positive prostate cancer. Urology, 46:213, 1995.

522. D'Amico, A.V., Whittington, R., Malkowicz, S.B., Schultz, D., Schnall, M.,Tomaszewski, J.E.,

Wein, A.J.: A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer. J Urol, 154:131, 1995.

523. Wein, A.J.: Pharmacology of incontinence. Urologic Clinics North America, 22:557-577, 1995.

524. Wein, A.J.: Bladder outlet obstruction - overview. In, Zderic, S.A. (ed.), Muscle, Matrix, and

Bladder Function, Advances in Experimental Medicine and Biology, vol. 385, Plenum Press, New York, London, 1995, pp. 3-6.


54

525. Levin, R.M., Wein, A.J.: Commentary on the scientific method revisited. J. Urol., 154:1628, 1995.

526. Gilbert, J.B., Malkowicz, S.B., Wein, A.J.: Cell saver and radical retropubic prostatectomy:

analysis of cost effectiveness. Urology, 46:542-544, 1995.

527. Henly, D.R., Barrett, D.M., Weiland, T.L., O’Connor, M.K., Malizia, A.A., Wein, A.J.: Particulate silicone for use in periurethral injections: local tissue effects and search for migration. J. Urol., 153:2039-2043, 1995.

528. Kwon, H.Y., Wein, A.J., Levin, R.M.: Effect of anoxia on the urethral response to phenylephrine.

J. Urol., 154:1527-1531, 1995.

529. Levin, R.M., Wein, A.J., Krasnopolsky, L., Atta, M.A., Ghoneim, G.M.: Effect of mucosal removal on the response of the feline bladder to pharmacological stimulation. J. Urol., 153:1291-1294, 1995.

530. Broderick, G.A., Longhurst, P.A., Juniewicz, P., Wein, A.J., Levin, R.M.: A novel canine model of

partial outlet obstruction secondary to prostate hypertrophy. World Journal of Urology, 12:245-248, 1995.

531. Levin, R.M., Wein, A.J., Eika, B., Tammela, T.L.J., Longhurst, P.A.: Effects of diuresis on

micturition. Neurourology Urodynamics, 14:169-176, 1995.

532. Roelofs, M., Wein, A.J., Barasha, B., Monson, F.C., Passerini-Glazel, G., Koteliansky, V.E., Sartore, S., Levin, R.M.: Contractility and phenotype transitions in serosal thickening of obstructed rabbit bladder. J. Applied Physiol., 78:1432-1441, 1995.

533. Levin, R.M., Monson, F.C., Haugaard, N., Buttyan, R., Hudson, A., Roelofs, M., Sartore, S, Wein,

A.J.: Genetic and cellular characteristics of bladder outlet obstruction. Adv. Ben. Prost. Hyperpla, 22:263-283, 1995.

534. Lee, J.G., Levin, R.M., Krasnopolsky, L., Wein, A.J., Longhurst, P.A.: Effects of the peptide leukotriene receptor antagonist ICI 198,615 on the in vivo and in vitro changes in guinea pig bladder function which occur after sensitization with ovalbumin. J. Urol., 154:1217-1221, 1995.

535. Zhao, Y.,Wein, A.J., Levin, R.M.: Assessment of stress gene mRNAs (HSP-27, 50, and 70) in

obstructed rabbit urinary bladder using a semi-quantitative RT-PCR method. Mol. Cell Biochem., 148:1-7, 1995.

536. Yu, H-J, Hypolyte, J.A., Wein, A.J., Levin, R.M.: Effect of magnesium ions on rabbit detrusor

contractility and intracellular free calcium. Pharmacol., 51:186-194, 1995.

537. Koo, H.P., Macarak, E.J., Zderic, S.A., Duckett, J.W., Snyder, H.M., Wein, A.J., Levin, R.M.: The ontogeny of bladder function in the fetal calf: Demonstration of an active relaxant response. J. Urol., 154:283-287, 1995.

538. Koo, H.P., Macarek, E.J., Duckett, J.W., Snyder H.M., Wein, A.J., Levin, R.M.: Fetal bovine

bladder: physiology and pharmacology. Adv. Exp. Med. Biol., 385:251-253, 1995.

539. Monson, F.C., Sun, L., Wein, A.J., Levin, R.M.: Hyperplasia in the rabbit urothelium following partial outlet obstruction. Autoradiographic evidence. Mol. and Cell Biochemistry, 152:167-173, 1995.


55

540. Levin, R.M., Wein, A.J., Saito, M., Longhurst, P.A.: Factors that modulate the initiation of micturition. Scand. J. Urol. Neph., Supplement 175:3-10, 1995.

541. Levin, R.M., Haugaard, N., Levin, S.S., Buttyan, R., Chen, M-W, Monson, F.C., Wein, A.J.:

Bladder function in experimental outlet obstruction: Pharmacologic responses to alterations in innervation, energetics, calcium mobilization, and genetics. In, Zderic, S. (Ed): Muscle, Matrix, and Bladder Function. New York, Plenum Press, 1995, pp. 7-19.

542. Levin, R, Wein A: Neurophysiology and Pharmacology. In, Fitzpatrick JM, Krane RJ (eds): The

Bladder. Edinburgh, Churchill Livingstone, 1995, pp. 47-70.

543. Rohrmann, D., Zderic, S., Wein, A.J., Levin, R.M.: Effect of thapsigargin on the contractile response of the normal and obstructed rabbit urinary bladder. Pharmacol., 52:119-124, 1996.

544. Levin, RM, Riffaud, J-P, Rohrmann, D., Habib, M., Krasnopolsky, L., Zhao, Y., Wein, A.J.:

Protective effect of Tadenan on bladder function secondary to partial outlet obstruction. J. Urol, 155:1466-1470, 1996.

545. Kwon, H-Y, Longhurst, P.A., Parsons, K., Wein, A.J., Levin, R.M.: Effects of glucose deprivation

on the contractile response of the rabbit bladder to repetitive stimulation. Neurourology Urodynamics, 15:71-78l, 1996.

546. Levin, R.M., Hypolite, J.A., Haugaard, N., Wein, A.J.: Comparative response of rabbit bladder

smooth muscle and mucosa to anoxia. Neurourology urodynamics, 15:79-84,1996.

547. Kwon, H-Y, Longhurst, PA, Parson, K, Wein, AJ, Levin, RM: The effects of partial outlet obstruction on bladder strip sensitivity to glucose deprivation: an in vitro study in the rat. World J Urol; 14:38-42,1996.

548. Yu, H-J, Wein, A.J., Levin, R.M.: Age related differential susceptibility to calcium channel blocker and low calcium medium in rat detrusor muscle response to field stimulation. Neurourology Urodynamics, 15:563-576, 1996.

549. Zderic, S., Rohrmann, D., Gong, C., Snyder, H.M., Duckett, J.W., Wein, A.J., Levin, R.M.: The decompensated detrusor II; evidence for loss of sarcoplasmic reticulum function following bladder outlet obstruction in the rabbit. J. Urol, 156:587-592, 1996.

550. Levin, R.M., Levin, S.S., Wein, A.J.: Etiology of incontinence: A review and hypothesis. Scand. J. Urol. Nephrol. 30, Supplement, 179:15-25, 1996.

551. Zderic, S.A., Levin, R.M., Wein, A.J.: Voiding function: relevant anatomy, physiology, pharmacology, and molecular aspects. In, Gillenwater, J.Y., Grayhack, J.T., Howards, S.S., Duckett, J.W., (eds). Adult and Pediatric Urology, Mosby-Yearbook, Inc., St. Louis, 1996, pp. 1159-1219.

552. Steers, W.D., Barrett, D.M., Wein, A.J.: Voiding dysfunction: diagnosis, classification, and management. In, Gillenwater, J.Y., Grayhack, J.T., Howards, S.S., Duckett, J.W., (eds). Adult and Pediatric Urology, Mosby-Yearbook, Inc., St. Louis, 1996, pp. 1220-1326.

553. Langer, J.E., Rovner, E.S., Coleman, B.G., Yin, D., Arger, P.H., Malkowicz, S.B., Nisenbaum, H.L., Rowling, S.E., Tomaszewski, J.E., Wein, A.J.: Strategy for repeat biopsy of patients with prostatic intraepithelial neoplasia detected by prostate needle biopsy. J. Urol, 155:228-231, 1996.

554. D’Amico, A.V., Whittington, R., Malkowicz, S.B., Shultz, D., Schnall, M., Tomaszewski, J.E.,


56

Wein, A.J.: Critical analysis of the ability of the endorectal coil MRI scan to predict pathologic stage, margin status, and postoperative prostate specific antigen failure in patients with clinically organ confined prostate cancer. J. Clin Oncol., 14:1770-77, 1996.

555. Turek, P.J., Malkowicz, S.B., Tomaszewski, J.E., Wein, A.J., Peehl, D.: The Role of the Sertoli cell in active immunosuppression in the human testis. Brit J. Urol., 77(6):891-895, June 1996.

556. Van Arsdalen, K.N., Broderick, G.A., Malkowicz, S.B., Wein, A.J.: Laparoscopic lymphadenectomy based on magnetic resonance imaging: Is a unilateral dissection adequate for staging prostate cancer? Techniques in Urology, 1996, 2:93-98.

557. Haugaard, N., Wein, A.J., Chandy, B., Soyupak, B., Zderic, S.A., Levin, R.M.: Properties of Ca2+Mg++ATP-ase in rabbit bladder muscle and mucosa: Effect of urinary outlet obstruction. Neurourology Urodynamics, 15:555-561, 1996.

558. Soyupak, B ., Wein, A.J., Levin, R.M., Haugaard, N.: Effect of ischemia of the rabbit bladder on Ca-Mg-activated ATP-ase activity. Neurourology Urodynamics, 15:666-671, 1996.

559. Chaikin, D.C., Broderick, G.A., Malloy, T.R., Malkowicz, S.B., Whittington, R., Wein, A.J.: Erectile dysfunction following minimally invasive treatments for prostate cancer. Urology, 48:100-104, 1996.

560. D’Amico, A.V., Whittington, R., Malkowicz, S.B., Schultz, D., Schnall, M., Tomaszewski, J.E.,

Wein, A.J.: Role of percent positive biopsies and endorectal coil MRI in predicting prognosis in intermediate-risk prostate cancer patients. Cancer J Sci Am, 2:343-350, 1996.

561. Wein, A.J.: Principles of pharmacologic therapy: Practical drug treatment of voiding dysfunction in the female. In, Raz, S. (Ed.), Female Urology, 2nd edition. W.B. Saunders, Philadelphia, 1996, pp. 283-316.

562. Levin, R.M., Riffaud, J-P, Bellamy, F., Rohrmann, D., Krasnopolsky, L., Haugaard, N., Zhao, Y.,

Wein, A.J.: Effects of Tadenan pretreatment on bladder physiology and biochemistry following partial outlet obstruction. J. Urol., 156:2084-2088, 1996.

563. Saito, M. , Broderick, G. , Wein, A.J. , Levin, R.M.: Effect of alteration in the extracellular

potassium and calcium on field-stimulated relaxation of the rabbit corpus cavernosum. Gen Pharnacol 27:375-378, 1996.

564. D’Amico, A.V. , Whittington, R. , Malkowicz, S.B. , Loughlin, K. , Schultz, D. , Schnall, M. ,

Tenpany, C. , Tomaszewski, J.E. , Renshaw, A, Wein, A.J.: An analysis of the time course of postoperative prostate specific antigen failure inpatients with positive surgical margins: implications on the use of adjuvant therapy. Urology 47:538-547, 1996.

565. Simon, L., Landis, J.R., Erickson, D. R., Nyberg, L.M., ICDB Study Group: The interstitial cystitis

data base (ICDB) study: concepts and preliminary baseline descriptive statistics. Urology (suppl.), 49:64-75, 1997.

566. Kirkemo, A., Peabody, M., Diokno, A., Afanasyev, A., Nyberg, LM, Landis, J., Cook, Y., Simon,

L., ICDB Study Group: Associations among urodynamic findings and symptoms in women enrolled in the interstitial cystitis data base (ICDB) study. Urology (suppl.), 49:76-80, 1997.

567. Messing, E., Pauk, D., Schaeffer, A., Nieweglowski, M., Nyberg, L., Landis, J., Cook, Y., Simon


57

L., ICDB Study Group: Associations among cystoscopic findings and symptoms and physical examination findings in women enrolled in the interstitial cystitis data base (ICDB) study. Urology (suppl.), 49:81-85, 1997.

568. Nigro, D.A., Wein, A.H., Foy, M., Parsons, C.L., Williams, M., Nyberg, L., Landis, J., Cook, Y.,

Simon, L, ICDB Study Group: Associations among cystoscopic and urodynamic findings for women enrolled in the interstitial cystitis data base (ICDB) study group. Urology (suppl.), 49:86-92, 1997.

569. Pontari, M.A., Hanno, P.M., Wein, A.J.: Logical and systematic approach to the evaluation and

management of patients suspected of having interstitial cystitis. Urology (suppl.), 49:114-120, 1997.

570. D’Amico, A.V., Whittington, R., Malkowicz, S.B., Schultz, D., Tomaszewski, J.E., Wein, A.:

Prostate specific antigen failure despite pathologically organ-confined and margin-negative prostate cancer: the basis for an adjuvant therapy trial. J. Clin. Oncol., 15:1465-1469, 1997.

571. Zhao, Y., Levin, S.S., Wein, A.J., Levin, R.M.: Correlation of ischemia/reperfusion or partial outlet

obstruction-induced spectrin proteolysis by calpain with contractile dysfunction in rabbit bladder. Urology, 49:293-300, 1997.

572. Damaser, M.S., Kim, K-B, Longhurst, P.A., Wein, A.J., Levin, R.M.: Calcium regulation of urinary

bladder function. J. Urol., 157:732-738, 1997. 573. Yu, H-J, Wein, A.J., Levin, R.M.: Contractile responses and calcium mobilization induced by

muscarinic agonists in the rat urinary bladder: Effects of age. Gen. Pharmacol., 28:623-628,1997.

574. Vaughn, D.J., Malkowicz, S. B., Zoltick, B., Ramchandani, P., Tonkonow, B., Armstead, B., Wein,

A.J.: Phase I trial of paclitaxel/carboplatin in advanced carcinoma of the urothelium. Semin Oncol 24 (suppl 2): S2-S47, 1997.

575. Chacko, S., DiSanto, M., Wang, Z., Zderic, S.A., Wein, A.J.: Contractile protein changes in

urinary bladder smooth muscle during obstruction-induced hypertrophy. Scand. J. Urol. Nephrol. (Suppl.) 184; 67-76, 1997.

576. Levin, R.M., Yu, H-J, Kim, K-B, Longhurst, P.A., Wein, A.J., Damaser, M.S.: Etiology of bladder

dysfunction secondary to partial obstruction. Calcium disregulation in bladder power generation and the ability to perform work. Scand. J. Nephrol. Suppl. 184:43-50, 1997

577. Blaivas, J.G., Appell, R.A., Fantl, J.A., Leach, G, McGuire, E.J., Resnick, N.M., Raz, S., Wein,

A.J.: Standards of efficacy for evaluation of treatment outcomes in urinary incontinence: Recommendations of the Urodynamics Society. Neurourology and Urodynamics, 16:145-147,1997.

578. Blaivas, J.G., Appell, R.A., Fantl, J.A., Leach, G, McGuire, E.J., Resnick, N.M., Raz, S., Wein,

A.J.: Definition and classification of urinary incontinence: Recommendations of the Urodynamics Society. Neurourology and Urodynamics, 16:149-151, 1997.

579. Ebling, D.W., Ruffer, J., Whittington, R., Van Arsdalen, K., Broderick, G.A., Malkowicz, S.B.,

Wein, A.J.: Development of prostate cancer after pituitary dysfunction: A report of 8 patients. Urology 49:564-568, 1997.

580. Rovner, E.S., Schanne, F.J., Malkowicz, S.B., Wein, A.J.: Transurethral biopsy of the prostate for


58

persistently elevated or increasing prostate specific antigen following multiple negative transrectal biopsies. J. Urol., 158:138-142, 1997.

581. Werner-Wasik, M., Whittington, R., Malkowicz, S.B., Corn, B.W., Arger, P., Reisinger, S., Anglotz,

C., Alexander, A., D’Amico, A.V., Hyslop, T., Gomella, L., Brownstein, K., Wein, A.J.: Prostate imaging may not be necessary in nonpalpable carcinoma of the prostate. Urology, 50:385-389, 1997.

582. Whittington, R., Malkowicz, S.B., Machtay, M., Van Arsdalen, K., Barnes, M.M., Broderick, G.A.,

Wein, A.J.: The use of combined radiation therapy and hormonal therapy in the management of lymph node positive prostate cancer. Int. J. Radiation Oncology Biol. Phys., 39:3, 673-680, 1997.

583. Sánchez-Ortiz, R.F., Broderick, G.A., Chaikin, D.C., Malkowicz, S.B., Van Arsdalen, K. Blander,

D.S., Wein, A.J.: Collagen injection therapy for post-radical retropubic prostatectomy incontinence: Role of Valsalva leak point pressure. J. Urol., 158:2132-2136, 1997.

584. Nigro, D.A., Wein, A.J.: Pharmacologic Therapy. In, O’Donnell, P.D. (ed.), Urinary Incontinence.

Mosby, St. Louis, 1997, pp. 277-286.

585. Wein, A.J.: Pathophysiology and Categorization of Voiding Dysfunction. In, Walsh, P., Retik, A., Vaughan, E.D., Jr., Wein, A.J. (eds): Campbell’s Urology, 7th edition, Saunders, Philadelphia, 1997, pp. 917- 926.

586. Wein, A.J.: Neuromuscular Dysfunction of the Lower Urinary Tract and Its Treatment. In, Walsh, P., Retik, A., Vaughan, E.D., Jr., Wein, A.J. (eds): Campbell’s Urology, 7th edition, Saunders, Philadelphia, 1997, pp. 953-1006.

587. Nigro, D.A., Wein, A.J.: Interstitial Cystitis: Clinical and Endoscopic Features. In, Sant, G.R.

(ed.) Interstitial Cystitis. Lippincott-Raven Publishers, Philadelphia, 1997, pp. 137-142.

588. Abrams, P.A., Wein, A.J.: Introduction: The overactive bladder: from basic science to clinical management. Urology, 50 (Suppl 6A):1-3, 1997.

589. Wein A.J. (guest editor): Contemporary surgical management of sphincteric incontinence. World

J. of Urol., 15 (5), 1997.

590. Bernstein, M.R., Malkowicz, S.B., Siegelman, E.S., Acker, M., Tomaszewski, J.E., Wein, A.J.: Progressive angiomyolipoma with inferior vena cava tumor thrombus. Urology, 50:975-977, 1997.

591. D’Amico AV, Whittington R, Kaplan I, Beard C, Schultz D, Malkowicz SB, Tomaszewski JE, Wein

A.J., Coleman CN: Equivalent 5 year bNED in select prostate cancer patients managed with surgery or radiation therapy despite exclusion of the seminal vesicles from the clinical target volume. Internl J Radiation Oncol Biology Physics, 39:216-219, 1997.

592. Rovner, E.S. , Wein, A.J.: Sling tension in stress incontinence surgery. Issues in Incontinence

3(2):1, 1997.

593. D’Amico, A.V. , Whittington, R. , Malkowicz, S.B. , Schultz, D. , Schnall, M. , Tomaszewski, J.E. Wein, A.J.: Combined modality staging of prostate carcinoma and its utility in defining pathological stage: The role of endorectal coil magnetic resonance imaging. Urology 49:23-30, 1997.

594. D’Amico, A.V. , Whittington, R. , Schultz, D. , Malkowicz, S..B. , Tomaszewski, J.E. , Wein, A.J.:


59

Outcome based staging for clinically localized adenocarcinoma of the prostate. J. Urol. 158:1422-1426, 1997.

595. Malkowicz, S.B. , Wein, A.J.: Approach to the patient with a prostate nodule or elevated PSA. In,

Kelley, W. (ed) Textbook of Internal Medicine, 3rd edition, Lippincott-Raven Publishers, Philadelphia, 1281-1284, 1997.

596. Malkowicz, S.B. , Wein, A.J.: Prostate Cancer. In, Kelley, W. (ed) Textbook of Internal Medicine,

3rd edition, Lippincott-Raven Publishers, Philadelphia. 1354-1357, 1997.

597. Vaughn, D.J., Malkowicz, S.B., Zoltick, B., Mick, R., Ramchandani, P., Holroyd, C., Armstead, B., Fox, K., Wein, A.: Paclitaxel plus carboplatin in advanced carcinoma of the urothelium: An active and tolerable outpatient regimen. J. Clin. Oncol., 16:255-260, 1998.

598. Wein, A.J.: Introduction: urinary incontinence: The scope of the problem -- the solutions on the

horizon. Urology, 51 (Suppl. 2A):1-2, 1998.

599. Wein, A.J.: Pharmacologic options for the overactive bladder. Urology, 51, (Suppl. 2A):43-46,1998

600. D’Amico, AV, Schnall, M, Whittington, R, Malkowicz, SB, Schultz D, Tomaszewski, JE, Wein, A: Endorectal coil magnetic resonance imaging identifies locally advanced prostate cancer in select patients with clinically localized disease. Urology 51:449-454, 1998.

601. Gottschalk A, Smith DS, Jobes DR, Kennedy SK, Lally SE, Noble VE, Grugan KF, Seifert HA,

Cheung, A, Malkowicz SB, Gutsche BB, Wein A.J.: Preemptive epidural analgesia and recovery from radical prostatectomy: a randomized controlled trial. JAMA, 279:1076-1082, 1998.

602. D’Amico, AV, Whittington R, Kaplan I, Beard C, Schultz D. Malkowicz SB, Wein A, Tomaszewski

JE, Coleman CN: Calculated prostate carcinoma volume: The optimal predictor of 3-year prostate specific antigen (PSA) failure free survival after surgery or radiation therapy of patients with pretreatment PSA levels of 4-20 nanograms per milliliter. Cancer 82(2):334-341, 1998.

603. Blaivas JG, Chaikin D, Chancellor MB, Linsenmeyer TA, Rivas DA, Steers W, Wein A.J.

(Faculty): Continuum: Neurourology, American Academy of Neurology, Williams and Wilkins, Baltimore, 4:4, 8-98, 1998, pp. 7-164.

604. Rebbeck TR, Jaffe JM, Walker AH, Wein A.J., Malkowicz, SB: Modification of clinical

presentation of prostate tumors by a novel genetic variant in CYP3A4. J Natl Cancer Inst, 90:1225-1229, 1998.

605. D’Amico AV, Whittington R, Malkowicz SB, Schultz D, Kaplan I, Beard CJ, Tomaszewski JE,

Renshaw AA, Loughlin KR, Richie JP, Wein A.J.: Calculated prostate cancer volume greater than 4.0cm3 identifies patients with localized prostate cancer who have a poor prognosis following radical prostatectomy or external beam radiation therapy. J Clin Oncol 16:3094-3100, 1998.

606. Zderic SA, Wein A.J., Rohrman D, Gong CL, Nigro D, Haugaard N, Levin RM: Mechanisms of

bladder smooth muscle hypertrophy and decompensation: lessons from normal development and the response to outlet obstruction. World J Urol, 16:350-358, 1998.

607. D’Amico AV, Whittington R, Malkowicz SB, Schultz D, Tomaszewski JE, Wein A.J.: A prostate

gland volume of more than 75 cm3 predicts for a favorable outcome after radical prostatectomy for localized prostate cancer. Urology 52:631-636, 1998.


60

608. DiSanto M, Chacko T, Hypolite J, Broderick G, Wein A.J., Chacko S: Molecular basis of erectile function: Expression of myosin isoforms in smooth muscle cells in corpus cavernosum penis. Am J Physiology (Cell Physiol.), 275:C976-C987, 1998.

609. D’Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, Tomaszewski JE,

Renshaw AA, Kaplan I, Beard CJ, Wein A.J.: Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA, 280:969-974, 1998.

610. Gottschalk A, Smith DS, Malkowicz SB, Wein A.J.: Pre-emptive analgesia for prostatectomy --

Reply. JAMA, 280:517-518, 1998.

611. D’Amico AV, Desjardin A, Chen MH, Schultz D, Whittington R, Malkowicz SB, Wein A.J. Tomaszewski JE, Renshaw AA, Loughlin K, Richie JP: Assessment of outcome prediction models for patients with localized prostate carcinoma managed with radical prostatectomy external beam radiation therapy. Cancer, 82:1887-1896, 1998.

612. Rovner ES, Wein A.J.: Pharmacologic treatment for non-BPH induced voiding dysfunction: facilitation of bladder emptying, Part I. AUA Update Series, American Urological Association, Inc., Houston, TX, Volume 17, lesson 33, pp. 258-265, 1998.

613. Rovner ES, Wein A.J.: Pharmacologic Treatment for non-BPH induced voiding dysfunction:

facilitation of urine storage, Part II. AUA Update Series, American Urological Association, Inc., Houston, TX, volume 17, lesson 34, pp. 266-272, 1998.

614. D’Amico AV, Whittington R, Malkowicz SB, Schultz D, Tomaszewski JE, Renshaw AA, Wein, AJ:

Brachytherapy or external beam therapy -- a guide to patient selection. AUA Update Series, American Urological Association, Inc., Houston, TX, Volume 18, Lesson 30, pp. 234-240, 1998.

615. DiSanto ME, Hypolite J, Broderick G, Wein A.J., Chacko S.: Myosin heavy chain isoform

expression in the human corpus cavernosum. In, Meuleman E, Nijeholt G, Vanderschueren D (eds), The 8th World Meeting on Impotence Research, Monduzzi Editore, Bologna, Italy, 1998, pp. 175-177.

616. DiSanto ME, Hypolite J, Broderick G, Wein A.J., Chacko S: Regulation of corpus cavernosum

contraction by myosin light chain phosphorylation. In, Meuleman E, Nijeholt G, Vanderschueren D (eds), The 8th World Meeting on Impotence Research, Monduzzi Editore, Bologna, Italy, 1998, pp.169-173.

617. D’Amico AV, Whittington R, Malkowicz, SB, Fondurulia J, Chen, M, Tomaszewski JE, Wein AJ: A

combination of preoperative prostate specific antigen level and postoperative pathologic findings to predict PSA outcome in men with clinically localized prostate cancer. J. Urol. 160:2096-2101, 1998.

618. D’Amico AV, Whittington R, Malkowicz SB, Fondurulia J, Chen M-H, Kaplan I, Beard CJ,

Tomaszewski JE, Renshaw AA, Wein A.J., Coleman CN: Pretreatment nomogram for prostate specific antigen recurrence after radical prostatectomy or external beam radiation therapy for clinically localized prostate cancer. J Clin Oncol 17:168-172, 1999.

619. Wein A.J., Rovner ES: Assessing outcomes following treatment for benign prostatic hyperplasia.

AUA Update Series, American Urological Association, Inc., Houston, TX, volume 18, lesson 5, pp, 34-39, 1999.


61

620. Wein A.J., Rovner ES: Adult voiding dysfunction secondary to neurologic disease or injury. AUA Update Series, American Urological Association Inc., Houston, TX, volume 18, lesson 6, pp. 42-47,1999.

621. Wein A.J., Rovner ES: The overactive bladder: An overview for primary care health providers.

Int J Fertil 44(2):56-66, 1999.

622. Rebbeck TR, Walker AH, Jaffe JM, White DL, Wein A.J., Malkowicz SB: Glutathione S transferase- (GSTMI) and - (GSTTI) genotypes in the etiology of prostate cancer. Cancer Epidemiology, Biomarkers & Prevention, 8:283-287, 1999.

623. Bernstein MR, Wein A.J., Siegelman ES, Tomaszewski JE, Malkowicz SB: Lack of correlation of clinical and pathologic staging of capsular involvement in prostate cancer using endorectal coil magnetic resonance imaging. J. of Pelvic Surgery, 5:1, 1999.

624. Levin R, Haugaard N, Hypolite J, Wein A, Buttyan R: Metabolic factors influencing lower urinary tract function. Exptl. Physiology, 84:179-194, 1999.

625. Abrams P, Larsson G, Chapple C, Wein A.J.: Factors involved in the success of antimuscarinic

treatment. Brit J Urol. Int, 83 (suppl. 2):42-47, 1999.

626. Chacko S, DiSanto M, Menon C, Zheng Y, Hypolite J, Wein A: Contractile protein changes in urinary bladder smooth muscle following outlet obstruction. Advances Exp. Med. Biol. 462:137-154, 1999.

627. Zderic S, Gong C, DiSanto M, Hypolite J, Hutcheson J, Wein A.J., Chacko S: Calcium ion

homeostasis in urinary bladder smooth muscle. Advances Exp. Med. Biol. 462:155-169, 1999.

628. Gupta S, Wein A.J.: Role of Na+-K+-ATPase activity in regulation of detrusor contractility and diabetic bladder dysfunction. . Advances Exp. Med. Biol. 462:293-302, 1999.

629. Abrams P, Wein A.J.: The overactive bladder and incontinence: Definitions and a plea for

discussion. Neurourology and Urodynamics 18:413-416, 1999.

630. Hypolite JA, DiSanto ME, Wein A.J., Chacko S: Myosin light chain phosphorylation at resting level and the composition of myosin isoforms in the bladder body and urethra. Scand J Urol Nephrol (Suppl. 201): 46-50, 1999.

631. D’Amico AV, Whittington R, Malkowicz SB, Schultz D, Renshaw AA, Tomaszewski JE, Richie JP,

Wein AJ: Optimizing patient selection for dose escalation techniques using the prostate-specific antigen level, biopsy gleason score, and clinical T-stage. Int J Radiat Oncol Biol Phys, 45(5): 1227-1234, 1999.

632. Kirby, TRS, Aarnick R, Abbou C, Rabaian R, Damiao R, Keily P, Parkinson C, Pontes JE,

Resnick M, deReijke TM, Wein A: Diagnosis and staging of prostate cancer. In, Murphy G, Khoury S, Partin A, Denis L (eds) Prostate Cancer. Heath Publications, Ltd., Plymbridge Distributors, Ltd., 1999, pp. 235

633. Nigro DA, Haugaard N, Wein A.J., Levin, RM: Metabolic basis for contractile dysfunction

following chronic partial bladder outlet obstruction in rabbits. Mol Cell Biochem 100:106, 1999.

634. Rovner ES, Wein A.J.: Interstitial cystitis: clinical features. Urol Integr Invest 4(4):307-314, 1999.


62

635. Blander DS, Broderick GA, Malkowicz SB, VanArsdalen, KN, Wein AJ: Retrospective review of

flow patterns following retropubic prostatectomy. Int. J. Impot. Res 11:309-313, 1999.

636. Blank KR, Whittington R, Arjomandy B,m Wein AJ, Broderick G, Staley J, Malkowicz SB: Neoadjuvant androgen deprivation prior to transperineal prostate brachytherapy: smaller volumes, less morbidity. Cancer J. Sci. Am. 5:370-373, 1999.

637. Chacko SK, DiSanto M, Zheng Y, Wein A.J.: Changes in the composition of myosin isoforms in

smooth muscle hypertrophy following urinary bladder outlet obstruction. Advances in Organ Biology 8:81-100, 2000.

638. DiSanto ME, Wein A.J., Chacko S: Lower urinary tract physiology and pharmacology. Current Urology Reports 1:227-234, 2000.

639. Bernstein MR, Cangiano T, D’Amico A, Chittams J, Hardy C, Whittington RD, Tomaszewski JE,

Schnall MD, Wein A.J., Malkowicz SB: Endorectal coil magnetic resonance imaging and clinicopathologic findings in T1c adenocarcinoma of the prostate. Uro Onc. 5:104-111, 2000.

640. Wein A.J., Monga AK: Applied pharmacology. In Stanton SL, Monga AK (eds) Clinical

Urogynaecology. London, Churchill Livingstone, pp. 487-520, 2000.

641. Rovner ES, Gomes CM, Banner MP, Wein A.J.: Ventral hernia of the urinary bladder with mixed urinary incontinence: treatment with herniorrhaphy and allograft fascial sling. Urology 55, (1):145, 2000.

642. Abrams P, Wein A.J., (guest editors). Overactive bladder and its treatments consensus

conference. Urology 55 (Supp. 5A), 2000.

643. Abrams P, Wein A.J.: Introduction: Overactive bladder and its treatments. Urology 55 (Supp. 5A), pp. 1-3, 2000.

644. Wein A.J.: Closing remarks. Urology 55 (Supp. 5A), pp. 83-84, 2000.

645. Whittington R, Malkowicz SB, Schultz D, Fondurulia J, Chen M-H, Tomaszewski JE, Renshaw

AA, Wein AJ, Richie JP: Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer. J Clin Onc 18:6, 1164-1172, 2000.

646. Chancellor M, Freedman S. Mitcheson HD, Antoci J, Primus G, Wein A: Tolterodine, an effective

and well tolerated treatment for urge incontinence and other overactive bladder symptoms. Clin Drug Invest, 2 2):83-91, 2000.

647. Rovner ES, Wein A.J.: Today’s treatment of overactive bladder and urge incontinence. Women’s

Health Primary Care 3(3):179-186, 2000.

648. Rovner ES, Wein A.J.: Overactive bladder and urge incontinence: Establishing the diagnosis. Women’s Health Primary Care, 3(2):117-126, 2000.

649. Rovner ES, Wein A.J.: How to regain control over your overactive bladder. Women’s Health

Primary Care 3(3), 189-192, 2000.

650. Jaffe JM, Malkowicz SB, Walker AH, MacBride S, Peschel R, Tomaszewski J, Van Arsdalen K, Wein A.J., Rebbeck TR: Association of SRD5A2 genotype and pathological characteristics of


63

prostate tumors. Cancer Research 60:1626-1630, 2000.

651. Sanchez-Ortiz RF, Broderick GA, Rovner ES, Wein A.J., Whittington R, Malkowicz SB: Erectile function and quality of life after interstitial radiation therapy for prostate cancer. Int. J. of Impotence Research, 12 (Suppl. 3):S18-S24, 2000.

652. Wein A.J.: Section Editor, Neuromuscular disorders (neurourology) In, Clinical Urography (Second Edition). Pollack HM, McClennan BL (eds). Philadelphia, PA, WB Saunders, Co., (1):S8-2271-2282, 2000.

653. Wein A.J.: Overview of voiding function and dysfunction: relevant anatomy, physiology,

pharmacology, classifications and definitions. In, Pollack HM, McClennan BL (eds), Clinical Urography (Second Edition). Philadelphia, PA, WB Saunders Co., 2000, pp. 2272-2282.

654. Wein A.J., Rovner ES: Pathophysiology and classification of voiding dysfunction. In, Appell RA

(ed): Voiding Dysfunction Diagnosis and Treatment. Totowa NJ, Humana Press, Inc., 2000, pp. 3-24.

655. Wein A.J.: Criteria for assessing outcome following intervention for benign prostatic hyperplasia.

In, Lepor H (ed) Prostatic Diseases. Philadelphia, PA, WB Saunders Co., 2000, pp. 210-231.

656. Gomes CM, Broderick GA, Sanchez-Ortiz RF, Preate D Jr., Rovner ES, Wein A.J.: Artificial urinary sphincter for post-prostatectomy incontinence: impact of prior collagen injection on cost and clinical outcome. J Urol, 163:87-90, 2000.

657. Groutz A, Blaivas JG, Chaikin DC, Resnick NM, Engleman K, Anzalone D, Bryzinski B, Wein A.J.:

Noninvasive outcome measures of urinary incontinence and lower urinary tract symptoms. A multicenter study of micturition diary and pad tests. J Urol 164:698-701, 2000.

658. Bernstein MR, Wein AJ, D’Amico AV, Cangiano TA, Whittington R, Tomaszewski JE, Schnall MD,

Malkowicz SB: Endorectal coil magnetic resonance imaging and clinico-pathologic findings in T1c adenocarcinoma of the prostate. Urology 164:759-763, 2000.

659. Rebbeck TR, Walker AH, Ziegler-Johnson C, Weisburg S, Martin A, Nathanson K, Wein A.J.,

Malkowicz SB: Association of HPC2/ELAC2 genotypes and prostate cancer. Am J Hum Genet. 67:1014-1019, 2000.

660. Blander DS, Sanchez-Ortiz, RF, Wein A.J., Broderick GA: Efficacy of sildenafil in erectile

dysfunction after radical prostatectomy. Intl J. of Impotence Research 12:165-168, 2000.

661. Rovner ES, Wein A.J.: Modern pharmacotherapy of urge urinary incontinence in the USA: tolterodine and oxybutynin. BJU international, 86 (2):44-54, 2000.

662. Chacko S, Hypolite J, DiSanto M, Wein A.J.: Myosin light chain phosphorylation at resting level

and the composition of myosin isoforms in the bladder body and urethra. Scand J Urol Nephol Suppl. 203:46-50, 2000.

663. Kelada SN, Karadia SL, Walker AH, Wein A.J., Malkowicz SB, Rebbeck TR: The glutathione S-

transferase-µand Θ genotypes in the etiology of prostate cancer: Genotype environment interactions with smoking. Cancer, Epidemiology, Biomarkers & Prevention, 9:1329-1334, 2000.

664. D’Amico AV, Whittington R, Malkowicz SB, Schultz D, Silver B, Henry L, Hurwitz M, Kaplan I,

Beard CJ, Tomaszewski, JE, Renshaw AA, Wein A, Richie JP: Investigating the clinical utility of the percent of positive prostate biopsies in predicting PSA outcome following local therapy for


64

patients with clinically localized prostate cancer. Prostate Cancer and Prostatic Diseases, 3:259-264, 2000.

665. Chacko S, Hypolite J, DiSanto M, Wein A.J.: Myosin light chain phosphorylation at resting level and the composition of myosin isoforms in the bladder body and urethra. Scand. J Urol Nephrol Suppl. 203:46-50, 2000.

666. Chang S, Hypolite JA, Wein A.J., Chacko S, DiSanto ME: Expression of myosin light chain

kinase and Rho-associated kinase in corpus cavernosum smooth muscle. Biophys. J. 78:24A, 2000.

667. Gomes CM, DiSanto ME, Horan P, Levin RM, Wein A.J., Chacko S: Improved contractility of

bladders after tadenen treatment is associated with reversal of altered myosin isoform expression. J Urol 163:2008-2013, 2000.

668. Maki DD, Banner MP, Ramchandani P, Stolpen A, Rovner ES, Wein A.J.: Injected periurethral

collagen for postprostatectomy urinary incontinence: MR and CT appearance. Abdominal Imaging 25(6):658-662, 2000.

669. Metro MJ, Ramchandani P, Banner MP, Siegelman ES, Stolpen AH, Wein A.J., Rovner ES:

Angiomyolipoma of the renal sinus: Diagnosis by percutaneous biopsy. Urology, 55(2):286-289, 2000.

670. Rovner ES, Propert KJ, Brensinger C, Wein A.J., Foy M, Kirkemo A, Landis JR, Kusek JW,

Nyberg LM and the ICDB Study Group: Treatments used in women with interstitial cystitis: The interstitial cystitis database (ICDB) study experience. Urology, 56(6):940-5, 2000.

671. Wein A.J.: Overactive bladder: defining the disease. Am J Managed Care, 6 (suppl):S559-564,

2000.

672. D’Amico AV, Whittington R, Malkowicz SB, Schultz D, Tomaszewski JE, Wein A.J.: Prostate specific antigen outcome based on the extent of extracapsular extension and margin status in patients with seminal vesicle negative prostate carcinoma of Gleason score ≥ 7. Cancer, 88:2110-2115, 2000.

673. D’Amico AV, Whittington R, Malkowicz SB, Wu YH, Chen MH, Hurwitz M, Kantoff PW,

Tomaszewski JE, Renshaw AA, Wein A.J., Richie JP: Utilizing predications of early prostate specific antigen failure to optimize patient selection for adjuvant systemic therapy trials. J of Clin Onc, 18:3240-3246, 2000.

674. Kirby R, Aarnick R, Abboo C, Babaian R, Damiao R, Kiely P, Parkinson C, Edson-Pontes J,

Resnick M, deReijke TM, Wein AJ: Diagnosis and staging of prostate cancer. In Murphy GP, Khoury S, Partin A, Denis L (eds), Prostate Cancer, 2nd International Consultation, Plymgridge Distributors, Plymouth, UK, 2000, pp 235-263.

675. Rovner, E.S., Bernstein, M.R., Metro, M., Ramchandani, P., Wein, A.J.: Refractory postoperative

priapism following radical retropubic prostatectomy. British J. of Urology International Online, 86(9):1093, 2000.

676. D’Amico AV, Whittington R, Malkowicz SB, Schultz D, Fondurulia J, Chen MH, Tomaszewski JE,

Renshaw AA, Wein AJ, Ritchie JP: Clinical utility of the percentage positive biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer. Jour Clin Oncol 18:1164-1172, 2000.

677. D’Amico AV, Whittington R, Malkowicz SB, Wu YH, Chen MH, Art M, Tomaszewski JE, Wein AJ:


65

Combination of the preoperative PSA level, biopsy Gleason score, percentage positive biopsies,and MRI T-stage to predict early PSA failure in men with clinically localized prostate cancer. Urology 55:572-577, 2000.

678. Rovner ES, Gomes CM, Banner MP, Wein AJ: Ventral hernia of the urinary bladder with mixed

urinary incontinence: treatment with herniorrhaphy and allograft fascial sling. Urology 55:145, 2000.

679. D’Amico AV, Whittington R, Malkowicz SB, Schultz D, Silver B, Henry L, Hurwitz M, Kaplan I,

Beard CJ, Tomaszewski JE, Renshaw AA, Wein AJ, Ritchie JP: Clinical utility of percent positive prostate biopsies in predicting biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate cancer. Molecular Urol 4:171-175, discussion 177, 2000.

680. Cheung R, Altschuler MD, D’Amico AV, Malkowicz SB, Wein A.J., Whittington R: ROC

optimization may improve stratification of prostate cancer patients. Urology 57:286-290, 2001.

681. Hypolite J, DiSanto M, Zheng Y, Chang S, Wein A.J., Chacko S: Regional variation in myosin isoforms and phosphorylation at the resting tone in urinary bladder smooth muscle. Am J. Physiol (Cell) 280:C254-259, 2001.

682. Resnick M, Ackermann R, Bosch J, Cidre J, Foo K, Frank I, Koyanagi T, Palmtag H, Price D,

Vallancien G, Vaughan E, Wein A: Initial evaluation of LUTS. In, Chatelain C, Denis L, Foo KT, Khoury S, McConnell J (eds): Benign Prostatic Hyperplasia. Plymouth, UK, Heath Publications Ltd., 2001, pp.167-200.

683. Gomes CM, Sanchez-Ortiz R, Harris C, Wein A.J., Rovner ES: Significance of hematuria in

patients with interstitial cystitis: review of radiographic and endoscopic findings. Urology, 57(2):262-265, 2001.

684. Sanchez-Ortiz R, Wang Z, Menon C, DiSanto M, Wein A.J., Chacko S: Estrogen modulates the

expression of myosin heavy chain in detrusor smooth muscle. Am J Physiol-Cell Physiology. 280:C433-C440, 2001.

685. VanKerrebroeck P, Kreder K, Jonas U, Zinner N, Wein A on behalf of the tolterodine study group:

Tolterodine once daily: superior efficacy and tolerability in the treatment of the overactive bladder. Urology 57:414-421, 2001.

686. Abrams P, Wein A: Recent advances: Urology. BMJ, 321:1393-1396, 2001.

687. Blander DS, Rovner ES, Schnall M, Ramchandani P, Banner MP, Broderick GA, Wein AJ:

Endoluminal magnetic resonance imaging in the evaluation of urethral diverticula in females. Urology 57(4):660-665, 2001.

688. Gomes CM, Rovner ES, Banner MP, Ramchandani P, Wein A.J.: Simultaneous upper and lower

urinary tract obstruction associated with severe genital prolapse: Diagnosis and evaluation with magnetic resonance imaging. International Urogynecology J.,12:144-146, 2001.

689. Abrams P, Malone-Lee J, Jacquetin B, Wyndaele J-J, Tammela T, Jonas U, Wein A: Twelve month treatment of overactive bladder: Efficacy and tolerability of tolterodine. Drugs and Aging, 18(7):551-562, 2001.

690. Arafat HA, Kim GS, DiSanto ME, Wein A.J., Chacko S: Heterogeneity of bladder myocytes in


66

vitro: modulation of myosin isoform expression. Tissue & Cell, 33(3):219-232, 2001.

691. Wein A.J., Rovner ES: Pharmacologic management of the overactive bladder. Contemporary Urology, Suppl. 6:22-35, June 2001.

692. Appell RA, Abrams P, Drutz HP, VanKerrebroeck PEVA, Millard R, Wein A: Treatment of

overactive bladder: long-term tolerability and efficacy of tolterodine. World J Urol 19:141-147, 2001.

693. Malkowicz SB, McKenna WG, Vaughn DJ, Wan SX, Propert KJ, Rockwell K, Marks SHF, Wein

A.J., Kennedy AR: Effects of Bowman-Birk inhibitor concentrate (BBIC) in patients with benign prostatic hyperplasia. The Prostate, 48:16-28, 2001.

694. Ricci JA, Baggish JS, Hunt TL, Stewart WF, Wein A.J., Herzog AR, Diokno AC: Coping

strategies and health care seeking behavior in a US national sample of adults with symptoms suggestive of overactive bladder. Clinical Therapeutics 23(8), 1245-1253, 2001.

695. D’Amico AV, Whittington R, Malkowicz AB, Renshaw AA, Tomaszewski JE, Bentley C, Schultz D,

Rocha S, Wein A, Richie JP: Estimating the impact on prostate cancer mortality of incorporating prostate-specific antigen testing into screening. Urology, 58:406-410, 2001.

696. Cheung R, Altschuler MD, D’Amico AV, Malkowicz SB, Wein A.J., Whittington, R: Using the

receiver operating characteristic curve to select pretreatment and pathologic predictors for early and late postprostatectomy PSA failure. Urology 58:400-405, 2001.

697. Milsom I, Abrams P, Cardozo L, Roberts RG, Thüroff J, Wein A.J.: How widespread are the

symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU International, 87:760-766, 2001.

698. Andersson KE, Chapple C, Wein A: The basis for drug treatment of the overactive bladder.

World J Urol, 19:294-298, 2001.

699. Wein A.J., Rovner ES: Voiding function and dysfunction. In, Hanno PM, Malkowicz BM, Wein A.J. (eds), Clinical Manual of Urology, Third Edition. New York, McGraw-Hill, 2001, pp. 337-436, 2001.

700. Wein A.J., Rovner ES: Benign prostatic hyperplasia. In, Hanno PM, Malkowicz BM, Wein AJ

(eds), Clinical Manual of Urology, Third Edition. New York, McGraw-Hill, 2001, pp. 437-470.

701. Malkowicz SB, Wein A.J.: Adult Genitourinary Cancer. In, Hanno PM, Malkowicz BM, Wein A.J. (eds), Clinical Manual of Urology, Third Edition. New York, McGraw-Hill, 2001, pp. 471-487.

702. Wein A.J.: Pharmacological agents for the treatment of urinary incontinence due to overactive

bladder. Exp. Opin,. Invest. Drugs 10(1):65-83, 2001. 703. Liberman JN, Hunt TL, Stewart WF, Wein A, Zhou Z, Herzog AR, Lipton RB, Diokno AC: Health-

related quality of life among adults with symptoms of overactive bladder: Results from a US community-based survey. Urology, 57:1044-1050, 2001.

704. Cheung R, Altschuler MD, D’Amico AV, Malkowicz SB, Wein AJ, Whittington R,: ROC

optimization may improve risk stratification of prostate cancer patients. Urology 57:286-290, 2001.

705. Arafat, H.A., Kim, G., DiSanto, M.E., Wein, A.J. Chacko, S: Heterogeneity of bladder myocytes in


67

vitro: modulation of myosin isoform expression. Tissue and Cell. 33:219-232, 2001.

706. Sanchez-Ortiz, R., Wang, Z., Menon, C., DiSanto, M.E., Wein, A.J. Chacko, S: Estrogen modulates the expression of myosin heavy chain in detrusor smooth muscle. American J. of Physiology:Cell, 280: C433-C440, 2001.

707. Hypolite, J., DiSanto, M.E., Zheng, Y. Wein, A.J. Chacko, S: Regional variation in myosin

isoforms and phosphorylation at the resting tone in urinary bladder smooth muscle. American J. of Physiology:Cell. 280:C254-C264, 2001.

708. Rovner, ES and Wein, A.J.: Drug treatment of voiding dysfunction in women. (Textbook of

Female Urology and Urogynaecology, Cardozo L and Staskin, D, Isis Medical Media, Ltd, 7-7 Pratt Street, London NW1 OAE, 2001), Section IV, 32 – Treatment of Incontinence, Prolapse and Related Conditions, 2001, pp 359-408.

709. Wein A.J.: Pathophysiology and categorization of voiding dysfunction. Objectives for Urology

Residency Education. 5th Edition. Soc University Urology, 156-157, 2001.

710. Wein A.J.: Neurourologic and urodynamic assessment of the lower urinary tract. Objectives for Urology Residency Education. 5th Edition. Soc University Urology, 158-164, 2001.

711. D’Amico AV, Whittington R, Malkowicz SB, Weinstein M, Tomaszewski JE, Schultz D, Rhude M,

Rocha S, Wein AJ, Richie J: Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era. J Urol 166:2185-2188, 2001.

712. Wein A.J.: Neuromuscular dysfunction of the lower urinary tract in the adult and its treatment.

Objectives for Urology Residency Education. 5th Edition. Soc University Urology, 165-170, 2001.

713. Sanchez-Ortiz RF, Wein A.J., and Malkowicz SB: Benign and malignant tumors of the renal pelvis and ureter. Objectives for Urology Residency Education. 5th Edition. Soc University Urology, 269-271, 2001.

714. Steers WD, Barrett DM, Wein A.J.: Voiding dysfunction: diagnosis, classification and

management. In, Gillenwater JY, Grayhack JT, Howards SS, Mitchell ME (eds), Adult and Pediatric Urology, Fourth Edition. Philadelphia, Lippincott Williams & Wilkins, 2002, pp. 1115-1216.

715. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, vanKerrebroeck P, Victor A, Wein

A: The standardisation of terminology of lower urinary tract function: Report from the standardisation subcommittee of the International Continence Society. Neurourology and Urodynamics, 21:167-178, 2002.

716. Abrams P, Wein A.J.: The impact of overactive bladder on patients and society, and current

approaches to treatment. Monograph sponsored by Yamanouchi Europe BV, 2002, pp., 1-15.

717. Arafat HA, Wein A.J., Chacko S: Osteopontin gene expression and immunolocalization in the rabbit urinary tract. J Urol, 167:746-752, 2002.

718. Rovner ES, Wein A.J.: Once-daily, extended-release formulations of antimuscarinic agents in the

treatment of overactive bladder: A review. European Urology 41:6-14, 2002.

719. Robnett, T.J., Whittington, R., Malkowicz, S.B., Brereton, H.D., Van Arsdalen, K., Drach, G., Wein, A.J.: Long-term use of combined radiation therapy and hormonal therapy in the


68

management of stage D1 prostate cancer. Int. J. Radiation Oncology Biol. Phys., 53:1146-1151, 2002.

720. D’Amico AV, Whittington R, Malkowicz SB, Cote K, Loffredo M, Schultz D, Chen MH,

Tomaszewski JE, Renshaw AA, Wein AJ, Richie JP: Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era. Cancer 95:281-186, 2002.

721. Rovner, E, Wein, AJ: The treatment of overactive bladder in the geriatric patient, Clinical

Geriatrics 10:1-12, 2002.

722. Wein, A.J.: Pathophysiology and categorization of voiding dysfunction. In, Walsh, P., Retik, A., Vaughan, E.D., Jr., Wein, A.J. (eds): Campbell’s Urology, Eighth Edition, Saunders, Philadelphia, pp. 887-899, 2002.

723. Wein, A.J.: Neuromuscular dysfunction of the lower urinary tract and its treatment. In, Walsh, P.,

Retik, A., Vaughan, E.D., Jr., Wein, A.J. (eds): Campbell’s Urology, Eighth Edition, Saunders, Philadelphia, 2002, pp. 931-1026.

724. Margolis DJ, Wein A.J.: Color atlas of genital dermatology. In Walsh, P., Retik, A., Vaughan,

E.D., Wein, A.J. (eds): Campbell’s Urology, Eighth Edition, WB Saunders, Philadelphia, pp. 731-742, 2002.

725. Wein, A.J.: Pathophysiology and categorization of voiding dysfunction. In, Walsh, P., Retik, A.,

Vaughan, E.D., Jr., Wein, A.J. (eds): Campbell’s Urology Study Guide, 2nd edition, Saunders, Philadelphia, 2002, pp. 85-87.

726. Wein, A.J.: Neuromuscular dysfunction of the lower urinary tract. In, Walsh, P., Retik, A.,

Vaughan, E.D., Jr., Wein, A.J. (eds): Campbell’s Urology Study Guide, 2nd edition, Saunders, Philadelphia, 2002, pp. 94-106.

727. Chang S, Hypolite, JA, Zderic A, Wein, A.J., Chacko, S and DiSanto, ME: Enhanced force

generation by corpus cavernosum smooth muscle in rabbits with partial bladder outlet obstruction. J. Urol., 167:2636-2644, 2002.

728. Andersson, KE, Appell, R, Awad, S, Chapple, C, Drutz, H, Finkbeiner, A, Fourcroy, Haab, F,

Wein, A.J.: Pharmacological treatment of urinary incontinence. In Abrams P, Cardozo L, Khory S, Wein a. Incontinence, 2nd Edition, Plymbridge Distributors, Plymouth UK, 2002, pp 479-513.

729. Rovner ES, and Wein, A.J.: Practical urodynamics, Part I. AUA Update Series, American Urological Association, Inc., Volume XX1 (19):146-151, 2002.

730. Rovner ES, and Wein, A.J.: Practical urodynamics, Part II. AUA Update Series, American

Urological Association, Inc., Volume XX1 (20):154-159, 2002.

731. Zheng, Y., Weber, W.T., Wang, S., Wein, A.J., Zderic, S.A., Chacko, S., DiSanto, M.E.:. Generation of a cell line with smooth muscle phenotype from hypertrophied urinary bladder. Am. J. of Physiology:Cell, 283:C373-C382, 2002.

732. Chang, S., Hypolite, J.A., Zderic, S.A., Wein, A.J., Chacko, S., DiSanto, M.E.: Enhanced force

generation by corpus cavernosum smooth muscle in rabbits with partial bladder outlet obstruction. J. Urol., 167:2636-2644, 2002.


69

733. Rovner, E.S., and Wein, A.J.: Evaluation and management of overactive bladder in the elderly. Clinical Geriatrics, 10(1): 20-35, 2002.

734. Wein A.J., Lose G.R., Robertson G.L.: Nocturia in men, women and the elderly: a practical

approach. Brit J Urol Int., 90(3):28-31, 2002.

735. Wein A.J, Abrams P.: Statement from the First International Consultation on Nocturia: reaching for a consensus. Brit J. of Urol Int., 90(3):37, 2002.

736. Staskin D.R., Wein A.J., Andersson K.E., Bauer S.B., Blaivas J.G., Burgio K.L., Cardozo L.,

Chapple C.R., Dmochowski R.R., Gupta S., Mostwin J.L., Ouslander J.G., Weiss J.P., and King L: Overview consensus statement. Urology 60:5A (suppl):1-6, 2002.

737. Wein, A.J. and Rovner, E.S.: Pharmacologic management of urinary incontinence in women.,

Urol. Clinics North America 2002; 29:537-550.

738. Wein, A.J., and Rovner, E.S.: Definition and epidemiology of overactive bladder. Urology 60:5A (suppl):7-12, 2002.

739. Lieberfarb ME, Schultz D, Whittington R, Malkowicz SB, Tomaszewski JE, Weinstein M, Wein AJ,

Richie JP, D’Amico AV: Using PSA, biopsy Gleason score, clinical stage, and the percentage of positive biopsies to identify optimal candidates for prostate only radiation therapy. International Journal of Radiation Oncology, Biology, Physics. 53:898-903, 2002.

740. D’Amico AV, Chen MH, Malkowicz SB, Whittington R, Renshaw AA, Tomaszewski JE, Samofalov

Y, Wein AJ, Richie JP: Lower prostate specific antigen outcome than expected following radical prostatectomy in patients with high grade prostate and a prostatic specific antigen level of 4 ng/ml or less. J Urol 167:2025-20390, 2002.

741. Rovner ES, Wein AJ: Incidence and prevalence of overactive bladder. Curr Urol Rep 3:434-438,

2002.

742. Wein AJ, Hanno PM: Targets for therapy of the painful bladder. Urology 59 (5 Suppl 1):68-73, 2002.

743. Rovner ES, Gomes CM, Trigo-Rocha FE, Arap S, Wein AJ: Evaluation and treatment of the

overactive bladder. Rev Hosp Clin Fac Med Sao Paulo, 57:39-48. Review. 2002.

744. Rovner, E.S., Wein, A.J., Itano, N.B., Raz, S.: Diagnosis and reconstruction of the dorsal or circumferential urethral diverticulum. J. Urol. 170(1):82-86, 2003.

745. Mattiasson, A., Blaakaer, J., Hoye, K., Wein, A.J.; Tolterodine Scandanavian Study Group:

Simplified bladder training augments the effectiveness of tolterodine in patients with an overactive bladder. BJU Int. 91(1):54-60, 2003.

746. Chang, S., Hypolite, J.A., Changolkar, A., Wein, A.J., Chacko, S., DiSanto, M.E.: Increased

contractility of diabetic rabbit corpora smooth muscle in response to endothelin is mediated via Rho-kinase beta. Int. J. Impot. Res. 15(1):53-62, 2003.

747. Thomas, A., Woodard, C., Rovner, E.S., Wein, A.J.: Urologic complications of non-urologic

medications. Urol. Clin. North Am. 30(1):123-31, 2003.

748. Rovner ES, Wein AJ: Update on overactive bladder: pharmacologic approaches on the horizon. Curr Urol Rep 4(5):385-390, 2003.


70

749. Abrams, P., Cardozo, L., Fall, M., Griffiths, D., Rosier, P., Ulmsten, U., Van Kerrebroeck, P.,

Victor, A., Wein, A., Standardisation Sub-Committee of the International Continence Society: The standardization of terminology in lower urinary tract function: report from the standardization sub-committee of the International Continence Society. Urology. 61(1):37-49, 2003.

750. Malkowicz, S.B., Liu, S.P., Broderick, G.A., Wein, A.J., Kennedy, A.R.: Effect of the Bowman-

Birk inhibitor (a soy protein) on in vitro bladder neck/urethral and penile corporal smooth muscle activity. Neurourol. Urodyn. 22(1):54-7, 2003.

751. Sanchez-Ortiz, R.F., Huang, W.C., Mick, R., Van Arsdalen, K.N., Wein, A.J., Malkowicz, S.B.: An

interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. J. Urol. 169(1):110-5; discussion 115, 2003.

752. DiSanto, M.E., Stein, R., Chang, S., Hypolite, J., Zheng, Y., Zderic, S., Wein, A.J., Chacko, S.:

Alteration in expression of myosin isoforms in detrusor smooth muscle following bladder outlet obstruction. Am. J. Physiol. Cell Physiol. 285: C1397-C1410, 2003.

753. Sant, G.R., Propert, K.J., Hanno, P.M., Burks, D., Culkin, D., Diokno, A.C., Hardy, C., Landis,

J.R., Mayer, R., Madigan, R., Messing, E.M., Peters, K., Theoharides, T.C., Warren, J., Wein, A.J., Steers, W., Kusek, J.W., Nyberg, L.M., The Interstitial Cystitis Clinical Trials Group: A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. J. Urol. 170: 810-815, 2003.

754. Bing, W., Chang, S., Hypolite, J.A., DiSanto, M.E., Zderic, S.A., Rolf, L., Wein, A.J., Chacko, S.:

Obstruction-induced changes in urinary bladder smooth muscle contractility: a role for Rho kinase. Am. J. Phys. 285(5):F990-7, 2003.

755. Stewart, W.F., Van Rooyen, J.B., Cundiff, G.W., Abrams, P., Herzog, A.R., Corey, R., Hunt, T.L,

Wein, A.J.: Prevalence and burden of overactive bladder in the United States. World J. Urol. 20(6):327-36, 2003.

756. Rovner, E.S., Banner, M.P., Ramchandani, P., Wein, A.J.: Clinical video urodynamics: AUA

Update Series, 22(lesson 35): 278-283, 2003.

757. Wein, A.J.: Treatment of overactive bladder: New studies with trospium chloride. Am. J. Urol. Rev. (Supplement), 1(5): 12-15, 2003.

758. Rovner,E.S., Wein, A.J.: The overactive bladder. Campbell’s Urology Updates 8th Edition, 1(3):

pp.1-12, 2003.

759. Colli, E., Artibani, W., Goka, J., Parazzini, A.J.: Are urodynamic tests useful tools for the initial conservative management of non-neurogenic urinary incontinence? A review of the literature. Eur. Urol. 43, 63-69, 2003.

760. Rovner ES, Wein AJ: Evaluation of lower urinary tract symptoms in females. Current Opinion in

Urology, 13(4):273-278, 2003.

761. Rovner ES, Wein, AJ: Diagnosis and reconstruction of the dorsal or circumferential urethral diverticulum. JUrol 170:82-86, discussion, 2003.

762. Wein AJ: Diagnosis and treatment of the overactive bladder. Urology 62(5 Suppl 2):20-27, 2003.


71

763. Chang, S., Hypolite, J.A., Changolkar, A., Wein, A.J., Chacko, S., DiSanto, M.E.: Increased

contractility of diabetic rabbit corpora smooth muscle in response to endothelin is mediated via Rho-kinase β. Int. J. Impotence Res., 15, 53-62, 2003.

764. Chang, S., Hypolite, J.A., Zderic, S.A., Wein, A.J., Chacko, S., DiSanto, M.E. Enhanced force

generation by corpus cavernosum smooth muscle in rabbits with partial bladder outlet obstruction. J. of Urol. 167:2636-2644, 2003.

765. Rovner ES, Wein AJ: Stress incontinence after radical prostatectomy. In, Mydlo JH and Godec

CJ (eds) Prostate Cancer: Science and Clinical Practice, San Diego, CA, Academic Press, pp, 327-338, 2003.

766. Hutcheson JC, Stein R, Canning DA, Wein AJ, Chacko SK, Zderic SA: Murine in vitro whole

bladder physiology. Adv Esp Med Biol 539 (Pt A):337-345, 2003.

767. Shukla A, Zheng Y, DiSanto M, Wein AJ, Zderic SA, Chacko S: Transfectioin and bethanechol exposure induce over-expression of h-caldesmon and filament assembly in bladder smooth muscles. J Urol 169:168-169, 2003.

768. Wu, H., Zderic, S., Wein, A.J., Chacko, S. Decrease in maximal force generation in the neonatal

mouse bladder corresponds to shift in myosin heavy chain isoform composition. J. Urol. 171: 841-844, 2004.

769. Zhang, E.Y., Stein, R., Chang, S., Zheng, Y., Zderic, S.A., Wein, A.J., Chacko, S. Smooth

muscle hypertrophy following partial bladder outlet obstruction is associated with overexpression of non-muscle caldesmon. Am. J. Path., 164(2): 601-612, 2004.

770. Rovner, E.S., Wein, A.J. Treatment options for stress urinary incontinence. Reviews in Urology, 6(suppl 3): S29-S47, 2004.

771. Smith, R.P., Malkowicz, S.B., Whittington, R., VanArsdalen, K., Tochner, Z., Wein, A.J.:

Identification of clinically significant prostate cancer by prostate-specific antigen screening. Arch. Intern. Med., 164: 1227-1230, 2004.

772. Rovner, E., Wein, A.J. Causes and consequences of OAB. Contemporary Urology

(supplement): S4-S6, 2004.

773. Rovner ES, Wein AJ: Stress urinary incontinence. In, Resnick M, Elder JA, Spirnak JP (eds): Decision Making in Urology 3rd edition. Hamilton, Ontario: BC Decker, Inc. 2004, pp. 268-273.

774. Rovner ES, Wein AJ: Bladder diverticula in adults. In, Resnick M, Elder JA, Spirnak JP (eds):

Decision Making in Urology 3rd edition. Hamilton, Ontario: BC Decker, Inc. 2004, pp. 260-263.

775. Rovner ES, Wein AJ: Neurogenic bladder. In, Resnick M, Elder JA, Spirnak JP (eds): Decision Making in Urology 3rd edition. Hamilton, Ontario: BC Decker, Inc. 2004, pp. 278-283.

776. Zeigler-Johnson,C., Friebel,T., Walker, A., Wang,Y., Spangler,E., Panossian,S., Patacsil, M.,

Aplenc,R., Wein,A.J., Malkowicz, S.B., Rebbeck, T.R. CYP3A4, CYP3A5, and CYP3A43 genotypes and haplotypes in the etiology and severity of prostate cancer. Cancer Research, 64: 8461-8467, 2004.

777. Andersson KE, Wein AJ. Pharmacology of the lower urinary tract: basis for current and future


72

treatments of urinary incontinence. Pharmacological Reviews, 56:581-631, 2004.

778. Rovner ES, Wein AJ: Pharmacologic management of urinary incontinence in the female. Minerva Ginecol 56:327-347, Review, 2004.

779. Chang S, Hypolite JA, Velez M, Changolkar A, Wein AJ, Chacko S, DiSanto M: Downregulation

of cGMP-dependent protein kinase-1 activity in the corpus cavernosum smooth muscle of diabetic rabbits. Am J Physiol Regul Integr Comp Physiol 287:R950-960, 2004.

780. Shukla AR, Nguyen T, Zheng Y, Zderic SA, DiSanto M, Wein AJ, Chacko S: Over expression of

smooth muscle specific caldesmon by transfection and intermittent agonist induced contraction alters cellular morphology and restores differentiated smooth muscle phenotype. J Urol 171:1949-1954, 2004.

781. Chacko S, Chang S, Hypollite J, DiSanto M, Wein AJ: Alteration of contractile and regulatory

proteins following partial bladder outlet obstruction. Scandinavian Journal of Urology and Nephrology, 215:26-36, 2004.

782. Spangler E, Zeigler-Johnson CM, Malkowicz SB, Wein AJ, Rebbeck TR. Association of prostate

cancer family history with histopathological and clinical characteristics of prostate tumors. Int. J. Cancer, 113: 471-474, 2005.

783. Kothary N, Soulen MC, Clark TWI, Wein AJ, Shlansky-Goldberg RD, Crino PB, Stavropoulos SW.

Renal angiomyolipoma: Long-term results after arterial embolization. J Vasc Interv Radiol, 16:45-50, 2005

784. Guzzo TJ, Manish V, Wei-Ting H, D’Amico A, Tomaszewski J, Whittington R, Wein AJ, Van Arsdalen K, Malkowicz B. Impact of multiple biopsy cores on predicting final tumor volume in prostate cancer detected by a single microscopic focus of cancer on Biopsy. Urology; 66: 361-365, 2005.

785. Staskin DR, Wein A. Is it possible to make cross-study comparisons of urinary continence rates

in patients with overactive bladder? Current Medical Research and Opinions, 21:(6); 835-837, 2005.

786. Chang, S, Hypolite JA, Zderic SA, Wein AJ, Chacko S, DiSanto ME. Increased corpus

cavernosum smooth muscle tone associated with partial bladder outlet obstruction is mediated via Rho-kinase. Am J Physiol Regul Integr Comp Physiol 289: R1124-R1130, June 2005.

787. Staskin DR, Dmochowski RR, Wein AJ. Solifenacin versus tolterodine—A head-to-head study:

Finally! But not final? Curr Urol Rep. 6(6);403-4, 2005.

788. Vira MA, Tomaszewski JE, Hwang WT, D’Amico AV, Whittington R, VanArsdalen K, Wein AJ, Malkowicz SB. Impact of the percentage of positive biopsy cores on the further stratification of primary grade 3 and grade 4 Gleason score 7 tumors in radical prostatectomy patients. Urology, 66(5): 1015-19, 2005.

789. Chapple CR, Wein AJ, Artibani W, Bribaker L, Haab F, Heesakkers JP, Lightner D: A critical

review of diagnostic criteria for evaluating patients with symptomatic stress urinary incontinence. BJU Int 95:327-334, 2005.

790. Chapple CR, Wein AJ: The urgency of the problem and the problem of urgency in the overactive

bladder. BJU Int 95:274-275, 2005.


73

791. Wein AJ: Conversations. BJU Int. 2005;95(1):1-2

792. Mannukarottu AS, Hypolite JA, Zderic SA, Wein AJ, Chacko S, DiSanto M: Regional alterations in the expression of smooth muscle myosin isoforms in response to partial bladder outlet obstruction. J Urol 173:302-308, 2005.

793. Changolkar AK, Hypolite JA, DiSanto M, Oates PJ, Wein AJ, Chacko S: Diabetes induced

decrease in detrusor smooth muscle force is associated with oxidative stress and overactivity of aldose reductase. J Urol 173:309-313, 2005.

794. Mayer R, Propert KJ, Peters KM, Payne CK, Zhang Y, Burks D, Culkin DJ, Diokno A, Hanno P,

Landis JR, Madigan R, Messing EM, Nickel JC, Sant GR, Warren J, Wein AJ, Kusek JW, Nyberg LM, Foster HE, Interstitial Cystitis Clinical Trials Group: A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitis. J Urol 173:1186-1191, 2005.

795. Abrams P, Hanno P, Wein A: Overactive Bladder and Painful Bladder Syndrome: There Need

not be Confusion. (Wiley InterScience Online Publication 2 December 2004); Neurourology and Urodynamics 24:149-150 (2005)

796. Mannukarottu AS, Changolkar AK, DiSanto ME, Wein AJ, Chacko S: Over expression of smooth

muscle thin filament associated proteins in the bladder wall of diabetics. J Urol 174:360-364, 2005.

797. Chapple CR, Wein AJ, Brubaker L, Dmochowski R, Pons ME, Haab F, Hill S: Stress

incontinence injection therapy: what is best for our patients? Eur Urol 48:552-565, 2005.

798. Jayadevappa R, Bloom BS, Fomberstein SC, Wein AJ, Malkowicz SB: Health related quality of life and direct medical care cost in newly diagnosed younger men with prostate cancer. J Urol 174:1059-1064, 2005.

799. McAleer S, Schultz D, Whittington R, Malkowicz SB, Renshaw A, Wein AJ, RIchie J, D’Amico A:

PSA outcome following radical prostatectomy for patients with localized prostate Ca stratified by prostatectomy findings and the preop PSA level. Urologic Oncology 5:311-317, 2005.

800. Rennert H, Zeigler-Johnson CM, Addya K, Finley MJ, Walker AH, Spangler E, Leonard DG, Wein

AJ, Malkowicz SB, Rebbeck TR: Association of susceptibility Alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men. Cancer Epidemiol Biomarkers Prev 14:949-957, 2005.

801. Chang S, Hypolite JA, Zderic SA, Wein AJ, Chacko S, Disanto ME. Increased corpus

cavernosum smooth muscle tone associated with partial bladder outlet obstruction is mediated via Rho-kinase. Am J Physiol Regul Integr Comp Physiol. 2005;289:R1124-1130.

802. Chang S, Hypolite JA, DiSanto ME, Changolkar A, Wein AJ, Chacko S. Increased basal

phosphorylation of detrusor smooth muscle myosin in alloxan-induced diabetic rabbit is mediated by upregulation of Rho-kinase {beta} and CPI-l7. Am J Physiol Renal Physiol, 2006 Mar:290(3):F650-6. Epub 2005 Oct 4

803. Mannukarottu AS, DiSanto ME, Zderic SA, Wein AJ, Chacko S: Altered expression of thin

filament-associated proteins in hypertrophied urinary bladder smooth muscle. Neurourol Urodyn 25:78-88, 2006.


74

804. Hypolite J, Chang S, Zheng Y, DiSanto M, Zderic S, Wein AJ, Chacko S: Partial bladder outlet obstruction induces urethral smooth muscle hypertrophy and decreased force generation. J Urol 175:777-782, 2006.

805. Rovner ES, Wein AJ: Antimuscarinic drugs for the treatment of female urinary incontinence.

Women’s Health 2:1-15, 2006.

806. Propert KJ, Mayer RD, Wang Y, Sant GR, Hanno PM, Peters KM, Kusek JW and the Interstitial Cystitis Clinical Trials Group (Wein AJ Primary Investigator, University of Pennsylvania): Responsiveness of symptom scales for interstitial cystitis. Urology 67:55-59, 2006.

807. Blaivas JG; Burnett AL; Wein AJ. Current Trends in Lower Urinary Tract Health Highlights From

Annual Advances in Genitourinary Health: Scientific Update. J Urol, suppl. 175:3 Part 2; S1-S4, March 2006.

808. Wein AJ; Rackley RR. Overactive Bladder: A Better Understanding of Pathophysiology,

Diagnosis and Management. J Urol, suppl. 175:3 Part 2; S5-S10, March 2006.

809. Burnett AL; Wein AJ. Benign Prostatic Hyperplasia in Primary Care: What You Need to Know. J Urol, suppl. 175:3 Part 2; S19-S24, March 2006.

810. LaBelle E; Zderic S; Delaney D; Hypolite J; Wein A; Chacko S. Lipid Signaling Changes in

Smooth Muscle Remodeling Associated With Partial Urinary Bladder Outlet Obstruction. Neurourology and Urodynamics Vol 25:2; 179-184, January 2006.

811. Wein AJ. Overview: Developments in the pharmacological therapy for overactive bladder.

British Journal of Urology International (BJUI), 98:suppl.1; pp 88-89, September 2006.

812. Wein AJ, Khullar V, Wang JT, Guan Z. Achieving continence with antimuscarinic therapy for overactive bladder: effects of baseline incontinence severity and bladder diary duration. British Journal of Urology International (BJUI), 2006; 99:360-363

813. Wein AJ, Sand P, Newman DK. The Challenges of Managing OverActive Bladder. Institute for

Continuing Healthcare Education; Philadelphia, PA 2006; pp. 7-32.

814. Abrams P, Andersson K-E, Buccasfusco JJ, Chapple C, deGroat WC, Fryer AD, Kay G, Laties A, Nathanson NM, Pasricha PJ, Wein AJ. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. British Journal of Pharmacology (2006)148; pp 565-578.

815. Basha M, Chang S, Smolock EM, Moreland RS, Wein AJ, Chacko SK. Regional differences in myosin heavy chain isoform expression and maximal shortening velocity of the rat vaginal wall smooth muscle. Am J Physiol Regul Integr Comp Physiol 291: R1076-1084, 2006

816. D’Ancona C, Griffiths D, VAN Kerrebroeck P, Nishizawa O, Nitti V, Keong Tatt F, Tubaro A, Wein

A, Belal M. Lower Urinary Tract Symptoms: Etiology, Patient Assessment and Predicting Outcome from Therapy in J. McConnell, P. Abrams, L. Denis, S. Khoury, C. Roehrborn (editors) Male Lower Urinary Tract Dysfunction-Edition 2006 Health Publications, Editions 21 Paris, France: pp. 69-142.

817. Staskin D, Wein AJ. Classification of Voiding Dysfunction in the Female Patient in Cardozo L,

Staskin D (editors) Textbook of Female Urology and Urogynecology Informa Healthcare, Milton Park, England (UK) 2006, pp. 173-184.


75

818. Wein AJ, Moy ML. Drug Treatment of Voiding Dysfunction in Women in Cardozo L, Staskin D

(editors) Textbook of Female Urology and Urogynecology Informa Healthcare, Milton Park, England (UK) 2006, pp. 485-532.

819. Rosenberg MT, Wein AJ, Andersson K-E, Dmochowski RR, Kaplan SA, Luber KM, Nitti VW,

Rovner ES. Advances in Management of Overactive Bladder. Urology Times Supplement, December 2006; pp. 3-15.

820. Clark TW, Malkowicz B, Stavropoulos SW, et al. Radiofrequency ablation of small renal cell

carcinomas using multitined expandable electrodes: preliminary experience. J Vasc Interv Radiol. 2006;17:513-519.

821. Hurwitz MD, Schultz D, Richie JP, et al. Radical prostatectomy for high-grade prostate cancer.

Urology. 2006;68:367-370.

822. Jayadevappa R, Chhatre S, Whittington R, Bloom BS, Wein AJ, Malkowicz SB. Health-related quality of life and satisfaction with care among older men treated for prostate cancer with either radical prostatectomy or external beam radiation therapy. BJU Int. 2006;97:955-962.

823. Kutikov A, Fossett LK, Ramchandani P, et al. Incidence of benign pathologic findings at partial

nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging. Urology. 2006;68:737-740.

824. Resnick MJ, Wein AJ. Transitional cell carcinoma of the fossa navicularis in a man with

preexisting adenocarcinoma of the prostate. Urol Int. 2006;76:186-188.

825. Staskin DR, Kaplan SA, Wein AJ. Antimuscarinic therapy in men with bladder outlet obstruction. Curr Urol Rep. 2006;7:437-439.

826. Wein AJ. Re: Blaivas JG. 2004. Ghost unwriting. Neurourol Urodynam 23:287. Neurourol Urodyn.

2006;25:297; author reply 297.

827. Wein AJ. The Urology Report: Selected Reports from the 2006 Annual Meeting of the American Urological Association, Direct One Communications, Inc., 2007

828. Wein AJ. Pathophysiology and Classification of Voiding Dysfunction in Wein AJ, Kavoussi LR,

Novick AC, Partin AW, Peters CA. Campbell-Walsh Urology Ninth Edition, Saunders/Elsevier, Philadelphia, PA 2007, pp.1973-1985

829. Wein AJ. Lower Urinary Tract Dysfunction and Neurologic Injury and Disease in Wein AJ,

Kavoussi LR, Novick AC, Partin AW, Peters CA. Campbell-Walsh Urology Ninth Edition Saunders/Elsevier, Philadelphia, PA 2007, pp. 2011-2045

830. Andersson K-E, Wein AJ. Pharmacologic Management of Storage and Emptying Failure in Wein

AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA. Campbell-Walsh Urology Ninth Edition Saunders/Elsevier, Philadelphia, PA 2007, pp. 2091-2123

831. Moy ML, Wein AJ. Additional Therapies for Storage and Emptying Failure in Wein AJ, Kavoussi

LR, Novick AC, Partin AW, Peters CA. Campbell-Walsh Urology Ninth Edition Saunders/Elsevier, Philadelphia, PA 2007, pp. 2288-2304.

832. Wein AJ. Pathophysiology and Classification of Voiding Dysfunction. Campbell-Walsh Urology


76

Ninth Edition Review, Saunders/Elsevier, Philadelphia, PA 2007, pp. 251-254

833. Wein AJ. Lower Urinary Tract Dysfunction in Neurologic Injury and Disease. Campbell-Walsh Urology Ninth Edition Review, Saunders/Elsevier, Philadelphia, PA 2007, pp. 262-267

834. Andersson K-E, Wein AJ. Pharmacologic Management of Storage and Emptying Failure.

Campbell-Walsh Urology Ninth Edition Review, Saunders/Elsevier, Philadelphia, PA 2007, pp. 275-280

835. Moy ML, Wein AJ. Additional Therapies for Storage and Emptying Failure. Campbell-Walsh

Urology Ninth Edition Review, Saunders/Elsevier, Philadelphia, PA 2007, pp. 313-315

836. Wein AJ, Moy ML. Voiding Function and Dysfunction; Urinary Incontinence. Penn Clinical Manual of Urology, 1st Edition, Saunders/Elsevier, Philadelphia, PA 2007, pp 341-478

837. Wein AJ, Lee DI. Benign Prostatic Hyperplasia and Related Entities. Penn Clinical Manual of

Urology, 1st Edition, Saunders/Elsevier, Philadelphia, PA 2007, pp 479-522

838. Malkowicz SB, Vaughn DJ, Wein AJ. Adult Genitourinary Cancer – Prostate and Bladder. Penn Clinical Manual of Urology, 1st Edition, Saunders/Elsevier, Philadelphia, PA 2007, pp 523-570

839. Guzzo TJ, Vira MA, Neway W, Hwang W-T, Tomaszewski J, VanArsdalen K, Wein AJ, Malkowicz

SB. Minimal Tumor Volume May Provide Additional Prognostic Information in Good Performance Patients After Radical Prostatectomy. Elsevier, Inc., Urology 2007; 69:1147-1151

840. Spangler E, Zeigler-Johnson CM, Coomes M, Malkowicz SB, Wein A, Rebbeck TR. Association

of obesity with tumor characteristics and treatment failure of prostate cancer in African-American and European-American Men. J Urol 178:1939-1944, 2007

841. Jayadevappa R, Johnson JC, Chhatre S, Wein AJ, Malkowicz SB. Ethnic Variation in Return to

Baseline Values of Patient-Reported Outcomes in Older Prostate Cancer Patients. American Cancer Society – Cancer 2007; 109:2229-2238

842. Wein AJ, Dmochowski RR. Strategies for data comparison for drugs used in the treatment of

overactive bladder. The Overactive Bladder Evaluation and Management, Informa Healthcare (Informa UK, Ltd) 2007; pp 239-252

843. Kasturi S, Kutikov A, Guzzo TJ, Smith AL, Wein AJ. Modern management of

pheochromocytoma. Nature Clinical Practice Urology, 2007; Vol 4:11:pp 630-633

844. Lee U, Baskin L, Schaefer W, Lemack GE, Wein AJ, Daneshgari F. Highlights of the Urethral Dysfunction Sessions at the Society for Urodynamics and Female Urology. Current Bladder Dysfunction Reports 2007, 2:71-76

845. Griffiths D, Abrams P, D’Ancona CA, van Kerrebroeck P, Nishizawa O, Nitti VW, Tatt FK, Tubaro A, Wein AJ, Belal M. The Urodynamic Evaluation of Lower Urinary Tract Symptoms in Men. Current Bladder Dysfunction Reports 2008, 3;Vol 1:49-57

846. Vira MA, Guzzo T, Heitjan DF, Tomaszewski JE, D’Amico§, Wein AJ, Malkowicz SB. Is the biopsy Gleason score important in predicting outcomes for patients after radical prostatectomy once the pathological Gleason score is known? British Journal of Urology International, 2008; Vol 101:pp 1232-1236

847. Wein AJ, Moy ML. Categorization of Voiding Dysfunction. Female Urology, Third Edition, 2008;


77

pp 161-171

848. Wein AJ, Moy ML. Drug Treatment of Urinary Incontinence in Women. Female Urology, Third Edition, 2008; pp 233-256

849. Cetnar JP, Malkowicz SB, Palmer SC, Wein AJ, Vaughn DJ. Pilot trial of adjuvnt paclitaxel plus estramustine in resected, High-risk prostate cancer. Urology 71:942-946, 2008

850. Chapple CR, Wein AJ, Abrams P, Dmochowski RR, Guiliano F, Kaplan SA, McVary KT, Roehrborn CG. Lower urinary tract symptoms revisited: A broader clinical perspective. European Urology 54:563-569, 2008.

851. Kaplan SA, Wein AJ, Staskin DR, Roehrborn CG, Steers WD. Urinary Retention and Post-Void Residual Urine in Men: Separating Truth From Tradition. J Urol 2008, 180:47-54

852. Canter D, Guzzo TJ, Resnick MJ, Brucker B, Vira M, Chen Z, Tomaszewski J, VanArsdalen K, Wein AJ, Malkowicz SB. Hydronephrosis is an independent predictor of poor clinical outcome in patients treated for muscle-invasive transitional cell carcinoma with radical cystectomy. Urology. 2008;72:379-383

853. Guzzo TJ, Kutikov A, Canter DJ, Tomaszewski JE, Magerfleish L, VanArsdalen K, Wein AJ, Malkowicz SB. The clinical and pathological history of prostate cancer progression in men with a prior history of high grade prostatic intraepithelial neoplasia. Can J Urol. 2008;15:4174-4178; discussion 4179.

854. Rebbeck TR, Rennert H, Walker AH, Panossian S, Tran T, Walker K, Spangler E, Patacsil-Coomes M, Sachdeva R, Wein AJ, Malkowicz SB, Zeigler-Johnson C. Joint effects of inflammation and androgen metabolism on prostate cancer severity. Int J Cancer. 2008;123:1385-1389.

855. Resnick MJ, Canter D, Brucker BM, Kutikov A, Guzzo TJ, Wein AJ. A case of synchronous bilateral testicular seminoma. Nat Clin Pract Urol. 2008;5:397-401.

856. Andersson KE, Chapple CR, Cardozo L, Cruz F, Hashim H, Michel MC, Tannenbaum C, Wein AJ. Pharmacological Treatment of Urinary Incontinence. INCONTINENCE, 4th Edition, Health Publication, Ltd; 631-700, 2009.

857. Andersson KE, Chapple CR, Cardozo L, Cruz F, Hashim H, Michel MC, Tannenbaum C, Wein AJ. Pharmacological Treatment of Overactive Bladder: report from the International Consultation on Incontinence. Current Opinion In Urology 2009,19:380-394

858. Abrams P, Andersson KE, Birder L, Brubaker L, Cardozo L, Chapple C, Cottenden A, Davila W, de Ridder D, Dmochowski R, Drake M, DuBeau C, Fry C, Hanno P, Hay Smith J, Herschorn S, Hosker G, Kelleher C, Koelbl H, Khoury S, Madoff R, Milsom I, Moore K, Newman D, Nitti V, Norton C, Nygaard I, Payne C, Smith A, Staskin D, Tekgul S, Thuroff J, Tubaro A, Vodusek DB, Wein A, Wyndaele JJ, et al. 4th International Consultation on Incontinence, Recommendations of the International Scientific Committee: Evaluation and Treatment of Urinary Incontinence, Pelvic Organ Prolapse and Faecal Incontinence. INCONTINENCE, 4th Edition, Health Publication, Ltd; 1767-1820, 2009.

859. Coyne KS, Wein AJ, Tubaro A, Sexton CC, Thompson CL, Kopp ZS, Aiyer LP. The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS. British Journal of Urology International (BJUI), 103:suppl.3; pp 4-11, April 2009.

860. Sexton CC, Coyne KS, Kopp ZS, Irwin DE, Milsom I, Aiyer LP, Tubaro A, Chapple CR, Wein AJ on behalf of the EpiLUTS Team. The overlap of storage, voiding and postmicturition symptoms


78

and implications for treatment seeking in the USA, UK and Sweden: EpiLUTS. British Journal of Urology International (BJUI), 103:suppl.3; pp 12-23, April 2009.

861. Wein AJ, Coyne KS, Tubaro A, Sexton CC, Kopp ZS, Aiyer LP. The impact of lower urinary tract symptoms on male sexual health: EpiLUTS. British Journal of Urology International (BJUI), 103:suppl.3; pp 33-41, April 2009.

862. Hypolite JA, Chang S, LaBelle E, Babu GJ, Periasamy M, Wein AJ, Chacko S. Deletion of SM-B, the high ATPase isoform of myosin, upregulates the PKC-mediated signal transduction pathway in murine urinary bladder smooth muscle. Am J Physiol Renal Physiol. 2009 Mar;296(3):F658-665. Epub 2008 Dec 3

863. Resnick MJ, Canter DJ, Guzzo TJ, Brucker BM, Bergey M, Sonnad SS, Wein AJ, Malkowicz SB.

Does race affect postoperative outcomes in patients with low-risk prostate cancer who undergo radical prostatectomy? Urology. 2009 Mar;73(3):620-623. Epub 2008 Dec 18

864. Hall SA, Link CL, Tennstedt SL, Mollon P, Aiyer LP, Chapple CR, Wein AJ, Rosen RC.

Urological symptom clusters and health-related quality-of-life: results from the Boston Area Community Health Survey. BJU Int. 2009 Jun; 103(11):1502-1508 Epub 2009 Jan 14

865. Chang S, Hypolite JA, Mohanan S, Zderic SA, Wein AJ, Chacko S. Alteration of the PKC-mediated signaling pathway for smooth muscle contraction in obstruction-induced hypertrophy of the urinary bladder. Lab Invest. Jul 2009;89:823-832.

866. Jayadevappa R, Chhatre S, Wein AJ, Malkowicz SB. Predictors of patient reported outcomes and cost of care in younger men with newly diagnosed prostate cancer. The Prostate 2009 Jul;69:1067-1076

867. Coyne KS, Sexton CC, Thompson CL, Milsom I, Irwin D, Kopp ZS, Chapple CR, Kaplan S,

Tubaro A, Aiyer LP, Wein AJ. The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study. BJU Int. 2009 Aug; 104(3);352-360. Epub 2009 Mar 5

868. Basha M, LaBelle EF, Northington GM, Wang T, Wein AJ, Chacko S. Functional significance of muscarinic receptor expression within the proximal and distal rat vagina. Am J Physiol Regul Integr Comp Physiol 297:R1486-R1493, 3 September 2009

869. Ellsworth PI, Brunton SA, Wein AJ, Rovner ES. Frequently asked questions in the evaluation and management of overactive bladder. An Expert Panel Review. Supplement to The Journarl of Family Practice, Vol 58, No. 10, October 2009.

870. Resnick MJ, Canter DJ, Guzzo TJ, Magerfleisch L, Tomaszewski JE, Brucker BM, Bergey MR, Sonnad SS, Wein AJ, Malkowicz SB. Defining pathological variables to predict biochemical failure in patients with positive surgical margins at radical prostatectomy: implications for adjuvant radiotherapy. BJU International (accepted Jul 2009; published online Nov 2009)

871. Polyák E, Boopathi E, Mohanan S, Deng M, Zderic SA, Wein AJ, Chacko S. Alterations in Caveolin Expression and Ultrastructure After Bladder Smooth Muscle Hypertrophy. J Urol 182(5):2497-2503 November 2009

872. Cardozo L, Chapple C, Wein A. Urgency as the cardinal symptom of overactive bladder: a critical analysis. World J Urol 2009 Dec; 27(6):701-703. Epub 2009 Nov 15


79

873. Andersson K-E, Dmochowski R, Wein AJ. Minimally Invasive Therapy for Neurogenic Detrusor Overactivity: A Review. UroToday International Journal Vol 2(6) Dec 2009

874. Staskin DR, Wein AJ. Classification of Lower Urinary Tract Dysfunction in the Female Patient. In Textbook of Female Urology and Urogynecology, Third Edition, Volume 1. Published in 2010 by Informa Healthcare (in London, UK and simultaneously in New York, USA).

875. Smith AL, Wein AJ. Antimuscarinic Pharmacotherapy for Overactive Bladder: CML – Urology (Current Medical Literature-Urology) 2010;16(1):1-11

876. Smith AL, Wein AJ. Drug treatment of voiding dysfunction in women. In Cardozo L, Staskin DR (eds): Textbook of Female Urology and Urogynecology, 3rd Edition, Chapter 42, pp: 418-446. London: Informa Healthcare, 2010 (accepted, in press).

877. Smith AL, Wein AJ. Recent advances in management of bladder overactivity. F1000 Medicine Reports February 2010, 2:9. PMID: 20948824

878. Hanno P, Lin A, Nordling J, Nyberg L, van Ophoven A, Ueda T, Wein A. Bladder Pain Syndrome: International Consultation on Incontinence-Research Society. Neurourol Urodyn 29(1):191-198, 2010

879. Abrams P, Cardozo L, Wein A. The International Consultation on Incontinence, Research Society (ICI-RS). Neurourology and Urodynamics 2010 April;29(4):596-597

880. Wyndaele JJ, Bruschini H, Madersbacher H, Moore K, Pontari M, Wein A. Neurological Patients Need Evidence-Based Urological Care. Neurourol Urodyn 2010 Apr;29(4):662-669

881. Resnick MJ, Guzzo TJ, Canter DJ, Tomaszewski JE, Bergy MR, Sonnad S, Wein AJ, Malkowicz SB. Defining pathologic parameters to predict biochemical failure in patients with positive surgical margins at radical prostatectomy: Implications for adjuvant radiation therapy. BJU International Vol 105(10)pp.1377-1380(4) May 2010. (Epub Nov 2009)

882. Chang S, Gomes CM, Hypolite JA, Marx J, Alanzi J, Zderic SA, Malkowicz B, Wein AJ, Chacko S. Detrusor overactivity is associated with downregulation of large-conductance calcium- and voltage-activated potassium channel protein. Am J Phys – Renal Phys 298(6):F1416-23, Jun 2010. (Epub April 2010)

883. Mucksavage P, Mitchell C, Kutikov A, Wein AJ, Torigian D, Malkowicz SB. Anthropometric differences in obese men with biochemical failure after radical retropubic prostatectomy. ARTICLE IN PRESS (accepted May 10; received in revised form Jul 12; accepted Jul 13 2010) Urol Oncol. 2011 Mar 9 [Epub ahead of print]

884. Jayadevappa R, Schwartz JS, Chhatre S, Gallo JJ, Wein AJ, Malkowicz SB. The Burden of Out-of-Pocket and Indirect Costs of Prostate Cancer. The Prostate 2010 Aug;70(11):1255-64

885. Smith, AL, Wein AJ. Recent advances in the development of antimuscarinic agents for overactive bladder. Trends Pharmacol Sci. 2010 Oct:31(10):470-5. PMID: 20801529

886. Mucksavage P, Kutikov A, Magerfleisch L, Van Arsdalen K, Wein AJ, Ramchandani P, Malkowicz SB. Comparison of radiographical imaging modalities for measuring the diameter of renal masses: is there a sizeable difference? BJU International (accepted for publication 8 October 2010) BJU Int. 2011 Feb 23 [Epub ahead of print)


80

887. Sehgal SS, Wein AJ, Bing Z, Malkowicz SB, Guzzo TJ. Neuroendocrine Tumor of the Bladder. Reviews In Urology, 2010 Fall;12(4):e197-201

888. Pan XQ, Gonzalez JA, Chang S, Chacko S, Wein AJ, Malykhina AP. Experimental colitis triggers the release of substance P and calcitonin gene-related peptide in the urinary bladder via TRPV1 signaling pathways. Experimental Neurology. 225(2):262-73, 2010 Oct

889. Valentino RJ, Wood SK, Wein AJ, Zderic SA. The bladder-brain connection: putative role of corticotrophin-releasing factor. Nat Rev Urol. 2010 Dec 7 [Epub ahead of print]. Nat Rev Urol 2011 Jan;8(1):19-28

890. Smith AL, Wein AJ. Estrogen replacement therapy for the treatment of postmenopausal genitourinary tract dysfunction. (Review) Discovery Medicine, 10(55):500-510, 2010 December

891. Smith AL, Wein AJ. Estrogen replacement for the Urologist: Effects on Genitourinary Function. AUA Update Series 2011 Volume 30, Lesson 8, pp: 69-80

892. Chhatre Sumedha, Wein AJ, Malkowicz SB, Jayadevappa Ravishanikar. Racial differences in well-being and cancer concerns in prostate cancer paients. J Cancer Surviv 2011; 5:182-190 (accepted 7 Jan 2011/published online 28 Jan 2011).

893. Northington GM, Basha M, Arya LA, Wein AJ, Chacko S. Contractile Response of Human Anterior Vaginal Muscularis in Women With and Without Pelvic Organ Prolapse. Reproductive Sciences March 2011:18(3);296-303 (published online Dec 2010)

894. Laryngakis NA, Caesar SR, Berns JS, Wein AJ. Runner’s Bladder: Exercise-Induced Hematuria With Lower Urinary Tract Pathology. UroToday Int J. 2011 Apr;4(2):art 19

895. Resnick MJ, Lee DJ, Magerfleisch L, VanArsdalen KN, Tomaszewski JE, Wein AJ, Malkowicz SB, Guzzo TJ. Repeat Prostate Biospy and the Incremental Risk of Clinically Insignificant Prostate Cancer. UROLOGY 77(5):548-552, 2011 May

896. Boopathi E, Gomes CM, Goldfarb R, John M, Srinivasan VG, Alanzi J, Malkowicz SB, Kathuria H, Zderic SA, Wein AJ, Chacko S. Transcriptional Repression of Caveolin-1 (CAV1) Gene Expression by GATA-6 in Bladder Smooth Muscle Hypertrophy in Mice and Human Beings. The American Journal of Pathology (AJP) 2011 May;178(5):2236-51

897. Smith AL, Ferlise VJ, Wein AJ, Ramchandani P, Rovner ES. Effect of a 7F Transurethral Catheter on Abdominal Leak Point Pressure Measurement in Men with Post-prostatectomy Incontinence. UROLOGY 77(5):1188-1193, May 2011

898. Smith AL, Wein AJ. Outcomes of pharmacological management of nocturia with non-antidiuretic agents: Does statistically significant equal clinically significant? British Journal of Urology International May 2011:107;1550-1554

899. Asfaw TS, Hypolite J, Northington GM, Arya LA, Wein AJ, Malykhina AP. Acute colonic inflammation triggers detrusor instability via activation of TRPV1 receptors in a rat model of pelvic organ cross-sensitization. Am J Physiol Regul Integr Comp Physiol 300:R1392-R1400, June 2011

900. Smith AL, Wein AJ. Urinary Incontinence – pharmacotherapy options. Annals of Medicine. 2011;43(6):461-76. [Epub ahead of print 2011 Jun 3]


81

901. Weiss JP, Blaivas JG, Bliwise DL, Dmochowski RR, DuBeau CE, Lowe FC, Petrou SP, Van Kerrebroeck PEV, Rosen RC, Wein AJ. The evaluation and treatment of nocturia: a consensus statement. BJU Int July 2011:108(1);6-21

902. Weiss JP, Wein AJ, van Kerrebroeck P, Dmochowski R, Fitzgerald M, Tikkinen KAO, Abrams P. Nocturia: New Directions. Neurourology and Urodynamics 30:700-703 (2011)

903. Wein AJ. Pathophysiology and Classification of Lower Urinary Tract Dysfunction: Overview. Campbell-Walsh Urology Tenth Edition, Volume 3, Section XIV, Urine Transport, Storage, and Emptying, Chapter 61, pp 1834-1846. Elsevier Saunders, Copyright©2012

904. Wein AJ, Dmochowski RR. Neuromuscular Dysfunction of the Lower Urinary Tract. Campbell-Walsh Urology Tenth Edition, Volume 3, Section XIV, Urine Transport, Storage, and Emptying, Chapter 65, pp 1909-1946. Elsevier Saunders, Copyright©2012

905. Andersson K-E, Wein AJ. Pharmacologic Management of Lower Urinary Tract and Emptying Failure. Campbell-Walsh Urology Tenth Edition, Volume 3, Section XIV, Urine Transport, Storage, and Emptying, Chapter 68, pp 1967-2002. Elsevier Saunders, Copyright©2012

906. Wein AJ. Pathophysiology and Classification of Lower Urinary Tract Dysfunction: Overview. Campbell-Walsh Urology Tenth Edition Review, Elsevier Saunders, Copyright©2012, Chapter 61, pp 335-339

907. Wein AJ, Dmochowski RR. Neuromuscular Dysfunction of the Lower Urinary Tract. Campbell-Walsh Urology Tenth Edition Review, Elsevier Saunders, Copyright©2012, Chapter 65, pp 351-339-358

908. Andersson K-E, Wein AJ. Pharmacologic Management of Lower Urinary Tract Storage and Emptying Failure. Campbell-Walsh Urology Tenth Edition Review, Elsevier Saunders, Copyright©2012, Chapter 68, pp 363-371

909. Wein A. Symptom-based diagnosis of overactive bladder: an overview. CUAJ 2011;5(5Suppl2):S135-S136

910. Wehrenberg-Klee E, Clark Timothy WI, Malkowicz SB, Soulen MC, Wein AJ, Mondschein JI, Van Arsdalen K, Guzzo TJ, Stavropoulos SW. Impact on Renal Function of Percutaneous Thermal Ablation of Renal Masses in Patients in Patients with Preexisting Chronic Kidney Disease. J Vasc Interv Radiol 2012;23:41-45

911. Jayadevappa R, Malkowicz SB, Wittink M, Wein AJ, Chhatre S. Comparison of Distribution- and Anchor-Based Approaches to Infer Changes in Health-Related Quality of Life of Prostate Cancer Survivors. Health Services Research (early online review March 14, 2012) ©Health Research and Educational Trust DOI: 10.1111/j.1475-6773.2012.01395.x

912. Smith AL, Wein AJ. Contemporary Management of Overactive Bladder. Postgraduate Medicine 2012;124(1):104-116

913. Weiss JP, Bosch JLH, Drake M, Dmochowski RR, Hashim H, Hijaz A, Johnson TM, Juul KV, Norgaard JP, Norton P, Robinson D, Tikkinen KAO, Van Kerrebroeck PEV, Wein AJ. Nocturia Think Tank: Focus on Nocturnal Polyuria: ICI-RS 2011. Neurourology and Urodynamics 31:330-339 (2012)

914. Sievert K-D, Amen B, Toomey PA, Robinson D, Milsom I, Koelbl H, Abrams P, Cardozo L, Wein


82

A, Smith AL, Newman DK. Can We Prevent Incontinence?: ICI-RS 2011. Neurourology and Urodynamics 31:390-399 (2012)

915. Smith AL, Jaffe WI, Wang M, Wein AJ. Detrusor Overactivity Leak Point Pressure in Women with Urgency Incontinence. International Urogynecology Journal 2012 April;23(4):443-446 PMID: 22419382

916. Smith AL, Wein AJ. Predicting the future of urodynamics. Transl Androl Urol 2012;1(2):76-77. DOI: 10.3975/j.issn.2223-4683.2012.06.01

917. Smith AL, Wein AJ. Clinical trials and overactive bladder: lessons learned. Clinical Investigation, July 2012 [Accepted for Publication]

918. Menchen L, Wein AJ, Smith AL. An appraisal of the Food and Drug Administration warning on Urogynecologic Surgical Mesh. Curr Urol Rep. 2012;13(3):231-9. PMID: 22434331

919. Dmochowski R, Wein AJ. Lower Urinary Tract Phamacotherapy for Nocturia. In Nocturia:Causes, Consequences and Clinical Approaches Weiss JP, Blaivas JG, Van Kerrebroeck PEV, Wein AJ (eds). Springer Science+Business Media, LLC, 2012

920. Guzzo TJ, Resnick MJ, Canter DJ, Bivalacqua TJ, Rosen MA, Bergey MR, Magerfleisch L, Tomazewski JE, Wein AJ, Malkowicz SB. Endorectal T2-Weighted MRI does not differentiate between favorable and adverse pathologic features in men with prostate cancer who would qualify for active surveillance. Urologic Oncology: Seminars and Original Investigations 30(2012);301-305.

921. Winters JC, Dmochowski RR, Goldman HG, Herndon CDA, Kobashi KC, Kraus SR, Lemack GE, Nitti VW, Rovner ES, Wein AJ. Urodynamic Studies in Adults: AUA/SUFU Guideline. The Journal of Urology, Vol 188, Number 6, Part 2 of 2, 2464-2472


83

BOOKS

1. Barrett, DM, and Wein, AJ: Controversies In Neuro-Urology, London and New York, Churchill Livingstone, 1984.

2. Mundy, AR, Stephenson, TP, and Wein, AJ: Urodynamics: Principles, Practice and Application.- Churchill Livingstone, London and New York, 1984.

3. Hanno, PM, and Wein, AJ: A Clinical Manual of Urology, Appleton-Century-Crofts, Norwalk, CT., 1987.

4. Wein, AJ, and Barrett, DM: Voiding Function and Dysfunction: A Logical and Practical

Approach Year Book Medical Publishers, Inc., London, New York and Boca Raton, 1988.

5. Hanno, PM, Staskin, DR, Krane, RJ, Wein, AJ: Interstitial Cystitis, Springer Verlag,

London, Berlin, New York, 1990.

6. Wein AJ (editor) Common Problems in Urology: Common problems in infertility and impotence (J.Rajfer, volume editor). Yearbook Medical Publishers, Chicago, London, Boca Raton, 1990.

7. Hanno, PM, Wein, AJ: A Clinical Manual of Urology, Second Edition, McGraw Hill

Publications, New York, St. Louis, San Francisco, 1994.

8. Mundy, AR, Stephenson, TP, Wein, AJ: Urodynamics: Principles, Practice and Application, Second Edition. Churchill-Livingstone, London and New York, 1994.

9. Walsh, PC, Retik, AB, Vaughan, ED Jr., Wein, AJ(eds.): Campbell’s Urology, Seventh

Edition. W. B. Saunders, Philadelphia, 1997.

10. Walsh, PC, Retik, AB, Vaughan, ED, Jr., Wein, AJ (eds.): Campbell’s Urology Study Guide, W.B. Saunders, Philadelphia, 1997.

11. Abrams, P, Wein, AJ: The Overactive Bladder: A Widespread and Treatable Condition.

Sparre Medical Group, Stockholm, Sweden, 1998.

12. Abrams P, Khoury S, Wein A (eds): Incontinence. 1st International Consultation on Incontinence, June 28-July 1, 1998, Monaco, co-sponsored by World Health Organization and International Union Against Cancer. Health Publications Ltd., 1999; distributed by Plymbridge Distributors, Ltd.

13. Wein AJ, Flanigan R, Resnick M (eds): Objectives for Urologic Residency Education.

Society University Urologists, 2001.

14. Hanno PM, Malkowicz SB, Wein AJ: A Clinical Manual of Urology, Third Edition, McGraw-Hill, New York, 2001.


84

15. Rovner, ES, Wein, AJ, Caruso, D: A Woman’s Guide To Regaining Bladder Control: Everything you need to know for the diagnosis and cure of incontinence., M. Evans and Co, Inc., New York, 2002. 16. Abrams, P, Cardozo, L, Khoury, S, Wein, AJ (eds): Incontinence. Health Publication Limited, Plymbridge Distributors, Ltd, 2nd Edition, 2002.

17. Walsh P, Retik A, Vaughan, ED, Jr., Wein, AJ: (eds): Campbell’s Urology, 8th Edition, Saunders, Philadelphia, 2002. 18. Walsh P, Retik A, Vaughan ED, Jr., Wein AJ (eds): Campbell’s Urology Study Guide, 2nd Edition, Saunders, Philadelphia, 2002. 19. Newman DK, Wein AJ: Overcoming Overactive Bladder: Your Complete Self-Care

Guide. New Harbinger Publications, Inc., 2004. 20. Abrams P, Artibani W, Cardozo L, Khoury S, Wein A: Clinical Manual of Incontinence in Women, Health Publications, 2005. 21. Abrams P, Cardozo L, Khoury S, Wein AJ: Incontinence Volume 1 (Basics and

Evaluation), Volume 2 (Management). Health Publications Limited, Editions 21, Paris, 2005.

22. Hanno PM, Malkowicz SB, Wein AJ: Penn Clinical Manual of Urology, 1st Edition,

Saunders/Elsevier, Inc., Philadelphia, PA 2007 23. Wein AJ (editor-in-chief), Kavoussi LR, Novick AC, Partin AW, Peters CA (eds)

Campbell-Walsh Urology Ninth Edition, Saunders/Elsevier, Philadelphia, PA 2007

24. Wein AJ (editor-in-chief), Kavoussi LR, Novick AC, Partin AW, Peters CA (eds) Campbell-Walsh Urology Ninth Edition Review, Saunders/Elsevier, Philadelphia, PA 2007

25. Slack A, Jackson S, Wein AJ: Fast Facts: Bladder Disorders. Health Press Limited, Oxford,

UK, 2008 (Courtesy distribution Dec 2007; available to the public Jan 2008)

26. Newman DK, Wein AJ: Managing and Treating Urinary Incontinence, 2nd Edition, Health Professions Press, Inc., Baltimore, Maryland, 2009 (AWARD: Presented to Health Professions Press in 2009 - 18th Annual National Mature Media AwardsSM for “Managing and Treating Urinary Incontinence 2nd Edition (honoring the Best in Advertising, Marketing & Educational Materials for Older Adults: Division: Media. Category: Book)

27. Abrams, P, Cardozo, L, Khoury, S, Wein, AJ (eds): INCONTINENCE. 4th International Consultation on Incontinence (ICI), July 5-8, 2008, Paris, France. Health Publication Ltd, 2009.

28. Ellsworth P, Wein AJ. Questions & Answers About Overactive Bladder, 2nd Edition, Jones and Bartlett Publishers, Sudbury, MA, Copyright © 2010


85

29. Guzzo TG, Drach G, Wein AJ (eds): Primer of Geriatric Urology, 1st Edition, 2011, published by Springer Science and Business Media, LLC, Philadelphia, Pennsylvania USA – (IN PRESS)

30. Slack A, Newman DK, Wein AJ (eds): Fast Facts: Bladder Disorders, 2nd Edition, 2011. Health Press, Ltd, Abingdon Oxford, United Kingdom

31. Wein AJ, Chapple C (eds): Managing Overactive Bladder, Springer Healthcare, Ltd., London, United Kingdom – Copyright©2011

32. Wein AJ (editor-in-chief), Kavoussi LR, Novick AC, Partin AW, Peters CA (eds) Campbell-

Walsh Urology Tenth Edition, Saunders/Elsevier, Philadelphia, PA – Copyright©2012

33. McDougal SW, Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, Ramchandani P (eds): Campbell-Walsh Urology Tenth Edition Review, Elsevier/Saunders, Philadelphia, PA - Copyright©2012

34. Weiss JP, Blaivas JG, Van Kerrebroeck PEV, Wein AJ (eds): Nocturia: Causes, Consequences and Clinical Approaches. Springer Science+Business Media, LLC. Library of Congress Control Number: 2011939061


86

ABSTRACTS, EDITORIALS

(Unassociated with other publications)

1. Benson, G.S., Raezer, D.M., and Wein, A.J.: Muscle length: an important factor in determining response to autonomic stimulation. Presented at Urodynamics Society Annual Meeting, American Urological Association, Inc., May 1975.

2. Wein, A.J.: Perineal and scrotal flap urethroplasty in urethral stricture disease. Presented at Mid-Atlantic Section Meeting, American Urological Association, Inc., October 1975.

3. Greenberg, S.H., Lipshultz, L.I., and Wein, A.J.: A preliminary report on "subclinical varicocele": diagnosis by Doppler ultrasonic stethoscope examination and initial results of surgical therapy. Fertil. Steril., 29:243, 1978.

4. Richter, M.P., Ring, E., Mikuta, J.J., Wein, A.J., Littman, P., and Goodman, R.L.: Skinny needle biopsy as an adjunct to diagnosis and staging. Presented to American Society for Therapeutic Radiology, 1978.

5. Wein, A.J.: Anatomy and physiology of continence and micturition. Controversies in Clinical Neurourology, American Urological Association, Inc., Boston, MA., November 1978, pp. 1, 1-6.

6. Wein, A.J.: Electrical stimulation in the treatment of urinary incontinence. Female Urology, American Urological Association, Inc., Cherry Hill, NJ, April 1978, pp. IV, 5.

7. Wein, A.J.: Evaluation of the impotent patient. Controversies in Clinical Neurourology, American Urological Association, Inc., Boston, MA, November 1978, pp. XXX, 1-4.

8. Wein, A.J.: Neurogenic vesicourethral dysfunction in the child. Controversies in Clinical Neurourology, American Urological Association, Inc., Boston, November 1978, pp. XXVII, 1-3.

9. Wein, A.J.: Neurophysiology of erection. Syllabus, Seminar on Erection, Mid-Atlantic Section, American Urological Association, Inc., White Sulphur Spring, WV, October 1978.

10. Wein, A.J.: Physiology of bladder function. Female Urology, American Urological Association, Inc., Cherry Hill, NJ, April 1978, pp. 1, 1-5.

11. Wein, A.J.: Surgical treatment of neurogenic retention. Controversies in Clinical Neurourology, American Urological Association, Inc., Boston, November 1978, pp. XXIV, 1-4.

12. Wein, A.J.: Total management of bladder carcinoma, stage B-2 and C. Syllabus, American College of Radiology Seminar on Bladder and Prostate Carcinoma, Philadelphia, PA, September 1978.

13. Carpiniello, V.L., Malloy, T.R., Wein, A.J. and Hanno, P.: Noninvasive papillary transitional cell carcinoma of the kidney: 20 cases with a review of the literature. Program Abstract Book, American Urological Association, Inc., May 1979, P. 169.

14. Carpiniello, V.L., Malloy, T.R., Wein, A.J., Hanno, P., and Hennesey, W.: A prospective comparison of morbidity following transrectal and transperineal prostatic needle biopsy: 120 cases. Program


87

Abstract Book, American Urological Association, Inc., May 1979, P. 192. 15. Levin, R.M., and Wein, A.J.: Autonomic receptor methodology in the study of urinary tract function.

Proceedings, Urodynamics Society, New York, May 12, 1979.

16. Pollack, H.M., Banner, M.P., Ring, E.J., and Wein, A.J.: Applications of thin-needle biopsy in uroradiology. Am. J. Roent., 132:1031, 1979.

17. Wein, A.J.: Disorders of lower urinary tract function associated with peripheral nerve injury. Advances in Clinical Urology, American Urological Association, Inc., San Francisco, April 1979, pp. 66-68.

18. Wein, A.J.: Disorders of lower urinary tract function associated with suprasacral lesions. Advances in Clinical Urology, American Urological Association, Inc., San Francisco, April 1979, pp. 61-63.

19. Wein, A.J.: Effect of pharmacologic agents on continence-incontinence and on sexual function-dysfunction. Instructional Book, Postgraduate Course II (Urologic Surgery), Clinical Congress, American College of Surgeons, October 1979, pp. 51-56.

20. Wein, A.J.: How to treat neurogenic bladders: medical versus surgical approach. Syllabus, Postgraduate Seminar, American Urological Association, Inc., San Francisco, April 1979, pp.76-77.

21. Wein, A.J.: Intermittent catheterization. Advances in Clinical Urology, American Urological Association, Inc., San Francisco, April 1979, pp. 76-77.

22. Wein, A.J.: More endourology. Urologists' Correspondence Club, October 24, 1979.

23. Wein, A.J.: The neurologic evaluation. Advances in Clinical Urology, American Urological Association, Inc., San Francisco, April 1979, pp. 52-54.

24. Wein, A.J.: Neurology of micturition. Syllabus, Postgraduate Seminar, American Urological Association, Inc., Washington, D.C., March 1979.

25. Wein, A.J.: The role of urodynamics in private practice. Instructional Book, Postgraduate Course II (Urologic Surgery), Clinical Congress, American College of Surgeons, October 1979, pp. 19-22.

26. Hanno, P.M., Jacobs, J., Greenberg, S.H., and Wein, A.J.: Use of nitrofurantoin crystals after transurethral prostatectomy. Program Abstract Book, American Urological Association, Inc., May 1980, P. 206.

27. Levin, R.M. and Wein, A.J.: Studies on the autonomic innervation of the lower urinary tract. Program Abstract Book, Urodynamics Society Workshop, May 1980, pp. 31-33.

28. Silverman, D.G., Gray, D.C., Smith, T.C., Harty, M., Harshman, M., and Wein, A.J.: Pudendal plexus block: a new technique for transurethral surgery. Scientific Exhibit, American Society of Anesthesiologists, October 1980.

29. Wein, A.J.: Criteria to establish biological activity of a drug; criteria to establish clinical efficacy of a drug. Program Abstract Book, Urodynamics Society Workshop, May 1980, pp. 24-27.


88

30. Wein, A.J.: Further observations on cystometric and uroflowmetric effects of bethanechol chloride on human bladder. J. Urol., 123:793, 1980.

31. Wein, A.J.: Malacoplakia of the bladder; efficacy of bethanechol chloride therapy.Urol., 123:606, 1980.

32. Wein, A.J., and Barrett, D.M.: Non-dyssynergic causes of simultaneous increases in intravesical pressure and striated sphincter activity. Program Abstract Book, American Urological Association, Inc., May 1980, P. 277.

33. Wein, A.J., Glick, J.H., Greenberg, S.H., Padovic, K., Negendank, W., Harris, D., and Brodovsky, H.: Tamoxifen in refractory metastatic carcinoma of the prostate. Program Abstract Book, American Urological Association, Inc., May 1980, P. 249.

34. Wein, A.J., and Levin, R.M.: The biological activity and clinical efficacy (or lack of it) of bethanechol chloride. Program Abstract Book, Urodynamics Society Workshop, May 1980, P. 249.

35. Wein, A.J.: Clinical value of urodynamics. Urology Course Syllabus, Cleveland Clinic Educational Foundation, March 1981.

36. Wein, A.J.: Phenoxybenzamine therapy of benign prostatic hypertrophy. J.A.M.A., 245:1685, 1981.

37. Wein, A.J.: Physiology of micturition. Syllabus, Course on Neurogenic Vesical Dysfunction, Annual Meeting, American Urological Association, Inc., May 1981.

38. Wein, A.J.: Physiology of Micturition; Voiding Dysfunction in Neurologic Disease; Non-operative Treatment of Unstable Bladder; Burch Urethropexy. Syllabus on Female Urinary Incontinence, Albert Einstein College of Medicine, March 1981.

39. Wein, A.J., and Malloy, T.R.: Commentary (Sex problems: when to treat and when to refer). Med. Asp. Hum. Sexual., 15:72, 1981.

40. Wein, A.J., Pollack, H.M., and Banner, M.P.: Percutaneous extraction of renal and ureteral calculi. Urologists' Correspondence Club, March 18, 1981, pp. 24-25.

41. Malloy, T.R., and Wein, A.J.: Commentary (Urologic problems which sabotage sexual functioning). Med. Asp. Hum. Sexual., March 1982, pp. 157-158.

42. Wein, A.J.: Pharmacologic management of voiding dysfunction. Syllabus, Course on Pharmacologic Management of Voiding Dysfunction, Annual Meeting, American Urological Association, Inc., May 1982.

43. Wein, A.J.: Physiology and Pharmacology of Micturition; Urodynamics; Classification and Management of Voiding Dysfunction. Syllabus, Course on Basic Sciences in Urology, American Urological Association, Inc., June 1982.

44. Wein, A.J.: Physiology of micturition. Syllabus, Course on Neurogenic Bladder Dysfunction, Annual Meeting, American Urological Association, Inc., May 1982.


89

45. Wein, A.J.: Physiology of Micturition; Management of Neurogenic Vesical Dysfunction. Syllabus, Postgraduate Seminar, New England Section, American Urological Association, Inc., September 1982.

46. Wein, A.J.: Recurrent perineal and urethral pain. J.A.M.A., 248:3177, 1982.

47. Wein, A.J., and Hanno, P.M.: Self-intermittent catheterization as an adjunct to optical urethrotomy. Urologists' Correspondence Club, October 1982, P. 70.

48. Wein, A.J.: Pathophysiology of Female Incontinence; Urethral Syndrome; Vesicovaginal Fistula Repair; Urinary Retention. Syllabus, Subject Oriented Seminar on Female Urology, American Urological Association, Inc., March 1983.

49. Wein, A.J.: Physiology of Micturition; Incontinence Related to Outlet Obstruction; Post-prostatectomy Incontinence; Retropubic Vesicourethral Suspension Procedures. Syllabus, Subject Oriented Seminar on Incontinence, American Urological Association, Inc., February 1983.

50. Wein, A.J., and Pollack, H.M.: Stents and ileal conduits: further brief comments. Urologists' Correspondence Club, September 7, 1983, P. 87.

51. Malloy, T.R., Carpiniello, V.L., and Wein, A.J.: Superficial transitional cell carcinoma of the bladder treated with neodymium-YAG laser: 18 month follow up. Lasers in Surgery and Medicine, 3:309, 1984.

52. Malloy, T.R., and Wein, A.J.: Carcinoma in a solitary kidney treated with the neodymium-YAG laser. Lasers in Surgery and Medicine, 3:310, 1984.

53. Malloy, T.R., and Wein, A.J.: Sexual dysfunction following urologic symptoms. Med. Asp. Hum. Sexual., October 1984, pp. 48-54.

54. Wein, A.J.: Incontinence in the elderly. Newsletter, Center for the Study of Aging, University of Pennsylvania, Vol. 6. University of Pennsylvania Press, 1984, pp. 3,

55. Wein, A.J.: Myelomeningocele and sphincteric incontinence. J.A.M.A., 251:2269, 1984.

56. Wein, A.J.: Urodynamics: an introduction. World J. Urol., 1:167, 1984.

57. Wein, A.J., and Pollack, H.M.: Reply to "A Plea for the IVP", Urologists' Correspondence Club, February 13, 1985, P. 15.

58. Wein, A.J.: Pathophysiology of Urinary Incontinence in the Female; Urethral Syndrome; Sling Procedures; Urodynamic and Neurologic Evaluation of Incontinence. Syllabus, Seminar on Female Urology, American Urological Association, Inc., March 1985.

59. Wein, A.J., and Barrett, D.M.: Syllabus on Voiding Dysfunction, American Urological Association, Inc., July 1985 (515 pages).

60. Wein, A.J.: New techniques of percutaneous renal surgery. C close-up: Surgery. Smith Kline French Company, July 1985.


90

61. Wein, A.J.: Vasectomies - informed consent. Physicians' Medical Law Letter. New York,

Professional Liability Publications Company, August 1985.

62. Wein, A.J. (Editorial). Tell her to get a urine culture, take some of that medicine I prescribed a while ago, and call me in a few days. Neurourol. and Urodyn. 4:153, 1985.

63. Wein, A.J.: Physiology of Renal, Pelvic and Ureteral Transport, Physiology of Micturition, Effective Uropharmacology. Syllabus, New England Section, Postgraduate Seminar (American Urological Association, Inc.), April 1986.

64. Wein, A.J.: Physiology of Micturition, Evaluation and Treatment of Neurogenic Bladder Dysfunction. Syllabus, Cook County Graduate School of Medicine, April 1986.

65. Wein, A.J.: Effectiveness of propantheline bromide on the treatment of geriatric patients with detrusor instability. Neurourol. and Urodynam. 5:141, 1986.

66. Wein, A.J.: Erectile Physiology; Status of Nocturnal Penile Tumescence Testing Today; lntracorporeal Injections for Erectile Dysfunction; Diagnostic Testing - Current Status, Where Are We Going? Syllabus, American Urological Association, Inc. Regional Subject Oriented Seminar, Erectile Dysfunction, September 1986.

67. Wein, A.J.: Organic Retention: Etiology and Treatment; Detrusor Instability; Etiology, Diagnosis, Medical Management; Abdominal Procedures for Stress Incontinence. Syllabus, American Urological Association, Inc., Regional Subject Oriented Seminar, Female Urology, December 1986.

68. Wein, A.J.: Managing Incontinence (book review) J. Urol. 137:368, 1987.

69. Wein, A.J.: Erectile Physiology; Status of Nocturnal Penile Tumescence Testing Today; Intracorporeal Injections for Erectile Dysfunction; Diagnostic Testing - Current Status, Where Are We Going? Syllabus, American Urological Association, Inc. Regional Subject Oriented Seminar, Erectile Dysfunction, April 1987.

70. Wein, A.J., Pollack, H.P.: Further information regarding ESWL X-ray imaging. Urologists' Correspondence Club, May 25, 1987, P. 53.

71. Wein, A.J.: Urethral diverticulum in females. Urology, 29:463, 1987.

72. Orland, S.M., Wein, A.J.: Injured urethra repair. Urologists' Correspondence Club, June 8, 1987, pg. 60.

73. Wein, A.J., Vaughan, E.D.: Residency training in the future. Urology Times, December. 1987.

74. Wein, A.J.: Urinary incontinence. AUA Today, Volume 1, Spring 1988, p. 29.

75. Malloy, T.R., Wein, A.J.: Erectile dysfunction: effects of pharmacotherapy. Med. Aspects Human Sexuality, June 1988, pp. 42-48.

76. Wein, A.J., Malloy, T.R.: Renal injuries due to retroperitoneal lymphadenectomy. Urologists Correspondence Club, August 21, 1988, p. 49.


91

77. Zderic, S.A., Carpiniello, V.L., Malloy, T.R., Wein, A.J.: Urology Grand Rounds: Human papilloma virus infection. McCann Healthcare Advertising Education Division, Chicago, 1988 (Number 25), pp. 2-5.

78. Wein, A.J., Malloy, T.R., Hanno, P.M., Barrett, D.M., Furlow, W.L.: Evaluation of erectile dysfunction with continuous monitoring of penile rigidity. J. Urol. 1 39:1072, 1988.

79. Wein, A.J., Kitada, S., Kato, K., Whitmore, K.: The effect of contractile activity on muscarinic receptor density and the response to muscarinic agents. Neurourology and Urodynamics 7:203; 1988.

80. Kato, K., Kitada, S., Wein, A.J., Levin, R.t.4.: Intravesical instillation of antispasmodic agents. Neurourology and Urodynamics 7:210, 1988.

81. Kitada, S., Kato, K., Wein, A.J., Levin, R.M.: Experimental models of reflex contractile activity in rabbits. Neurourology and Urodynamics 7:249, 1988.

82. Wein, A.J.: Research update. ICA Update and Doctor's Forum. Vol. 4, Number 1, 1989.

83. Hanno, P.M., Wein, A.J., Fletcher, S.: Initial pharmacologic treatment of erectile dysfunction. AUA Today, March 1990, p. 8.

84. Wein, A.J.: "Urethral Syndrome and Interstitial Cystitis", "Diagnosis and Pharmacotherapy of Urge Incontinence", "Abdominal Repair of Vesicovaginal Fistula", "Pharmacotherapy of Sphincter Incontinence", Syllabus. AUA Regional Subject Oriented Seminar on Female Urology, February 1990. (American Urological Association Office of Education, Houston, Texas).

85. Wein, A.J.: Benign prostatic hyperplasia and urgency. Center for the Study of Aging Newsletter, University of Pennsylvania. 12 (2), Spring 1990, pp. 5-6.

86. Wein, A.J.: Pharmacologic therapy for urinary incontinence. AUA Today, vol. 3, Sept., 1990, pp. 1 & 13.

87. Haugaard, N., Hypolite, J., Wein, A.J., Levin, R.M.: Correlation between contractile force and metabolism in rabbit urinary bladder. Neurourology and Urodynamics 9:358, 1990.

88. Monson, F.C., Wein, A.J., McKenna, B.A.W., Levin, R.M.: Preliminary investigation of rabbit urinary bladder hypertrophy using 3H thymidine and radioautography. Neurourology and Urodynamics 9:420, 1990.

89. Wein, A.J., Krane, R.J.: Editorial (editors) World Journal of Urology. Advances in Neurourology 8(4), 1990.

90. Braren, V., Vaughan, E.D., Jr., Mostofi, F.K., Pennington, R.D., Salvatierra, O., Wein, Long-range plan of the National Kidney and Urologic Diseases Advisory Board. Urol. 145:567, 1991.

91. Wein, A.J.: Introduction. Seminars in Urology 9:71, 1991. (Editor of issue on Interstitial Cystitis).

92. Wein, A.J.: Oral and intravaginal estrogens alone and in combination with alpha-adrenergic stimulation in genuine stress incontinence. J Urol 1991, 146:2


92

93. Wein, A.J.: Effect on narcotic anesthesia and skeletal muscle paralysis in passive and dynamic urethral function of stress continent and incontinent women. Neurourol. Urodyn. 10:530, 1991.

94. Wein, A.J.: Neurourologic and urodynamic assessment of the lower urinary tract. Objectives for Urology Residency Education, 4th edition, Society of University Urologists, 1993, pp. 46-52.

95. Wein, A.J.: Pathophysiology and categorization of voiding dysfunction: a simple system. In: Voiding Dysfunction Update, 1993, American Urological Association Office of Education, San Francisco, CA, pp. 1-22.

96. Wein, A.J.: Fluoroscopic examination. In: Voiding Dysfunction Update, 1993, American Urological Office of Education, San Francisco, CA pp. 53-54.

97. Wein, A.J.: Sphincteric incontinence; Overview, conservative treatment, retropubic suspension surgery. In: Voiding Dysfunction Update, 1993, American Urological Office of Education, San Francisco, CA, pp. 135-138.

98. Wein, A.J.: Conservative therapy for sphincteric incontinence; behavioral techniques. In: Voiding Dysfunction Update, 1993, American Urological Office of Education, San Francisco, CA, pp. 139-150.

99. Wein, A.J.: Retropubic approaches to the surgical repair of stress urethral incontinence. In: Voiding Dysfunction Update, 1993, American Urological Office of Education, San Francisco, CA, pp. 151-152.

100. Wein, A.J.: Detrusor incontinence: Overview, conservative treatment. In: Voiding Dysfunction Update, 1993, American Urological Office of Education, San Francisco, CA, pp. 235-236.

101. Wein, A.J.: BPH: Watchful waiting and drug therapy. In: Voiding Dysfunction Update, 1993, American Urological Office of Education, San Francisco, CA, pp. 259-278.

102. Wein, A.J.: Urodynamics: Correlation of neuropathology with voiding dysfunction; treatment of neurogenic voiding dysfunction; sensory disorders. In: Voiding Dysfunction Update, 1993, American Urological Office of Education, San Francisco, CA, pp. 316-330.

103. Wein, A.J.: Pathophysiology and categorization of female voiding dysfunction: A simple system. In, Pelvic Reconstruction and Voiding Dysfunction, American Urological Association Office of Education, Houston, Texas, 1994, pp. 1-8.

104. Wein, A.J.: Detrusor hyperactivity. In, Pelvic Reconstruction and Voiding Dysfunction, American Urological Association Office of Education, Houston, Texas, 1994, pp. 65-70.

105. Wein, A.J.: Conservative therapy for sphincteric incontinence: Behavioral techniques. In, Pelvic Reconstruction and Voiding Dysfunction, American Urological Association Office of Education, Houston, Texas, 1994, pp. 11 1-1 16.

106. Wein, A.J.: Retropubic approach to the surgical repair of stress urethral incontinence. In, Pelvic Reconstruction and Voiding Dysfunction, American Urological Association Office of Education, Houston, Texas, 1994, pp. 117-118.


93

107. Ghoniem, G.M., Wein, A.J.: Animal research. Neurourology Urodynamics 1994; 13:89-90.

108. Wein, A.J.: Lower urinary tract dysfunction: pathophysiology and classification. In: Incontinence and Voiding Dysfunction. American Urological Association Office of Education, Houston, Texas (Orlando, FL conference), 1994, pp. 3-9.

109. Wein, A.J.: Spinal cord and root lesions; lower motor neuron and peripheral lesions. In: Incontinence and voiding dysfunction. American Urological Association Office of Education, Houston, Texas (Orlando, FL conference), 1994, pp. 39-50.

110. Wein, A.J.: Interstitial cystitis syndrome and sensory urge incontinence. American Urological Association Office of Education, Houston, Texas (Orlando, FL conference), 1994, pp. 102-111.

111. Wein, A.J.: Conservative management of urinary incontinence. American Urological Association Office of Education, Houston, Texas (Orlando, FL conference), 1994, pp. 121-138.

112. Wein, A.J.: Treatment of the intractable bladder with augmentation cystoplasty. American Urological Association Office of Education, Houston, Texas (Orlando, FL conference), pp. 139-186.

113. Wein, A.J.: Incontinence in the elderly. Family Urology, Spring, 1995 (American Foundation for Urologic Disease, Baltimore, MD).

114. Wein, A.J.: Overview of Urodynamics; cystometry; combined studies; detrusor-sphincter dyssynergy; leak pressures; urethral profilometry. Syllabus, Practical Urodynamics, AUA Office of Education, Houston, TX (Annual meeting postgraduate course), 1995 (yearly).

115. DiSanto, M., Menon,C., Chacko, T., Zheng, Y-M, Hypolite, J., Broderick, G., Wein, A.J., Chacko, S.: Expression of myosin II isoforms in the smooth muscles of human and rabbit corpora cavernosum penis.

116. DiSanto, M., Hypolite, J., Broderick, G., Wein, A.J., Chacko, S.: Regulation of tone and force by the smooth muscle tissue in rabbit corpora cavernosum penis by myosin light chain phosphorylation.

117. Wein, A.J.: Foreword. In, Blaivas, J., Chancellor, M. (Eds.). Atlas of Urodynamics. Williams and Wilkins, Baltimore, 1996.

118. Wein, A.J.: Foreword. In, Raz, S. (Ed.). Female Urology, 2nd edition. W. B. Saunders, Philadelphia, 1996.

119. Wein, A.J.: Incontinence. American Urological Association Office of Education, Houston, TX, New Orleans Conference, 1997.

120. Rovner, E.S., Wein, A.J.: Sling tension for stress incontinence surgery. Issues in Incontinence, vol. 3, no. 2, 1997.

121. Wein, A.J.: (guest editor): Contemporary surgical management of sphincteric incontinence. World J. of Urology, 15:5, 267, 1997.


94

122. Abrams, P.A., Wein, A.J. (guest editors): The overactive bladder: from basic science to clinical management consensus conference. Urology, 50 (Suppl 6A), 1997.

123. Wein, A.J.: Closing remarks. Urology, 50 (Suppl 6A):114, 1997.

124. Wein, A.J. (Guest editor): Urinary Incontinence: The scope of the problem – the solutions on the horizon. Urology, 51 (Suppl. 2A), 1998.

125. Wein AJ, (Program Director): Female urology and incontinence AUA Subject Oriented Seminar. June 20-22, 1997, Dallas TX. Introduction, Objectives; Pathophysiology of Urinary Incontinence: Overview of Treatment; Non-Hormonal Medical Therapy; Therapy after Conservative Treatment Failure (corrective surgery, bulking agents, prosthetics, denervation, augmentation); Setting up a Multidisciplinary Incontinence Center, Philadelphia modifications.

126. Wein AJ: Treating an overactive bladder. Family Urology, volume III, Issue 3, p. 7, 1998.

127. Gupta S, Wein AJ, Kotlikoff MI: ATP relaxes bladder smooth muscle by interacting with P2Y-purinoceptors. Neurourol and Urodynamics, 1998, 17;4:335-336.

128. DiSanto M, Menon C, Wein AJ, Chacko S: Changes in the composition of Myosin isoforms and caldesmon in the detrusor muscle following partial outlet obstruction Neurourol and Urodynamics, 1998, 17;4:444-445.

129. Hypolite J, DiSanto M, Wein AJ, Chacko S: Mechanisms for coordinated contraction of smooth muscles in different regions of the bladder wall. Neurourol and Urodynamics, 1998, 17;4:450.

130. DiSanto M, Menon C, Chacko T, Zheng Y, Broderick G, Wein AJ, Chacko S: Regulation of contraction in smooth muscles in the corpus cavernosum penis. Biophys J 74:A39, 1998.

131. Hypolite J, DiSanto M, Zheng Y, Wein AJ, Chacko S: Regional variations in the composition of myosin isoforms and light chain phosphorylation at the resting tone in rabbit smooth muscle. J Urol 159:23, 1998.

132. Wein, AJ (Course Director), American Urological Association Annual Review Course, Female Urology and Incontinence. Fort Lauderdale, FL, September 17-19, 1999. Pathophysiology of urinary incontinence: overview of treatment; Non-hormonal medical therapy; Occlusive devices

133. DiSanto M, Hypolite JA, Nigro D, Zheng Y, Wein AJ, Chacko S: Bladder outlet obstruction induces the expression of a myosin isoforms which has a low actin-activated ATPase activity. J Urol 159:35-35, 1998.

134. DiSanto ME, Hypolite JA, Broderick GA, Wein AJ, Chacko S: Regulation of tone and force by the smooth muscle tissue in rabbit corpus cavernosum penis by myosin light chain phosphorylation. J Urol 159:101-101, 1998.

135. DiSanto ME, Hypolite J, Zheng Y, Wein AJ, Chacko S: Difference in the composition of myosin isoforms contributes to the varied contractility of smooth muscle tissues in bladder body and urethra. Biophys J., 76:A13, 1999.


95

136. Hypolite J, DiSanto ME, Zheng Y, Malkowicz B, Wein AJ, Chacko S: Alteration of contractility in hypertrophied urinary bladder smooth muscle is associated with an overexpression of the SM-A and LC 17b myosin isoforms. Biophys J., 76:A83, 1999.

137. Wein AJ, Roberts RW: Overactive bladder survey: evaluates the extent of symptoms in family doctor setting. Family Urology, 1:7, 2000.

138. Wein AJ: Overactive bladder: defining the disease. Am J Managed Care 6 (11):S559-S564, 2000.

139. Wein AJ (Co-Chairman), American Urological Association Annual Postgraduate Seminar. Dallas, TX, March 9-12, 2000. Physiology of micturition; Pathophysiology of voiding dysfunction; Voiding dysfunction in neurologic disease and injury.

140. Wein AJ (Invited Lecturer): Basic Science Course sponsored by AUA Office of Education. Charlottesville, VA, June 14, 2000. Physiology and pharmacology of the lower urinary tract; Evaluation of voiding dysfunction; Classification of voiding dysfunction; Voiding dysfunction associated with neurologic disease; Management of voiding dysfunction.

141. Sanchez-Ortiz R, Broderick GA, Rovner ES, Whittington R, Wein AJ: Relationship between erectile function and quality of life after interstitial radiation therapy for prostate cancer. AUA Mid-Atlantic Sectional Meeting, Rio Mar Puerto Rico, October 15, 2000.

142. Sanchez-Ortiz R, Rovner ES, Broderick GA, Wein AJ: Erectile function and health related quality of life after interstitial radiation therapy for prostate cancer. Annual Meeting, American Urological Association, Atlanta, GA, April 2000.

143. Early J, Gomes C, DiSanto ME, Wein AJ, Chacko SK: Decreased contractility of detrusor smooth muscle from diabetic rabbits is associated with translocation of protein kinase C. Biophys. J. 78:113A, 2000.

144. DiSanto, M.E., Zheng, Y., Stein, R., Zderic, S., Wein, A.J., and Chacko, S.K. 2000. Decompensated detrusor smooth muscle in partial bladder obstruction shows an overexpression of myosin isoform SM-A which utilizes less ATP during actin myosin interaction and force generation. American Urological Association Annual Meeting. Journal of Urology. 163: 248A.

145. Xu, D., DiSanto, M.E., Hypolite, J.A., Barsotti, R.J., Wein, A.J., and Chacko, S.K. 2000. Mechanisms for urinary continence: A correlation between smooth muscle myosin isoform and shortening velocity on different layers of rabbit urethra. American Urological Association Annual Meeting. Journal of Urology. 163: 42A.

146. Earley, J.J., Gomes, C.M., DiSanto, M.E., Wein, A.J., and Chacko, S. 2000. Mechanism for the diabetes-induced decrease in detrusor dontractility involves translocation of protein kinase C isoforms. American Urological Association Annual Meeting. Journal of Urology. 163: 229A.

147. Chang, S., Hypolite, J.A., Wein, A.J., Chacko, S.K., DiSanto, M.E. 2000. Expression of myosin light chain kinase and Rho-associated kinase in corpus cavernosum smooth muscle. Biophysical Society Annual Meeting. Biophysical Journal. 78: 24A.


96

148. Earley, J.J., Gomes, C., DiSanto, M.E., Wein, A.J. and Chacko, S. 2000. Decreased contractility of detrusor smooth muscle from diabetic rabbits is associated with translocation of protein kinase C 2. Biophysical Society Annual Meeting. Biophysical Journal. 78:113A.

149. Xu DG, DiSanto ME, Hypolite JA, Chacko SK, Barsotti RJ: Expression of smooth muscle myosin SM-B isoform in different layers of rabbit urethra correlates with shortening velocity. Biophys. J., 87:117A, 2000.

150. Chang S, Hypolite JA, Wein AJ, Chacko SK, DiSanto ME: Expression of myosin light chain kinase and Rho-associated kinase in corpus cavernosum smooth muscle. Biophys. J., 78:24A, 2000.

151. Nehra A, Rovner ES, Wein AJ, Lange P, Ellis W, Keane T, McCammon K: Interim analysis of a multicenter study of extracorporeal magnetic innervation (ExMI) for the treatment of urinary incontinence following radical prostatectomy. International Bladder Symposium, Washington, DC, March 16, 2001.

152. Chacko S, Changolkar AK, Kesavanm P, Arafat H, Zheng Y, DiSanto ME, Wu HY, Bing W, Zderic SA, Wein AJ: Ablation of functional domains in the C-terminal region of caldesmon in mice by homologous recombination. Biophys. J., 80:341A, 2001.

153. Wein AJ (Co-Director) American Urological Association Annual Postgraduate Seminar. Chicago, IL, March 22-24, 2001. Physiology of micturition; Pathophysiology of voiding dysfunction; Neuropathic voiding dysfunction: Voiding dysfunction associated with neurologic disease.

154. Zhang E, Stein R, Zderic SA, Wein AJ, Chacko S: Overexpression of non-muscle caldesmon in hypertrophied bladder smooth muscle cells. Biophys J., 80:358A, 2001.

155. Arafat HA, Kim G, DiSanto ME, Wein AJ, Chacko S: Heterogeneity of bladder myocytes in vitro: modulation of myosin isoform gene expression. Biophys. J. 80:388A, 2001.

156. Bing W, DiSanto ME, Zderic SA, Wein AJ, Chacko S: Changes in myosin light chain kinase and phosphatase activities in hypertrophied smooth muscle. Biophys. J., 80:389A, 2001.

157. Chang S, Hypolite JA, Changolkar A, Wein AJ, Chacko S, DiSanto ME: The mechanism of diabetes-induced erectile dysfunction involves an increased sensitivity to endothelin-1 resulting from overexpression of endothelin B receptors in the corpus cavernosum of the penis. Diabetes 50:A92, 2001.

158. DiSanto ME, Chang S, Hypolite J, Zderic SA, Wein AJ, Chacko S: Enhancement of force generation by corpus cavernosum smooth muscle in rabbits with partial bladder outlet obstruction. Intl. J. Impot. Res. 13:S40, 2001.

159. DiSanto ME, Chang S, Hypolite J, Zderic SA, Wein AJ, Chacko S: Alteration of corpus cavernosum smooth muscle contractility: A mechanism for diabetes-induced erectile dysfunction. Intl. J. Impot. Res. 13:S14, 2001.

160. Appell RA, Abrams P, Drutz Hp, VanKerrebroeck, PE, Millard R, Wein A: Treatment of overactive bladder: long-term tolerability and efficacy of Tolterodine. Clinical Trial, World Journal of Urology, 19(2): 141-7, 2001 April.


97

161. DiSanto, M.E., Chang, S., Hypolite, J., Zderic, S.A., Wein, AJ., Chacko, S. 2001. Enhancement of force generation by corpus cavernosum smooth muscle in rabbits with partial bladder outlet obstruction. Biannual European Society for Sexual Impotence Research Meeting. International Journal of Impotence Research. 13: S40.

162. DiSanto, M.E., Chang, S., Hypolite, J., Zderic, S.A., Wein, A.J., Chacko, S. 2001. Alteration of corpus cavernosum smooth muscle contractility: A mechanism for diabetes-induced erectile dysfunction. Biannual European Society for Sexual Impotence Research Meeting. International Journal of Impotence Research.13: S14.

163. Chang, S, Hypolite, J.A., Changolkar, A., Wein, A.J., Chacko, S., DiSanto, M.E. 2001. The Mechanism of Diabetes-Induced Erectile Dysfunction Involves an Increased Sensitivity to Endothelin-1 Resulting from Overexpression of Endothelin B Receptor in the Corpus Cavernosum of the Penis. American Diabetes Association Annual Meeting. Diabetes. 50:A92.

164. Arafat, H.A., Sanchez-Ortiz, R.F., DiSanto, M.E., Wein, A.J., and Chacko, S. 2001. Osteopontin Overexpression in Ovariectomized Rabbit Bladder. American Urological Association Annual Meeting. Journal of Urology 165: 36A.

165. Zheng, Y., Weber, W.T., Wang, S., Wein, A.J., Chacko, S., and DiSanto, M.E. 2001. Establishment of a Phenotypically Stable Bladder Myocyte Cell Line from Hypertrophied Detrusor Smooth Muscle. American Urological Association Annual Meeting. Journal of Urology. 165: 38A.

166. Chang, S., Hypolite, J.A., Wein, A.J., Chacko, S., DiSanto, M.E. 2001. The Effect of Bladder Outlet Obstruction on Rabbit Corpus Cavernosum Smooth Muscle Contractility. American Urological Association Annual Meeting. Journal of Urology. 165:228A.

167. Rovner, E.S., Banner, M., Ramchandani, P., Wein, A.J.: Diagnosis and reconstruction of the circumferential urethral diverticulum. (Abstract) J. Urol. 165(5):196, 2001

168. Changolkar, A.K., Hypolite, J.A., DiSanto, M.E., Chacko, S., and Wein, A.J. 2001. Induction of Free Radicals and Activation of Aldose Reductase Markers for Detrusor Contractile Dysfunction in Diabetes. American Urological Association Annual Meeting. Journal of Urology. 165: 248A.

169. Stein, S., Thuroff, J.W., DiSanto, M.E., Zderic, S.A., Hutcheson, J.C., Canning, D.A., Wein, A.J. and Chacko, S.K. 2001. Changes in Myosin Isoform Expression After Partial Bladder Outlet Obstruction and Reversal: Correlation with Functional Outcome in an Experimental Study. American Urological Association Annual Meeting. Journal of Urology. 165: 248A.

170. Arafat, H.A., Kim, G., DiSanto, M.E., Wein, A.J., and Chacko, S.K. 2001. Heterogeneity of Bladder Myocytes In Vitro: Modulation of Myosin Isoform Gene Expression. Annual Biophysical Society Meeting. Biophysical Journal. 80:388A.

171. Chacko, S., Changolkar, A., Kesavan, P., Arafat, H., Zheng, Y., DiSanto, M.E., Wu, H.Y., Bing, W., Zderic, S.A., and Wein, A.J. 2001. Ablation of Functional Domains in the C-terminal Region of Caldesmon in Mice by Homologous Recombination. Annual Biophysical Society Meeting. Biophysical Journal. 80:341A.


98

172. Sanchez-Ortiz, R.F., Wang, Z.E., Menon, C., DiSanto, M.E., Wein, A.J., and Chacko, S. 2001. Estrogen Modulates the Expression of Myosin Heavy Chains in Urinary Bladder Smooth Muscle. Annual Biophysical Society Meeting. Biophysical Journal. 80:575AA.

173. Bing, W., DiSanto, M.E., Zderic, S.A., Wein, A.J., Chacko, S. 2001. Changes in Myosin Light Chain Kinase and Phosphatase Activities in Hypertrophied Smooth Muscle. Annual Biophysical Society Meeting. Biophysical Journal. 80:389A.

174. Wein AJ: Nocturia in men. 1st International Consultation on Nocturia, London, England, February 22, 2002.

175. Wein AJ: Current thoughts about the patient with refractory overactive bladder and potential targets for new drug therapy. State of the art AUA (invited) Lecture at the European Association of Urology, Birmingham, England, February 24, 2002.

176. Chang, S., Velez, M., Hypolite, J.A., Changolkar, Wein, A.J., Chacko, S., DiSanto, M.E. Enhancement of the endothelin/Rho-kinase contractile pathway and decreased activity of cGMP-dependent protein kinase in corpus cavernosum smooth muscle: A possible molecular mechanism for diabetes-induced erectile dysfunction. American Society for Pharmacology and Experimental Pharmacology Ray Fuller Symposium on Lower Urinary Tract Disorders.

177. Hypolite, J.A., Chang, S., DiSanto, M., Zheng, Y.M., Wein, A.J., Zderic, S.A., Chacko, S. Obstruction-induced bladder hypertrophy causes alterations in the myosin isoform expression and contractility of the urethral smooth muscle. American Urological Association Annual Meeting. Journal of Urology 167: 42A.

178. Chang, S., Hypolite, J.A., Zderic, S.A., Wein, A.J., Chacko, S., DiSanto, M.E. 2002. Altered contractility of corpus cavernosum smooth muscle: A possible molecular basis for erectile dysfunction associated with partial bladder outlet obstruction resulting from benign prostatic hyperplasia. American Urological Association Annual Meeting. Journal of Urology 167: 236A.

179. Chang, S., Hypolite, J.A., Changolkar, A., Wein, A.J., Chacko, S., DiSanto, M.E. 2002. Diabetes associated erectile dysfunction: Role of endothelin and Rho-kinase. American Urological Association Annual Meeting. Journal of Urology 167: 237A.

180. Chang, S., Velez, M., Hypolite, J.A., Changolkar, A., Wein, A.J., Chacko, S., DiSanto, M.E. 2002. Expression and regulation of cGMP-dependent protein kinase in corpus cavernosum smooth muscle from normal and diabetic rabbits. American Urological Association Annual Meeting. Journal of Urology 167: 240A.

181. Bing, W., Chang, S., Hypolite, J.A., DiSanto, M., Zderic, S.A., Wein, A.J., Chacko, S. Obstruction-induced changes in detrusor contractility and alteration in myosin light chain phosphorylation: A role for Rho-kinase. American Urological Association Annual Meeting. Journal of Urology 167: 247A.

182. Zheng, Y.M., Weber, W.T., Wang, S., Wein, A.J., Zderic, S.A., Chacko, S., DiSanto, M.E. 2002. A smooth muscle cell line from urinary bladder that expresses SM-B myosin isoform. Annual Biophysical Society Meeting. Biophysical Journal. 82:357A.


99

183. Chang, S., Hypolite, J.A., Zderic, S.A., Wein, A.J., Chacko, S., DiSanto, M.E. 2002. Alterations in the expression of myosin isoforms and contractility in smooth muscle associated with neurological changes. Annual Biophysical Society Meeting. Biophysical Journal. 82:425A.

184. D’Amico A, Boston MA, Whittington R, Malkowicz S, Cote K, Loffredo M, Schultz D, Ming-Hui C, Tomaszewski JE, Renshaw AA, Wein A.J., Richie JP: Biochemical outcome following radical prostatectomy or external beam radiation therapy for clinically localized prostate cancer diagnosed during the PSA era. J Urol, 167 (4):624, 2002.

185. Chang S, Velez M, Hypolite J, Changolkar A, Wein A.J., Chacko S, Disanto ME: Expression and Regulation of cyclic GMP-dependent protein kinase in corpus cavernosum smooth muscle from normal and diabetic rabbits. J Urology, Vol 167, 4, 941, 2002.

186. Chang S, Hypolite J, Wein A.J., Chacko S, Disanto ME: Altered Contractility of corpus cavernosum smooth muscle: A possible molecular basis for erectile dysfunction associated with partial bladder outlet obstruction resulting from benign prostatic hyperplasia. J Urology, Vol 167, 4, 927, 2002.

187. Malkowicz SB, Sanchez-Ortiz RF, Huang WC, Soyupak B, VanArsdalen K, Vaughn DJ, Wein A.J.: Favorable prognostic characteristics in node positive bladder cancer after radical cystectomy. J Urology, Vol 157, 4, 1210, 2002.

188. Chung BI, Burlington MA, Sanchez-Ortiz RF, Genega EM, Tomaszewski JE, VanArsdalen KN, Wein A.J.: Comparison of bladder cancer staging between academic and community hospitals. J Urology, Vol 157, 4, 1216, 2002.

189. Sanchez-Ortiz RF, Huang W, Van Arsdalen KN, Wein A.J., Malkowicz SB: Hydronephrosis predicts poor outcome in bladder carcinoma after radical cystectomy. J Urology, Vol 167, 4, 1219, 2002.

190. Sanchez-Ortiz RF, Broderick GA, Rovner ES, Wein A.J., Whittington R, Malkowicz SB: Urinary, bowel, erectile function and health-related quality of life after interstitial radiation therapy for prostate cancer. J Urology, Vol 167, 4, 1344, 2002.

191. Hypolite J, Chang SH, DiSanto M, Zheng YM, Wein A.J., Zderic SA, Chacko S.: Obstruction-induced bladder hypertrophy causes alterations in the myosin isoform expression and contractility of the urethral smooth muscle. J. Urol. 167:4 (suppl):42, 2002.

192. Chang SH, Hypolite JA, Zderic SA, Wein A.J. Chacko S.: Altered contractility of corpus cavernosum smooth muscle: a possible molecular basis for erectile dysfunction associated with partial bladder outlet obstruction resulting from benign prostatic hyperplasia. J. Urol. 167:4 (suppl):236, 2002.

193. Wein, AJ: Subjective and objective incontinence 5 to 10 years after Burch colposuspension. J Urol 2002, 168:1292-1293.

194. Wein, AJ: A systematic review of tension-free urethropexy for stress urinary incontinence: intravaginal slingplasty and the tension-free vaginal tape procedures. J Urol 2002, 1291-1292.


100

195. Wein, AJ: Polypropylene sling for the treatment of stress urinary incontinence. J Urol 2002, 168:1291.

196. Wein, AJ: Objective and subjective cure rates after tension-free vaginal tape for treatment of urinary incontinence. J Urol 2002, 168:1291.

197. Wein, AJ: Long-term (10-15 years) follow up after Burch colposuspension for urinary stress incontinence. J Urol 2002, 168:1290-1291.

198. Wein, AJ: Pelvic floor muscle training for urinary incontinence in women. J Urol 2002, 168:2729.

199. Wein, AJ: Tension-free vaginal tape operation: results of the Austrian registry. J Urol 2003, 169:2428.

200. Wein, AJ: Review of cadaveric allografts in urology. J Urol 2003, 169: 2427-2428.

201. Wein, AJ: Quality of life and seeking help in women with urinary incontinence. A population-based study. J Urol 2003, 169: 2427.

202. Wein, AJ: Urinary incontinence in Canada. National survey of family physicians’ knowledge, attitudes, and practices. J Urol 2003, 169: 2426-2427.

203. Wein, AJ: Should measurement of maximum urinary flow rate and residual urine volume be a part of a “minimal care” assessment programme in female incontinence? J Urol 2003, 169:2426.

204. Wein, AJ: Antimicrobial prophylaxis for urinary tract infection in persons with spinal cord dysfunction. J Urol 2003, 169:2425.

205. Wein, AJ: Association between competing interests and authors’ conclusions: epidemiological study of randomised clinical trials published in the BMJ. J Urol 2003, 169: 2424-2425.

206. Wein, AJ: Anterior vaginal repair for urinary incontinence in women. J Urol 2003, 169:2431-2432.

207. Wein, AJ: Bladder injection of “naked” hSlo/pcDNA3 ameliorates detrusor hyperactivity in obstructed rats in vivo. J Urol 2003, 169:2431.

208. Wein, AJ: Differing effects of N(G)-monomethyl L-arginine and 7-nitroindazole on detrusor activity. J Urol 2003, 169:2430.

209. Wein, AJ: Efficacy of botulinum-A toxin in children with detrusor hyperreflexia due to myelomeningocele: preliminary results. J Urol 2003, 169:2430.

210. Wein, AJ: Posterior tibial nerve stimulation in the treatment of urge incontinence. J Urol 2003, 169:2429-2430.

211. Wein AJ: Prevention of postpartum stress incontinence in primigravidae with increased bladder neck mobility: a randomised controlled trial of antenatal pelvic floor exercises. J Urol 2003, 169:2429.


101

212. Wein, AJ: Vaginal palpation of pelvic floor muscle strength: inter-test reproducibility and comparison between palpation and vaginal squeeze pressure. J Urol 2003, 169:2428-2429.

213. Wein, AJ: Conservative management for Postprostatectomy urinary incontinence. J Urol 2003, 169:2431-2433.

214. Rovner ES, Wein, AJ: Update on overactive bladder: pharmacologic approaches on the horizon. Curr Urol Rep, 2003:385-390.

215. Wein, AJ: A method to minimize indwelling catheter calcification and bladder stones in individuals with spinal cord injury. J Urol 2003, 170:1052-1053.

216. Wein, AJ: Posterior tibial nerve stimulation in the treatment of idiopathic non-obstructive voiding dysfunction. J Urol 2003, 170:1051-1052.

217. Wein, AJ: Weighted vaginal cones for urinary incontinence. J Urol 2003, 170:1045-1046.

218. Wein, AJ: Conservative management for post prostatectomy urinary incontinence. J Urol 2003, 170:1045.

219. Wein, AJ: Treatment of post prostatectomy incontinence: Is the bulbourethral sling a viable alternative to the artificial urinary sphincter? J Urol 2003, 170:1044-1045.

220. Wein, AJ: Emerging role of botulinum toxin in the treatment of neurogenic and non-neurogenic voiding dysfunction. J Urol 2003, 170:1044.

221. Wein, AJ: Randomized trial of porcine dermal sling (Pelvicol implant) vs tension-free vaginal tape (TVT) in the surgical treatment of stress incontinence: A questionnaire-based study. J Urol 2003, 170:1049.

222. Wein, AJ: The mesh wallstent in the treatment of detrusor external sphincter dyssynergia in men with spinal cord injury: a 12-year follow up. J Urol 2003, 170:1049.

223. Wein, AJ: Effect of botulinum A toxin in the treatment of voiding dysfunction due to detrusor under-activity. J Urol 2003, 170:1048.

224. Wein, AJ: Use and misuse of the concept of quality of life in evaluating surgical treatments for lower urinary tract symptoms. J Urol 2003, 170:1048.

225. Wein, AJ: Why do women have voiding dysfunction and de novo detrusor instability after colposuspension? J Urol 2003, 170:1047-1048.

226. Wein, AJ: A randomized trial of behavioral management for continence with older rural women. J Urol 2003, 170: 1047.

227. Wein, AJ: The impact of urinary incontinence in African American women. J Urol 2003, 170: 1046-1047.


102

228. Wein, AJ: Percutaneous tibial nerve stimulation in the treatment of overactive bladder: urodynamic data. J Urol 2003, 170:1051.

229. Wein, AJ: Changes in dopaminergic and glutamatergic excitatory mechanisms of micturition reflex after middle cerebral artery occlusion in conscious rats. J Urol 2003, 170:1050-1051.

230. Wein, AJ: The role of beta3-adrenoceptors in mediating relaxation of porcine detrusor muscle. J Urol 2003, 170:1050.

231. Wein, AJ: A randomized crossover study to evaluate RO 115-1240, a selective alpha1A/1L-adrenoceptor partial agonist in women with stress urinary incontinence. BJU Int. 2004; 93:1361.

232. Wein, AJ: A randomized crossover study to evaluate Ro 115-1240, a selective alpha-adrenoceptor partial agonist in women with stress urinary incontinence. BJU Int. 2004; 93:1115.

233. Chang S, Hypolite JA, Changolkar A, DiSanto ME, Wein AJ, Chacko S. Diabetes-Induced Increase in Detrusor Smooth Muscle Myosin Basal Phosphorylation Level Is Associated With An Upregulation of Rho-Kinase and CPI-17. J Urol 173:4(suppl):161, 2005.

234. Vira MA, Bearn L, Sanchez RF, Tomaszewski JE, VanArsdalen K, Wein AJ, Malkowicz SB. Radical cystectomy among elderly patients: Decreased patient survival at 6 and 12 Months. J Urol 173:4(suppl): 1114, 2005.

235. Polyak E, Zderic SA, Mannikarottu A, Wein AJ, Chacko S. Alteration of caveolae and caveolins in detrusor smooth muscle hypertrophy produced by partial bladder outlet obstruction. J Urol 173:4(suppl): 1200, 2005.

236. LaBelle E, Zderic SA, Hypolite JA, Wein AJ, Chacko S. Partial outlet obstruction alters lipid-dependent signaling in rabbit bladder detrusor muscle. J Urol 173:4(suppl): 1226, 2005.

237. Chang, S, Hypolite JA, Wein AJ, Chacko S, DiSanto ME. Effects of short-term partial bladder outlet obstruction on the expression of smooth muscle contractile and regulatory proteins J Urol 173:4(suppl): 1227, 2005.

238. Vira MA, Tomaszewski JE, D’Amico AV, VanArsdalen K, Wein AJ, Malkowicz SB. Gleason score migration between prostate biopsy and radical prostatectomy specimens. J Urol 173:4(suppl): 1607, 2005.

239. Wein, AJ. How much is enough and who says so? The case of the King’s Health Questionnaire and overactive bladder. J Urol 2005, 173:908.

240. Wein, AJ: ICIQ: A brief and robust measure for evaluating the symptoms and impact of urinary incontinence. J Urol 2005, 173:908-909.

241. Wein, AJ: An antiproliferative factor from interstitial cystitis patients is a frizzled 8 protein-related sialoglycopeptide. J Urol 2005, 173:909-1l0.

242. Wein, AJ: Hypoxia inhibits human bladder smooth muscle cell proliferation: a potential mechanism of bladder dysfunction. J Urol 2005, 173:910.


103

243. Wein, AJ: The effect of previous treatment experience and incontinence severity on the placebo response of stress urinary incontinence. J Urol 2005, 173:910-911.

244. Wein, AJ: Pharmacotherapy for stress urinary incontinence: present and future options. J Urol 2005, 173:911.

245. Wein, AJ: Bulking agents for stress urinary incontinence: short-term results and complications in a randomized comparison of periurethral and transurethral injections. J Urol 2005, 173:911-912.

246. Wein, AJ: An open label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis. J Urol 2005, 173:1262.

247. Wein, AJ: 1) VTimed Voiding for the Management of Urinary Incontinence in Adults. 2) Bladder training for urinary incontinence in adults. J Urol 2005, 173:1262-1264

248. Wein, AJ: Deafferentation of the urinary bladder and implantation of a sacral anterior root stimulator (SARS) for treatment of the neurogenic bladder in paraplegic patients. J Urol 2005, 173:1264-1265.

249. Wein, AJ: Incidence of pubic osteomyelitis after bladder neck suspension using bone anchors. J Urol 2005, 173:1265.

250. Wein, AJ: TVT and Sparc suburethral slings: A case-control series. J Urol 2005, 173:1265-1266.

251. Wein, AJ: 1) Surgical Treatment of Female Stress Urinary Incontinence With a Trans-Obturator-Tape (T.O.T.) Uratape: Short Term Results of a Prospective Multicentre Study. 2) Intravesical Resiniferatoxin for Refractory Detrusor Hyperreflexia: A Multicenter, Blinded, Randomized, Placebo-Controlled Trial. 3) Resiniferatoxin for Detrusor Instability Refractory to Anticholinergics. J Urol 2005, 173:1661-1663

252. Wein, AJ: Intravesical Therapy Options for Neurogenic Detrusor Overactivity. J Urol 2005, 173:1661-1662

253. Wein, AJ: Nocturia and Associated Morbidity in a Community-Dwelling Elderly Population. J Urol 2005, 173:1663-1664

254. Wein, AJ: Degree of Bother Caused by Nocturia in Women. J Urol 2005, 173:1664

255. Wein, AJ: Nocturnal Polyuria in Community-Dwelling Women. J Urol 2005, 173:1664-1665

256. Wein, AJ: The Effect of Different Types of Hysterectomy on Urinary and Sexual Functions: A Prospective Study. J Urol 2005, 173:1665

257. Wein, AJ: The Impact of Hysterectomy on Lower Urinary Tract Symptoms. J Urol 2005, 173:1665

258. Wein, AJ: Interstitial Cystitis Antiproliferative Factor (APF) as a Cell-Cycle Modulator. J Urol 2005, 173:1666

259. Wein, AJ: Urgency: the cornerstone symptom of overactive bladder. J Urol 2005, 173:2054


104

260. Wein, AJ: Antidiuresis: a new concept in managing female daytime urinary incontinence. J Urol 2005, 173:2054-2055

261. Wein, AJ: 1) Mixed incontinence. 2) Mixed Incontinence Stressing About Urge. 3) Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial. J Urol 2005, 173:2055-2057

262. Wein, AJ: 1) The Erlangen Stroke Project. 2) Impact of urinary incontinence after stroke: results from a prospective population-based stroke register. J Urol 2005, 173:2057

263. Wein, AJ: Muscarinic Acetylcholine Receptor Knockout Mice: Novel Phenotypes and Clinical Implications. J Urol 2005, 173:2199

264. Wein, AJ: 1) Role of the urothelium in bladder function. 2) The urothelium in overactive bladder: passive bystander or active participant? J Urol 2005, 173:2199-2200

265. Wein, AJ: A Prospective Multicenter Randomized Trial of Tension-Free Vaginal Tape and Colposuspension for Primary Urodynamic Stress Incontinence: Two-Year Follow-Up. J Urol 2005, 174:215

266. Wein, AJ: 1) Patient-Selected Goals: A New Perspective on Surgical Outcome. 2) Patient- Centered Goals for Pelvic Floor Dysfunction Surgery: Long-Term Follow-Up. J Urol 2005, 174:216-217

267. Wein, AJ: 1) The Prevalence of Urinary Incontinence in Community-Dwelling Married Women: A Matter of Definition. 2) The Prevalence of Urinary Incontinence in Women in Four European Countries. J Urol 2005, 174:217-218

268. Wein, AJ: 1) Behavioral Treatment Options for Urinary Incontinence. 2) Predictors of Treatment Response to Behavioral Therapy and Pharmacotherapy for Urinary Incontinence. J Urol 2005, 174:218-219

269. Wein, AJ: The natural history of lower urinary tract dysfunction in men: the influence of detrusor underactivity o the outcome after transurethral resection of the prostate with a minimum 10 year urodynamic follow up. J Urol 2005, 174:608.

270. Wein, AJ: Autonomic nervous system pharmacogenomics: a progress report. J Urol 2005, 174:608-609.

271. Wein, AJ: “Unblinding” in randomized controlled drug trials for urinary incontinence: implications for assessing outcomes when adverse effects are evident. J Urol 2005, 174:609-610.

272. Wein, AJ: 1) Botulinum toxin for the treatment of lower urinary tract symptoms: a review. 2) Single institution experience in 110 patients with botulinum toxin A injection into bladder or urethra. 3) Botulinum toxin in the management of lower urinary tract dysfunction: contemporary update. J Urol 2005, 174:610-612

273. Wein, AJ: Transvaginal electrical stimulation in the treatment of urinary incontinence. J Urol 2005, 174:1007.


105

274. Wein, AJ: Posterior tibial nerve stimulation in the treatment of voiding dysfunction: urodynamic data. J Urol 2005, 174:1008.

275. Wein, AJ: Long-term results of sacral neuromodulation for women with urinary retention. J Urol 2005, 174:1008.

276. Wein, AJ: Transvaginal surgery in the octogenarian using cadaveric fascia for pelvic prolapse and stress incontinence: minimal one year results compared to younger patients. J Urol 2005, 174:1009.

277. Wein, AJ: Tension-free vaginal tape: do patients who fail to follow up have the same results of those who do? J Urol 2005, 174:1009-1010.

278. Wein, AJ: The effects of the tension-free vaginal tape on voiding function: a prospective evaluation. J Urol 2005, 174:1010.

279. Wein, AJ: Functional impairment as a risk factor for urinary incontinence among older Americans. J Urol 2005, 174:1349.

280. Wein AJ: Collagen Synthesis is Not Altered in Women With Stress Urinary Incontinence. J Urol 2005, 174:1349

281. Wein AJ: Impact of Menopause on Collagen Subtypes in the Arcus Tendineous Fasciae Pelvis. J Urol 174:1350

282. Wein, AJ: Effects of estrogen with and without progestin on urinary incontinence. J Urol 2005, 174:1350-1351

283. Wein, AJ: Full Publication of Abstracts of Randomised Controlled Trials Published at International Continence Society Meetings. J Urol November 2005, 174:1902

284. Wein, AJ: New Theories in Interstitial Cystitis. J Urol November 2005, 174:1903

285. Wein, AJ: Prostate Botulinum A Toxin Injection—An Alternative Treatment for Benign Prostatic Obstruction in Poor Surgical Candidates. J Urol November 2005, 174:1903

286. Wein, AJ: International Consultation on IC—Rome, September 2004/Forging an International Consensus: Progress in Painful Bladder Syndrome/Interstitial Cystitis. Keynote Presentation: Urine Markers and Interstitial Cystitis—Complete Characterization of an Antiproliferative Factor From the Urine of IC Patients. J Urol 2005, 174:2246-2249.

287. Wein, AJ: A Prospective, Double-Blind, Randomized Cross-Over Study Evaluating Changes in Urinary pH for Relieving the Symptoms of Interstitial Cystitis. J Urol 2005, 174:2247

288. Wein, AJ: How Do You Stretch a Bladder? A Survey of UK Practice, a Literature Review, and a Recommendation of a Standard Approach. J Urol 2005, 174:2247

289. Wein, AJ: Pilot Study of the Feasibility of In-Office Bladder Distention Using Electromotive Drug Administration (EMDA). J Urol 2005, 174:2247


106

290. Wein, AJ: Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis. J Urol 2005, 174:2248-2249.

291. Wein, AJ: A Normal Flow Pattern in Women Does Not Exclude Voiding Pathology. J Urol 2005, 174:2277

292. Wein, AJ: 1) Chronic Pudenal Nerve Neuromodulation in Women With Idiopathic Refractory Detrusor Overactivity Incontinence: Results of a Pilot Study With a Novel Minimally Invasive Implantable Mini-Stimulator. 2) Botulinum A Toxin Injections Into the Detrusor: An Effective Treatment in Idiopathic and Neurogenic Detrusor Overactivity? J Urol December 2005, 174:2278

293. Wein, AJ: Variability of Detrusor Overactivity on Repeated Filling Cystometry in Men With Urge Symptoms: Comparison With Spinal Cord Injury Patients. J Urol December 2005, 174:2279

294. Wein, AJ: Correlation of abdominal leak point pressure with objective incontinence severity in men with post-radical prostatectomy stress incontinence. J Urol 2005, 174:2278-2279.

295. Wein, AJ: Patient satisfaction and clinical efficacy of the new perineal bone-anchored male sling. J Urol 2005, 174:2280-2281.

296. Wein AJ: Compilation: 1.Complications From Transvaginal Pubovaginal Slings Using Bone Anchor Fixation. 2.Incidence of Public Osteomyelitis After Bladder Neck Suspension Using Bone Anchors. J Urol January 2006, 175(1):222-223

297. Wein, AJ: Compilation: 1.Seven-Year Follow-Up of the Tension-Free Vaginal Tape Procedure for Treatment of Urinary Incontinence. 2.Tension-Free Vaginal Tape: A Prospective Subjective and Objective Outcome Analysis. 3.Randomized Clinical Trial. Comparing Suprapubic Arch Sling (SPARC) and Tension-Free Vaginal Tape (TVT): One-Year Results. 4.Laparoscopic Burch Colposuspension Versus Tension-Free Vaginal Tape: A Randomized Trial. 5.A Randomised Trial Comparing Open Burch Colposuspension Using Sutures With Laparoscopic Colposuspension Using Mesh and Staples in Women With Stress Urinary Incontinence. 6.The Treatment of Stress. Incontinence—Is there a Role for Laparoscopy? J Urol January 2006, 175(1):223-226

298. Wein AJ: Three-Dimensional Ultrasonography to Assess Long-Term Durability of Periurethral Collagen in Women With Stress Incontinence Due to Intrinsic Sphincter Deficiency. J Urol January 2006, 175(1):226

299. Wein AJ: New Objective Measures to Quantify Stress Urinary Incontinence in a Novel Durable Animal Model of Intrinsic Sphincter Deficiency. J Urol January 2006, 175(1):227

300. Wein AJ: Compilation: 1.Pelvic Floor Muscle Training is Effective in Treatment of Female Stress Urinary Incontinence, but how Does it Work? 2.Who Will Benefit From Pelvic Floor Muscle Training for Stress Urinary Incontinence? 3.The Role of Pelvic Floor Muscle Training in Urinary Incontinence. 4.Behavioral Treatment Options for Urinary Incontinence. 5.Predictors of Treatment Response to Behavioral Therapy and Pharmacotherapy for Urinary Incontinence. J Urol February 2006, 175(2):629-31


107

301. Wein AJ: Pharmacological Treatment of Women Awaiting Surgery for Stress Urinary Incontinence. J Urol February 2006, 175(2):631-632

302. Wein AJ: Sacral Neuromodulation: Long-Term Experience of One Center. J Urol February 2006, 175(2):632

303. Wein AJ: Autonomic Dysreflexia: A Medical Emergency. The Importance of Autonomic Dysreflexia to the Urologist. J Urol March 2006, 175(3):1028

304. Wein AJ: Spastic Bladder and Spinal Cord Injury: Seventeen Years of Experience with Sacral Deafferentiation and Implantation of an Anterior Root Stimulator. J Urol March 2006, 175(3):1029

305. Wein AJ: Compilation: 1.Which Factors Predict Upper Urinary Tract Deterioration in Overactive Neurogenic Bladder Dysfunction? 2.Incidence of Upper Tract Abnormalities in Patients With Neurovesical Dysfunction Secondary to Multiple Sclerosis: Analysis of Risk Factors at Initial Urologic Evaluation. J Urol March 2006, 175(3):1029-1030

306. Wein AJ: Compilation: 1.New Tined Lead Electrode in Sacral Neuromodulation: Experience from a Multicentre European Study. 2.A New Minimally Invasive Procedure for Pudendal Nerve Stimulation to Treat Neurogenic Bladder: Description of the Method and Preliminary Data. J Urol March 2006, 175(3):1031-1032

307. Wein AJ: Compilation: 1.Association Between Suicide Attempts and Selective Serotonin Reuptake Inhibitors: Systematic Review of Randomised Controlled Trials. 2.Selective Serotonin Reuptake Inhibitors (SSRIs) and Suicide in Adults: Meta-Analysis of Drug Company Data From Placebo Controlled, Randomised Controlled Trials Submitted to the MHRA’s Safety Review. J Urol April 2006, 175(4):1433-1434

308. Wein AJ: Compilation: 1.Effects of Behavioral and Drug Therapy on Nocturia in Older Incontinent Women. 2.Oral Dryness, Nocturia and the Menopause. J Urol April 2006, 175(4):1434-1435

309. Wein AJ: Prospective, Randomized, Double-Blind Study of Safety and Tolerability of Intravesical Resiniferatoxin (RTX) in Interstitial Cystitis (IC) J Urol April 2006, 175(4):1435-1436

310. Wein, AJ: Enucleation of Renal Cell Carcinoma with Ablation of Tumor Base: Is Cancer Control Comparable to Partial Nephrectomy? J Urol Supplement 175(4):16, April 2006

311. Wein. AJ: Deletion of SM-B, the high ATPase isoform of myosin, upregulates the PKC-mediated spinal transduction pathway in the urinary bladder smooth muscle. J Urol Supplement 175(4):51, April 2006

312. Wein, AJ: Regional difference in the myosin isoform of vaginal wall smooth muscle. J Urol Supplement 175(4):389, April 2006

313. Wein, AJ: Partial bladder outlet obstruction induces the up-regulation of CPI-17 in detrusor smooth muscle. J Urol Supplement 175(4):409, April 2006


108

314. Wein AJ: Urinary Incontinence in US Women. A Population-Based Study. J Urol May 2006, 175(5):1800

315. Wein AJ: Compilation: 1.Intraurethral Muscle-Derived Cell Injections Increase Leak Point Pressure in a Rat Model of Intrinsic Sphincter Deficiency. 2.Stem Cell Therapy for Urinary Stress Incontinence. J Urol, May 2006, 175(5):1801

316. Wein AJ: Diagnosis and Treatment of Primary Bladder Neck Obstruction in Men. J Urol May 2006, 175(5):1802

317. Wein AJ: Refining Diagnosis of Anatomic Female Bladder Outlet Obstruction: Comparison of Pressure-Flow Study Parameters in Clinically Obstructed Women With Those of Normal Controls . J Urol May 2006, 175(5):1802-1803

318. Wein AJ: Compilation: 1.Critical Appraisal of Dimethyl Sulfoxide Treatment for Interstitial Cystitis: Discomfort, Side-Effects and Treatment Outcome. 2.Treatment of Interstitial Cystitis With Cystistat®: A Hyaluronic Acid Product. J Urol June 2006, 175(6):2207-2208

319. Wein AJ: Compilation: 1.Argument for the Use of the Potassium Sensitivity Test in the Diagnosis of Interstitial Cystitis. 2.Is the Potassium Sensitivity Test A Valid and Useful Test for the Diagnosis of Interstitial Cystitis? J Urol June 2006, 175(6):2208-2209

320. Wein AJ: Increased Prevalence of Interstitial Cystitis in Women With Detrusor Overactivity Refractory to Anticholinergic Therapy. J Urol June 2006, 175(6):2209

321. Wein AJ: Prevalence, Diagnosis, Characterization, and Treatment of Prostatitis, Interstitial Cystitis, and Epididymitis in Outpatient Urological Practice: The Canadian PIE Study. J Urol June 2006, 175(6):2209-2210

322. Wein AJ: Augmented Extracellular ATP Signaling in Bladder Urothelial Cells From Patients With Interstitial Cystitis. J Urol June 2006, 175(6):2210-2211

323. Wein AJ: Non-Degenerative Mild Cognitive Impairment in Elderly People and Use of Anticholinergic Drugs: Longitudinal Cohort Study. J Urol July 2006, 176(7):210

324. Wein AJ: Clinical Observations of the Effect of Antidiuretic Hormone on Nocturia in Elderly Men. J Urol July 2006, 176:210-211

325. Wein AJ: Sacral nUromodulation for Intractable Urge Incontinence: Are There Factors Associated with Cure? J Urol July 2006, 176:211

326. Wein AJ: Sacral Versus Pudendal Nerve Stimulation for Voidign Dysfunction: A Prospective, Single-Blinded, Randomized, Crossover Trial. J Urol July 2006, 176:212

327. Wein AJ: Understanding Detrusor Sphincter Dyssynergia—Significance of Chronology. J Urol July 2006, 176:212


109

328. Wein AJ: The Natural History of Lower Urinary Tract Dysfunction in Men: Minimum 10-Year Urodynamic Follow-Up of Untreated Detrusor Underactivity. J Urol July 2006, 176:213

329. Wein AJ: The Natural History of Lower Urinary Tract Dysfunction in Men: Minimum 10-Year Urodynamic Follow-Up of Untreated Bladder Outlet Obstruction. J Urol July 2006, 176:213-214

330. Wein AJ: Changes in Bladder Nerve-Growth Factor and p75NTR Genetic Expression in Streptozotocin-Induced Diabetic Rats. J Urol July 2006, 176:837

331. Wein AJ: Bladder-Health Diaries: An Assessment of 3-Day vs 7-Day Entries. J Urol August 2006, 176:672

332. Wein AJ: The Completely Dry Rate: A Critical Re-Evaluation of the Outcomes of Slings. J Urol August 2006, 176:672-673

333. Wein AJ: The Male Perineal Sling: Intermediate-Term Results. J Urol August 2006, 176:673

334. Wein AJ: Acupuncture for Overactive Bladder: A Randomized Controlled Trial. J Urol August 2006, 176:674

335. Wein AJ: The Effect of Pregnancy and Mode of Delivery on the Prevalence of Urinary and Fecal Incontinence. J Urol August 2006, 176:674-675

336. Wein AJ: Is There a Role for Periurethral Collagen Injection in the Management of Urodynamically Proven Mixed Urinary Incontinence? J Urol September 2006, 176:1057

337. Wein AJ: Proposed Mechanism for the Efficacy of Injected Botulinum Toxin in the Treatment of Human Detrusor Overactivity. J Urol September 2006, 176:1058

338. Wein AJ: Botulinum A Toxin Intravesical Injections in the Treatment of Painful Bladder Syndrome: A Pilot Study. J Urol September 2006, 176:1058-1059

339. Wein AJ: Abdominal Sacrocolpopexy With Burch Colposuspension to Reduce Urinary Stress Incontinence. J Urol September 2006, 176:1059

340. Wein AJ: Tissue-Engineered Autologous Bladders for Patients Needing Cystoplasty. J Urol September 2006, 176:1059-1060

341. Wein AJ: Reduction of Moderate-to-Large Cystocele During Urodynamic Evaluation Using a Vaginal Gauze Pack: 8-Year Experience. J Urol October 2006, 176:1507

342. Wein AJ: Long-Term Results With Tension-Free Vaginal Tape on Mixed and Stress Urinary Incontinence. J Urol October 2006, 176:1507-1508

343. Wein AJ: Effect of Tension-Free Vaginal Tape in Women With A Urodynamic Diagnosis of Idiopathic Detrusor Overactivity and Stress Incontinence. J Urol October 2006, 176:1508


110

344. Wein AJ: Urinary Retention in Women: Its Causes and Management. J Urol October 2006, 176:1508-1509

345. Wein AJ: Evidence of Occult Dysautonomia in Fowler’s Syndrome: Alteration of Cardiovascular Autonomic Function Tests in Female Patients Presenting with Urinary Retention J Urol October 2006, 176:1509

346. Wein AJ: Concentric Needle Electrodes are Superior to Perineal Surface-Patch Electrodes for Electromyographic Documentation of Urethral Sphincter Relaxation During Voiding. J Urol October 2006, 176:1510

347. Wein AJ: Urinary Incontinence in Women (Editorial Comment only). J Urol November 2006, 176:2119

348. Wein AJ: Incontinence-Specific Quality of Life Measures Used in Trials of Treatments for Female Urinary Incontinence: A Systematic Review. J Urol November 2006, 176:2119

349. Wein AJ: Correlation Between Quality of Life and Voiding Variables in Patients Treated With Precutaneous Tibial Nerve Stimulation. J Urol November 2006, 176:2120

350. Wein AJ: Efficacy of Sacral Neuromodulation for Symptomatic Treatment of Refractory Urinary Urge Incontinence. J Urol November 2006, 176:2120-2121

351. Wein AJ: Major Depression in Female Urinary Incontinence. J Urol November 2006, 175:2121

352. Wein AJ: Intraoperative ‘Floppy Iris’ Syndrome and Its Relationship to Tamsulosin: A Urologist’s Guide (Editorial Comment only). J Urol November 2006, 176-2121

353. Wein AJ: Expression of Functional Nicotinic Acetylcholine Receptors in Rat Urinary Bladder Epithelial Cells. J Urol November 2006, 176-2306

354. Wein AJ: Hysterectomy and Pelvic Organ Dysfunction. J Urol December 2006, 176:2566

355. Wein AJ: Recent Advances in Basic Science for Overactive Bladder. J Urol December 2006, 176:2566-2567

356. Wein AJ: Urodynamic Assessment of Bladder-Outlet Obstruction in Women. J Urol December 2006, 176:2567

357. Wein AJ: Effect of Different Sized Transurethral Catheters on Pressure-Flow Studies in Women With Lower Urinary Tract Symptoms. J Urol December 2006, 176:2567-2568

358. Wein AJ: Factors Associated with Incontinence Frequency in a Surgical Cohort of Stress Incontinent Women. J Urol December 2006, 176:2568-2569


111

359. Wein AJ: 1) Techniques for the Intradetrusor Administration of Botulinum Toxin. 2) Quality of Life Changes in Patients with Neurogenic Versus Idiopathic Detrusor Overactivity After Intradetrusor Injections of Botulinum Neurotoxin Type A and Correlations With Lower Urinary Tract Symptoms and Urodynamic Changes. J Urol December 2006, 176:2569

360. Wein AJ: Cost-Consequence Analysis Evaluating the Use of Botulinum Neurotoxin-A in Patients with Detrusor Overactivity Based on Clinical Outcomes Observed at a Single UK Centre. J Urol December 2006, 176:2569-2570

361. Wein AJ: Selective Beta-Adrenoceptor Agonists, Calcium Antagonists and Potassium Channel Openers as a Possible Medical Treatment of the Overactive Bladder and Urge Incontinence. J Urol January 2007, 177:230

362. Wein AJ: Transurethral Radiofrequency Energy Collagen Micro-Remodeling for the Treatment of Female Stress Urinary Incontinence. J Urol January 2007, 177:231

363. Wein AJ: Objective and Subjective Cure Rates After Trans-Obturator Tape (OBTAPE) Treatment of Female Urinary Incontinence. J Urol January 2007, 177:232

364. Wein AJ: A Nationwide Analysis of Transvaginal Tape Release of Urinary Retention After Tension-Free Vaginal Tape Procedure. J Urol January 2007, 177:232-233

365. Wein AJ: The Efficacy of the Tension-Free Vaginal Tape in the Treatment of Five Subtypes of Stress Urinary Incontinence. J Urol January 2007, 177:233

366. Wein AJ: M2 and M3 Muscarinic Receptor Activation of Urinary Bladder Contractile Signal Transduction. I. Normal Rat Bladder. J Urol January 2007, 177:401-402

367. Wein AJ: M2 and M3 Muscarinic Receptor Activation of Urinary Bladder Contractile Signal Transduction. II. Denervated Rat Bladder. J Urol January 2007, 177.402-403

368. Wein AJ: Introduction to the 2005 IUGA Grafts Roundtable: Clinical Implications of the Biology of Grafts: Conclusions of the 2005 IUGA Grafts Roundtable. J Urol February 2007, 177:620-621

369. Wein AJ: Synthetic Biomaterials for Pelvic Floor Reconstruction. J Urol February 2007, 177:622

370. Wein AJ: The Use of Synthetic Mesh in Female Pelvic Reconstructive Surgery. J Urol February 2007, 177:622-623

371. Wein AJ: Preliminary Results on the Off-Label Use of Duloxetine for the Treatment of Stress Incontinence After Radical Prostatectomy or Cystectomy. J Urol March 2007, 177:963-964

372. Wein AJ: Is HCI Duloxetine Effective in the Management of Urinary Stress Incontinence After Radical Prostatectomy? J Urol March 2007, 177:964

373. Wein AJ: Ultrasound Measurement of Detrusor Wall Thickness in Healthy Adults. J Urol March 2007, 177:1052


112

374. Wein AJ: Effects of Potassium Channel Modulators on Human Detrusor Smooth Muscle Myogenic Phasic Contractile Activity: Potential Therapeutic Targets for Overactive Bladder. J Urol March 2007, 177:1052-1053

375. Wein AJ: 1) Botulinum Toxin-Type A in the Treatment of Drug-Resistant Neurogenic Detrusor Overactivity Secondary to Traumatic Spinal Cord Injury. 2) Therapeutic Effects of Suburothelial Injection of Botulinum A Toxin for Neurogenic Detrusor Overactivity Due to Chronic Cerebrovascular Accident and Spinal Cord Lesions. J Urol March 2007, 177:1053-1054

376. Wein AJ: Five-Year Outcomes of the Tension-Free Vaginal Tape Procedure for Treatment of Female Stress Urinary Incontinence. J Urol April 2007, 177:1427

377. Wein AJ: Tension-Free Vaginal Tape for the Treatment of Urodynamic Stress Incontinence With Intrinsic Sphincteric Deficiency. J Urol April 2007, 177:1427-1428

378. Wein AJ: A Randomized Controlled Equivalence Trial of Short-Term Complications and Efficacy of Tension-Free Vaginal Tape and Suprapubic Urethral Support Sling for Treating Stress Incontinence. J Urol April 2007, 177:1428-1429

379. Wein AJ: Various Surgical Approaches to Treat Voiding Dysfunction Following Anti-Incontinence Surgery. J Urol April 2007, 177:1429-1430

380. Spangler E, Malkowicz SB, Zeigler-Johnson C, Van Arsdalen K, Wein AJ, Rebbeck TR. Body Mass Index Correlates With Tumor Characteristics and Biochemical Failure in African-American Men. J Urol Supplement 177(4):96, April 2007

381. Jayavedappa R, Chhatre S, Whittington R, Wein AJ, Malkowicz SB. Assessment of Indirect Costs of Newly Diagnosed Prostate Cancer Patients. J Urol Supplement 177(4):97, April 2007

382. Boopathi E, Mohanan S, Zheng Y, Wein AJ, Chacko S. Urologic Complications of Diabetes: High Glucose-Induced Oxidative Stress Activates The Transcriptional Factor NF-KB in the Detrusor Smooth Muscle Cells. J Urol Supplement 177(4):324, April 2007

383. Marx JO, Basha M, Mohanan S, Hypolite J, Chang S, Hu E, Sulpizio A, Malkowicz SB, Wein AJ, Laping NJ, Chacko S. Rho-Kinase Inhibitor Decreases Spontaneous Activity in Detrusor Smooth Muscle with Partial Bladder Outlet Obstruction. J Urol Supplement 177(4):325, April 2007

384. Hypolite J, Chang S, Zderic SA, Wein AJ, Chacko S. Bladder Dysfunction is Associated with Impaired Contractility and Decreased Density of Nerve Fiber in The Rabbit Model of Partial Bladder Outlet Obstruction. J Urol Supplement 177(4):326, April 2007

385. Abraham N, Guzzo TJ, Tomaszewski JE, Chen Z, Magerfleish L, VanArsdalen K, Wein AJ, Malkowicz SB. Estimated Tumor Volume Provides Independent Predictive Information on Biochemical Outcome in High Grade Radical Prostatectomy Patients. J Urol Supplement 177(4):466, April 2007

386. Basha M, Wang T, Lassmann J, Moreland RS, Wein AJ, Chacko S. Estrogen Upregulates Smooth Muscle Myosin Isoform SM2 in the Rat Vaginal Wall. J Urol Supplement 177(4):483, April 2007


113

387. Chang S, Basha M, Wein AJ, Chacko S. Estrogen-Depletion Induces The Up-Regulation of the Regulatory Pathway Involved in the Maintenance of Tone in the Lower Urinary Tract Smooth Muscle. J Urol Supplement 177(4):487, April 2007

388. Guzzo TJ, Canter DJ, Tomaszewski JE, Magerfleish L, VanArsdalen K, Wein AJ, Malkowicz SB. The Antecedent History of High Grade Prostatic Intraepithelial Neoplasia in a Radical Prostatectomy Cohort. J Urol Supplement 177(4):584, April 2007

389. Malkowicz SB, Zeigler-Johnson C, Spangler E, Panossian S, Wein AJ, Rebbeck TR. Obesity is Associated with Poorer Clinical Outcomes in Prostate Cancer Patients with High-Risk Androgen Receptor Genotypes. J Urol Supplement 177(4):588, April 2007

390. Jayadevappa R, Chhatre S, Whittington R, Wein AJ, Malkowicz SB. Hospital Ownership and Quality of Prostate Cancer Care. J Urol Supplement 177(4):592, April 2007

391. Wein AJ: Reevaluating Occult Incontinence. J Urol May 2007, 177:1820-1821

392. Wein AJ: Neurological Disease That Cause Detrusor Hyperactivity With Impaired Contractile Function. J Urol May 2007, 177:1821

393. Wein AJ: Antimuscarinic Drugs in Detrusor Overactivity and the Overactive Bladder Syndrome: Motor or Sensory Actions? J Urol May 2007, 177:1822-1823

394. Wein AJ: Botulinum Toxin Injections for Neurogenic and Idiopathic Detrusor Overactivity: A Critical Analysis of Results. J Urol June 2007, 177:2242

395. Wein AJ: Will Suburothelial Injection of Small Dose of Botulinum A Toxin Have Similar Therapeutic Effects and Less Adverse Events for Refractory Detrusor Overactivity? J Urol June 2007, 177:2243

396. Wein AJ: Persistence of Therapeutic Effect After Repeated Injections of Botulinum Toxin Type A to Treat Incontinence due to Neurogenic Detrusor Overactivity. J Urol June 2007, 177:2244

397. Wein AJ: Sustained Beneficial Effects of Intraprostatic Botulinum Toxin Type A on Lower Urinary Tract Symptoms and Quality of Life in Men With Benign Prostatic Hyperplasia. J Urol June 2007, 177:2244-2245

398. Wein AJ: The Effects of a New Selective Beta3-Adrenoceptor Agonist (GW427353) on Spontaneous Activity and Detrusor Relaxation in Human Bladder. J Urol June 2007, 177:2245

399. Wein AJ: The Effect of Cannabis on Urge Incontinence in Patients With Multiple Sclerosis: A Multicentre, Randomised Placebo-Controlled Trial (CAMS-LUTS). J Urol June 2007, 177:2246

400. Wein AJ: Different Brain Effects During Chronic and Acute Sacral Neuromodulation in Urge Incontinent Patients With Implanted Neurostimulators. J Urol June 2007, 177:2246-2247

401. Wein AJ: Recommendations for Urodynamic Assessment in the Evaluation of Women With Stress Urinary Incontinence. J Urol July 2007, 178:217


114

402. Wein AJ: A Prospective Observational Trial of Pelvic Floor Muscle Training for Female Stress Urinary Incontinence. J Urol July 2007, 178:217-218

403. Wein AJ: A Randomized Controlled Trial of the Effectiveness of Pelvic Floor Therapies for Urodynamic Stress and Mixed Incontinence. J Urol July 2007, 178:218-219

404. Wein AJ: 1) The Motion: Injectables are Justified as a First Option for Stress Urinary Incontinence. 2) Injectables are Justified as a First Option for Stress Urinary Incontinence: Against the Motion. J Urol July 2007, 178:219-220

405. Wein AJ: Is it Possible to Improve Elderly Male Bladder Function by Having Them Drink More Water? A Randomized Trial of Effects of Increased Fluid Intake/Urine Output on Male Lower Urinary Tract Function. J Urol July 2007, 178:220

406. Wein AJ: Tolterodine and Tamsulosin for Treatment of Men With Lower Urinary Tract Symptoms and Overactive Bladder: A Randomized Controlled Trial. J Urol July 2007, 178:220-221

407. Wein AJ: Duloxetine Treatment for Women Awaiting Continence Surgery. J Urol August 2007, 178:584

408. Wein AJ: TVT vs Monarc: A Comparative Study. J Urol August 2007, 178:584-585

409. Wein AJ: Childbearing After TVT: How I Have my Baby When I Have a TVT. J Urol August 2007, 178:585

410. Wein AJ: Male Bulbourethral Sling After Radical Prostatectomy: Intermediate Outcomes at 2 to 4-Year Followup. J Urol August 2007, 178:585-586

411. Wein AJ: Naftopidil Monotherapy vs Naftopidil and an Anticholinergic Agent Combined Therapy for Storage Symptoms Associated With Benign Prostatic Hyperplasia: A Prospective Randomized Controlled Study. J Urol August 2007, 178:586-587

412. Wein AJ: Estrogen Therapy and Urinary Incontinence: What Is the Evidence and What Do We Tell Our Patients? J Urol September 2007, 178:1002

413. Wein AJ: Health Care Discussions and Treatment for Urinary Incontinence in U.S. Women. J Urol September 2007, 178:1002-1003

414. Wein AJ: A Prospective Observational Trial of Pelvic Floor Muscle Training for Female Stress Urinary Incontinence. J Urol September 2007, 178:1003-1004

415. Wein AJ: The Treatment of Female Bladder Outlet Obstruction. J Urol September 2007, 178:1004

416. Wein AJ: Recurrent Stress Incontinence is Associated With Decreased Neuromuscular Function in the Striated Urethral Sphincter. J Urol September 2007, 178:1004-1005


115

417. Wein AJ: Prospective Randomized Comparison of Transobturator Suburethral Sling (Monarc) vs Suprapubic Arc (Sparc) Sling Procedures for Female Urodynamic Stress Incontinence. J Urol October 2007, 178:1381

418. Wein AJ: Multicenter Experience With the Monarc Transobturator Sling System to Treat Stress Urinary Incontinence. J Urol October 2007, 178:1381-1382

419. Wein AJ: Is Transobturator Tape as Effective as Tension-Free Vaginal Tape in Patient With Borderline Maximum Urethral Closure Pressure? J Urol October 2007, 178:1382

420. Wein AJ: Transobturator Tape Sling for Female Stress Incontinence With Polypropylene Tape and Outside-In Procedure: Prospective Study With 1 Year of Minimal Follow-Up and Review of Transobturator Tape Sling. J Urol October 2007, 178:1383

421. Wein AJ: Tension-Free Vaginal Tape for the Treatment of Urodynamic Stress Incontinence With Intrinsic Sphincteric Deficiency. J Urol October 2007, 178:1383-1384

422. Wein AJ: Role of Bladder Neck Mobility and Urethral Closure Pressure in Predicting Outcome of Tension-Free Vaginal Tape (TVT) Procedure. J Urol October 2007, 178:1384

423. Wein AJ: Outcome of Tension-Free Vaginal Tape Procedure When Complicated by Intraoperative Cystotomy. J Urol October 2007, 178:1385

424. Wein AJ: Overactive Bladder. J Urol November 2007, 178:2055

425. Wein AJ: Urinary Incontinence After Hysterectomy—Three-Year Observational Study. J Urol November 2007, 178:2056

426. Wein AJ: Impact of Parkinson’s Disease on Continence After Radical Prostatectomy. J Urol November 2007, 178:2056-2057

427. Wein AJ: The Role of Ca2+ Influx and Intracellular Ca2+ Release in the Muscarinic-Mediated Contraction of Mammalian Urinary Bladder Smooth Muscle. J Urol November 2007, 178:2220

428. Wein AJ: Burch Colposuspension Versus Fascial Sling to Reduce Urinary Stress Incontinence. J Urol December 2007, 178:2501-2502

429. Wein AJ: Laparoscopic Colposuspension for Urinary Incontinence in Women. J Urol December 2007, 178:2502-2503

430. Wein AJ: Treatment Options for Patients With Suboptimal Response to Surgery for Stress Urinary Incontinence. J Urol December 2007, 178:2503-2504

431. Wein AJ: Gabapentin Treatment of Neurogenic Overactive Bladder. J Urol December 2007, 178:2504-2505


116

432. Wein AJ: Prevalence and Risk Factors for Urinary Incontinence in Women With Type 2 Diabetes and Impaired Fasting Glucose: Findings From the National Health and Nutrition Examination Survey (NHANES) 2001-2002. J Urol January 2008, 179:232

433. Wein AJ: Retropubic Compared With Transobturator Tape Placement in Treatment of Urinary Incontinence: A Randomized Controlled Trial. J Urol January 2008, 179:233

434. Wein AJ: Tension-Free Vaginal Tape (TVT) and Intravaginal Slingplasty (IVS) for Stress Urinary Incontinence: A Multicenter Randomized Trial. J Urol January 2008, 179:234

435. Wein AJ: Is Transobturator Tape as Effective as Tension-Free Vaginal Tape in Patients With Borderline Maximum Urethral Closure Pressure? J Urol January 2008, 179:234-235

436. Wein AJ: Clinical Relevance of Urodynamic Investigation Tests Prior to Surgical Correction of Genital Prolapse: A Literature Review. J Urol January 2008, 179:235-236

437. Wein AJ: EGF and HB-EGF Modulate Inward Potassium Current in Human Bladder Urothelial Cells From Normal and Interstitial Cystitis Patients. J Urol February 2008, 179:562-563

438. Wein AJ: BXL-628, a Vitamin D Receptor Agonist Effective in Benign Prostatic Hyperplasia Treatment, Prevents RhoA Activation and Inhibits RhoA/Rho Kinase Signaling in Rat and Human Bladder. J Urol February 2008, 179:622

439. Wein AJ: Assessment of the Impact of Sildenafil Citrate on Lower Urinary Tract Symptoms in Men With Erectile Dysfunction. J Urol February 2008, 179:623

440. Wein AJ: Bipolar Transurethral Resection of the Prostate—Technical Modifications and Early Clinical Experience. J Urol February 2008, 179:624

441. Wein AJ: Duloxetine, a Serotonin and Noradrenaline Reuptake Inhibitor (SNRI) for the Treatment of Stress Urinary Incontinence: A Systematic Review. J Urol March 2008, 179:1047

442. Wein AJ: Transobturator Tape for Treatment of Female Stress Urinary Incontinence: Objective and Subjective Results After a Mean Follow-Up of Two Years. J Urol March 2008, 179:1048

443. Wein AJ: Outcome of Transvaginal Radiofrequency for Treatment of Women With Stress Urinary Incontinence. J Urol March 2008, 179:1048-1049

444. Wein AJ: Transvaginal Urethrolysis for Obstruction After Antiincontinence Surgery. J Urol March 2008, 179:1049-1050

445. Wein AJ: Mid-Urethral Slings: Surgical Evolution as Manifest by Technology. J Urol March 2008, 179:1050

446. Wein AJ: 1. Efficacy of the InVance Male Sling in Men With Stress Urinary Incontinence. 2. Urethral Compression for the Treatment of Postprostatectomy Urinary Incontinence: Is History Repeating Itself? J Urol March 2008, 179:1050-1051


117

447. Wein AJ: 1. Phosphodiesterase Type 5 Inhibitors: The Day After. 2. Relaxation of Phasic Contractile Activity of Human Detrusor Strips by Cyclic Nucleotide Phosphodiesterase Type 4 Inhibition. J Urol March 2008, 179:1051-1052

448. Wein AJ: Bladder Diary Measurements in Asymptomatic Females: Functional Bladder Capacity, Frequency, and 24-Hr Volume. J Urol April 2008, 179:1480

449. Wein AJ: Reference Urodynamic Values for Stress Incontinent Women. J Urol April 2008, 179:1480-1481

450. Wein AJ: Does Urodynamic Investigation Improve Outcome in Patients Undergoing Prolapse Surgery? J Urol April 2008, 179:1481-1482

451. Wein AJ: What’s a “Cure”? Patient-Centred Outcomes of Treatments for Stress Urinary Incontinence. J Urol April 2008, 179:1482-1483

452. Wein AJ: Rho Kinase: A Target for Treatment of Urinary Bladder Dysfunction? J Urol April 2008, 179:1483

453. Wein AJ: The Detrusor Muscle: An Innocent Victim of Bladder Outlet Obstruction. J Urol April 2008, 179:1483-1484

454. Mucksavage P, Mitchell CR, Kutikov A, Wein AJ, Torigian DA, Malkowicz SB. Anthropomorphic Differences In Obese Men With Biochemical Failure After Radical Retropublic Prostatectomy. J Urol Supplement 179(4):67, April 2008

455. Brucker BM, Bergey M, Resnick MJ, Sonnad A, Canter D, Guzzo TJ, Rebbeck TR, Wein AJ, Malkowicz SB. The Impact of Obesity on Biochemical Failure After Radical Prostatectomy in African-American and European-American Patients. J Urol Supplement 179(4):152, April 2008

456. Jayadevappa R, Chhatre S, Weiner M, Soldo B, Wein AJ, Malkowicz SB. Variations in Care of Older Men with Prostate Cancer. J Urol Supplement 179(4):162, April 2008

457. Coyne KS, Sexton C, Kopp ZS, Irwin D, Milsom I, Aiyer L, Wein AJ, Chapple CR, Tubaro A. The Impact of Lower Urinary Tract Symptoms on Men’s Sexual Health: Results from EpiLUTS. J Urol Supplement 179(4):361, April 2008

458. Ettickan B, John M, Zderic SA, Wein AJ, Chacko S. The Effect of Partial Bladder Outlet Obstruction on Caveolin: Role of Gata-6 in Transcriptional Regulation of Caveolin-1 Gene Expression in Murine Detrusor Smooth Muscle. J Urol Supplement 179(4):450, April 2008

459. Coyne KS, Sexton C, Kopp ZS, Thompson C, Irwin D, Milsom I, Chapple CR, Tubaro A, Wein AJ. The Impact of Lower Urinary Tract Symptoms on Women’s Sexual Health: Results from EpiLUTS Study. J Urol Supplement 179(4):536, April 2008

460. Zheng Y, Malkowicz SB, Mohanan S, Chang S, Wein AJ, Chacko S. Generation of a Human Detrusor Smooth Cell Line. J Urol Supplement 179(4):537, April 2008


118

461. Chang S, Hypolite J, Marx J, Zderic SA, Wein AJ, Chacko S. The Role of Large Conductance Calcium and Voltage-Activated Potassium Channel (BK) in Detrusor Overactivity Induced by Partial Bladder Outlet Obstruction. J Urol Supplement 179(4):539, April 2008

462. Wein AJ: Prevalence and Correlates for Interstitial Cystitis Symptoms in Women Participating in a Health Screening Project. J Urol May 2008, 179(5):1864-1865

463. Wein AJ: Potassium Sensitivity Test (PST) as a Measurement of Treatment Efficacy of Painful Bladder Syndrome/Interstitial Cystitis: A Prospective Study with Cyclosporine A and Pentosan Polysulfate Sodium. J Urol May 2008, 179(5):1865

464. Wein AJ: Prevalence of Incontinence in Women With Benign Joint Hypermobility Syndrome. J Urol May 2008, 179(5):1923

465. Wein AJ: Incidence and Remission of Urinary Incontinence After Hysterectomy—A 3-Year Follow-Up Study. J Urol May 2008, 179(5):1923-1924

466. Wein AJ: The Presence of Fowler’s Syndrome Predicts Successful Long-Term Outcome of Sacral Nerve Stimulation in Women With Urinary Retention. J Urol May 2008, 179(5):1924-1925

467. Wein AJ: Post-Stroke Urinary Incontinence With Impaired Awareness of the Need to Void: Clinical and Urodynamic Features. J Urol May 2008, 179(5):1925-1926

468. Wein AJ: Extracorporeal Magnetic Stimulation is of Limited Clinical Benefit to Women With Idiopathic Detrusor Overactivity: A Randomized Sham Controlled Trial. J Urol June 2008, 179(6):2296-2297

469. Wein AJ: Do Repeat Intradetrusor Botulinum Toxin Type A Injections Yield Valuable Results? Clinical and Urodynamic Results After Five Injections in Patients With Neurogenic Detrusor Overactivity. J Urol June 2008, 179(6):2297-2298

470. Wein AJ: Tension-Free Midurethral Slings in the Treatment of Female Stress Urinary Incontinence: A Systematic Review and Meta-Analysis of Randomized Controlled Trials of Effectiveness. J Urol June 2008, 179(6):2298-2299

471. Wein AJ: Tension-Free Vaginal Tape Versus Transobturator Tape as Surgery for Stress Urinary Incontinence: Results of a Multicentre Randomised Trial. J Urol June 2008, 179(6):2299-2300

472. Wein AJ: Diagnostic Accuracy of Noninvasive Tests to Evaluate Bladder Outlet Obstruction in Men: Detrusor Wall Thickness, Uroflowmetry, Postvoid Residual Urine, and Prostate Urine. J Urol July 2008, 180(1):250

473. Wein AJ: Adjustable Continence Therapy (ProACT): Evolution of the Surgical Technique and Comparison of the Original 50 Patients With the Most Recent 50 Patients at a Single Centre. J Urol July 2008, 180(1):250-251

474. Wein AJ: Adjustable Suburethral Sling (Male Remeex System) in the Treatment of Male Stress Urinary Incontinence: A Multicentric European Study. J Urol July 2008, 180(1):251-252


119

475. Wein AJ: Botulinum Toxin A Improves the Quality of Life of Patients With Neurogenic Urinary Incontinence. J Urol July 2008, 180(1):252

476. Wein AJ: Effects of the M3 Receptor Selective Muscarinic Antagonist Darifenacin on Bladder Afferent Activity of the Rat Pelvic Nerve. J Urol July 2008, 180(1):407

477. Wein AJ: Urodynamics and Stress Urinary Incontinence: The Dark Side of a Gold Standard. J Urol Aug 2008, 180(2):630

478. Wein AJ: Detrusor Overactivity Does Not Predict Outcome of Sacral Neuromodulation Test Stimulation. J Urol Aug 2008, 180(2):630-631

479. Wein AJ: Human Idiopathic and Neurogenic Overactive Bladders and the Role of M2 Muscarinic Receptors in Contraction. J Urol Aug 2008, 180(2):631

480. Wein AJ: The Function of Suburothelial Myofibroblasts in the Bladder. J Urol Aug 2008, 180(2)631-632

481. Wein AJ: Diabetic Cystopathy. J Urol Aug 2008, 180(2):632

482. Wein AJ: LUTS Treatment: Future Treatment Options. J Urol Sept 2008, 180(3)1047

483. Wein AJ: Repeated Botulinum-A Toxin Injections in the Treatment of Myelodysplastic Children and Patients With Spinal Cord Injuries With Neurogenic Bladder Dysfunction. J Urol Sept 2008, 180(3)1047-1048

484. Wein AJ: Dysfunctional Voiding Confirmed by Transdermal Perineal Electromyography, and its Effective Treatment With Baclofen in Women With Lower Urinary Tract Symptoms: A Randomized Double-Blind Placebo-Controlled Crossover Trial. J Urol Sept 2008, 180(3)1048-1049

485. Wein AJ: 1) Is Abuse Causally Related to Urologic Symptoms? Results From the Boston Area Community Health (BACH) Survey. 2) Beyond the Lower Urinary Tract: The Association of Urologic and Sexual Symptoms With Common Illnesses. J Urol Sept 2008, 180(3)1049-1050

486. Wein AJ: Functional and Histological Changes After Myoblast Injections in the Porcine Rhabdosphincter. J Urol Sept 2008, 180(3)1180-1181

487. Wein AJ: 1) Overactive Bladder in Diabetes: A Peripheral or Central Mechanism? 2) Bladder Dysfunction in Type 2 Diabetic Patients. J Urol Oct 2008, 180(4)Part 1:1409-1410

488. Wein AJ: Duloxetine Compared With Placebo for Treating Women With Symptoms of Overactive Bladder. J Urol Oct 2008, 180(4)Part 1:1410-1411

489. Wein AJ: Augmented Repairs and Use of Interposition Grafts in Pelvic Reconstructive Surgery: Part II. J Urol Oct 2008, 180(4)Part 1:1411-1412

490. Wein AJ: Robotics and Laparoscopy for Vaginal Prolapse and Incontinence. J Urol Oct 2008, 180(4)Part 1:1412-1413


120

491. Wein AJ: Do Overactive Bladder Symptoms Improve After Repair of Anterior Vaginal Wall Prolapse? J Urol Oct 2008, 180(4)Part 1:1413

492. Wein AJ: Treatment Outcome of Tension-Free Vaginal Tape in Stress Urinary Incontinence: Comparison of Intrinsic Sphincter Deficiency and Nonintrinsic Sphincter Deficiency Patients. J Urol Oct 2008, 180(4)Part 1:1413-1414

493. Wein AJ: Update on Detrusor Hyperactivity With Impaired Contractility. J Urol Nov 2008, 180(5)2097-2098

494. Wein AJ: Beta3-Adrenoceptors in Urinary Bladder. J Urol Nov 2008, 180(5)2098

495. Wein AJ: Outcomes and Quality of Life of Adults Undergoing Continent Catheterizable Vesicostomy for Neurogenic Bladder. J Urol Nov 2008, 180(5)2098-2099

496. Wein AJ: The Relationship Between Objective Frequency-Volume Chart Data and the I-PSS in Men With Lower Urinary Tract Symptoms. J Urol Nov 2008, 180(5)2099

497. Wein AJ: Surgery Insight: Surgical Management of Postprostatectomy Incontinence—The Artificial Urinary Sphincter and Male Sling. J Urol Nov 2008, 180(5)2100

498. Wein AJ: Adherence to the 1997 American Urological Association Guidelines for the Surgical Treatment of Stress Urinary Incontinence. J Urol Dec 2008, 180(6)2532

499. Wein AJ: Transobturator Tapes for Stress Urinary Incontinence: Results of the Austrian Registry. J Urol Dec 2008, 180(6)2533

500. Wein AJ: Transobturator Tape Compared with Tension-Free Vaginal Tape for the Treatment of Stress Urinary Incontinence: A Randomized Controlled Trial. J Urol Dec 2008, 180(6)2533-2534

501. Wein AJ: The Use of Synthetic Sub-Urethral Slings in the Treatment of Female Stress Urinary Incontinence. J Urol Dec 2008, 180(6)2534-2535

502. Wein AJ: A Randomised Controlled Trial Comparing Two Autologous Fascial Sling Techniques for the Treatment of Stress Urinary Incontinence in Women: Short, Medium and Long-Term Follow Up. J Urol Dec 2008, 180(6)2535-2536

503. Wein AJ: A Prospective, Single-Sling, Randomized Crossover Trial of Sacral vs Pudenal Nerve Stimulation for Interstitial Cystitis. J Urol Jan 2009, 181(1)137-138

504. Wein AJ: Update on Bladder Evaluation Recommendations and Bladder Management Guideline in Patients with Spinal Cord Injury. J Urol Jan 2009, 181(1)184-185

505. Wein AJ: The Immediate and 6-Mo Reproducibility of Pressure-Flow Studies in Men With Benign Prostatic Enlargement. J Urol Jan 2009, 181(1)238-239

506. Wein AJ: The Function of Suburothelial Myofibroblasts in the Bladder. J Urol Feb 2009, 181(2)915-916


121

507. Wein AJ: Functional and Histological Changes After Myoblast Injections in the Porcine Rhabdosphincter. J Urol Feb 2009, 181(2)916-917

508. Wein AJ: 1) Changes of Gap Junctional Cell-Cell Communication in Overactive Detrusor in Rats. 2) Bladder Afferent Sensitivity in Wild-Type and TRPV1 Knockout Mice. 3)Increased Expression of Transient Receptor Potential Vanilloid Subfamily 1 in the Bladder Predicts the Response to Intravesical Instillations of Resiniferatoxin in Patients With Refractory Idiopathic Detrusor Overactivity. J Urol Mar 2009, 181(3)1495-1498

509. Wein AJ: Urgency Assessment in the Evaluation of Overactive Bladder (OAB). J Urol Apr 2009, 181(4)1800-1801

510. Wein AJ: Botulinum Toxin A (Botox) Intradetrusor Injections in Adults With Neurogenic Detrusor Overactivity/Neurogenic Overactive Bladder: A Systematic Literature Review. J Urol Apr 2009, 181(4)1802

511. Wein AJ: Changes in Urinary Bladder Smooth Muscle Function in Response to Colonic Inflammation. J Urol Apr 2009, 181(4)1957-1958

512. Wein AJ: Impact of Overactive Bladder on the Brain: Central Sequelae of a Visceral Pathology. J Urol Apr 2009, 181(4)1958

513. Resnick MJ, Canter DJ, Guzzo TJ, Brucker BM, Bergey MR, Sonnad SS, Wein AJ, Malkowicz SB. Defining Pathologic Parameters to Predict Biochemical Failure in Patients with Positive Surgical Margins at Radical Prostatectomy: Implications for Adjuvant Radiation Therapy. Abstract 151 - presented at the Annual Meeting of the American Urological Association Meeting, Chicago, IL, April 2009

514. Coyne KS, Sexton CC, Weinstein D, Kopp ZS, Ebel-Bitoun C, Milsom I, Wein AJ, Chapple CR. The Prevalence of OAB in the US, UK, and Sweden: Results from EPILUTS. Abstract 446 -presented at the Annual Meeting of the American Urological Association Meeting, Chicago, IL, April 2009

515. Ravishankar J, Chhatre S, Wein AJ, Malkowicz SB. Cost-Effectiveness of Prostate Cancer Curative Treatment Among Younger Patients. Abstract 547 - presented at the Annual Meeting of the American Urological Association Meeting, Chicago, IL, April 2009

516. Mucksavage P, Van Arsdalen K, Wein AJ, Malkowicz SB. Characteristics of Very Late Biochemical Failure After Radical Retropubic Prostatectomy. Abstract 586 - presented at the Annual Meeting of the American Urological Association Meeting, Chicago, IL, April 2009

517. Mucksavage P, Magerfleisch L, Van Arsdalen K, Wein AJ, Malkowicz SB. Waiting Times to Nephrectomy Does Not Significantly Affect Recurrence. Abstract 982 - presented at the Annual Meeting of the American Urological Association Meeting, Chicago, IL, April 2009

518. Ettickan B, Zderic SA, Wein AJ, Chacko S. Transcription Factor NF-KB Mediates the Gene Expression of Proteins Involved in the Regulation of Calcium Sensitization Pathway in Partial Bladder Outlet Obstruction in Mice. Abstract 1511 - presented at the Annual Meeting of the American Urological Association Meeting, Chicago, IL, April 2009


122

519. Alanzi JA, Gomes CM, Chang S, Malkowicz SB, Wein AJ, Chacko S. Changes in Myosin Heavy Chain Isoforms and Proteins Involved in CA2+ Sensitization Pathway in the Detrusor Smooth Muscle from Men with Outlet Obstruction Induced by Benign Prostatic Hyperplasia. Abstract 1513 - presented at the Annual Meeting of the American Urological Association Meeting, Chicago, IL, April 2009

520. Chang S, Basha M, Wein AJ, Chacko S. Estrogen-Depletion Down-Regulates Protein Kinase C Pathway in Female Urethral Smooth Muscle. Abstract 1535 - presented at the Annual Meeting of the American Urological Association Meeting, Chicago, IL, April 2009

521. Ettickan B, Gomes CM, Malkowicz SB, Alanzi JA, Wein AJ, Chacko S. Down-Regulation of Caveolin Gene Expression in Detrusor Smooth Muscle From Men with Benign Prostatic Hyperplasia (BPH)-Induced Bladder Outlet Obstruction. Abstract 1574 - presented at the Annual Meeting of the American Urological Association Meeting, Chicago, IL, April 2009

522. Chang S, John M, Hypolite JA, Zderic SA, Wein AJ, Chacko S. Temporal Changes of Intermediate Filament Proteins in Obstruction-Induced Detrusor Remodeling. Abstract 1577 - presented at the Annual Meeting of the American Urological Association Meeting, Chicago, IL, April 2009

523. Brucker BM, Spence A, Resnick MJ, Pukenas B, Van Arsdalen K, Wein AJ, Malkowicz SB, Ramchandani P. Ureteral Pseudodiverticula: Associated with Urothelial Malignancy. Abstract 2149 - presented at the Annual Meeting of the American Urological Association Meeting, Chicago, IL, April 2009

524. Wein AJ. Periurethral Injection Therapy for Urinary Incontinence in Women. J Urol May 2009 181(5)2223-2224

525. Wein AJ. Systematic Review: Randomized, Controlled Trials of Nonsurgical Treatments for Urinary Incontinence in Women. J Urol May 2009, 181(5)2224-2225

526. Wein AJ. The Neural Control of Micturition. J Urol May 2009, 181(5)2225

527. Wein AJ. 1) Cluster Analysis and Lower Urinary Tract Symptoms in Men: Findings From the Boston Area Community Health Survey. 2) Do Urological Symptoms Cluster Among Women? Results From the Boston Area Community Health Survey. 3) Examining Lower Urinary Tract Symptom Constellations Using Cluster Analysis. 4) Beyond the Cluster: Methodological and Clinical Implications in the Boston Area Community Health Survey and EPIC Studies. J Urol May 2009, 181(5) 2225-2228

528. Wein AJ. The Uroepithelial-Associated Sensory Web. J Urol June 2009, 181(6)2563

529. Wein AJ. Ketamine-Associated Ulcerative Cystitis: A New Clinical Entity. J Urol June 2009, 181(6)2564

530. Wein AJ. Loss of Prostaglandin E2 Release From Immortalized Urothelial Cells Obtained From Interstitial Cystitis Patient Bladders. J Urol June 2009, 181(6)2564-2565


123

531. Wein AJ. Does the Patient’s Position Influence the Detection of Detrusor Overactivity? J Urol June 2009, 181(6)2647-2648

532. Wein AJ. How Should Patients With an Overactive Bladder Manipulate Their Fluid Intake? J Urol June 2009, 181(6)2648-2649

533. Wein AJ. Emerging Pharmacological Targets in Overactive Bladder Therapy: Experimental and Clinical Evidences. J Urol June 2009, 181(6)2649

534. Wein AJ. The Effects of Antimuscarinic Treatments in Overactive Bladder: An Update of a Systematic Review and Meta-Analysis. J Urol June 2009, 181(6)2649-2650

535. Wein AJ. Spinal-Injured Neuropathic Bladder Antisepsis (SINBA) Trial. J Urol July 2009, 182(1)164

536. Wein AJ. The Aetiology of Prolapse. J Urol July 2009, 182(1)229

537. Wein AJ. Incidence of Recurrent Pelvic Organ Prolapse 10 Years Following Primary Surgical Management: A Retrospective Cohort Study. J Urol July 2009, 182(1)229-230

538. Wein AJ. Long-Term Patient Satisfaction With Prolapse Surgery in General Gynecology. J Urol July 2009, 182(1)230

539. Wein AJ. Sexual Function After Vaginal Surgery for Pelvic Organ Prolapse and Urinary Incontinence. J Urol July 2009, 182(1)231

540. Wein AJ. Surgical Management of Pelvic Organ Prolapse in Women. J Urol July 2009, 182(1)231-233

541. Wein AJ. Mixed Incontinence is More Bothersome Than Pure Incontinence Subtypes. J Urol Aug 2009, 182(2)633

542. Wein AJ. Botulinum Neurotoxin Type A in Urology: Antibiotics as a Cause of Therapy Failure. J Urol Aug 2009, 182(2)634

543. Wein AJ. Efficacy and Safety of Duloxetine in Elderly Women With Stress Urinary Incontinence or Stress-Predominant Mixed Urinary Incontinence. J Urol Aug 2009, 182(2)634-635

544. Wein AJ. Mechanical Devices for Urinary Incontinence in Women. J Urol Aug 2009,182(2)635-636

545. Wein AJ. Tension-Free Vaginal Tape Versus Colposuspension for Primary Urodynamic Stress Incontinence: 5-Year Follow Up. J Urol Aug 2009, 182(2)636-637

546. Wein AJ. Efficacy and Safety of Extended-Release Oxybutynin in Combination With Tamsulosin for Treatment of Lower Urinary Tract Symptoms in Men: Randomized, Double-Blind, Placebo-Controlled Study. J Urol Aug 2009, 182(2)637-638


124

547. Wein AJ. Activation and Inhibition of the Micturition Reflex by Penile Afferents in the Cat. J Urol Aug 2009, 182(2)796

548. Wein AJ. Postpartum Depression, Urge Urinary Incontinence, and Overactive Bladder Syndrome: Is There an Association? J Urol Sept 2009, 182(3)1083

549. Wein AJ. A Review of Adherence to Drug Therapy in Patients With Overactive Bladder. J Urol Sept 2009, 182(3)1084

550. Wein AJ. Validation of Treatment Benefit Scale for Assessing Subjective Outcomes in Treatment of Overactive Bladder. J Urol Sept 2009, 182(3)1084-1085

551. Wein AJ. A Prospective Assessment of Overactive Bladder Symptoms in a Cohort of Elderly Women Who Underwent Transvaginal Surgery for Advanced Pelvic Organ Prolapse. J Urol Sept 2009, 182(3)1085-1086

552. Wein AJ. Timed Voiding for the Management of Urinary Incontinence in Adults. J Urol Oct 2009, Part 1 of 2, 182(4)1469-1470

553. Wein AJ. 1) A Randomized Trial Comparing TVT With TVT-O: 12-Month Results; 2) Eleven Years Prospective Follow-Up of the Tension-Free Vaginal Tape Procedure for Treatment of Stress Urinary Incontinence. J Urol Oct 2009 Part 1 of 2, 182(4)1470-1471

554. Wein AJ. A Multi-Centre, Randomised Clinical Control Trial Comparing the Retropubic (RP) Approach Versus the Transobturator Approach (TO_ for Tension-Free, Suburethral Sling Treatment of Urodynamic Stress Incontinence: The TORP Study. J Urol Oct 2009 Part 1 of 2, 182(4)1471

555. Wein AJ. Resiniferatoxin in the Treatment of Interstitial Cystitis: A Systematic Review. J Urol Nov 2009, 182(5):2328-2329

556. Wein AJ. The Long-Term Effectiveness of Antenatal Pelvic Floor Muscle Training: Eight-Year Follow Up of a Randomised Controlled Trial. J Urol Nov 2009, 182(5):2415

557. Wein AJ. On the Origin of Bladder Sensing: TR(1)Ps in Urology. J Urol Nov 2009, 182(5):2529

558. Wein AJ. Basic Fibroblast Growth Factor Modulates Proliferation and Collagen Expression in Urinary Bladder Smooth Muscle Cells. J Urol Nov 2009, 182(5):2529-2530

559. Wein AJ. Physical and Cognitive Performance and Burden of Anticholinergics, Sedatives, and ACE Inhibitors in Older Women. J Urol Dec 2009 Part 1 of 2, 182(6):2836

560. Wein AJ. The Management of Voiding Dysfunction in Persons with Dementia. J Urol Dec 2009 Part 1 of 2, 182(6):2837

561. Wein AJ. Neurogenic Bladder From Multiple Sclerosis. J Urol Dec 2009 Part 1 of 2, 182(6):2837-2838


125

562. Wein AJ. The Impact of Lower Urinary Tract Symptoms and Urinary Incontinence on Female Sexual Dysfunction Using a Validated Instrument. J Urol Dec 2009 Part 1 of 2, 182(6):2864

563. Wein AJ. Urinary Incontinence in Women: Direct Costs of Routine Care. J Urol Jan 2010, 183(1):253

564. Wein AJ. The Impact of Multichannel Urodynamics Upon Treatment Recommendations for Female Urinary Incontinence. J Urol Jan 2010, 183(1):253-254

565. Wein AJ. Reliability Testing of Urodynamics, Pressure Flow Studies and Cough Leak Point Pressure in Women With Urodynamic Stress Incontinence With and Without Detrusor Overactivity. J Urol Jan 2010, 183(1):254

566. Wein AJ. Clarification and Confirmation of the Knack Maneuver: The Effect of Volitional Pelvic Floor Muscle Contraction to Preempt Expected Stress Incontinence. J Urol Jan 2010, 183(1):255

567. Wein AJ. Radiofrequency Remodelling of the Endopelvic Fascia is Not an Effective Procedure for Urodynamic Stress Incontinence in Women. J Urol Jan 2010, 183(1):255-256

568. Wein AJ. Rate of De Novo Stress Urinary Incontinence After Urethral (sic) Diverticulum Repair. J Urol Jan 2010, 183(1)256-257

569. Wein AJ. Surgical Management of Pelvic Organ Prolapse in Women: A Short Version Cochrane Review. J Urol Jan 2010, 183(1):257-258

570. Wein AJ. Short-Term Results of Bilateral S2-S4 Sacral Neuromodulation for the Treatment of Refractory Interstitial Cystitis, Painful Bladder Syndrome, and Chronic Pelvic Pain. J Urol Feb 2010, 183(2):570

571. Wein AJ. A Positive Modulator of KCa2 and KCa3 Channels, 4,5-Dichloro-1,3-Diethyl-1,3-Dihydro-Benzoimidazol-2-One (NS4591), Inhibits Bladder Afferent Firing in Vitro and Bladder Overactivity In Vivo. J Urol Feb 2010, 183(2):646

572. Wein AJ. Sacral Nerve Stimulation for Neuromodulation of the Lower Urinary Tract. J Urol Feb 2010, 183(2):646-647

573. Wein AJ. Does Urodynamic Verification of Overactive Bladder Determine Treatment Success? Results from a Randomized Placebo-Controlled Study. J Urol Feb 2010, 183(2):647-648

574. Wein AJ. Catecholamines Relax Detrusor Through 2-Adrenoceptors in Mouse and 3-Adrenoceptors in Man. J Urol Feb 2010, 183(2):823

575. Wein AJ. Do Women With Pure Stress Urinary Incontinence Need Urodynamics? J Urol Mar 2010, 183(3):1110-1111

576. Wein AJ. Follow-Up of TVT Operations in 1,113 Women With Mixed Urinary Incontinence at 7 and 38 Months. J Urol Mar 2010, 183(3):1111-1112


126

577. Wein AJ. A Systematic Review of Overweight and Obesity as Risk Factors and Targets for Clinical Intervention for Urinary Incontinence in Women. J Urol Apr 2010, 183(4):1479-1480

578. Wein AJ. Basic Mechanisms of Urgency: Preclinical and Clinical Evidence. J Urol Apr 2010, 183(4):1480-1481

579. Wein AJ. Effect of Intensive Glycemic Control and Diabetes Complications on Lower Urinary Tract Symptoms in Men With Type 1 Diabetes: Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. J Urol May 2010, 183(5):1927-1928

580. Wein AJ. Urinary and Erectile Dysfunction in Multiple System Atrophy (MSA). J Urol May 2010, 183(5):1928-1929

581. Wein AJ. Prophylactic Antibiotics in Urodynamics: A Systematic Review of Effectiveness and Safety. J Urol June 2010, 183(6):2275

582. Wein AJ. Evaluation and Outcome Measures in the Treatment of Female Urinary Stress Incontinence: International Urogynecological Association (IUGA) Guidelines for Research and Clinical Practice. J Urol June 2010, 183(6):2276

583. Wein AJ. Nocturia, Nocturnal Incontinence Prevalence, and Response to Anticholinergic and Behavioral Therapy. J Urol June 2010, 183(6):2277

584. Wein AJ. Enhanced Bladder Capacity and Reduced Prostaglandin E2-Mediated Bladder Hyperactivity in EP3 Receptor Knockout Mice. J Urol June 2010, 183(6):2463-2464

585. Wein AJ. Long-Lasting Breaches in the Bladder Epithelium Lead to Storage Dysfunction With Increase in Bladder PGE2 Levels in the Rat. J Urol June 2010, 183(6):2464-2465

586. Hypolite J, Chang S, Zderic S, Wein A, Butler S, Chacko S. Role of Myosin Light Chain Phosphorylation in Partial Bladder Outlet Obstruction: Compensated Versus Decompensated. Abstract 183, presented at the Annual Meeting of the American Urological Association, San Francisco, CA, May 30, 2010. J Urol 183(4):e73A

587. Hypolite J, Chang S, Zderic S, Wein A, Butler S, Chacko S. Large Conductance Calcium-And Voltage-Activated Potassium Channel (BK) Opener Inhibits Spontaneous Overactive Contraction of Detrusor Smooth Muscle in Obstructed Bladders. Abstract 186, presented at the Annual Meeting of the American Urological Association, San Francisco, CA, May 30, 2010. J Urol 2010:183(4):e74A

588. Resnick M, Lee D, Van Arsdalen K, Wein A, Malkowicz SB, Guzzo T. Repeat Prostate Biopsy and the Incremental Risk of Clinically Insignificant Prostate Cancer. Abstract 247, presented at the Annual Meeting of the American Urological Association, San Francisco, CA, May 30, 2010

589. Stansell L, Newman D, Magerfleisch L, Wein A, Guzzo T, Malkowicz SB. Increased Basal Resting Tone During EMG Biofeedback is Associated with Improved Voiding for Patients with Orthotopic Neobladder Dysfunction. Abstract 749, presented at the Annual Meeting of the American Urological Association, San Francisco, CA, May 31, 2010


127

590. Asfaw T, Hypolite J, Northington G, Arya L, Wein A, Malykhina A. Diminished Detrusor Muscle Contractility Underlies the Urinary Bladder Dysfunction Induced by Experimental Colitis: Mechanism For Pelvic Organ Cross-Talk. Abstract 1001, presented at the Annual Meeting of the American Urological Association, San Francisco, CA, May 31, 2010

591. Lei Q, Pan X-Q, Wein A, Malykhina A. Acute Inflammation in the Pelvis Modulates the Excitability of Bladder Extrinsic Sensory Neurons Via Activation of Voltage Gated Sodium Channels and Non-Selective Cation Channels. Abstract 1002, presented at the Annual Meeting of the American Urological Association, San Francisco, CA, May 31, 2010

592. Chang S, Alanzi J, Hanno PM, Newman DK, Northington G, Wein AJ, Chacko S. Endothelin-1 as a Regulator of Urothelial Cell Proliferation and a Potential Urinary Biomarker in Interstitial Cystitis(IC). Abstract 1042, presented at the Annual Meeting of the American Urological Association, San Francisco, CA, May 31, 2010. J Urol 2010:183(4):e405-e406A

593. Boopathi E, Hypolite J, Liou H-C, Wein A, Chacko S. Transcription Factor NF-KB is Required for Gene Expression of a 17-KDA PKC-Potentiated Inhibitory Protein of Protein Phosphatase-1 (CPI-17) and PKC-Mediated Signal Transduction of Detrusor Smooth Muscle Contraction. Abstract 1685, presented at the Annual Meeting of the American Urological Association, San Francisco, CA, June 1, 2010; J Urol 2010:183(4):e651A

594. Wein AJ. Gene Therapy for Bladder Overactivity and Nociception With Herpes Simplex Virus Vectors Expressing Preproenkephalin. J Urol July 2010, 184(1):224

595. Wein AJ. Neuromuscular Electrical Stimulation and the Treatment of Lower Urinary Tract Dysfunction in Multiple Sclerosis – A Double Blind, Placebo Controlled, Randomised Clinical Trial. J Urol July 2010, 184(1):225

596. Wein AJ. 1) Botulinum Injections for the Treatment of Bladder Symptoms of Multiple Sclerosis; 2) Neurogenic Detrusor Overactivity Treated With English Botulinum Toxin A: 8-Year Experience of One Single Centre. J Urol July 2010, 184(1):226-227

597. Wein AJ. Bladder Diary Measurements in Asymptomatic Males: Frequency, Volume per Void, and 24-Hr Volume. J Urol August 2010, 184(2):643

598. Wein AJ. Do alpha1-Adrenoceptor Antagonists Improve Lower Urinary Tract Symptoms by Reducing Bladder Outlet Resistance? J Urol August 2010, 184(2):643-644

599. Wein AJ. Ileovesicostomy for Adults With Neurogenic Bladders: Complications and Potential Risk Factors for Adverse Outcomes. J Urol August 2010, 184(2):644-645

600. Wein AJ. Incontinent Ileovesicostomy: Long-Term Outcomes and Complications. J Urol August 2010, 184(2):645-646

601. Wein AJ. Prospective Pharmacologic Therapies for the Overactive Bladder. J Urol August 2010, 184(2):800-801


128

602. Wein AJ. 1) The Evolving Physiology of the Lower Urinary Tract: What We are Learning and Where We Need to Go. 2) Antihyperalgesic Effects of (R,E)-N-(2-Hydroxy-2,3-Dihydro-1H-Inden-4-yl)-3-(2-(Piperidin-1-yl)-4-(Trifluoromethyl)Phenyl)-Acrylamide (AMG8562), a Novel Transient Receptor Potential Vanilloid Type 1 Modulator That Does Not Cause Hyperthermia in Rats. 3) AMTB, a TRPM8 Channel Blocker: Evidence in Rats for Activity in Overactive Bladder and Painful Bladder Syndrome. J Urol August 2010, 184(2):801-803

603. Wein AJ. 1) Chronic Suprapubic Catheterization in the Management of Patients With Spinal Cord Injuries: Analysis of Upper and Lower Urinary Tract Complications. 2) Contemporary Role of Suprapubic Cystostomy in Treatment of Neuropathic Bladder Dysfunction in Spinal Cord Injured Patients. J Urol September 2010, 184(3):997-999

604. Wein AJ. Defining Success Following Sling Surgery: Association of Satisfaction With Patient Reported Outcomes. J Urol September 2010, 184(3):1045-1046

605. Wein AJ. Predictors of Persistent Detrusor Overactivity After Transvaginal Sling Procedures. J Urol September 2010, 184(3):1046-1047

606. Wein AJ. Pregnancy and Delivery After Mid-Urethral Sling Procedures for Stress Urinary Incontinence: Case Reports and a Review of Literature. J Urol September 2010, 184(3):1047-1048

607. Wein AJ. Follow-Up of TVT Operations in 1,113 Women With Mixed Urinary Incontinence at 7 and 38 Months. J Urol September 2010, 184(3):1048

608. Wein AJ. A 5-Year Prospective Follow-Up Study of Vaginal Surgery for Pelvic Organ Prolapse. J Urol September 2010, 184(3):1049

609. Wein AJ. Sacral Neuromodulation for Urinary Retention. J Urol September 2010, 184(3):1049-1050

610. Wein AJ. Is it possible to diagnosis intrinsic sphincter deficiency in women? J Urol October 2010, 184(4):1419

611. Wein AJ. A review of the concordance of diagnoses made after multi-channel urodynamics and video urodynamics in women with urinary incontinence. J Urol October 2010, 184(4):1420

612. Wein AJ. The role of preoperative urodynamic testing in stress-continent women undergoing sacrocolpopexy: The Colpopexy and urinary reduction efforts (CARE) randomized surgical trial. J Urol October 2010, 184(4):1421

613. Wein AJ. “The Cough Game”: Are there characteristic urethrovesical movement patterns associated with stress incontinence? J Urol October 2010, 184(4):1421-1422

614. Wein AJ. Obstructive voiding symptoms are not predictive of elevated postvoid residual urine volumes. J Urol October 2010, 184(4):1422-1423


129

615. Wein AJ. Differences between the data from free flow and intubated flow in women with urinary incontinence. What do they mean? J Urol October 2010, 184(4):1423

616. Wein AJ. Bladder Control, Urgency, and Urge Incontinence: Evidence From Functional Brain Imaging. J Urol November 2010, 184(5):2029

617. Wein AJ. Practical Aspects of Lifestyle Modifications and Behavioural Interventions in the Treatment of Overactive Bladder and Urgency Urinary Incontinence. J Urol November 2010, 184(5):2030

618. Wein AJ. Randomized, Placebo-Controlled Trial of the Cognitive Effect, Safety, and Tolerability of Oral Extended-Release Oxybutynin in Cognitively Impaired Nursing Home Residents With Urge Urinary Incontinence. J Urol November 2010, 184(5):2030-2031

619. Wein AJ. Has Botulinum Toxin Therapy Come of Age: What Do We Know, What Do We Need to Know, and Should We Use It? J Urol November 2010, 184(5):2031-2032

620. Wein AJ. Recommendations on the Use of Botulinum Toxin in the Treatment of Lower Urinary Tract Disorders and Pelvic Floor Dysfunctions: A European Consensus Report. J Urol November 2010, 184(5):2032-2033

621. Wein AJ. Duloxetine 1 Year On: The Long-Term Outcome of a Cohort of Women Prescribed Duloxetine. J Urol November 2010, 184(5):2033

622. Wein AJ. The Destruction of the Lower Urinary Tract by Ketamine Abuse: A New Syndrome? J Urol November 2010, 184(5):2034

623. Wein AJ. Effect of Long-Term Oxybutynin Administration on C-Fos Expression in Spinal Neurons: Inhibition of Antimuscarinics on Bladder Afferents in Conscious Rats. J Urol November 2010, 184(5):2209-2210

624. Wein AJ. Weight Loss to Treat Urinary Incontinence in Overweight and Obese Women. J Urol December 2010, 184(6):2456-2457

625. Wein AJ. Retropubic Versus Transobturator Midurethral Slings for Stress Incontinence. J Urol December 2010, 184(6):2457-2458

626. Wein AJ. Urinary Dysfunction in Parkinson’s Disease: A Review. J Urol January 2011, 185(1):224

627. Wein AJ. The Effect of Bladder Outlet Obstruction on alpha1- and beta-Adrenoceptor Expression and Function. J Urol Jan 2011, 185(1):355

628. Wein AJ. Discontinuation Rates of Anticholinergic Medications Used for the Treatment of Lower Urinary Tract Symptoms. J Urol Feb 2011, 185(2):600-601

629. Wein AJ. The Impact of Lower Urinary Tract Symptoms and Urinary Incontinence on Female Sexual Dysfunction Using a Validated Instrument. J Urol Feb 2011, 185(2):601-602


130

630. Wein AJ. Outcome Measure for Stress Urinary Incontinence Treatment (OMIT): Results of Two Society of Urodynamics and Female Urology (SUFU) Surveys. J Urol Mar 2011, 185(3):1010-1011

631. Wein AJ. Continence Pessary Compared With Behavioral Therapy or Combined Therapy for Stress Incontinence: A Randomized Controlled Trial. J Urol Mar 2011, 185(3):1011-1012

632. Wein AJ. Updated Systematic Review and Meta-Analysis of the Comparative Data on Colposuspensions, Pubovaginal Slings, and Midurethral Tapes in the Surgical Treatment of Female Stress Urinary Incontinence. J Urol Mar 2011, 185(3):1012-1013

633. Wein AJ. Defining the Role of Urodynamics in Predicting Voiding Dysfunction After Anti-incontinence Surgery: A Work in Progress. J Urol Mar 2011, 185(3):1013

634. Smith AL, Wang M, Jaffe WI, Wein AJ. Detrusor leak point pressure (DLPP) in non-neurogenic women with urge incontinence SUFU Mar 2011, Arizona

635. Wein AJ. Visceral Organ Cross-Sensitization—An Integrated Perspective. J Urol Apr 2011, 185(4):1379

636. Wein AJ. Stem Cell Therapy for Stress Urinary Incontinence. J Urol Apr 2011, 185(4):1379-1380

637. Wein AJ. Antimuscarinics and Bladder Outlet Obstruction: From a Contraindication to an Indication? J Urol Apr 2011, 185(4):1380-1381

638. Wein AJ. Urethral Versus Suprapubic Catheter: Choosing the Best Bladder Management for Male Spinal Cord Injury Patients With Indwelling Catheters. J Urol Apr 2011, 185(4):1381

639. Wein AJ. Transabdominal Ultrasonography of Detrusor Wall Thickness in Women With Overactive Bladder. J Urol May 2011, 185(5):1811

640. Wein AJ. An International Urogynecological Association (IUGA)/International Continence Society (ICS) Joint Report on the Terminology for Female Pelvic Floor Dysfunction. J Urol May 2011, 185(5):1812

641. Wein AJ. Parity is Not Associated With Urgency With or Without Urinary Incontinence. J Urol May 2011, 185(5) 1813

642. Wein AJ. The Use of Mesh in Vaginal Prolapse Repair: Do the Benefits Justify the Risks? J Urol May 2011, 185(5) 1813

643. Boopathi E, Hypolite J, Chang S, Liou H-C, Zderic S, Wein A, Chacko S. Downregulation of NF-&[KAPPA]B Inhibits PKC-Mediated Smooth Muscle Contraction and Induce Non-Voiding Contractions in Murine Bladder. (Abstract #1947, presented at the Annual Meeting of the American Urological Association, Washington, DC, May 17, 2011)


131

644. Boopathi E, Gomes C, Goldfard R, John M, Srinivasan V, Alanzi J, Malkowicz SB, Kathuria H, Zderic S, Wein A, Chacko S. Caveolin-1 Gene Expression is Down Regulated in Bladder Smooth Muscle Hypertrophy in Mice and Humans with PBOO. (Abstract #1948, presented at the Annual Meeting of the American Urological Association, Washington, DC, May 17, 2011)

645. Boopathi E, Zderic S, Wein A, Chacko S. Temporal Gene Expression Profiling of Proteins Involved in CA2+-Sensitization Following Partial Bladder Outlet Obstruction: Mechanism for Upregulation of RHOA and ROKβ Gene Expression. (Abstract #1949, presented at the Annual Meeting of the American Urological Association, Washington, DC, May 17, 2011)

646. Hypolite J, Lei Q, Chang S, Malykhina A, Zderic S, Wein A, Butler S, Chacko S. Protein Kinase C Inhibits Spontaneous and Non-Voiding Contractions in Detrusor Smooth Muscle: Role and Interaction With BK Channels. (Abstract #1950, presented at the Annual Meeting of the American Urological Association, Washington, DC, May 17, 2011)

647. Wein AJ. Effects of Cl316,243, a Beta 3-Adrenoceptor Agonist, and Intravesical Postaglandin E2 on the Primary Bladder Afferent Activity of the Rat. J Urol May 2011, 185(5):1978-1979

648. Wein AJ. What is the Predictive Value of Urodynamics to Reproduce Clinical Findings of Urinary Frequency, Urge Urinary Incontinence, and/or Stress Urinary Incontinence? J Urol Jun 2011, 185(6):2260-2261

649. Wein AJ. Bladder Dysfunction in Hereditary Spastic Paraplegia: What to Expect? J Urol Jun 2011, 185(6):2261

650. Wein AJ. Vulvovaginal Atrophy. J Urol Jun 2011, 185(6):2262

651. Wein AJ. Cystoscopic Injections of Dextranomer Hyaluronic Acid Into Proximal Urethra for Urethral Incompetence: Efficacy and Adverse Outcomes. J Urol Jun 2011, 185(6):2262

652. Wein AJ. Systemic Adverse Events Following Botulinum Toxin A Therapy in Children With Cerebral Palsy. J Urol Jun 2011, 185(6):2347

653. Wein AJ. Intravesical Botulinum Toxin A Injections in the Treatment of Painful Bladder Syndrome/Interstitial Cystitis: A Systematic Review. J Urol Jul 2011, 186(1):133-134

654. Wein AJ. The Science Behind Biomaterials in Female Stress Urinary Incontinence Surgery. J Urol Jul 2011, 186(1):209-210

655. Wein AJ. A Randomized Trial Comparing Tension-Free Vaginal Tape With Tension-Free Vaginal Tape-Obturator: 36-Month Results. J Urol Jul 2011, 186(1):210

656. Wein AJ. Long-Term Efficacy of the Tension-Free Vaginal Tape Procedure for the Treatment of Urinary Incontinence: A Retrospective Follow-Up 11.5 Years Post-Operatively. J Urol Jul 2011, 186(1):210-211

657. Wein AJ. Is Mid-Urethral Placement of Synthetic Minimal Access Tapes Important in Stress Urinary Incontinence Surgery? J Urol Jul 2011, 186(1):211


132

658. Wein AJ. Post-Prostatectomy Stress Urinary Incontinence: What Treatment for Which Patient? J Urol Aug 2011, 186(2):536

659. Wein AJ. Male Incontinence Surgery in the 21st Century: Past, Present and Future. J Urol Aug 2011, 186(2):536-537

660. Wein AJ. Cross-Talk and Sensitization of Bladder Afferent Nerves. J Urol Aug 2011, 186(2):615

661. Wein AJ. A Decade of Functional Brain Imaging Applied to Bladder Control. J Urol Aug 2011, 186(2):615-616

662. Wein AJ. Sacral Neuromodulation in Diabetic Patients: Success and Complications in the Treatment of Voiding Dysfunction. J Urol Aug 2011, 186(2):616-617

663. Wein AJ. Physiotherapy as an Adjunct to Prolapse Surgery: An Assessor-Blinded Randomized Controlled Trial. J Urol Aug 2011, 186(2):617

664. Wein AJ. International Consultation on Incontinence-Research Society (ICI-RS) Report on Non-Invasive Urodynamics: The Need of Standardization of Ultrasound Bladder and Detrusor Wall Thickness Measurements to Quantify Bladder Wall Hypertrophy. J Urol Sept 2011, 186(3):986-987

665. Wein AJ. Dynamic Progression of Overactive Bladder and Urinary Incontinence Symptoms: A Systematic Review. J Urol Sept 2011, 186(3):987-988

666. Wein AJ. Re: An Update on Sacral Neuromodulation: Where Do We Stand With This In The Management of Lower Urinary Tract Dysfunction in 2010? J Urol Oct 2011, 186(4)Part 1of2:1376

667. Wein AJ. Re: Is Robotic Sacrocolpopexy a Marketing Gimmick or a Technological Advancement? J Urol Oct 2011, 186(4)Part 1of2:1376-1377

668. Wein AJ. Re: Behavioral Therapy With or Without Biofeedback and Pelvic Floor Electrical Stimulation for Persistent Postprostatectomy Incontinence: A Randomized Controlled Trial. J Urol Oct 2011, 186(4)Part 1of2:1377-1378

669. Wein AJ. Re: Surgical Approach to Incontinence. Preface. J Urol Oct 2011, 186(4)Part 1of2:1378

670. Wein AJ. Re: The Role of the Transient Receptor Potential (TRP) Superfamily of Cation-Selective Channels in the Management of the Overactive Bladder. Re: Sensor Mechanism and Afferent Signal Transduction of the Urinary Bladder: Special Focus on Transient Receptor Potential Ion Channels. J Urol Nov 2011;186(5):2125-2126

671. Wein AJ. Re: Urothelial Signaling. Re: Interstitial Cells in the Urinary Bladder-Localization and Function. Re: Detrusor Myocyte Activity and Afferent Signaling. J Urol Nov 2011;186(5):2127-2128

672. Wein AJ. Re: Effects of Phenazopyridine on Rat Bladder Primary Afferent Activity, and Comparison With Lidocaine and Acetaminophen. J Urol Nov 2011;186(5):2128-2129


133

673. Wein AJ. Re: FDA Safety Communication: Update on Serious Complications Associated with Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse – U.S. Food and Drug Administration. Re: Urogynecologic Surgical Mesh: Update on the Safety and Effectiveness of Transvaginal Placement for Pelvic Organ Prolapse – U.S. Food and Drug Administration Center for Devices and Radiological Health. Re: American Urogynecologic Society (AUGS) Response: FDA Safety Communication: Update on Serious Complications Associated With Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse (July 2011). Re: Society for Female Urology and Urodynamics (SUFU) Response: FDA Safety Communication: Update on Serious Complications Associated With Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse (July 2011) J Urol Dec 2011;186(6):2328-2330

674. Wein AJ. Re: Urodynamics, the Supine Empty Bladder Stress Test, and Incontinence Severity. J Urol Jan 2012;187(1):201-202

675. Wein AJ, Penson DF. Re: Retropubic Versus Transobturator Midurethral Slings for Stress Incontinence. Re: Transobturator TVT-O Versus Retropubic TVT: Results of a Multicenter Randomized Controlled Trial at 24 Months Follow-Up. Re: What Patients Think: Patient-Reported Outcomes of Retropubic Versus Trans-Obturator Mid-Urethral Slings for Urodynamic Stress Incontinence—A Multi-Centre Randomised Controlled Trial. J Urol Jan 2012;187(1):202-205

676. Wein AJ. Re: Should an Anti-Incontinence Procedure be Routinely Performed at the Time of Pelvic Organ Prolapse Repair? An Evidence-Based Review. J Urol Jan 2012;187(1):205

677. Wein AJ. Re: Are Multichannel Urodynamics Required Prior to Surgery in a Woman With Stress Urinary Incontinence? J Urol Jan 2012;187(1):206

678. Wein AJ. Re: Mixed Incontinence: Comparing Definitions in Non-Surgical Patients. J Urol Feb 2012;187(2):580

679. Wein AJ. Re: National Community Prevalence of Overactive Bladder in the United States Stratified by Sex and Age. J Urol Feb 2012;187(2):581

680. Wein AJ. Re: Patient Satisfaction With the Benefits of Overactive Bladder Treatment Exploration of Influencing Factors and Development of a Satisfaction Assessment Instrument. J Urol Feb 2012;187(2):582

681. Wein AJ. Re: Current Status of Urodynamics for Evaluation of Incontinence. J Urol Mar 2012;187(3):962-963

682. Wein AJ. Re: Abdominal Diurnal Rhythm of Urine Output Following Renal Transplantation: The Impact of Blood Pressure and Diuretics. J Urol Mar 2012;187(3):964

683. Wein AJ. Re: Pediatric Kidney Recipients With Small Capacity, Defunctionalized Urinary Bladders Receiving Adult-Sized Kidney Without Prior Bladder Augmentation. J Urol Mar 2012;187(3):1056

684. Wein AJ. Re: Validation of the Urinary Sensation Scale (USS). J Urol Apr 2012;187(4):352-1353


134

685. Wein AJ. Re: Perceptions of “Urgency” in Women With Interstitial Cystitis/Bladder Pain Syndrome or Overactive Bladder. J Urol Apr 2012;187(4):1353

686. Wein AJ. Re: Pelvic Floor Exercise for Urinary Incontinence: A Systematic Literature Review. J Urol Apr 2012;187(4):1353-1354

687. Wein AJ. Re: A Qualitative Study of Women’s Preferences for Treatment of Pelvic Floor Disorders. J Urol Apr 2012;187(4):1354-1355

688. Wein AJ. Re: Bladder Neck Closure and Suprapubic Catheter Placement as Definitive Management of Neurogenic Bladder. J Urol Apr 2012;187(4):1355-1356

689. Abrams P, Cardozo L, Wein A. Editorial—3rd International Consultation on Incontinence—Research Society 2011. Neurourology and Urodynamics 31:291-292 (2012)

690. Wein AJ. Re: Promise of Urinary Nerve Growth Factor for Assessment of Overactive Bladder Syndrome. J Urol May 2012;187(5):1747-1748

691. Wein AJ. Re: Rectal Distension: The Effect on Bladder Function. J Urol May 2012;187(5):1748

692. Wein AJ. Re: Contemporary Management of Postprostatectomy Incontinence. J Urol May 2012;187(5):1749

693. Wein AJ. Re: The role of Invasive and Non-Invasive Urodynamics in Male Voiding Lower Urinary Tract Symptoms. J Urol May 2012;187(5):1750

694. Wein AJ. Re: Silodosin Therapy for Lower Urinary Tract Symptoms in Men With Suspected Benign Prostatic Hyperplasia: Results of an International Randomized, Double-Blind, Placebo- and Active-Controlled Clinical Trial Performed in Europe. J Urol May 2012;187(5):1751-1752

695. Boopathi E, Hypolite J, Zderic S, Wein A, Chacko S. GATA-6 and NF-KB Synergistically Upregulates CPI-17 Gene Expression in Obstruction-Induced Murine Bladder Smooth Muscle Hypertrophy (Abstract #490, presented at the Annual Meeting of the American Urological Association, Atlanta, GA (USA), May 20, 2012)

696. Lei Q, Pan X-Q, Asfaw T, Hypolite J, Wein A, Malykhina A. Development of a Neurogenic Bladder in Transient Receptor Potential Vanilloid 1 Knockout Mice. (Abstract #493, presented at the Annual Meeting of the American Urological Association, Atlanta, GA (USA), May 20, 2012)

697. Lei Q, Hypolite J, Chang S, Seftel R, Chacko S, Wein A, Seftel A, Malykhina A. Impairment of Sensory Innervation in the Bladder Neck by Outlet Obstruction Contributes to the Development of Erectile Dysfunction. (Abstract #1006, presented at the Annual Meeting of the American Urological Association, Atlanta, GA (USA), May 21, 2012)

698. Ravishankar J, Chhatre S, Wein A, Malkowicz SB. Association of Prostate Cancer Treatment with Satisfaction with Care and Utility. (Abstract #1629, presented at the Annual Meeting of the American Urological Association, Atlanta, GA (USA), May 17, 2012)


135

699. Boopathi E, Zderic S, Addya S, Fortina P, Wein A, Chacko S. Down-Regulation of large Conductance, Calcium-Activated K+ Channel Gene Expression in Mice and Human Detrusor Smooth Muscle Following Partial Bladder Outlet Obstruction: Effects of Stretch and Hypoxia. (Abstract #1965, presented at the Annual Meeting of the American Urological Association, Atlanta, GA (USA), May 22, 2012)

700. Weiss B, Wein A, Malkowicz SB, Guzzo T. Comparison of Prostate Volume Measured by Transrectal Ultrasound and Magnetic Resonance Imaging. (Abstract #2052, presented at the Annual Meeting of the American Urological Association, Atlanta, GA (USA), May 23, 2012)

701. Wein AJ. Re: Detrusor Underactivity: A Plea for New Approaches to a Common Bladder Dysfunction. J Urol June 2012;187(6):2154-2155

702. Wein AJ. Re: Neural Control of the Female Urethral and Anal Rhabdosphincters and Pelvic Floor Muscles. –and– Re: Properties of Urethral Rhabdosphincter Motoneurons and Their Regulation by Noradrenaline. J Urol June 2012;187(6):2155-2156

703. Wein AJ. Re: Duloxetine for Mild to Moderate Postprostatectomy Incontinence: Preliminary Results of a Randomised, Placebo-Controlled Trial. J Urol June 2012;187(6):2156-2157

704. Wein AJ. Re: Sacral Neuromodulation for Nonobstructive Urinary Retention: A Meta-Analysis. J Urol July 2012;188(1):222

705. Wein AJ. Re: Interstim Sacral Neuromodulation and Botox Botulinum-A Toxin Intradetrusor Injections for Refractory Urge Urinary Incontinence: A Decision Analysis Comparing Outcomes Including Efficacy and Complications. J Urol July 2012;188(1):223

706. Wein AJ. Re: SUI Surgery at the Time of Vaginal POP Repair: Is a Surgical Algorithm Possible or Desirable? J Urol Aug 2012;188(2):507-508

707. Wein AJ. Re: Prevalence o Urinary Urgency Symptoms Decreases by Mid-Urethral Sling Procedures for Treatment of Stress Incontinence. J Urol Aug 2012;188(2):508

708. Wein AJ. Re: Antimuscarinic Mechanisms and the Overactive Detrusor: An Update. J Urol Sept 2012;188(3);888-889

709. Wein AJ. Re: Pharmacodynamics of Overactive Bladder Drugs: Shifting the Curve. – and – Women’s Perspective of Botulinum Toxin Treatment for Overactive Bladders Symptoms. J Urol Sept 2012;188(3);889-890

710. Wein AJ. Re: Urological Outcome After Myelomeningocele: 20 Years of Follow-up. J Urol Sept 2012;188(3);890-891

711. Wein AJ. Re: Defining Cure. J Urol Oct 2012;188(4);1231

712. Wein AJ. Re: Incontinence Improves in Older Women After Intensive Pelvic Floor Muscle Training: An Assessor-Blinded Randomized Controlled Trial. J Urol Oct 2012;188(4);1232


136

713. Wein AJ. Re: Reducing Nocturia in the Elderly: A Randomized Placebo-Controlled Trial of Staggered Furosemide and Desmopressin. J Urol Oct 2012;188(4);1232-1233

714. Wein AJ. Re: Nocturia and Quality of Life: Results from the Boston Area Community Health Survey. J Urol Oct 2012;188(4);1233-1234

715. Wein AJ. Re: Surgical Management of Pelvic Organ Prolapse in Women: The Updated Summary Version Cochrane Review. J Urol Nov 2012;188(5):1842-1843

716. Wein AJ. Re: Guidelines for Providing Privileges and Credentials to Physicians for Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse. J Urol Dec 2012;188(6);Part 1of 2;2300-2301

717. Wein AJ. Re: The Efficacy and Safety of PSD503 (Phenylephrine 20%, w/w) for Topical Application in Women with Stress Urinary Incontinence. A Phrase II, Multicentre, Double-Blind, Placebo Controlled, 2-Way Cross Over Study. J Urol Dec 2012;188(6);Part 1of 2;2301-2302

718. Wein AJ. Re: Urethral Injection Therapy for Urinary Incontinence in Women. J Urol Dec 2012;188(6);Part 1of 2;2302-2303

719. Wein AJ. Re: The Clinical Relevance of Cell-Based Therapy for the Treatment of Stress Urinary Incontinence. Re: Stem Cell Therapy: A Future Treatment of Stress Urinary Incontinence. Re: Will We Ever Use Stem Cells for the Treatment of SUI? ICI-RS 2011. J Urol Dec 2012;188(6);Part 1of 2;2303-2305

720. Wein AJ: Re: Can Maximum Urethral Closure Pressure (MUCP) be Used to Predict Outcome of Surgical Treatment of Stress Urinary Incontinence? J Urol Dec 2012;188(6)Part 1of 2;2305-2306


137

TAPES 1. Wein, A.J.: Partial Nephrectomy. American Urological Association Council on Education,

1977. 2. Wein, A.J.: Syphilis. American Urological Association, AUA-Roche Consultative Line in

Urology, 1977. 3. Wein, A.J.: Gonorrhea. American Urological Association, AUA-Roche Consultative Line in

Urology, 1977. 4. Wein, A.J.: Venereal Warts. American Urological Association, AUA-Roche Consultative

Line in Urology, 1977. 5. Wein, A.J.: Chancroid, Lymphogranuloma Venerum, and Granuloma lnguinale. American Urological Association, AUA-Roche Consultative Line in Urology, 1977. 6. Wein, A.J.: Nongonococcal or Nonspecific Urethritis. American Urological Association, AUA-Roche Consultative Line in Urology, 1977. 7. Wein, A.J.; Classification of Voiding Dysfunction. American Urological Association, AUA- Roche Consultative Line in Urology, 1987. 8. Wein, A.J., Resnick, N., Vaughan, E.D.: Urinary Incontinence and Medical vs. Surgical Management. Counterpoints in Urology, 1989. 9. Wein, A.J., Resnick, N., Blaivas, J.: Urinary Incontinence. Advances in Urology (Scientific Medical Programs, sponsored by Schering Corporation), 1990. 10. Wein, A.J.: Classification of Neurogenic Bladder. AUA/Parke Davis Consultant Urologist, tapes 69 and 70, produced by Reactive Systems, Inc., Teaneck, NJ, 1991. 11. Wein, A.J.: Classification of Neurogenic Bladder, parts 1 and 2 (tapes 335, 336), AUA/Merck Consultant Urologist. RSI Communications, Oradell, NJ, 1994

(Phone 1-800-526-4641).

12. Wein, A.J., Appell, R.A., Blaivas, J.G., Fantl, J.A., O’Donnell, P.A., Payne, C.K.: Urinary Incontinence: The scope of the problem -- the solutions on the horizon. Provided through an unrestricted educational grant from Pharmacia & Upjohn, 1997.


138

FILMS

1. Neurogenic Bladder Dysfunction; Visits in Urology. Eaton Film Library, J. J. Kaufman, Editor, 1980.

2. Primary Care of Common Sexual Problems. AMA Video Tape Library, H. Lief, Editor, 1980. 3. Urodynamics. Interactive videodisc. Sponsored by Roerig Pharmaceutical Company and

produced by the Glyn Group, New York, NY, 1983. 4. Transrectal Stimulation in the Production of an Erection. Biosonics, Inc., Philadelphia, PA

1985. 5. Transsexual Surgery: Male to Female. A 17 Year Experience. Malloy, T.R., Wein, A.J.,

Carpiniello, V.L. Philadelphia, PA, 1987. (Presented at 82nd Annual AUA Meeting, Anaheim, CA May 17-21, 1987.)

6. Transurethral Ultrasonic Aspiration of the Prostate. Malloy, T.R., Wein, A.J., Carpiniello, V.C. Presented 84th annual AUA meeting, Dallas, Texas, May 6-11, 1989. Received

1989 Audiovisual Award, American Urological Association, Inc. 7. Invited Moderator, Bard Investigator Group. Colloquium (Collagen Implant for Incontinence), 1990. 8. Urinary Incontinence. Lifetime TV. Recorded and filmed June 29, 1990, New York, New York. 9. Urinary Incontinence: The Cutting Edge Medical Report. Show #1119, Information Television Network, Philadelphia, April, 1998 10. Prostate Cancer (2 parts). Seeking Solution with Suzanne. CN-8, Philadelphia 2002. 11. Prostate Cancer, Channel 10 (NBC), Philadelphia, 2002.


139

Academic Activities listed on the following pages do not include publications or

local committee activities except for CME activities and student courses


140

ACADEMIC ACTIVITIES -- 1974-75

1. Course Director, "Introduction to Urology. SU 305 (Weekly), School of Medicine. 2. "Genitourinary Cancer", Surgery Core Course, ID 200 (Monthly), School of Medicine. 3. "Postoperative Incontinence and Its management", Postdoctoral Seminar in Urology,

Philadelphia College of Osteopathic Medicine, September 1974. 4. Presentation, Mid-Atlantic Section Meeting, American Urological Association, Inc., October

1974 (see publication #25). 5. Discussion, Mid-Atlantic Section Meeting, American Urological Association, Inc., October 1974:

"The Baseline Approach to the Medical Management of Benign Prostatic Hypertrophy", "Computerized Description of Dose Response of Bladder Strips to Cholinergic and Anticholinergic Drugs", "Renal Metabolic Changes in Obstructive Uropathy".

6. Presentation, Kimbrough Urological Seminar, November 1974 (see publication #23). 7. "Management of Hypernephroma", Rochester Surgical Society, November 1974. 8. "History of the Art and Science of Urology", University of Pennsylvania Humanities Course,

December 1974. 9. "Hormonal Treatment of Prostatic Cancer", Oncology Course, ID 212, School of Medicine,

December 1974. 10. "Emergency Room Urology", Lecture Series, Course in Emergency Medicine, ID 302, School of

Medicine, April 1975. 11. Presentation, "New Concepts of Bladder Innervation and Their Clinical Significance",

Philadelphia Academy of Surgery, April 1975. 12. "Emergency Room Urology", Lecture, Pennsylvania Chapter, American College Emergency

Room Physicians, April 1975. 13. Presentation, Annual Meeting, American Urological Association, Inc., May 1975 (see

publication #26). 14. Presentation, Annual Meeting, American Urological Association, Inc., May 1975 (see

publication #29).


141

ACADEMIC ACTIVITIES - 1975-76 1. Course Director, "Introduction to Urology", SU 305 (Weekly), School of Medicine. 2. "Genitourinary Cancer", Surgery Core Course, ID 200 (Monthly), School of Medicine. 3. Visiting Professor, University of Eastern Virginia School of Medicine, September 1975.

Lectures: "Gram-Negative Sepsis", "The Physiology and Pharmacology of the Bladder", "Management of Neurogenic Bladder Dysfunction".

4. "Gram Negative Sepsis", Lecture, American Urological Association Paraurologic Continuation

Education Seminar, September 1975. 5. Presentation, Kimbrough Urological Seminar, October 1975 (see publication #43). 6. "Venereal Disease in the Male", Lecture, Operation Venus (United States Alliance for the

Eradication of Venereal Disease), October 1975. 7. "Lower Urinary Tract Damage in Gynecologic Surgery", Lecture, Grand Rounds, Department of

Obstetrics and Gynecology, School of Medicine, October 1975. 8. Panelist, "Urethral Stricture Disease", Mid-Atlantic Section Meeting, American Urological

Association, Inc., October 1975. 9. Presentation, Mid-Atlantic Section Meeting, American Urological Association, Inc., October

1975 (see publication #28). 10. Presentation, Mid-Atlantic Section Meeting, American Urological Association, Inc., October

1975 (see publication #30). 11. Presentation, Mid-Atlantic Section Meeting, American Urological Association, Inc., October

1975 (see publication #31). 12. "Genitourinary Cancer", Lecture Series, ID 212, Course in Oncology, School of Medicine,

November 1975. 13. "Urologic Sequelae of Abdominal and Pelvic Surgery and Their Management", Lecture, Grand

Rounds, Department of Surgery, School of Medicine, December 1975. 14. "Evaluation and Treatment of the Neurogenic Bladder", Lecture, Grand Rounds, Department of

Neurosurgery, School of Medicine, February 1976. 15. "Urologic Emergencies: Diagnostic and Therapeutic Considerations", Visiting Lecturer, Jersey

Shore Medical Center, Neptune, New Jersey, March 1976. 16. "Urologic Emergencies", Lecture Series, Emergency Medical Care Course, ID 302, School of

Medicine, April 1976.


142

17. Co-Director of Seminar, "New Approaches to the Management of the Neuropathic Bladder", sponsored by the Division of Urology, Hospital of the University of Pennsylvania, April 1976.

18. "Therapy of the Neuropathic Bladder: Specific Approaches and Results", Lecture at #17. 19. "Metabolic Basis of Stone Disease", Visiting Lecturer, Allentown Hospital, Allentown,

Pennsylvania, April 1976. 20. Presentation, Annual Meeting, American Urological Association, Inc., May 1976 (see

publication #37). 21. Presentation, Annual Meeting, American Urological Association, Inc., May 1976 (see

publication #34).


143

ACADEMIC ACTIVITIES 1976-77 1. Course Director, "Introduction to Urology", SU 305 (Weekly), School of Medicine. 2. "Genitourinary Cancer", Surgery Core Course, ID 200 (Monthly), School of Medicine. 3. Presentation, Mid-Atlantic Section Meeting, American Urological Association, Inc., September

1976 (see publication #36). 4. Presentation, Mid-Atlantic Section Meeting, American Urological Association, Inc., September




1976 (see publication #44). 8. Presentation, American Association for the Surgery of Trauma, September, 1976 (see

publication #45). 9. Presentation, Kimbrough Urological Seminar (Society of Government Service Urologists),

November 1976 (see publication #40). 10. Presentation, Kimbrough Urological Seminar (Society of Government Service Urologists),

November 1976 (see publication #41). 11. "Male Infertility", Short Course, American Medical Association Clinical Convention, December

1976. 12. "Genitourinary Cancer", Lecture Series, ID 212, School of Medicine, December 1976. 13. "Urolithiasis", Lecture, Grand Rounds, Department of Surgery, School of Medicine, December

1976. 14. Faculty, Postgraduate Seminar Sponsored by Mid-Atlantic Section, American Urological

Association. "Two-stage Urethroplasty for Urethral Stricture Disease." Panelist, "Urethral Stricture Disease", February 1977.

15. "Genitourinary Oncology", Postgraduate Lecture, Department of Surgery, West Jersey Hospital,

Camden/Voorhees/Berlin, New Jersey, March 1977. 16. "Emergency Room Urology", Lecture Series, Emergency Medical Care Course, ID 302, School

of Medicine, April 1977. 17. Presentation, Annual Meeting, American Urological Association, Inc., April 1977 (see

publication #46). 18. Presentation, Annual Meeting, American Urological Association, Inc., April 1977 (see

publication #50).


144

19. "Neurogenic Bladder Dysfunction", Presentation, Grand Rounds, Department of Neurology, School of Medicine, May 1977.

20. Co-Director, American Urological Association Postgraduate Seminar, Philadelphia, PA, June

1977. 21. Moderator, Session on Genitourinary Oncology, American Urological Association Postgraduate

Seminar, Philadelphia, PA, June 1977. 22. Faculty, "Neurogenic Bladder Dysfunction", American Urological Association Postgraduate

Seminar, Philadelphia, PA, June 1977.


145

ACADEMIC ACTIVITIES 1977-78

1. Course Director, "Introduction to Urology", SU 305 (Weekly), School of Medicine.

2. "Genitourinary Cancer", Surgery Core Course, ID 200 (Monthly), School of Medicine.

3. Interviewing Panel, Admissions Office, School of Medicine. 4. Visiting Lecturer, Norwich-Eaton Pharmaceutical Company, Norwich, New York, July 28-29,

1977: "The Effects of Drugs on Urinary Smooth Muscle". 5. Visiting Lecturer, American Medical Systems, Inc., Golden Valley, MN, September 22-23, 1977:

"Urodynamics". 6. Presentation, American College of Surgeons, Surgical Investigators' Forum, Dallas, TX,

October 17-21, 1977 (see publication #48). 7. Panel Moderator, Symposium on Urodynamics, Mid-Atlantic Section, American Urological

Association, Hot Springs, VA, October 26-30, 1977. 8. Presentation, "Electromyography in Urodynamics", Symposium on Urodynamics, Mid-Atlanti(

Section, American Urological Association, Hot Springs, VA, October 26-30, 1977. 9. Presentation, Annual Meeting, Mid-Atlantic Section, American Urological Association, Hot

Springs, VA, October 26-30, 1977 (see publication #74). 10. Presentation, Annual Meeting, Mid-Atlantic Section, American Urological Association, Hot

Springs, VA, October 26-30, 1977 (see publication #61). 11. Presentation, Kimbrough Urological Seminar, Denver, CO, November 7-11, 1977 (See

publication #56). 12. "Genitourinary Cancer", Lecture Series, ID 212, School of Medicine, December 1977. 13. Visiting Lecturer, Newcomb Hospital, Vineland, NJ, December 1977: "The Prostate and Its

Problems". 14. Presentation, Surgical Grand Rounds, Depatment of Surgery, School of Medicine, December

1977: "Urologic Oncology-. Current Status". 15. Visiting Lecturer, Grand Rounds, Crozer-Chester Medical Center, Chester, PA, January

"Diagnosis and Treatment of Neurogenic Bladder Dysfunction". 16. Visiting Lecturer, Grand Rounds, Hazleton State Hospital, Hazleton, PA., January "Injuries to

the Urinary Tract: Diagnosis and Management". 17. Visiting Lecturer, Grand Rounds, West Jersey Hospital, Voorhees, NJ, January 1978: "New

Concepts in the Management of Carcinoma of the Bladder". 18. Lecturer, International Urological Sciences Association, Philadelphia, PA, January, 1978.

"Neurogenic Bladder Dysfunction: Classification and Management".


146

19. Faculty, Mid-Winter Seminar, Mid-Atlantic Section, American Urological Association, Inc., Washington, D.C., February 1978: Lecture, "Controversies Surrounding and Limitations of Urodynamics"; Panel, "Urodynamics Update".

20. Presentation, American Fertility Society Annual Meeting, New Orleans, LA, March 29-April 1,

1978 (see publication #78). 21. "Emergency Room Urology", Lecture Series, Emergency Medical Care Course, ID 302, School

of Medicine, April 1978. 22. Faculty, Symposium on Urodynamics, incontinence, and Impotence (Syracuse NY, May 1978),

Sponsored by American Medical Systems, Inc.: Lectures, "Physiology of Micturition", "Urodynamic Testing: Methodology and Significance"; Panels, "Urodynamics", "Urinary Incontinence", "Impotence".

23. Presentation, American Urological Association Annual Meeting, Washington, DC, May 1978

(see publication #71). 24. Presentation, American Urological Association Annual Meeting, Washington, DC, May 1978



(see publication #67). 27. Moderator, Research Forum on Urodynamics and Urinary Diversion, American Urological

Association Annual Meeting, Washington, DC, May 1978.


147

ACADEMIC ACTIVITIES - 1978-79 1. Course Director, "Introduction to Urology", SU 305 (Weekly), School of Medicine. 2. "Genitourinary Cancer", Surgery Core Course, ID 200 (Monthly), School of Medicine. 3. "Genitourinary Cancer", Lecture Series, ID 212, School of Medicine, December 1978. 4. "Emergency Room Urology", Lecture Series, ID 302, Emergency Medical Care Course, School

of Medicine, April 1979. 5. Faculty Member, Seminar on Urodynamics and Prosthetics, sponsored by American Medical

Systems, Philadelphia, PA, July 16-17, 1978: "Neuroanatomy and Neurophysiology of Micturition", "Methodology of Urodynamics", "Treatment of Bladder Dysfunction", "Evaluation and Treatment of the Impotent Male", and Panel Discussions.

6. Lecture, Philadelphia Urological Society, "University of Pennsylvania Approach to Carcinoma of

the Prostate", September 15, 1978. 7. Faculty Member, Radiation Therapy Oncology Group, American College of Radiology, Seminar

on Bladder and Prostate Carcinoma: "Total Management of Bladder Carcinoma, Stage B-2 and C", and Panel Discussion, "Bladder Carcinoma", Philadelphia, PA, September 27, 1978.

8. Moderator, Panel on Impotence, Mid-Atlantic Section Meeting, American Urological

Association, Inc., White Sulphur Springs, WV, October 28-November 1, 1978. 9. Presentation, "Neurophysiology of Erection", Mid-Atlantic Section Meeting, American Urological

Association, Inc., White Sulphur Springs, WV, October 28-November 1, 1978. 10. Presentation, Mid-Atlantic Section Meeting, American Urological Association, Inc., White

Sulphur Springs, WV, October 28-November 1, 1978 (see publication #78). 11. Presentation, Mid-Atlantic Section Meeting, American Urological Association, Inc., White

Sulphur Springs, WV, October 28-November 1, 1978 (see publication #82). 12. Visiting Lecturer, Abington Hospital, Abington, PA, Grand Rounds, November 7, 1978:

"Neurogenic Vesical Dysfunction". 13. Faculty Member, American Urological Association Seminar, "Controversies in Clinical

Neurourology", Boston, MA, November 16-18, 1978. Lectures: "Anatomy and Physiology of Continence and Micturition", "Surgical Treatment of Neurogenic Retention", "Neurogenic Vesicourethral Dysfunction in the Child", "Evaluation of the Impotent Patient". Panel Discussions: "Clinical Conference on Diagnosis of Neurogenic Vesicourethral Dysfunction", "Clinical Conference on Treatment of Neurogenic Vesicourethral Dysfunction".

14. Faculty Member, Course on "Urodynamics in Clinical Urology", New York University School of

Medicine (Co-sponsored by A.U.A.), December 2-3, 1978. Lectures: "Neuropharmacological Basis of Drug Therapy in Disorders of Micturition", "A Urologist's Viewpoint of Neurogenic Vesical Dysfunction". Panel Discussions: "Urodynamics", "Treatment of Micturitional Disorders".

15. Visiting Lecturer, Salem Hospital, Salem, NJ, February 6, 1979: "Carcinoma of the Bladder".


148

16. Faculty Member, "Pediatric Urology for the Primary Care Physician", Philadelphia,PA, February

17, 1979: "Venereal Disease in the Adolescent", "Neurogenic Bladder Dysfunction and Associated Urodynamics", Panel Discussion.

17. Audiovisual Program Chairman, Pan American Congress of Andrology, Caracas, Venezuela,

March 12-16, 1979. 18. Guest Lecturer, Maryland Urologic Association, Baltimore, MD., March 31, 1979: "Urodynamics

for the Practicing Urologist: A Slightly Skeptical Approach", "Pharmacologic Approaches to the Management of Neurogenic Bladder Dysfunction".

19. Faculty Member, American Urological Association Postgraduate Seminar, Washington,

March 16-18, 1979: "Neurology of Micturition", "How to Treat Neurogenic Bladders: Medical vs. Surgical Approach".

20. Visiting Lecturer, Burlington County Memorial Hospital, Mt. Holly, NJ, March 22,

"Urodynamics". 21. Presentation, Surgical Grand Rounds, University of Pernsylvania School of Medicine, March 24,

1979: "Genitourinary Cancer: An Update". 22. Faculty Member, American Urological Association, Inc., Regional Subject Oriented Seminar,

"Advances in Clinical Neurourology", San Francisco, CA, April 19-21, 1979.

23. Lectures: "The Neurologic Evaluation", "Disorders of Lower Urinary Tract Function Associated with Peripheral Nerve Injury", "Intermittent Catheterization". Panel Discussions: "Classification and Evaluation", "Treatment", "Sexual Dysfunction".

24. Faculty Member, American Urological Association, Inc., Regional Subject Oriented Seminar,

"Female Urology", Cherry Hill, NJ, April 26-28, 1979. Lectures: "Physiology of Bladder Function", "Electrical Stimulation in the Treatment of Urinary Incontinence", "Selected Topics".

25. Panelist, Biomedical Engineering Forum, American Urological Association, Inc., Annual

Meeting, New York, NY, May 12-17, 1979. 26. Presentation, Annual Meeting, American Urological Association, Inc., New York, NY, May 12-

17, 1979 (see publication #80). 27. Presentation, Annual Meeting, American Urological Association, Inc., New York, NY, May 12-

17, 1979 (see publication #84). 28. Presentation, Annual Meeting, American Urological Association, Inc., New York, NY, May 12-

17, 1979 (see publication #93).


149

ACADEMIC ACTIVITIES 1979-80 1. Course Director, Urology Core Curriculum, School of Medicine. 2. Lecturer, Urology Core Course, "Genitourinary Cancer I", "Genitourinary Cancer II", "Voiding

Function and Dysfunction", "Sexual Function and Dysfunction", "Bladder Outlet Obstruction". Repeated six times yearly.

3. "Genitourinary Cancer", Lecture Series, ID 212, School of Medicine, December 1979. 4. Lecture, "Newer Pharmacologic Approaches to the Study, Evaluation and Management of

Voiding Function and Dysfunction", University of Texas School of Medicine at Houston, July 17, 1978.

5. Faculty Member, The Clinical Application and Methodology of Urodynamics and the Prosthetic

Management of Impotence, Lake Ozark, MO, July 19-22, 1979: "Physiology of Micturition", "Electromyography", "Pharmacologic Treatment of Voiding Dysfunction", and Panel Discussions.

6. Lecture and Discussion, Surgical Grand Rounds, University of Pennsylvania School of

Medicine, July 28, 1979: "Genitourinary Trauma". 7. Invited Guest, American Association for the Surgery of Trauma, Annual Meeting, September

13-15, 1979, Chicago, IL, Presentation (see publication #86). 8. Presentation, Mid-Atlantic Section Meeting, American Urological Association, Inc., Palm Beach,

FL, October 3-7, 1979 (see publication #102). 9. Presentation, Mid-Atlantic Section Meeting, American Urological Association, Inc., Palm Beach,

FL, October 3-7, 1979: "Etiologic Possibilities for Increased Pelvic Floor EMG Activity During Cystometry".

10. Presentation, Surgical Forum, American College of Surgeons, Chicago, IL, October 21-26,

1979 (see publication #77). 11. Faculty, Postgraduate Course in Urology, Clinical Congress, American College of Surgeons,

Chicago, IL, October 21-26, 1979, "The Role of Urodynamics in Private Practice". 12. Faculty, Postgraduate Course in Urology, Clinical Congress, American College of Surgeons,

Chicago, IL, October 21-26, 1979: "Effect of Pharmacologic Agents on Continence-Incontinence and on Sexual Function-Dysfunction".

13. Invited Lecture, Grand Rounds, Abington Hospital, Abington, PA, "Evaluation and Management

of Carcinoma of the Prostate", November 20, 1979. 14. Faculty, California Neurosurgical Society, Symposium on Neuro-Urological Topics, Los

Angeles, CA, December 5-6, 1979, "Pharmacologic Treatment of Neurogenic Bladder Dysfunction".

15. Invited Lecture, Medical Grand Rounds, Pennsylvania Hospital, Philadelphia, PA, "Germinal

Cell Neoplasms in the Adult", January 8, 1980.


150

16. Visiting Professor, Clinical Oncology Program, Allentown Sacred Heart Hospital, Allentown, PA: "Review of Cancer of the Kidney and Cancer of the Bladder", "Review of Cancer of the Prostate and Cancer of the Testis". Panel Discussion, February 2, 1980.

17. Invited Lecturer, Grand Rounds, Riverview Hospital, Red Bank, NJ: "Current Concepts of

Evaluation and Treatment of Carcinoma of the Prostate", March 12, 1980. 18. Faculty, Postgraduate Course, "Clinical Application of Urodynamics", Oklahoma University

School of Medicine, Oklahoma City, OK, March 20-22, 1980: "Pharmacologic Treatment of Neurogenic Bladder Dysfunction", "Practical Use of Urodynamics", Discussions.

19. Visiting Professor, Virginia Urologic Society, Irvington, VA, March 27-29, 1980: "Practical

Evaluation of Voiding Dysfunction", "Practical Treatment of Voiding Dysfunction", Case Discussions.

20. "Emergency Room Urology", Lecture Series, ID 302, Emergency Medical Care Course, School

of Medicine, April 1980. 21. Invited Lecturer, Cook County Graduate School of Medicine, Chicago, IL, April 7, "Physiology of

the Bladder", "Evaluation and Treatment of Neurogenic Bladder Dysfunction". 22. Invited Lecturer, Texas Association of Genitourinary Surgeons, Annual Meeting, Philadelphia

PA, April 14-15, 1980: "How We Treat Genitourinary Cancer", "Urodynamics: Use and Abuse", "Pharmacologic Treatment of Voiding Dysfunction".

23. Invited Lecturer, Surgical Grand Rounds, University of Pennsylvania School of Medicine, May

10, 1980: "The Etiology, Evaluation, and Management of Sexual Dysfunction in the Male". 24. Invited Lecturer, Urodynamics Society Workshop, San Francisco, CA, May 17, 1980: "Criteria to

Establish Biological Activity and Clinical Efficacy of a Drug", "Studies on the Autonomic Innervation of the Lower Urinary Tract", "The Biological Activity and Clinical Efficacy (or Lack of It) of Bethanechol Chloride".

25. Sole Faculty Member, Instructional Course sponsored by American Urological Association,

Annual Meeting, San Francisco, CA, May 18-22, 1980: "Pharmacological Manipulation of Lower Urinary Tract Function".

26. Faculty Member, Postgraduate Course sponsored by American Urological Association, Inc.,

Annual Meeting, San Francisco, CA, May 18-22, 1980: "Neurogenic Vesical Dysfunction' 27. Moderator, Research Forum on Urodynamics and Physiology and Pharmacology of Lower

Urinary Tract, American Urological Association, Inc., Annual Meeting, San Francisco, CA, May 18-22, 1980.

28. Presentations, American Urological Association, Inc., Annual Meeting, San Francisco, CA,

May 18-22, 1980:

a) The Pudendal Plexus Block: A New Technique for Transurethral Surgery (with David Silverman).

b) Expansion Without Rigidity During Nocturnal Penile Tumescence Testing: A Potential Source of Misinterpretation (with Ralph Fishkin, Victor Carpiniello, and Terrence Malloy).


151

c) Advanced Peyronie's Disease Treated with the Inflatable Penile Prosthesis (with Terrence Malloy and Victor Carpiniello).

d) Functional Alterations in Rabbit Urinary Bladder Contractility Following Estrogen Administration (with Robert Levin and Frances Shofer).

e) Urodynamics Testing: Recommendations of the Urodynamics Society (with Jerry Blaivas et al.)

f) Combined Flow-Striated Muscle Sphincter EMG in Clinical Urodynamics (with David Barrett).

29. Invited Lecturer, West Jersey Hospital, Voorhees, NJ, June 19, 1980: "Cancer of the

Prostate".


152

ACADEMIC ACTIVITIES - 1980-81 1. Course Director, Urology Core Curriculum, School of Medicine. 2. Lecturer, Urology Core Course, "Genitourinary Cancer I", "Genitourinary Cancer II, "Voiding


3. "Genitourinary Cancer", Lecture Series, ID 212, School of Medicine, December 1980. 4. "Emergency Room Urology", Lecture Series, ID 302, Emergency Medical Care Course, School

of Medicine, April 1981. 5. Visiting Professor, West Virginia University School of Medicine, Morgantown, WVA, July 10-1 2,

1980: "Physiology of Lower Urinary Tract Function", "Urodynamics", "Evaluation and Management of Sexual Dysfunction in the Male", "Pharmacologic Management of Voiding Dysfunction", Case Discussions and Presentations.

6. Faculty, American Urological Association, Inc., Regional Subject Oriented Seminar,

"Controversies in Neuro-Urology", Toronto, Canada, August 7-9, 1980. Moderator of Day 1 Program. Formal presentations: "Classification of Neurogenic Bladder Dysfunction "Surgical Treatment of Neurogenic Bladder Dysfunction", Panel Discussions, Small Group Discussions.

7. Faculty, Symposium on Urodynamics, Methodist Hospitals of Memphis, Memphis, TN, August

22-23, 1980: "Neurophysiology and Neuropharmacology of Micturition", "Electromyography", "Pharmacologic Alteration of Voiding Function", Case Discussions.

8. "Criteria to Evaluate the Biologic Activity and Clinical Efficacy of Pharmacologic Agents Which

Affect Voiding Function", Formal Invited Lecture, Mid-Atlantic Section Annual Meeting, American Urological Association, Inc., Hot Springs, VA, October 1-5, 1980.

9. Faculty, "Symposium on Clinical Applications of Urodynamic Testing", Life Tech Instrument Co.,

Inc., New York, October 4-5, 1980. Formal presentations: "Clinical Applications of Flowmetry, Electromyography, Cystometry, Profilometry, and Combined Studies".

10. Chairman, Clinical Trials Session, Combined Meeting of International Continence Society and

Urodynamics Society, Los Angeles, CA, October 9-12, 1980. 11. Invited Review and Critique, Clinical Trials Session, Combined Meeting of International

Continence Society and Urodynamics Society, Los Angeles, CA, October 9-12, 1980. 12. Presentation, American College of Surgeons, Surgical Forum for Investigators, Atlanta, GA,

October 19-23, 1980: "Quantitative Evaluation of Alpha and Beta-Adrenergic Receptors in Human Penile Corpus Cavernosum".

13. Faculty, "Urodynamics: Use and Abuse", Urology Program, American College of Surgeons

Clinical Congress, Atlanta, GA, October 19-23, 1980. 14. Invited Presentation, Philadelphia Urologic Society, October 27, 1980: "Omental Transposition

in Genitourinary Reconstructive Surgery".


153

15. Invited Presentation, Agnew Surgical Society, University of Pennsylvania School of Medicine, November 19, 1980: "Surgical Treatment of Male Sexual Dysfunction".

16. Visiting Professor, Chicago Urologic Society, Chicago, IL, December 3, 1980: "Lower Urinary

Tract Physiology and Pharmacology", "Pharmacologic Treatment of Voiding Dysfunction", Discussion of six papers presented by membership.

17. Invited Faculty Member, Cleveland Clinic, Cleveland, OH, "Controversies in Clinical Urology",

March 5-6, 1981: "Urodynamic Testing - Is It of Clinical Value?" 18. Invited Faculty Member, American Urological Association Seminar, "Advances in Treatment:

"Incontinence and Impotence", Los Angeles, CA, March 13-14, 1981: "Impotence Diagnosis; Surgical Indications", "Neurogenic Bladder", Pathophysiology of Female Incontinence", additional discussions and case presentations.

19. Invited Faculty Member, Seminar, "Female Urinary Incontinence", sponsored by Albert Einstein

Medical College, New York, NY, March 21-11, 1981: "Neuroanatomy and Neurophysiology of Micturition", "Female Urinary Incontinence in Neurological Disease", Nonoperative Treatment of Unstable Bladder", "Burch Urethropexy", Panel discussions.

20. Invited Faculty, Cook County Graduate School of Medicine, Specialty Review in Urology,

Chicago, IL, April 23-24, 1981: "Neuropharmacology and Neurophysiology of Micturition", "Evaluation and Management of Neurogenic Bladder Dysfunction".

21. Invited Faculty, Course in Urodynamics, sponsored by Life Tech Instrument Co., Atlanta, GA,

April 25-26, 1981: "Physiology of Micturition", "Urodynamic Evaluation of Voiding Dysfunction". 22. Invited Lecture, Surgical Grand Rounds, University of Pennsylvania School of Medicine, May 2,

1981: "Genitourinary Trauma". 23. Invited Discussion and Moderator, Session on Detrusor Hyperactivity, Urodynamics Society

Annual Symposium, Boston, May 9, 1981. 24. Invited Faculty, Postgraduate Course on Neurogenic Vesical Dysfunction, Annual Meeting,

American Urological Association, Inc., Boston, MA, May 10-14, 1981. 25. Sole Invited Faculty, Postgraduate Course on Pharmacologic Manipulation of Lower Urinary

Tract Function, Annual Meeting, American Urological Association, Inc., Boston,. MA, May 10-14, 1981.

26. Invited Discussion and Moderator, General Session on Adult Neurourology, Annual Meeting,

American Urological Association, Inc., Boston, MA, May 10-14, 1981. 27. Invited Discussion, three papers at Research Forum on Lower Urinary Tract Function, Annual

Meeting, American Urological Association, Inc., Boston, MA, May 10-14, 1981. 28. Presentations, Annual Meeting, American Urological Association, Inc., Boston, MA, May 10-14,

1981:

a) "Non-dyssyngergic Causes of Simultaneous Increases in lntravesical Pressure and Striated Sphincter Activity During Cystometry" (with David Barrett).


154

b) "Relief of Priapism Utilizing a Jackson-Pratt Drain (with Terrence Malloy and Victor

Carpiniello). c) "Quantitative Effect of Caffeine on Sperm Motility and Cyclic Adenosine Monophosphate

Phosphodiesterase" (with Robert Levin and Stanley Greenberg). d) "Direct Measurement of the Antimuscarinic Activity of a Series of Pharmacological

Compounds on the Canine Urinary Bladder" (with Robert Levin). e) "Development of Contractile Responses to Autonomic Agonists in the Rabbit Urinary

Bladder" (with Robert Levin and Bruce Malkowicz). 29. Visiting Professor, McGill University School of Medicine, Montreal, Canada, May 21, 1981:

"Male Sexual Function and Dysfunction: Physiology, Evaluation and Treatment", "Neurophysiology of Bladder and Urethral Function", Urodynamic Evaluation of Voiding Function", Urologic Oncology case presentation and discussions.

30. Invited Faculty, Basic Science in Urology, American Urological Association, Inc., Charlottesville,

VA, June 16-19, 1981: "Neurophysiology and Neuropharmacology of the Lower Urinary Tract", "Urodynamic Evaluation of Voiding Function", "Drug Treatment of Voiding Dysfunction".

31. Invited Lecturer, Raleigh County Medical Society, Beckley, WV, June 20, 1981: "Male Sexual

Function and Dysfunction", "Evaluation of Voiding Function", Case presentation and discussion.


155

ACADEMIC ACTIVITIES - 1981-82 1. Course Director, Urology Core Curriculum, School of Medicine. 2. Lecturer, Urology Core Course, "Genitourinary Cancer I", "Genitourinary Cancer II", "Voiding



of Medicine, April 1981. 5. Invited Chairman, Session on Pharmacology, International Continence Society Annual Meeting,

Lund, Sweden, September 3-5, 1981. 6. Invited Faculty, International Symposium on Dynamics of Male Sexual Dysfunction, Sponsored

by Mayo Clinic, Rochester, MN, September 14-16, 1981: "Nocturnal Penile Tumescence", "Evaluation of Impotence: Philadelphia Approach".

7. Invited Lecturer, Grand Rounds, Department of Obstetrics and Gynecology, University of

Pennsylvania School of Medicine, September 24, 1981: "Urodynamic Evaluation of Voiding Dysfunction in the FemaIe”.

8. Presentation, Forum on Fundamental Surgical Problems, American College of Surgeons, San

Francisco, CA, October 12-16, 1981: "Effects of Desmethylimipramine and Lithium on Human Sperm Motility".

9. Presentation, Forum on Fundamental Surgical Problems, American College of Surgeons, San

Francisco, CA, October 12-16, 1981: "Contractile and Metabolic Effects of Acute Overdistention on the Rabbit Urinary Bladder".

10. Invited Panel Chairman, Society of University Urologists Annual Meeting, San Francisco, CA,

October 15-16, 1981: "Uroradiology or Radiourology, Which" "Does the Presence of Renal or Ureteral Pathology Mandate Urological Consultation or Involvement".?

11. Invited Presentation, Philadelphia Urological Society, October 25, 1981: "Effects of a Series of

Pharmacologic Compounds on the Muscarinic Receptors of Human Urinary Bladder". 12. Invited Panel Chairman and Principal Discussant, "Female Stress Urinary Incontinence", Mid-

Atlantic Section, American Urological Association Annual Meeting, White Sulphur Springs, WVA, November 3-6, 1981.

13. Invited Chairman and Principal Lecturer, "Female Incontinence", Course sponsored by

American College of Surgeons, Bethlehem, PA, November 11, 1981. 14. Visiting Professor, Kimbrough Urological Seminar (sponsored by the Society of Government

Service Urologists). Judge, Residents' Essay Contest, lectures on the physiology of sexual function, evaluation and management of sexual dysfunction, drug treatment of voiding dysfunction, urodynamic evaluation of voiding function, discussion of session on bladder cancer. Denver, CO, November 16-19, 1981.


156

15. Visiting Professor, Department of Neurology, Wilmington Medical Center, Wilmington, DE, December 3, 1981: "Micturition - Physiology", "Evaluation and Treatment of Voiding Dysfunction".

16. Visiting Professor, Combined Medical Grand Rounds and American Cancer Society Lecture, St.

Luke's Hospital, Bethlehem, PA, January 19, 1982: "Carcinoma of the Prostate". 17. Invited Lecturer, Surgical Grand Rounds, Graduate Hospital, Philadelphia, PA, January 20,

1982: "Evaluation and Management of Male Sexual Dysfunction". 18. Invited Protocol Discussions, Radiation Therapy Oncology Group, St. Louis, MO, January 20-

22, 1982. 19. Residency Review Committee, Chairman of Ad Hoc Committee for Review of Appeal of

Program in Urology at Tulane University, Chicago, IL, January 29, 1982. 20. Invited Section Guest, Department of Urology, Mayo Clinic, Rochester, MN, February 25-27,

1982: "Drug Treatment of Voiding Dysfunction". Case presentation and discussion. 21. Distinguished Visiting Professor, Beth Israel Medical Center, New York, NY, March 11-12,

1982: "Physiology and Pharmacology of Micturition". Case presentation, discussion and surgery.

22. Invited Lecturer, New York Urodynamics Society, March 11, 1982: "Treatment of Neurogenic

and Non-neurogenic Voiding Dysfunction". 23. Chairman, Program Committee, Mid-Atlantic Section of AUA Mid-Winter Seminar, Washington,

DC, March 13, 1982. 24. Honorary Urology Lecture, Society of Uroradiology Annual Meeting, Palm Beach, FL, March 22-

25, 1982: "Urodynamics: Rationale, Caveats, and Personal Opinions". 25. Invited Lecturer, Cook County Graduate School of Medicine, Chicago, IL, April 19, 1982:

"Physiology of Micturition", "Neurogenic Bladder Dysfunction". 26. Invited Faculty, Course on Sexual Arousal (Fifth Annual Conference on Psychosomatic

Disorders), Jefferson Medical College, Philadelphia, PA, April 23, 1982: "Current Approaches in Urology".

27. Invited Lecture, Urodynamics Society Annual Meeting, Kansas City, MO, May 15,

"Pharmacology of Urethral Opening". 28. Invited Moderator, Session on Clinical Correlations, Urodynamics Society Annual Meeting,

Kansas City, MO, May 15, 1982. 29. Invited Faculty, Post Graduate Course, Annual Meeting, American Urological Association, Inc.,

Kansas City, MO, May 16-21, 1982: Pharmacologic Manipulation of Lower Urinary Tract Function".

30. Invited Faculty, Post Graduate Course, Annual Meeting, American Urological Association, Inc.,

Kansas City, MO, May 16-21, 1982: "Neurogenic Bladder".


157

31. Invited Faculty, Post Graduate Course, Annual Meeting, American Urological Association, Inc., Kansas City, MO, May 16-21, 1982: Included three presentations.

32. Invited Presentation, Urologic Research Society, Annual Meeting, Boston, MA, May 21-22,

1982: "Muscarinic Cholinergic Receptor Binding of Human Bladder Muscle". 33. Invited Faculty, American Urologic Association Basic Sciences Course, Charlottesville, VA,

June 13-19, 1982: "Neurophysiology and Neuropharmacology of the Lower Urinary Tract", "Urodynamics".

34. Invited Faculty, "Clinical Applications of Urodynamics", Beth Israel Medical Center, New York,

NY, June 25, 1982. 35. Invited Lecture, Eli Lilly Company, Indianapolis, IN, June 28, 1982: "Evaluation of Voiding

Dysfunction Secondary to Prostatic Enlargement".


158

ACADEMIC ACTIVITIES - 1982-83 1. Course Director, Urology Core Curriculum, School of Medicine. 2. Lecturer, Urology Course: "Genitourinary Cancer I", "Genitourinary Cancer II", "Voiding

Function and Dysfunction", "Sexual Function and Dysfunction", "Bladder Outlet Obstruction”, repeated six times yearly.

3. "Genitourinary Cancer", Lecture Series, ID 212, School of Medicine, December 1982. 4. "Emergency Room Urology", Lecture Series, ID 302, Emergency Medical Care Course,

School of Medicine, April 1983. 5. Invited Protocol Discussions, Radiation Therapy Oncology Group, Biannual Meeting,

Philadelphia, PA, July 19-21, 1982. 6. Invited Moderator, Session on Urodynamics and Neurourology, Société Internationale

d'Urologie (SIU), Tri-Yearly Meeting, San Francisco, CA, September 5-10, 1982. 7. Invited Presentation, Session on Drug Induced Changes in the Urodynamics of the Lower

Urinary Tract, Société Internationale d'Urologie (SIU), Tri Yearly Meeting, San Francisco, CA, September 5-10, 1982: "Physiology of Bladder Storage".

8. Invited Presentation, Session on Drug Induced Changes in the Urodynamics of the Lower

Urinary Tract, Société Internationale d'Urologie (SIU), Tri Yearly Meeting, San Francisco, CA, September 5-10, 1982: "Effectiveness of Bethanechol on Bladder Emptying", Panel discussion on Bladder Storage and Emptying.

9. Invited Presentation, Session on Drug Induced Changes in the Urodynamics of the Lower

Urinary Tract, Société Internationale d'Urologie (SIU), Tri Yearly Meeting, San Francisco, CA, September 5-10, 1982: "Urinary Retention in Relation to lnfravesical Obstruction.

10. Invited Faculty, Postgraduate Seminar, New England Section, American Urological

Association, Inc., Boston, MA, September 10-12, 1982: "Physiology and Pharmacology of Micturition", "Management of Neurogenic Bladder Dysfunction".

11. Invited Faculty, Seminar on Clinical Urodynamics, University of South Carolina School of

Medicine, September 24, 1982. 12. Invited Faculty, Seminar on Urodynamics in Clinical Practice, Sponsored by Life Tech

Corporation, Orlando, FL, September 25, 1982. 13. Invited Lecturer, New England Section, American Urological Association Annual Meeting,

Quebec City, Quebec, October 18-20, 1982: "Drug Treatment of Neuropathic Bladder Dysfunction". Panel: "Management of Neurogenic Bladder Dysfunction".


159

14. Visiting Professor, University of Toronto, October 21-22, 1982: "Management of Voiding Dysfunction", "Physiology of Sexual Function in the Male","Evaluation of Male Sexual Dysfunction". Case Discussions: "Voiding Dysfunction", "Urologic Oncology".

15. Invited Faculty, University of Pennsylvania - U.S. Army Trauma Symposium, Philadelphia,

PA, November 5-7, 1982. "Traumatic Injuries of the Upper Genitourinary Tract". 16. Course Director, Urodynamics: Clinical Application, Sponsored by Life Tech Corporation,

Houston, Texas, November 13-14, 1982. 17. Visiting Professor, Medical College of Virginia, Richmond, VA, December 2-4, 1982.

Honorary R. Carl Bunts Lecture: "Pharmacological Management of Voiding Dysfunction", "Pathophysiology and Evaluation of Male Sexual Dysfunction".

18. Invited Lecturer, Division of Urology, Temple University School of Medicine, Philadelphia,

PA, December 17, 1982: "Physiology of Micturition". 19. Invited Discussion, Coordinating Council, American Urological Association, Palm Beach,

FL, January 18, 1983: "Role of Urodynamics in Urologic Education". 20. Invited Faculty, Subject Oriented Seminar, Sponsored by American Urological

Association, Denver, CO, February 2-4, 1983. Presentations: "Physiology of Micturition", "Incontinence Related to Outlet Obstruction", "Post-Prostatectomy Incontinence", "Retropubic Vesicourethral Suspension Procedures".

21. Visiting Professor, University of Cincinnati, February 20-21, 1983. Case Presentation and

Discussion: "Male Sexual Function and Dysfunction". 22. Invited Lecturer, Cincinnati Urologic Society, February 20, 1983: Pharmacologic

Management of Voiding Dysfunction". 23. Invited Faculty, Regional Subject Oriented Seminar, American Urological Association Inc.,

New Orleans, LA, March 10-1 2, 1982: "Pathophysiology of Female Incontinence", "Urethral Syndrome", "Urinary Retention", “Vesicovaginal Fistula - Abdominal Repair", "Omentoplasty", "Urologic Evaluation - Summary".

24. Invited Faculty, Postgraduate Seminar, Mid-Atlantic Section, American Urological

Association , Philadelphia, PA, March 19-20, 1983: "Physiology of Micturition", "Evaluation and Treatment of Neurogenic Bladder Dysfunction".

25. Invited Faculty, Annual Urology Seminar, University of Missouri, Kansas City, MO, March

21-22, 1983: "Evaluation of Male Sexual Dysfunction", Pathophysiology of Female Incontinence", "Classification and Evaluation of Voiding Dysfunction", "Management of Neurogenic Bladder Dysfunction".

26. Visiting Professor, New York Section, American Urological Association, Inc., New York,

NY, April 6, 1983. Invited Judge, Resident Prize Essay Contest. Guest Lecture: "Evaluation of Pharmacologic Agents for the Treatment of Voiding Dysfunction".


160

27. Invited Faculty, Course on Female Urinary Incontinence, Case-Western Reserve

University, Cleveland, OH, April 9, 1983: "Pathophysiology of Female Incontinence", "Pharmacological Management".

28. Chairman, Program Committee, Urodynamics Society, Annual Meeting, Las Vegas, NE,

April 16, 1983. 29. Sole Faculty Member, Instructional Course, Pharmacological Management of Voiding

Dysfunction, American Urological Association, Inc., Annual Meeting, Las Vegas, NE, April 17-21, 1983.

30. Faculty Member, Course on Practical Aspects of Neurogenic Vesical Dysfunction,

American Urological Association, Inc., Annual Meeting, Las Vegas, NE, April 17-21, 1983. 31. Moderator, Session on Urodynamics and Urethra, American Urological Association, Inc.,

Annual Meeting, Las Vegas, NE, April 17-21, 1983. 32. Invited Presentation, American Urological Association, Inc., Annual Meeting, Las Vegas,

NE, April 17-21, 1983: "Impotence Evaluation, How We Do It". 33. Presentations (with Robert M. Levin and Philip M. Hanno), American Urological

Association, Inc., Annual Meeting, Las Vegas, NE, April 17-21, 1983:

a) "Anticholinergic and Musculotropic Effects of Desmethylimipramine". b) A Comparison of the Pharmacological Properties of an In-Vitro, Whole-Bladder

Preparation (Rabbit) with Those of Isolated Smooth Muscle Strips". c) "The Functional Response of the Rabbit Urinary Bladder to Anoxia" d) "Prevention of Klebsiella Adherence to Bladder Mucosa by Local Heparin

Administration". 34. Invited Faculty, Postgraduate Course in Urology, Cook County Graduate School of

Medicine, Chicago, IL, April 30, 1983: "Voiding Function and Dysfunction". 35. Visiting Professor, University of Arkansas School of Medicine, Little Rock, AR, May 5-6,

198 3. 36. Annual Urology Lecture, Arkansas Medical Society, Fayetteville, AR, May 7, 1983: "Male

Sexual Function and Dysfunction". 37. Invited Faculty, Urologic Problems of Aging, Beth Israel Medical Center, New York, NY,

May 11, 1983: "Pharmacologic Management of Voiding Dysfunction", "The Effect of Drugs on Sexual Function".

38. Invited Faculty, Junior Fellows Postgraduate Course, American College of Obstetrics and

Gynecology, Boston, MA, May 14, 1983: "Pathophysiology of Incontinence", "Drug Treatment of Incontinence".


161

39. Invited Lecturer, Travenol Sponsored Seminars on Difficult Problems in Urology, Philadelphia, PA, June 1, 1983: "Pitfalls of Urodynamics".

40. Course Director, Seminar on Urodynamics, Sponsored by Life Tech, Inc., Philadelphia,

PA., June 11-12, 1983. 41. Invited Faculty, Basic Sciences Course, Sponsored by American Urological Association,

Inc., Charlottesville, VA, June 15, 1983: "Neurophysiology and Neuropharmacology of the Lower Urinary Tract", "Evaluation and Management of Voiding Dysfunction".

42. Invited Course Director, Urodynamics Seminar, Sponsored by MEC Corporation, Palm

Beach, FL, June 17-18, 1983. 43. Invited Professor, Annual Outing, Wayne State University School of Medicine, Detroit, MI,

June 24-26, 1983.


162

ACADEMIC ACTIVITIES - 1983-84 1. Course Director, Urology Core Curriculum, School of Medicine. 2. Lecturer, Urology Course: "Genitourinary Cancer I", "Genitourinary Cancer II", "Voiding

Function and Dysfunction", "Sexual Function and Dysfunction", "Bladder Outlet Obstruction" Repeated six times yearly.


of Medicine, April 1984. 5. Presentation (with Robert M. Levin), Combined Meeting, International Continence Society

Urodynamics Society, Aachen, Germany, August 30 to September 3, 1983: "Metabolic and Contractile Effects of Bladder Outlet Obstruction".

6. Invited Chairman, Session on Neuropharmacology, Combined Meeting, International

Continence Society-Urodynamics Society, Aachen, Germany, August 30 to September 3, 1983. 7. Invited Faculty, "Super Seminar", Sponsored by American Urological Association, Inc., Norfolk,

VA, September 16-17, 1983: "Anatomy and Physiology of Micturition", "Urodynamics", "Classification of Voiding Dysfunction", Pharmacologic Treatment of Voiding Dysfunction".

8. Presentation, American Association for Surgery of Trauma, Chicago, IL, September 28-30,

1983: "Evaluation and Management of Erectile Failure After Pelvic Trauma". 9. Invited Moderator, Session on Endourology, Annual Meeting, Mid-Atlantic Section, American

Urological Association, Inc., Hot Springs, VA, October 2-4, 1983. 10. Invited Faculty, Seminar on Problems of Aging, Sponsored by the Department of Physical

Medicine and Rehabilitation, University of Pennsylvania School of Medicine, Philadelphia, PA, October 12, 1983: "Bladder Function in the Elderly".

11. Invited Faculty, Postgraduate Course on Incontinence, American College of Surgeons, Atlanta,

Georgia, October 16-21, 1983: "Anatomy and Physiology of Continence". 12. Invited Presentation, Annual Meeting, Society of University Urologists, Atlanta, GA, October 20-

21, 1983: "How Does Urodynamics Integrate into a University Urologic Program?" 13. Invited Faculty, Allied Yearly Seminar, Florida Chapter, American Urological Association, Inc.,

Jacksonville, FL, October 22, 1983: "Evaluation and Management of Male Sexual Dysfunction", "Pathophysiology of Female Incontinence".

14. Visiting Professor, Kimbrough Urological Seminar (Society of Government Service Urologists),

San Francisco, CA, November 6-10, 1983: "Overview of Micturition As It Relates to Evaluation, Classification and Treatment of Voiding Dysfunction", "Urodynamics, The Basics", "Pharmacologic Management of Voiding Dysfunction", "Pathophysiology of Female Incontinence". Judge, Resident's Prize Essay Contest.

15. Invited Lecturer, Annual Meeting, Society of Pelvic Surgeons, Philadelphia, PA, November 18,

1983: "The Use of the Omentum in Genitourinary Reconstructive Surgery".


163

16. Visiting Professor, University of California at Los Angeles, December 5-9, 1983: "Physiology of

Micturition - Overview and Clinical Correlations", "Pitfalls of Urodynamics", "Pharmacologic Management of Voiding Dysfunction - Which Drugs Really Work?", "Use of the Omentum in Reconstructive Surgery" (Surgical Grand Rounds). Rounds, operative cases.

17. Invited Faculty, Office Urodynamics Course, Sponsored by Medical Engineering Corporation,

New York, NY, December 16, 1983: "Overview of Urodynamics: Cystometry, Combined Studies, Urethral Profilometry".

18. Visiting Professor, Countway Rounds, Combined Harvard Programs in Urology, Boston, MA,

January 14, 1984: "Neurophysiology and Neuropharmacology of the Lower Urinary Tract". 19. Invited Faculty, Houston Everett Memorial Course in Gynecologic Urology, Johns Hopkins

Hospital, Baltimore, MD, February 11, 1984: "Pharmacology of Incontinence", "Urodynamics". 20. Visiting Professor, Oregon Health Sciences University, March 1-3, 1984: "Physiology of the

Lower Urinary Tract", "Pathophysiology of Female Urinary Incontinence and Its Correction". Operative cases.

21. Invited Lecturer, Course on Testis Cancer, Sponsored by Division of Surgical Nursing, School

of Nursing, University of Pennsylvania, Philadelphia, PA, March 7, 1984: "Surgical Aspects of Carcinoma of the Testis".

22. Faculty, Postgraduate Course on Adult and Pediatric Urology, University of South Carolina

School of Medicine, Charleston, SC, March 16-17, 1984: "Urodynamics for the Practicing Urologist", "Drug Treatment of Voiding Dysfunction".

23. Invited Faculty, Postgraduate Course in Urology, Cook County Graduate School of Medicine,

Chicago, IL, April 7, 1984: "Physiology of Micturition", "Evaluation and Management of Voiding Dysfunction".

24. Invited Faculty, Course on Voiding Dysfunction in Neurologic Disease, American Academy of

Neurology, Boston, MA, April 8, 1984: "Neurophysiology of Micturition". 25. Invited Lecturer, Annual Meeting, Urodynamics Society, New Orleans, LA, May 5, "Drug

Treatment of Bladder Hyperactivity/Sensory Urgency: Where Are We?" 26. Invited Lecturer, Urodynamics Society Program (within AUA Meeting), New Orleans, LA, May 7,

1984- "Detrusor Hyperactivity: Etiology, Differential Diagnosis, Evaluation". 27. Sole Faculty Member, Postgraduate Course on Pharmacologic Manipulation of Lower Urinary

Tract Dysfunction, Annual Meeting, American Urological Association, Inc., New Orleans, LA, May 7, 1984.

28. Faculty Member, Postgraduate Course on Neurogenic Bladder Dysfunction, Annual Meeting,

American Urological Association, Inc., New Orleans, LA, May 7, 1984. 29. Invited Moderator, Session on Urodynamics and Urethra, Annual Meeting, American Urological

Association, Inc., New Orleans, LA, May 8, 1984. 30. Presentations, Annual Meeting, American Urological Association, Inc., New Orleans, LA, May

5-10, 1984:


164

a) Effects of Chronic Partial Obstruction of the Rabbit Bladder (with Robert Levin and Janice High).The Effect of Diltiazem on the Function and Kinetics of the In-Vitro Whole Rabbit Bladder (with S. Bruce Malkowicz, Robert Levin and Kate Brendler).

b) Effect of Bilateral Decentralization on Urinary Bladder Function (with S. Bruce Malkowicz, Robert Levin, Drs. Atta and Ahmad Elbadawi).

c) Superficial Transitional Cell Carcinoma of the Bladder Treated with Neodymium-YAG d) Laser: A Study of Recurrence Rate Within the First Year (with Terrence Malloy). e) Percutaneous Management of Complications of Endourology (with Keith Van Arsdalen,

Marc Banner and Howard Pollack). f) Pathogenesis of Neurogenic Bladder Dysfunction After Spinal Cord Injury (with Robert

Levin and Keith Van Arsdalen). 31. Invited Presentation, Urologic Research Society Meeting, Durham, NC, May 11-12, "The Effects

of Five Tricyclic Antidepressant Compounds on the Rabbit Urinary Bladder". 32. Invited Faculty, Course on Basic Sciences, in Urology, New York University, New York, NY,

May 19, 1984: "Micturition Physiology", "Urodynamics", "Neurogenic Bladder", "Uropharmacology".

33. Invited Faculty, Course on Gynecologic Urology, Sponsored by Medical College of Virginia, Hot

Springs, VA, May 25-28, 1984: "Physiology of Voiding", "Evaluation of Voiding Problems", "Suprapubic Repair of Vesicovaginal Fistula", "A Urologist Looks at Stress Incontinence".

34. Invited Faculty, Postgraduate Course in Urology, Sponsored by Northwestern University,

Chicago, IL, June 8-9, 1984: "Urgency and Urgency Incontinence", "Continence Mechanisms" "Marshall-Marchetti Repair".

35. Invited Faculty, Course in Basic Science for Residents, Sponsored by American Urological

Association, Inc., Charlottesville, VA, June 11-15, 1984: "Physiology and Pharmacology of the Lower Urinary Tract", "Urodynamics", "Classification of Voiding Dysfunction".

36. Invited Lecturer, Pennsylvania Urological Association, Philadelphia, PA, June 17, "Urodynamics

for the Practicing Urologist". 37. Invited Faculty, Course on Urodynamics, Sponsored by Beth Israel Medical Center, New York,

NY, June 22-23, 1984: "Neurophysiology and Neuropharmacology of the Lower Urinary Tract". Case discussions.

38. Visiting Professor, Long Island Jewish Medical Center, Long Island, NY, June 28,

"Genitourinary Pharmacology". Case presentations.


165

ACADEMIC ACTIVITIES - 1984-85 1. Course Director, Urology Core Curriculum, School of Medicine. 2. Lecturer, Urology Course: "Genitourinary Cancer I", "Genitourinary Cancer II, "Voiding

Function and Dysfunction", "Sexual Function and Dysfunction", "Bladder Outlet Obstruction" Repeated six times yearly.

3. "Genitourinary Cancer", Lecture Series, ID 212, School of Medicine, December 1984. 4. "Emergency Room Urology", Lecture Series, ID 302, Emergency Medical Care Course,

School of Medicine, April 1985. 5. Invited Lecturer, Annual Meeting, Spinal Cord Society, Minneapolis, MN, August 22-25, 1984:

"Drug Treatment of Voiding Dysfunction in Spinal Cord Injury Patients". 6. Presentations, International Continence Society Meeting, Innsbruck, Austria, September 1 3-

16, 1984: "Effect of Tricyclic Antidepressants on the Rabbit Urinary Bladder", "The Effects of Short-Term Obstruction on the Rabbit Urinary Bladder" (both with Dr. Robert Levin).

7. Invited Chairman, Session on Research, International Continence Society, Innsbruck, Austria,

September 13-16, 1984. 8. Chairman, Postgraduate Course for Urology, Annual Meeting, American College of Surgeons,

San Francisco, CA, October 23, 1984. 9. Moderator, Postgraduate Course on Erectile Dysfunction, Annual Meeting, American College

of Surgeons, San Francisco, CA, October 23, 1984. 10. Moderator, Postgraduate Course on Controversies in Urologic Oncology, Annual Meeting,

American College of Surgeons, San Francisco, CA, October 24, 1984. 11. Presentation, Urologic Investigator's Forum, Nassau, Bahamas, November 7-10, "Effect of

Diltiazem on Rabbit Urinary Bladder Function". 12. Invited Lecturer, Surgical Grand Rounds, University of Pennsylvania School of Medicine,

January 10, 1985: "Urologic Trauma". 13. Invited Lecturer, Seminar on Voiding Dysfunction and Incontinence, Kaiser Foundation, Los

Angeles, CA, January 25, 1985: "Pathophysiology of Female Incontinence", "Pharmacologic Treatment of Lower Urinary Tract Dysfunction", Case Discussions.

14. Invited Faculty, Seminar on Sexual Dysfunction, Sponsored by American Urological Association, Tampa, FL, February 21-23, 1985: "Physiology of Male Sexual Function", "Nocturnal Penile Tumescence", "Electrostimulation in the Treatment of Sexual Dysfunction "Pharmacologic Management of of Erectile Dysfunction", Case Discussions. Moderator, Breakfast Summary Session.

15. Presentation, Annual Meeting, American Association of Genitourinary Surgeons, San Diego,

CA, March 6-9, 1985: "The Effect of Imipramine on Human Bladder Smooth Muscle".


166

16. Invited Faculty, Seminar on Female Urology, Sponsored by American Urological Association, Boston, MA, March 28-30, 1985: "The Urethral Syndrome", "Urodynamic and Neurologic Evaluation of Incontinence in the Female", "Pathophysiology of Female Incontinence", "Sling Procedure", Case Discussions and Workshop.

17. Visiting Professor, Seminar on Incontinence, Sponsored by State University of New York at

Buffalo, NY, April 13, 1985: "Physiology and Pharmacology of Micturition", "Medical and Surgical Management of Incontinence".


Chicago, IL, April 23, 1985: "Physiology and Pharmacology of the Lower Urinary Tract", "Urodynamics", "Classification of Voiding Dysfunction", "Treatment of Voiding Dysfunction".

19. American Urological Association Research Think Tank, Mt. Kisco, NY, April 26-28, 1 985. 20. Invited Lecturer, Course on Basic Sciences in Urology, New York University, New York, NY,

April 27, 1985: "Physiology of Micturition", "Pharmacology and Lower Urinary Tract Dysfunction".

21. Invited Lecturer, Neurourology Postgraduate Course, American Academy of Neurology,

Dallas, TX, April 29, 1985: "Physiology and Pathophysiology of Micturition", Case Discussion. 22. Invited Presentation, Annual Meeting, Urodynamics Society, Atlanta, GA, May 11,

"Pharmacologic Basis for Treatment of Outlet Obstruction". 23. Sole Faculty, Course on Pharmacologic Treatment of Voiding Dysfunction, Annual Meeting,

American Urological Association, Atlanta, GA, May 5-9, 1985. 24. Invited Moderator, Session on Urodynamics, Annual Meeting, American Urological

Association, Atlanta, GA, May 5-9, 1985. 25. Presentations, Annual Meeting, American Urological Association, Atlanta, GA, May 5-9, 1985:

a) Pharmacologic Management of Bladder Outlet Obstruction. b) Beta-adrenergic Stimulation of Cyclic AMP in the Rabbit Urinary Bladder (with Robert

Levin and Joseph Hypolite) c) Recovery from One Week Chronic Obstruction of the Rabbit Urinary Bladder (with

Robert Levin, S. Bruce Malkowicz, Dr. Atta, and Ahmad Elbadawi). d) Reversible Neuromuscular Changes in the Rabbit Detrusor Following One Week of

Outlet Obstruction (with Dr. Atta, Ahmad Elbadawi, Robert Levin, S. Bruce Malkowicz) e) Renal Preservation Utilizing the Neodymium-YAG Laser (with Terrence Malloy, Roger

Schultz, Victor Carpiniello). f) Rectal Electrostimulation of Erection in Macaca Fascicularis Primates (with Robert

Levin, Mr. Clayton, Mark Singer, Drs. Strong, Brenman and Katz). g) Invited discusser of Tuesday's highlights.

26. Co-director, Course on Lasers in Urology, Division of Urology, University of Pennsylvania,

May 31 to June 2, 1985. 27. Visiting Professor, Urology Grand Rounds, Temple University School of Medicine, June 3,

1985: "Physiology of Micturition", "Evaluation of Voiding Dysfunction".


167

28. Invited Faculty, Basic Sciences in Urology, American Urological Association, Charlottesville VA, June 12, 1985: "Physiology and Pharmacology of the Lower Urinary Tract", "Urodynamics”, "Neurogenic Bladder Dysfunction".


168

ACADEMIC ACTIVITIES - 1985-1986 1. Course Director, Urology Core Curriculum, School of Medicine. 2. Lecturer, Urology Core Course: "Genitourinary Cancer I"; "Genitourinary Cancer II"; Voiding

Function and Dysfunction"; "Sexual Function and Dysfunction"; "Bladder Outlet Obstruction". Repeated six times yearly.


of Medicine, April 1986. 5. Course Director, American Urological Association Subject Oriented Seminar: Voiding

Dysfunction, Orlando, FL, July 24-27, 1985. Formal presentations: "Physiology of Micturition"; "Urodynamics - Overview"; "Pharmacologic Management of Voiding Dysfunction: Which Drugs Really Work?"; "Detrusor Hyperactivity: Etiology and Evaluation".

6. Invited Lecturer, Eli Lilly Company, Indianapolis, IN, August 14-15, 1985: "Evaluation and

Management of Benign Prostatic Hypertrophy"; "Non-hormonal Pharmacologic Management of Erectile Dysfunction".

7. Invited Session Chairman, Session on Basic Research, International Continence Society,

London, September 4-7, 1985. 8. Presentation, International Continence Society, London, September 4-7, 1985: "Response of

the Bladder to Outlet Obstruction". 9. Invited Faculty, Regional Subject Oriented Session on Female Urology, American Urological

Association, San Antonio, TX, September 26-28, 1985. Formal presentations: "Pathophysiology of Female Continence"; “Vesicovaginal Fistula Repair: Abdominal Approach".

10. Program Chairman, Mid-Atlantic Section Meeting, American Urological Association,

Philadelphia, PA October 3-6, 1985. 11. Presentations Mid-Atlantic Section Meeting (See #10):

a) Acute functional alterations in the partially obstructed rabbit urinary bladder (with Bruce Malkowicz and Robert Levin).

b) Detection of the hypercalcemic hormone of malignancy in an adreno cortical carcinoma (with Steven Orland, Andrew Stewart and Virginia LiVoisi).

c) Reliability of the AMS M700 Inflatable Penile Prosthesis (with Terrence Malloy and Victor Carpiniello).

d) MPPS - a new technique for the diagnosis of occult condyloma acuminatum (with Burton Schlecker, Victor Carpiniello, Thomas Sedlacek and Terrence Malloy).

e) Moderator, Session on Urethral Stricture, Erectile Dysfunction, Voiding Dysfunction, Miscellaneous.

12. Visiting Professor, University of Wisconsin, Madison, WI, October 24-26, 1985: "Physiology of

Micturition", Pharmacologic Treatment of Voiding Dysfunction"; Case presentations, surgical cases.


169

13. Presentation, Society of Pelvic Surgeons annual meeting, Key Biscayne, FL, November 1 3-16, 1985: "Intracorporal Pharmacotherapy for Erectile Dysfunction".

14. Invited Presentations, Milano Medicina, Milan Italy, November 27-29, 1985: "Voiding Disorders

Induced by Drugs in the Elderly", "Drug Treatment of Bladder Outlet Obstruction". 15. Visiting Professor, University of Padua, Padua, Italy, November 30-December 2, 1985:

"Physiology of Erectile Dysfunction", Drug Treatment for Voiding Dysfunction", Case presentations, rounds.

16. Invited Lecturer, Medical College of Pennsylvania, Philadelphia, PA, February 11, 1986, Tumor

Rounds: "Cancer of the Prostate". 17. Invited Chairman, Session on Evaluation and Treatment of Organogenic Erectile Dysfunction,

Society for Sex Therapy and Research (SSTAR), March 8, 1986, Philadelphia, PA. 18. Invited Lecturer, American Society of Psychosomatic Obstetrics and Gynecology, Philadelphia,

PA, April 3, 1986: "Intracavernosal Pharmacotherapy in the Evaluation and Treatment of Male Sexual Dysfunction".

19. Invited Lecturer, Postgraduate Seminar, New England Section, American Urological

Association , Boston, MA, April 11-1 3, 1986: "Physiology of Renal, Pelvic and Ureteral Transport", "Physiology of Micturition", "Effective Uropharmacology".

20. Presentations, Urologic Investigators Forum, Tucson, AZ, April 13-16, 1986: "A Critical Look at

the Results of Non-hormonal Drug Treatment of Voiding Dysfunction Secondary to Benign Prostatic Hypertrophy", "Functional Effects of Purinergic Innervation of Rabbit Urinary Bladder".


Chicago, IL, April 19, 1986: "Physiology of Micturition", "Neurogenic Bladder Dysfunction". 22. Invited Presentations, American Academy of Neurology, New Orleans, LA, May 2-3, "Urinary

Incontinence: Pathophysiology, Classification and Evaluation", "Physiology of Erectile Function; Erectile Dysfunction in Neurologic Disease; Evaluation of Erectile Dysfunction".

23. Organizer and Host, Society of University Urology Residents, Annual Meeting, Split Rock

Lodge, Lake Harmony, PA, May 14-16, 1986. 24. Moderator, Session on Renal Tumors, Society of University Urology Residents Annual Meeting

(See #23). 25. Invited Presentation, "Pharmacologic Therapy of the Denervated/Decentralized Bladder and

Urethra”, Urodynamics Society Annual Meeting, May 17, 1986, New York City. 26. Sole Faculty Member, Course on Pharmacologic Treatment of Lower Urinary Tract Function,

American Urological Association Annual Meeting, May 18-22, 1986, New York City. 27. Invited Moderator, Session on Neurogenic Bladder, Incontinence. American Urological

Association Annual Meeting, May 18-22, 1986, New York City.


170

28. Presentations, American Urological Association Annual Meeting, May 18-22, 1986, New York City

a) Relationship between spontaneous activity and urinary,bladder function (with Robert

Levin, Satish Velagapudi, David Gordon). b) Functional effects of purinergic innervation of the rabbit bladder (with Michael Ruggieri). c) Functional effects of in-vitro obstruction of the rabbit urinary bladder (with Robert Levin,

S. Bruce Malkowicz). d) Comparison of calcium antagonist properties of antispasmodic agents (with Robert

Levin and S. Bruce Malkowicz). 29. Invited Presentations, Urologic Research Society Meeting, New York City, May 22-24, 1986.

a) What's new in neuropharmacology and neuroreceptors. b) Spontaneous activity of the bladder - does it exist? c) Calcium antagonist properties of lmipramine in-vitro.

30. Invited Lecturer, Basic Science Course, American Urological Association, Charlottesville, VA,

June 6-13, 1986: "Physiology of Micturition, Urodynamics, Uropharmacology". 31. Invited Presentations, Urologic Association of Pennsylvania Annual Meeting, Philadelphia, PA,

June 20-22,1986: "Alternatives to Penile Prosthesis", "Problem Cases in Urologic Oncology". 32. Invited Faculty, Harvard Course on Female Urinary Incontinence, sponsored by Massachusett

General Hospital, Boston, MA, June 26-27, 1986.

a) Anatomy and physiology of micturition. b) Pathophysiology of urinary incontinence in the female. c) Surgical injury to the urinary tract. d) Transabdominal repair of vesicovaginal fistula.


171

ACADEMIC ACTIVITIES - 1986-1987 1. Course Director, Urology Core Course, (in Surgery Core Course), School of Medicine. 2. Lecturer, ME I 00 Basic Science Clinical Bridge Course, School of Medicine. 3. Organizing Chairman, NIH sponsored symposium on interstitial cystitis, 1986-1987. 4. Invited Faculty, Seminar on Erectile Dysfunction sponsored by American Urological

Association, Inc., San Diego, CA, September 11-13, 1986. Presentations: a) "Erectile Physiology: Current Concepts" b) "Status of Nocturnal Penile Tumescence Testing Today" c) "Intracorporal Injections for Erectile Dysfunction" d) "Diagnostic Testing - Current Status, Where Are We Going?" e) Moderator, Summary Session on Treatment

5. Invited Presentations, combined meeting of Urodynamics Society/international Continence

Society, Boston, MA, September 17-20, 1986. Ad Hoc Meeting on Interstitial Cystitis, Boston University, Boston, MA, September 16, 1986. Presentations: a) "Interstitial Cystitis - What We Know, What We Think We Know, and What We Don't

Know" b) "Muscarinic Receptor Subtypes in Human and Rabbit Urinary Bladder" (with Drs.

Ruggieri, Levin and Bode) c) "Studies on the Biphasic Nature of Urinary Bladder Contraction" (with Dr. Levin) d) "Dynamic Measurement of NADH Fluoroscence in the Rabbit Urinary Bladder" (with

Drs. Levin, Hypolite and Ruggier!) e) Invited Moderator, Session on Clinical Pharmacology

6. Invited Faculty, Advances in Neurourology sponsored by University of California at San

Francisco, San Francisco, CA, October 10-1 1, 1986. Invited presentations: a) "Neurotransmitters and Bladder Function" b) "Urodynamics - How Much Do We Need?" c) "Drug Treatment of Voiding Dysfunction" d) Moderator, session on "Difficult Problems of Voiding Dysfunction"

7. American College of Surgeons, New Orleans, LA, October 19-23, 1986. Invited Faculty,

Obstetrics and Gynecology Postgraduate Course on Urologic Aspects of Gynecologic Practice and Surgery. Moderator, session on urinary incontinence. Presentation: "The Urethral Syndrome". Invited presentation, Surgical Forum, "Spontaneous Activity and Urinary Bladder Function" (with Drs. Levin and Ruggieri).

8. Invited lecturer, Neurology Grand Rounds, University of Pennsylvania, November 6, 1986.

"Approach to the Patient with Neuropathic Voiding Dysfunction". 9. Invited discussion, Society of Pelvic Surgeons, Newport Beach, CA, November 12-15, 1986.

"Chronic Bacterial Prostatitis: Role of Transurethral Prostatectomy and Therapy". 10. Invited Professor, Cleveland Urological Society, Northeastern Ohio University College of

Medicine, Cleveland and Akron, OH, November 20-21, 1986. Presentations: a) "Current Update of the Physiology of Erectile Function" b) "Intracorporeal Pharmacotherapy for the Treatment of Erectile Function" c) "Practical Urodynamics"


172

d) "Pharmacologic Management of Voiding Dysfunction" e) "Pathophysiology of Urinary Incontinence in the Female" f) "Surgical Correction of Stress Incontinence in the Female" g) Case presentations and discussions.

11. Invited Faculty, Seminar on Female Urology, American Urological Association, Inc., Atlanta,

GA, December 12-14, 1986. Presentations: a) Organic Retention: Etiology and Treatment b) Detrusor Instability: Etiology, Diagnosis, Medical Management c) Abdominal Procedures for Stress Incontinence d) Case Presentations and Discussions

12. Invited Faculty, University of Miami Postgraduate Seminar, Miami, FL, January 21-25, 1987.

a) Intracorporeal Injection for Evaluation and Management for Erectile Dysfunction b) Pharmacologic Management of the Abnormal Bladder in Children c) Physiology of Erection

13. Guest Examiner, American Board of Urology, Oral Examinations, Kansas City, KS, January 30-

February 1, 1987. 14. John Meyer Visiting Professor, Yale University, Section of Urology, New Haven, CT, March 9-

10, 1987. Case discussions, surgery, lectures, "Surgical Correction of Female Incontinence", "Erectile Physiology - Current Concepts"; "Use of Pharmacologic Intracorporeal Therapy for Erectile Dysfunction".

15. Invited Lecturer, Obstetrical Society of Philadelphia, Annual Residents' Course, "Urodynamics

in the Evaluation of Female Incontinence", March 12, 1987. 16. Ad Hoc Meeting on Criteria to Diagnose Interstitial Cystitis, National Institutes of Health, March

18, 1987. 17. Organizational Meeting, National Kidney and Urologic Diseases Advisory Board, Alexandria,

VA, March 18-19, 1987. 18. Invited Lectures. American Urological Association Allied, Issues and Answers in Urology;

"Etiology and Evaluation of Incontinence in the Female"; "Physiology of Erection"; "Intracorporeal Injection for Erectile Failure". Philadelphia, PA, March 27-28, 1987.

19. Invited Lectures. Cook County Postgraduate Course in Urology; "Physiology of Micturition";

"Evaluation and Management of Neurogenic Bladder". Chicago, IL, March 28, 1987. 20. Faculty Member, American Urological Association, Inc. Course on Erectile Dysfunction,

"Physiology of Erection"; "Nocturnal Penile Tumescence"; "Pharmacologic Erection as Treatment for Erectile Dysfunction"; "Diagnoses: Where We've Been, Where We're Going". Toronto, Canada, April 3-5, 1987.

21. Presentation, American Association of Genitourinary Surgeons, "Physiologic Plasticity of Ileal

Smooth Muscle Utilized to Augment Bladder". Bermuda, April 9-12, 1987. 22. Invited moderator, session on Basic Science, Symposium on Female Incontinence,

Urodynamics Society Annual Meeting, Anaheim, CA, May 16, 1987.


173

23. Invited moderator, poster session on Bladder Physiology and Pharmacology, American Urological Association Annual Meeting, Anaheim, CA, May 17-21, 1987.

24. Invited principal speaker, session on Urodynamics, American Urological Association Allied

Annual Meeting, Anaheim, CA, May 16-18, 1987, "The Role of the Allied Health Professional in Urodynamic Testing."

25. Poster presentation (with Dr. Gill), American Urological Association Annual Meeting, Anaheim,

CA, May 17-21, 1987, "The Effect of Chronic lschemia on Urinary Bladder Function". 26. Motion picture presentation (with Drs. Malloy and Carpiniello), American Urological Association

Annual Meeting, Anaheim, CA, May 17-21, 1987. "Transsexual Surgery - Male to Female - A Seventeen Year Experience".

27. Course Director, "Pharmacologic Treatment of Lower Urinary Tract Dysfunction", American

Urological Association Annual Meeting, Anaheim, CA, May 17-21, 1987. 28. Course Director, "Practical Urodynamics", American Urological Association Annual Meeting,

Anaheim, CA, May 17-21, 1987. 29. Invited Lecture, Delaware Valley Geriatric Education Center, University of Pennsylvania,

"Physiology of the Bladder", Philadelphia, PA, June 2, 1987. 30. Invited Lecture, American Urological Association, Basic Science Course, Charlottesville, VA,

June 6-13, 1987. "Physiology of Micturition", "Urodynamics", "Neurogenic Voiding Dysfunction", "Uropharmacology".

31. Faculty Member, Course on Female Urology, Humana Hospitals, San Antonio, TX, June 12-13,

1987. "Urethral Diverticulum", "Detrusor Instability", "Urethral Syndrome and Interstitial Cystitis", "Abdominal Repair of Stress Incontinence".


174

ACADEMIC ACTIVITIES - 1987-1988

1. Course Director, Urology 200 and 300 Course (Surgery).

2. Examination Committee, American Urological Association, Inc., Houston, TX, July 16-18, 1987. 3. Invited lecture, Merck Sharp and Dhome Masters in Urology Conference, Toronto, Canada,

August 1-2, 1987. "Physiology of Erection", "Intracavernosal Pharmacotherapy for Erectile Dysfunction.

4. Chairman, NIH Symposium on Interstitial Cystitis, Bethesda, MD, August 28-29, 1987. 5. Invited Presentation, NIH Symposium on Interstitial Cystitis, Bethesda, MD, August 28-29,

1987. "Drug Therapy for Bladder Storage Abnormalities". 6. International Continence Society, Presentations at annual meeting, Bristol, England, September

2-5, 1987. a) "Gas Cystometry", Invited Discussion b) "Altered Pharmacologic Properties of Cystoplastic Ileum" (Scientific session) (with Drs.

Levin and Gill). c) "Muscarinic Receptor Subtypes in Human and Animal Bladder" (Scientific session) (with

Drs. Levin and Ruggier!) 7. Presentation Urology Grand Rounds, University of Pennsylvania, September 18, 1987.

"Physiology of Micturition", "Urodynamics". 8. NKUDAB Meeting (National Kidney and Urology Diseases Advisory Board), Bethesda, MD,

October 5-6, 1987. 9. Invited Moderator Session on Male Sexual Dysfunction, Annual meeting Mid-Atlantic Section

American Urologic Association, Inc., Hot Springs, VA, October 4-7, 1987. 10. Invited Lecture, Annual Meeting Interstitial Cystitis Association, Los Angeles, CA, October 3,

1987. "Interstitial Cystitis: Definition, Resolved and Unresolved Issues". 11. Invited Faculty, Course on Incontinence. American College of Surgeons Annual meeting, San

Francisco, CA, October 11-15, 1987. 12. Presentation, Surgical Forum, American College of Surgeons, San Francisco, CA, October 11-

15, 1987. "The Effect of Chronic Atropine Administration on Muscarinic Receptor Density in the Rat Bladder", "Receptor Subtypes in the Rabbit and Human Urinary Bladder" (with Drs.Levin and Ruggieri).

13. Invited Presentation, Society of University Urologists Annual meeting, San Francisco, CA,

October 15-16, 1987. "Resident Selection: The Pre-Interview Process". 14. Visiting Professor, Brown University, Providence, RI, November 2-3, 1987. "Drug Treatment of

Voiding Dysfunction", "Practical Urodynamics", "Neuropathic Voiding Dysfunction". Case presentations and discussions.

15. Course Co-Director, Lasers in Urologic Surgery, Pennsylvania Hospital, Philadelphia, PA,

November 13-14, 1987.


175

16. NKUDAB Meeting, Washington, DC, November 30, 1987. 17. Examination Committee, American Urological Association, Inc., Key Largo, FL, January 10-13,

1988. 18. Vail Urology Conference, Vail, CO, February 14-17, 1988. Invited Presentations: "Physiology of

Erection", "Pharmacologic lntracavernosal Therapy", "Surgical Treatment of Stress Incontinence in the Female", "Urethral Syndrome and Interstitial Cystitis", "Pharmacologic Management of Voiding Dysfunction".

19. Incontinence Seminar, Marion Laboratories (Sponsor), Fort Lauderdale, FL, March 3-5, 1988.

Invited Presentations: "Definition and Classification of Incontinence", "Drug Treatment of Incontinence", Moderator (2 sessions).

20. Invited Lecturer, Philadelphia Chapter of College of Obstetrics and Gynecology, Residents'

Course, Philadelphia, PA, March 10, 1988. "Urodynamics in the Diagnosis of Incontinence". 21. NKUDAB Meeting, Los Angeles, CA, March 18-19, 1988. 22. Visiting Lecturer, ICI Pharmaceuticals, Inc., Wilmington, DE, March 28, 1988. "Pharmacology

of the Lower Urinary Tract", "Treatment of Urinary Incontinence", "Further Developments in the Treatment of Urinary Incontinence".

23. Visiting Professor, Ohio State University, Guest Speaker, Ohio Urologic Association, Columbus,

Ohio, April 8-9, 1988. Presentations: "Practical Urodynamics", "Surgical Treatment of Female Stress Incontinence", Case presentations and discussions.

24. Visiting Professor, Baylor University, Guest Speaker, Houston Urologic Society, Houston, TX,

April 10-12, 1988. Presentations: "Urethral Syndrome and Interstitial Cystitis", "Drug Treatment of Voiding Dysfunction", Case discussions, operative demonstration.

25. Invited Presentation, American Association of Genitourinary Surgeons, Annual Meeting, Sea

Island, GA, April 20-23, 1988. "Functional and Pharmacological Effects of Urinary Diversion". 26. Invited Presentation, National Kidney Foundation Science Writers News Briefing, Washington,

D.C., April 26, 1988. "New Developments in the Treatment of Incontinence and Other Voiding Disorders".

27. Invited Faculty, Mid-Atlantic Section Seminar, May 13-15, 1988, Washington, D.C. Moderator

and Discussor, section on Bladder Dysfunction Lecture "Trauma to the Bladder and Urethra". 28. Scientific Committee Meeting, International Continence Society, Oslo, Norway, May 17-19,

1988. 29. Urodynamics Society Meeting, AUA Annual Meeting, Boston, MA, June 1-7, 1988.

a) Urodynamics Society Executive Committee meeting (President and Chair). b) Urodynamics Society Meeting; Moderator, session on Afferent and Efferent Valve

Mechanisms in Augmentation and Substitution Cystoplasty. Chair, Business Meeting. c) Report from the National Kidney Urologic Diseases Advisory Board delivered to main

body of AUA meeting.


176

d) AUA Research Committee Meeting. e) Moderator, session on Bladder Physiology and Voiding Dysfunction. f) Presentations:

i) Report of the National Kidney and Urologic Diseases Advisory Board. ii) Magnetic Image Resonance Imagining and Staging of Clinically Localized

Prostate Cancer (with Drs. Altman, Pollack, Schiebler, Tomaszewski, Kressel). iii) Effect of Acute Obstruction on the Rabbit Urinary Bladder (with Drs. Kitada

and Levin) iv) Dissociation of the Metabolic from the Contractile Response to Muscarinic

Stimulation in the Rabbit Urinary Bladder (with Drs. Ruggieri, Hypolite and Levin).

v) Effect of lschemia on Rabbit Urinary Bladder Function (with Drs. Lin and Levin).

vi) Functional and Biochemical Alterations in Rabbit Urinary Bladder Following Ileocystoplasty (with Drs. Gill, Ruggieri, Levin and Whitmore)

vii) The Functional Effect of Mild Outlet Obstruction on the Rabbit Urinary Bladder (with Drs. Kato and Levin).

g) Ad Hoc Meeting of the Interstitial Cystitis Association Subcommittee Chair, Ethicon

Advisory Panel Meeting i) Course Director, Postgraduate Course on "Practical Urodynamics"

Presentations at Urodynamics Course ii) Introduction, Principles of Urodynamics, "The Rules" iii) Filling and Voiding Cystometry; Pressure Flow Studies iv) The Role of Urodynamics in Defining Bladder Outlet Obstruction (BPH, Smooth

and Striated Sphincter Dyssynergia, Low Pressure Low Flow)

h) Neurourology and Urodynamics Editorial Board Meeting (Associate Editor) Ad Hoc Meeting of small committee to organize follow up meeting on Interstitial

Cystitis (Drs. Hanno, Parsons, Striker, Rodgers, Nyberg) Invited state-of-the-art lecture: Neuropharmacology of the Lower Urinary Tract

Presentation: Long Term Follow Up of Initial Pharmacologic Treatment of Erectile Dysfunction (with Drs. Hanno and Fletcher) Presentation: The Use of a Serosal Elastic Lamina in the Sudy of Fibrotic Responses of the Bladder Wall in Specific Pathological Models (with Drs. Monson and Levin)

i) Program Committee Meeting Sole Faculty Member, Instructional Course on

"Pharmacological Manipulation of Lower Urinary Tract Dysfunction" Presentation: Mechanical Stability of the AMS M700 CX Inflatable Penile Prosthesis Cylinders (with Drs. Malloy and Carpiniello)

30. Invited Lectures, AUA Basic Science Seminar, Charlottesville, VA, June 22, 1988. "Physiology

and Pharmacology of the Lower Urinary Tract", "Evaluation and Management of Voiding Dysfunction".

31. NKUDAB Hearing Panel, Chicago, IL, June 23, 1988. 32. NKUDAB Meeting, Washington, D.C., June 24-25, 1988.


177


1. Course Director, Urology 200 and 300 (Surgery).

2. Invited Faculty, AUA Postgraduate Seminar on Female Urology, Seattle, WA, July 8-10, 1988. "Anatomy and Physiology of the Female Lower Urinary Tract", "Stress Incontinence - Treatment Guidelines and Norr--Surgical Treatment", "Urethral syndrome and Interstitial Cystitis", Case Discussions.

3. AUA Examination Committee Meeting, July 15-16, 1988, Charlottesville, VA.

4. International Continence Society Meeting, Oslo, Norway, Aug. 31-Sept. 3, 1988. Invited Co-Chairman, session on experimental pharmacology; presentation: "The Effect of Contractile Activity and Electrical Stimulation on Muscarinic Receptor Density and the Response to Muscarinic Agonists", co-author, "Intravesical Instillation of Antispasmodic Agents", "Experimental Models of Reflex Contractile Activity on Rabbits".

5. Surgical Grand Rounds, University of Pennsylvania, invited presentation, "Urological Trauma".

6. AUA Update Series Board Meeting, Montreal, Canada, Sept. 16-17, 1988.

7. International Continence Society Annual Meeting, invited co-chairman, session on basic pharmacology. Reappointed to Scientific Committee. Presentations (3) with Drs. Levin, Kato, Gill, Oslo, Norway, Aug. 31-Sept. 3, 1988.

8. Visiting Professor, New York Section Annual Meeting, American Urological Association. Invited lectures on "New Concepts in Voiding Function and Neuropharmacologic Treatment of Voiding Dysfunction", "Interstitial Cystitis" (as honorary Bard lecturer), panel discussion on urodynamics and voiding dysfunction. Amsterdam, Sept. 25-Oct. 1, 1988.

9. Invited presentation, "Pharmacologic Managements, Consensus Conference on Urinary Incontinence, sponsored by National Institutes of Health, Bethesda, MD, Oct. 3-4, 1988.

10. Invited Discussion, Society of Pelvic Surgeons Annual Meeting, "The Artificial Genitourinary Sphincter in the Treatment of Post-Radical Prostatectomy Incontinence", Montreal, Canada, Oct. 6-8, 1988.

11. Visiting Professor, University of Iowa and Iowa State Urologic Society. Presentations: "Physiology of Micturition", "Pharmacologic Management of Voiding Dysfunction" (Honorary David Culp Lecture), "The University of Pennsylvania Experience with the Mitrofanoff Continent Diversion"; Case Presentations. Iowa City, IA, Oct. 13-15, 1988.

12. Invited Lecturer, Pittsburgh Urologic Society, "Practical Urodynamics", Pittsburgh, PA, Oct. 24, 1988.

13. Invited Faculty, Postgraduate Assembly, Endocrine Society Clinical Workshop on Evaluation and Management of Impotence, Philadelphia, PA, Oct. 30, 1988.

14. Robert A. Garrett Visiting Professor, University of Indiana. Presentations: "Physiology of Micturition", "Practical Urodynamics in the Evaluation of Voiding Dysfunction", "Classification of Voiding Dysfunction", "Management of Voiding Dysfunction", "Voiding Dysfunction Associated with Specific Types of Neurologic Disease or Injury: Characterization, Evaluation and Management", "Pathophysiology of Female Urinary Incontinence", "Evaluation and Management of Female Urinary Incontinence", "Urethral Syndrome and Interstitial Cystitis". Case presentations and discussions, Nov. 2-4, 1988.


178

15. NKUDAB Steering Committee Meeting, Chicago, IL, Nov. 7, 1988.

16. Co-Organizer and Faculty, University of Pennsylvania Annual Meeting on Use of the Laser in Urology, Philadelphia, PA, Nov. 18-19, 1988.

14. Ad Hoc Committee on Interstitial Cystitis (NIH) Meeting, Bethesda, MD, Nov. 22, 1988.

15. Invited Lecturer, Philadelphia Urologic Society Seminar for General Medical Physicians. "Non-Surgical Management of Incontinence", Philadelphia, PA, Dec. 3, 1988.

16. Visiting Professor, Duke University, Durham, NC. Case discussions, presentations (Drug Treatment of Voiding Dysfunction), Dec. 5-6, 1988.

17. Invited Lecturer, Interstitial Cystitis Association, "Current Status of IC", Philadelphia, PA, Dec. 15, 1988.

18. American Urological Association Examination Committee, Chairman Task Force A, semi-annual meeting, Captiva Island, FL, January 15-18, 1989.

19. Minicourse in Neurourology, Part 1, "Physiology of Micturition", "Evaluation of Voiding Dysfunction", "Classification of Voiding Dysfunction", Philadelphia, PA January 28, 1989.

20. Minicourse in Neurourology, Part 11, "Treatment of Voiding Dysfunction - Non-Surgical and Surgical", "Neurogenic Voiding Dysfunction - Lesions and Types of Dysfunctions", Philadelphia, PA, February 11, 1989.

21. NKUDAB Steering Committee meeting, February 16-17, 1989, Washington, DC.

22. Invited Faculty Member, American Urological Association Regional Subject Oriented Seminar on Female Urology, Philadelphia, PA, March 10-1 2, 1989. "Physiology of Micturition and Continence", "Urethral Syndrome and Interstitial Cystitis", Moderator, session on Surgical Treatment.

23. American Urological Association Editorial Board meeting, Tucson, AZ, March 12-13, 1989.

24. Invited Presentation, American Association of Genitourinary Surgeons annual meeting, Tucson, AZ, March 15-18, 1989. "MRI Surface Coil Imaging in Prostate Cancer" (with Howard Pollack presenting), invited discussion "Metabolic Abnormalities Associated with Bowel Interposition in the Urinary Tract".

25. NKUDAB Board meeting, Linconshire, IL, March 30-31, 1989.

26. Minicourse in Neurourology Part III, "Evaluation and Management of Urinary Incontinence", "Painful Bladder and Interstitial Cystitis", Philadelphia, PA, April 8, 1989.

27. Clinical Society of Genitourinary Surgeons annual meeting, New York City, NY, April 12-14, 1989. "What's New in Urology at the University of Pennsylvania".

28. Invited Faculty, Course on Incontinence in the Female, Graduate Hospital, Philadelphia, PA, April 15, 1989, "Drug Treatment of Incontinence".

29. Urodynamics Society Meeting and AUA Annual Meeting, Dallas, TX, May 5-10, 1989 a) Urodynamics Society Executive Committee meeting (immediate past President). b) Urodynamics Society meeting; Co-chair of session on Mechanisms and Measurement of

Detrusor Contractility. Invited presentation on "Pharmacological Treatment of Prostatic Hypertrophy and

Obstruction".


179

c) Report from the National Kidney and Urologic Diseases Advisory Board delivered to main body of AUA meeting.

AUA Research Committee Meeting. Neurourology and Urodynamics Editorial Board Meeting (Associate Editor). Chair, Meeting of Female Urology and Urodynamics Committee of the AUA. International Journal of Impotence Research Editorial Board Meeting (Associate Editor).

d) Meeting of Associate Editors of Investigative Section of Journal of Urology (Associate

Editor). e) Invited panel member for discussion: Non-Surgical Treatment of Benign Prostatic

Hypertrophy (The Role of Alpha Adrenergic Blockade). f) Course Director, Postgraduate Course on "Practical Urodynamics" g) Presentations at Urodynamics Course:

i) Introduction: The "Rules" ii) Cystometry: Filling and Voiding; Pressure Flow Studies

Prostatism, Smooth Sphincter Dyssynergia, Neurogenic Bladder and Non Neurogenic Bladder, Low Pressure, Low Flow

h) Meeting of Editorial Board, Survey Section, Journal of Urology (Associate Editor).

h) American Urological Association Program Committee Meeting. Invited Lecture, Pharmacotherapy of Lower Urinary Tract, American Urological Association Allied Meeting.

i) Co-moderator Poster Session, "Bladder Physiology and Pharmacology" Presentations: "The Functional Effect of Long-Term Outlet Obstruction on the Rabbit Urinary Bladder" with Drs. Kato and Levin.

ii) "Correlation of Bladder Contraction with Calcium Fluorescence Using FURA-2" with Drs. Hypolite, Ruggieri, Levin.

iii) "Pharmacology of Subtotal Cystectomy (Rabbits) with Drs. Lin, Kato, Monson, Levin.

Meeting of National Kidney Foundation Council on Urology 30. Invited Faculty, Urogynecology and Pelvic Surgery Course sponsored by Medical College of

Virginia, Williamsburg, VA, May 26-29, 1989. "Physiology of the Lower Urinary Tract", "Urodynamics of the Emptying Phase of Micturition", "Urethral Syndrome and Interstitial Cystitis", Sling Procedures".

31. Invited Faculty, American Urological Association Basic Sciences Course in Urology,

Charlottesville, VA, June 6-7 (2-9), 1989. "Physiology and Pharmacology of the Lower Urinary Tract", "Evaluation and Management of Voiding Dysfunction".

32. NKUDAB Board Meeting, Bethesda, MD, June 22-23, 1989.


180


1. Course Director, Urology 300 (Surgery). 2. Urological Research Society, annual meeting, June 29-July 2, 1989, Palm Beach, FL.

Meeting Chairperson (President). Presentations: a) Energetics of Bladder Contraction (with Drs. R. Levin, N. Haugaard) b) Transurethral Ultrasonic Aspiration of the Prostate (with Drs. T. c) Malloy, V. Carpiniello) d) Clonal Selection of Metastatic Variants in Transitional Cell Carcinoma by

Adaptation to Protein Free Media (with Drs. S. Bruce Malkowicz, e) Herlyn) f) Moderator, session on Upper and Lower Urinary Tract Dysfunction

3. Invited Faculty, Aging Today and Tomorrow (Summer Institute Program at the University

of Pennsylvania), July 11, 1989. "Pathophysiology and Surgical Treatment of Urinary Incontinence in the Elderly".

4. Visiting Professor University of Colorado School of Medicine, Invited Lecture Rocky

Mountain Urologic Society, Denver, CO, July 27-28, 1989. "Drug Treatment of Voiding Dysfunction", "Surgical Treatment of Urinary Incontinence in the Female".

5. Visiting Professor, University of Texas, Dallas Southwestern, September 11-12, 1989. "A

Logical Approach to the Evaluation and Management of Voiding Dysfunction", "Neurophysiology and Neuropharmacology of the Lower Urinary Tract". Case presentations and discussions.

6. Invited Presentation, Neurology Grand Rounds, University of Pennsylvania, September

28, 1989. "Neurogenic Voiding Dysfunction: Pathophysiology, Evaluation, Treatment". 7. American College of Surgeons Meeting.

8. Society of University Urologists Meeting. Atlanta, GA, October 16-20, 1989.

a) Surgical Forum presentation (with Drs. Robert Levin, Penelope Longhurst) "Correlation of intracellular Free Calcium with the Metabolic Response of the Rabbit Urinary Bladder to Bethanechol” (10-16-89).

b) Invited Speaker, Postgraduate Course in Urologic Surgery. "The Diagnosis of Outlet Obstruction" (10-18-89).

c) Education Council of the American Urological Association Meeting, Consultant (10-18-89).

d) Research Committee of the American Urological Association Meeting, Member (I 0-18-89).

e) Measurement Protocol Committee American Urological Association. Prospective Study on Prostatectomy and Other Forms of Treatment for Obstructive BPH (10-19-89).

f) Session Chairman and Panel Moderator, Society of University Urologists Annual Meeting. "Impact of New Technology and Other Specialties on Urology Faculty Income" (10-20-89).


181

9. Invited Faculty, Female and Reconstructive Urology, University of South Florida,

Department of Surgery, Tampa, FL, October 20-21, 1989. "Urinary Retention: Organic vs. Psychogenic", "Medical Management of Female Incontinence", Abdominal Suspension Procedures for Stress Incontinence".

10. Invited Discussion, Society of Pelvic Surgeons Annual Meeting, November 2-4, 1989, Tampa, FL. "Bladder Function and the Ureteral Pump".

11. NKUDAB Meeting and Steering Committee Meeting, Phoenix, AZ, November 19-21, 1989.

12. Invited Speaker, Atlanta Urologic Society, Atlanta, GA, January 25, 1990. "Surgical Management of Female Sphincter Incontinence".

13. Visiting Professor, University of Florida School of Medicine and Invited Speaker, Selected Topic in Urology, Gainesville, FL, February 16, 1990. "Pharmacologic Management of Voiding Dysfunction", "Urethral Syndrome and Interstitial Cystitis", Case reports and discussions.

14. American Board of Urology Meeting. Examiner, Part II ABU Qualifying Examination, Detroit, MI, February 22-25, 1990.

15. Invited Faculty, Seminar on Female Urology, American Urological Association, St. Louis, MO, March 9-10, 1990. "Urethral Syndrome and Interstitial Cystitis", "Diagnosis and Drug Therapy of Urge Incontinence", "Abdominal Repair of Vesicovaginal fistula", "Drug Treatment of Sphincter Incontinence", Case presentations and discussions.

16. Visiting Professor, Medical College of Ohio (Toledo) and Visiting Lecturer, Northwest Ohio Urologic Society, Toledo, OH, March 14-15, 1990. "Evaluation and Surgical Management of Female Sphincter Incontinence", "Neurogenic Bladder: Types, Evaluation, Management", Case presentations and discussions.

17. Invited Speaker, Pharmacotherapy of Urge Incontinence sponsored by Forest Laboratories, Miami, FL, March 17, 1990. "Drug Treatment: Pharmacology of the Agents Utilized".

18. Urodynamics Society, Interstitial Cystitis-NIH Symposium, American Urological Association Annual Meeting, New Orleans, LA, May 1 1-1 7, 1990.

Courses: 1. Director: Practical Urodynamics Faculty: Difficult Problems in Urodynamics Presentations: URODYNAMICS SOCIETY

a) Effect of Distention on Bladder Structure and Function (with Drs. Monson, McKenna, Levin).

b) Morphologic Characterization of a Feline Model of Chronic Progressive Bladder Outlet Obstruction (with Drs. Miller, Regnier, Radzinski, Levin, McGuire, Elbadawi).

c) Physiological Studies on Experimental lleocystoplasty in the Rabbit (with Drs. Gill, Whitmore, Levin).


182

INTERSTITIAL CYSTITIS NIH SYMPOSIUM

d) Invited Lecture: Neuropharmacology of the Bladder as it Relates to Interstitial Cystitis.

INTERSTITIAL CYSTITIS ASSOCIATION: e) Invited NIH Lecture: "The Treatment of Interstitial Cystitis - an Overview"

OTHERS f) Bladder Outlet Obstruction Treated with Transurethral Ultrasonic Aspiration: One

Year Followup on 59 Patients (with Drs. Malloy, Carpiniello, Payne). g) Creative Kinase Activity of Normal and Diabetic Rat Bladders (with Drs. Levin,

Longhurst, Haugaard). h) Studies of Malate Dehydrogenase Activity of Bladder and Skeletal Muscle from

Normal and Diabetic Rats (with Drs. Haugaard, Chun, Longhurst, Levin). i) Identification of Secreted Proteins Induced by Severe Outlet Obstruction of the

Rabbit Urinary Bladder (with Drs. Monson, Zhou, Levin, Teuscher). j) Effect of Substrate Deprivation on the Response of the Rabbit Bladder to Field

Stimulation (with Drs. Haugaard, Hypolite, Levin). k) Ontogeny of Bladder Compliance (with Drs. Zderic, Snyder, Levin, Duckett). l) Comparative Length-Tension Relationship of Hamster, Rat, Guinea Pig, Rabbit

and Cat Urinary Bladder Strips (with Drs. Longhurst, Kang, Levin). m) Results of Conservative Therapy for Interstitial Cystitis (with Drs. Hanno,

Crawford). n) KTP/532 Laser Ablation of Urethral Strictures (with Drs.Malloy,Turek,Cendron,

Carpiniello). o) Selection of Invasive Transitional Cell Carcinoma Variants by Adaptation to

Growth Factor Deprived Serum Free Medium (with Drs. Malkowicz, Herlyn). MODERATOR (invited): Session on Bladder Physiology and Pharmacology. 19. Invited Lecture: Basic Science Course in Urology, American Urological Association,

Charlottesville, VA, June 6, 1990. "Physiology and Pharmacology of the Lower Urinary Tract", "Evaluation, Classification, and Treatment of Voiding Dysfunction".

20. Invited Lecturer: Urodynamics, Voiding Dysfunction and Incontinence: Update 1990;

sponsored by University of Miami School of Medicine and the Paralyzed Veterans Association of Florida, Miami Beach, FL, June 16-17, 1990. "Clinical Uropharmacology of the Lower Urinary Tract", "Practical Urodynamics", Workshop Breakout Groups.

21. Panel Moderator and Participant, Urinary Incontinence, Educational Tape. Sponsored by

Schering Corporation (Advances in Urology, via Scientific Medical Programs), Fort Lauderdale, FL, June 15, 1990.

22. Lifetime TV, Program on Urinary Incontinence. Invited Participant. New York, NY, June

29, 1990.


183


1. Course Director, Urology 300 (Surgery). 2. Invited Faculty, "Physiology of the Lower Urinary Tract", American Urological Association Basic

Research Conference, Houston, TX, July 13-14, 1990. "Animal Models and Methods of Drug Assessment for Lower Urinary Tract"; Session Moderator and Synopsis Formulation.

3. American Board of Urology Meeting, Santa Fe, NM (Board Member) July 28-August 3, 1990. 4. Consultant for Urinary Continence Program, Center for Diseases Control, Atlanta, GA, August

27, 1990. 5. Invited Lecture, Interstitial Cystitis Association of Pennsylvania. "Current Status of Treatment of

Interstitial Cystitis". Hospital of the University of Pennsylvania, Philadelphia, PA, September 5, 1990.

6. Presentations, International Continence Society, Aarhus, Denmark, September 12-15, 1990.

"Correlation Between Contractile Force and Metabolism in the Rabbit Urinary Bladder" (with Drs. Haugaard, Hypolite and Levin), "Developmental Factors in the Contractile Response to Bethanechol: Role of Calcium Translocation" (with Drs. Levin, Zderic, Duckett and Hypolite), "Preliminary Investigation of Rabbit Urinary Bladder Hypertrophy Using 3-H Thymodine and Radioautography (with Drs. Monson, Levin and Ms. McKenna).

7. Invited Participant, Pharmacologic Treatment of Urinary Incontinence: Theory and Practice,

Sept. 16-17, 1990, Monate, Italy (sponsored by the Recordati Co.). "Animal Models of Urinary Bladder Function" (with Drs. Levin and Longhurst), "Incontinence: Qualitative and Quantitative Measurements; Base Line Evaluation; Evaluation of Response to Therapy".

8. Planning Committee, Symposium on Advances in the Treatment and Management of

Incontinence. Invited Speaker "Evaluation of Incontinence: Guidelines for Treatment", October 1-2, 1990,Philadelphia, PA

9. Visiting Professor, University of Massachusetts Medical Center, Worcester, MA, October 11-12, 1990. Medical Grand Rounds "Pharmacologic Management of Voiding Dysfunction", Case discussions and teaching rounds. Invited Speaker, Countway Rounds, Harvard Program in Urology, Boston, MA, October 13, 1990. "Neurophysiology and Neuropharmacology of the Lower Urinary Tract--- Clinical Correlations".

10. Invited Moderator, Session on Rectal Cancer and the Urethra, Society of Pelvic Surgeons

Annual Meeting, Charleston, SC, November 8-10, 1990. 11. Chairman, first meeting of the Bladder Health Council of the American Foundation for Urologic

Diseases, Baltimore, MD, January 12, 1991. 12. Visiting Professor, Division of Urology, University of Missouri School of Medicine at Columbia,

MO, January 24-25, 1991. Lecture: "Urodynamic Evaluation of Voiding Dysfunction", "Classification of Voiding Dysfunction", "Neurogenic Bladder: Correlation of Urodynamic and Neurologic Findings", "Pharmacologic Treatment of Voiding Dysfunction", "Surgical Treatment of Voiding Dysfunction", and "Surgical Treatment of Sphincteric Urinary Incontinence in the Female". Case presentations and discussions.

13. Minicourse in Neurourology, University of Pennsylvania School of Medicine, Sole Faculty

Member (9 hours), January 19, February 2, March 2, 1991.


184

14. American Board of Urology: Board Meetings and Trustee Examiner, Part II of Certification

Exam, Dearborn, MI, Feb. 14-17, 1991. 15. Clinical Society of Genitourinary Surgeons, Annual Meeting, Durham, NC, Feb. 21-23, 1991. 16. Lecture, Neurosurgical Grand Rounds, Hospital of the University of Pennsylvania.

"Neurological Voiding Dysfunction", Feb. 28, 1991. 17. Visiting Professor, Cleveland Clinic Department of Urology, Cleveland, OH, March 5-6, 1991.

Lectures on urinary incontinence, urethral syndrome and interstitial cystitis; case discussions of various oncologic and non-oncologic topics; discussions of research papers presented by resident and attending staff.

18. Invited Faculty Member, Cleveland Clinic course on Advances in Urology, March 7, 1991.

Lectures on "Neurologic Disease and Voiding Dysfunction" and "Suspension and Sling Procedures for Urinary Incontinence", Cleveland, OH.

19. Invited honored guest and honorary Ballenger lecturer, Southeastern Section of American

Urological Association, Inc., Atlanta, GA, March 9-12, 1991. Lectures on "Evaluation and Management of Voiding Dysfunction" and "Interstitial Cystitis".

20. Organizer and Moderator, short course on "Current Status of Treatment of Benign and

Malignant Prostatic Diseases", University of Pennsylvania School of Medicine, March 17, 1991. 21. Annual meeting American Association of Genitourinary Surgeons, April 3-6, 1991. Invited

presentation, "The Ovalbumin Sensitized Guinea Pig: A Possible Model for IC". 22. Visiting Professor, University of Utah, Salt Lake City, UT, Fister Memorial Lecture, April 18-19,

1991. "Practical Urodynamics", Correlation of Neurologic Disease with Voiding Dysfunction", case discussions, presentations.

23. Invited Visiting Professor UCLA Division of Urology, Los Angeles, CA, May 9-1 1, 1991.

Lectures: "Approach to the Management of Voiding Dysfunction", "Pharmacologic Management of Voiding Dysfunction", "Practical Urodynamics", "Evaluation of Treatment Response in BPH". Surgeries and case conferences.

24. Invited Visiting Professor, 21st Annual Obstetrics and Gynecology Postgraduate Teaching Day,

State University of New York Health Science Center, Syracuse, NY, May 31, 1991. "Urodynamic Evaluation of Female Incontinence", "Pharmacologic Management of Incontinence in the Female".

25. Urodynamics Society meeting and American Urological Association annual meeting, Toronto,

Canada, May 31-June 6, 1991.

a) Urodynamics Society Executive Committee meeting. b) Urodynamics Society Symposium c) AUA Continuing Education Committee. d) Society of Urologic Oncology Scientific Program

e) Symposium participant, sponsored by Co-Med/Forest Laboratories/Bard, "Pharmacotherapy for Detrusor Instability".

f) Editorial Board Meeting, Neurourology and Urodynamics (Associate Editor).


185

g) Chair, Meeting of Female Urology Committee of the AUA. h) AFUD/AUA Research Committee meeting. i) AUA Education Council meeting. j) Moderator Poster Session on Voiding Dysfunction, Interstitial Cystitis. k) Meeting of Editorial Board of Investigative Section of Journal of Urology (Associate

Editor). l) Invited Presentation, Urodynamics Society Forum, "Pathophysiology of BPH". m) Meeting of Editorial Board, Survey Section, Journal of Urology (Associate Editor). n) Course Director, Postgraduate Course on "Practical Urodynamics" Presentations at

Urodynamics Course: 1. Introduction: The "Rules", o) Cystometry: Filling and Voiding; Pressure Flow Studies, 3. Prostatism, p) Smooth Sphincter Dyssynergia, Neurogenic Bladder and Non-Neurogenic q) Bladder, Low Pressure, Low Flow. r) Meeting of Bladder Health Council. s) Interview for Urology Times. t) Moderator of Panel Discussion, Biomedical Engineering Forum.

PRESENTATIONS:

u) Malate dehydrogenase, citrate synthase and creatine kinase activities of homogenates of normal and obstructed rabbit bladders with N.Haugaard, L. Potter, S. Levin, R. Levin.

v) The effects of pregnancy on rabbit urinary bladder physiology with S. Zderic, J. Plzak, J. Duckett, H. Snyder, R. Levin.

w) The ability of insulin treatment to reverse or prevent the changes in urinary bladder function caused by streptozotocin-induced diabetes mellitus with P. Longhurst, J. Kauer, R. Levin.

x) Effects of sensitization on female guinea pig urinary bladder function: in-vivo and in-vitro studies with Y. Kim, P. Longhurst, R. Levin.

y) Preliminary comparisons of DNA, RNA and protein biosynthesis in partially obstructed rabbit urinary bladder using biochemical and radioautographic methods with F. Monson, B. McKenna, R. Levin.

26. Meeting of Residency Review Committee of Accreditation Council for Graduate Medical

Education, June 21, 1991, Chicago, IL. 27. Invited Faculty Member, American Urological Association Basic Science Course,

Charlottesville, VA, June 26, 1991. "Neurophysiology and Neuropharmacology of the Lower Urinary Tract", "The Neurourologic Evaluation", "Classification of Voiding Dysfunction", "Voiding Dysfunction as a Consequence of Neurologic Disease", "Pharmacologic Management of Voiding Dysfunction".


186

ACADEMIC ACTIVITIES - 1991-1992 1. Course Director, Urology 300 (Surgery). 2. Residency Review Committee for Urology, ABMS, Chicago, IL, June 20-21, 1991. 3. Visiting Professor, Second Annual Meeting of Study Group for Frequency and Incontinence of

the Elderly, Tokyo, Japan, June 29-July 6, 1991. Lecture/seminar on "Treatment of Neurogenic Incontinence in the Elderly" given in Tokyo, Fukuoka, Osaka, Kyoto, Nagoya, and Takasaki. Lecture meeting, "Management of Micturition Disturbances" Akita, Japan, July 5, 1991.

4. Invited lecturer, Urodynamics and Voiding Dysfunction Course sponsored by University of

Miami School of Medicine and Paralyzed Veterans of America, Miami Beach, FL, July 20-21, 1991. "Urodynamics and Incontinence in the Elderly", "Drug Treatment of Incontinence".

5. American Board of Urology (Trustee), Annual Meeting, Silverado, CA, August 6-1 1, 1991. 6. Invited lecturer, Interstitial Cystitis Association Annual Seminar, Washington, DC, September

14, 1991. "Non-Surgical Management of IC". 7. Invited faculty member and moderator, course on "Update on Female Urinary Incontinence".

American College of Surgeons meeting, Chicago, IL, October 20-25, 1991. "Evaluation and Diagnosis of Female Urinary Incontinence". Presentation (Dr. Malkowicz) at the Surgical Forum, "The Selection and Phenotypic Characterization of Invasive Variants of Transitional Cell Carcinoma".

8. Invited lecturer, twelfth annual meeting American UroGynecologic Society, the Marion Sims

Lecturer, Newport Beach, CA, October 23-26, 1991. "Pathophysiology and Pharmacology of Involuntary Bladder Contraction", "Urodynamics in the Evaluation of Voiding Dysfunction".

9. Visiting Professor, Department of Urology, University of California at San Diego, San Diego,

October 25-26, 1991, lectures and case discussions, "Practical Urodynamics", "Management of Voiding Dysfunction".

10. Invited formal discussant Society of Pelvic Surgeons meeting, Scottsdale, AZ, November 13-16,

1991. "Cystosarcoma Phyllodes of the Prostate". 11. Invited lecturer, AUAA National Multispecialty Nursing Conference on Urinary Incontinence,

Orlando, FL, November 16, 1991. "Pharmacologic Interventions for Urinary Incontinence". 12. Invited lecturer NIH/NIDDK sponsored Conference on Aging: The Quality of Life, Washington,

DC, February 12, 1992. "Urinary Incontinence and Aging". 13. American Board of Urology meeting, Board member and examiner, Dearborn, MI, February 12-

16, 1992. 14. Invited faculty, Tulane University course on Urinary Incontinence and Urodynamics, New

Orleans, LA, February 21-22, 1992. Lecture: "Physiology of the Lower Urinary Tract with Special Reference to Incontinence"; "Urodynamic Evaluation of Incontinence"; "Drug Treatment of Urinary Incontinence".

15. Residency Review Committee meeting, Chicago, IL, February 29, 1992 (member for Urology).


187

16. Invited faculty, Memorial Hospital Annual Urology Symposium, "Urinary Incontinence - Its

Diagnosis and Treatment", Fort Lauderdale, FL, March 6-8, 1992. "Physiology of Micturition", "Pathophysiology of Urinary Incontinence in the Female", "Surgical Correction of Female Urinary Stress Incontinence: Simple and Complicated".

17. Invited lecturer, Urology Symposium, Kaiser Permanente Medical Group, Los Angeles, CA,

March 14, 1992. "Practical Urodynamics", Drug Treatment of Lower Urinary Tract Dysfunction", "Management of Advanced Prostate Cancer", "Approaches to Stress Incontinence".

18. William P. Burpeau Award Recipient, Section of Urology, New Jersey Academy of Medicine;

Burpeau Lecture, "Practical Urodynamics". West Orange, NJ, April 15, 1992. 19. AUA Update Editorial Board meeting, Hot Springs, VA, April 20-22, 1992. 20. Annual Meeting, American Association of Genitourinary Surgeons, Hot Springs, VA, April 23-

25, 1992. Invited Discussion, "Endothelin and the Bladder", "Increased Collagen Type 3 and Elastin in the Neurogenic Non-Compliant Bladder".

21. Urodynamics Society meeting, American Urological Association annual meeting, Meeting of

Interstitial Cystitis Database Committee, Washington, DC, May 9, 1992. a) Meeting of Executive Committee, Urodynamics Society. b) Urodynamics Society Symposium. c) Invited speaker, Society of Pediatric Urology meeting, "Non-interventional Therapy". d) AUA Continuing Education Committee meeting. e) Society of Urologic Oncology Scientific Program. f) Meeting of Editorial Board, Survey Section, Journal of Urology, g) Associate Editor. h) Meeting of Editorial Board, Investigative Section, Journal of Urology, Associate Editor. i) Course Director, Postgraduate Course on "Practical Urodynamics". j) Presentations: "Introduction: The "Rules", "Cystometry: Filling and Voiding; Pressure

Flow Studies", "Prostatism, Smooth Sphincter Dyssynergia, Neurogenic Bladder and Neurogenic Bladder, Low Pressure, Low Flow".

k) Co-Moderator, Podium Session. Topic: "Bladder Physiology and Pharmacology". l) Moderator of Panel Discussion, Urodynamics Forum, "Pathophysiology and Evaluation". m) Chairman of meeting of Female Urology and Urodynamics Committee. n) Interstitial Cystitis Database Steering Committee meeting, National Institutes of Health.

PRESENTATIONS:

o) The time course of the effect of bladder pressure on renal blood flow and glomerular filtration rate in chronic outlet obstructed feline model with E. McGuire, J. Schnermann, J. Liu, S. Woodard, R. Levin, Elabadawi, L. Miller.

p) Parameters of Doppler penile sonography: a critical analysis with Broderick, P. Arger. q) Studies on experimental bladder outlet obstruction in the cat: longterm functional effects

with R. Levin, P. Longhurst, B. Barasha, McGuire, A. Elbadawi. r) The realtionship btween proximal renal tubular and bladder pressure with E. McGuire, J.

Schnermann, J. Liu, S. Woodard, R. Levin, A. Elbadawi, L. Miller. s) The characterization of rabbit bladder smooth muscle in culture and its response to

fibroblast growth factors with S. Malkowicz, W. Li, Sorger, R. Levin. t) Differential susceptibility of peak and plateau responses to calcium channel blocker and

calcium free medium in the rabbit urinary bladder with Y. Zhao, R. Levin.


188

u) Particulate silicone for use in periurethral injection: a study of local tissue effects and a search for migration with D. Henly, D. Barrett, A. Malizia.

22. 18th Annual Justin J. Cordonnier Visiting Professor, Washington University School of Medicine,

St. Louis, MO, June 11-12, 1992. Lectures on Interstitial Cystitis, Practical Urodynamics and Alternate Strategies for the Treatment of BPH.

23. Invited faculty member, AUA course on Basic Science in Urology, Charlottesville, VA, June 17,

1992. Entire Neurourology section (lower tract physiology and pharmacology, evaluation of voiding dysfunction, classification of voiding dysfunction, pharmacologic management of voiding dysfunction).

24. Invited speaker, Raleigh County Medical Society, Beckley, W VA, June 18, 1992. "Alternate

Strategies for the Treatment of BPH". 25. Residency Review Committee, semi-annual meeting, Washington, DC, June 25-26, 1992.


189

ACADEMIC ACTIVITIES - 1992-1993 1. Course Director, Urology 300 (Surgery). 2. Lecture, Urology Grands Rounds, University of Pennsylvania, "Alternate Methods of

Management of BPH". July 17, 1992. 3. American Board of Urology Annual Meeting (Trustee), San Diego, CA, July 18-23, 1992. 4. Lecture, Urology Grand Rounds, University of Pennsylvania, University of Pennsylvania,

"Urodynamic Evaluation of Voiding Dysfunction", "Correlation of Voiding Dysfunction with Neurological Disease", August 7, 1992.

5. Lecture, Urology Grand Rounds, University of Pennsylvania, "Pharmacologic Management of

Voiding Dysfunction", August 14, 1992. 6. American Urological Association AUA Update Editorial Board Meeting, Kuai, Hawaii, August 29-

31, 1992. 7. Invited Lecture, National Institutes of Health sponsored meeting; International symposium on

prostate growth, Bethesda, MD, September 11-12, 1992. "Correlation of Outflow Obstruction and Symptoms".

8. Invited American Foundation of Urologic Disease Lecture and invited guest, combined meeting

Northeastern and New England Sections, American Urological Association, Toronto, September 12-14, 1992. "Evaluation of Treatment Response in BPH".

9. Society of University Urologists and American College of Surgeons, annual meeting, New

Orleans, LA, October 15-16, 1992. 10. Invited lecture, Merck Company, Haddonfield, NJ, October 20, 1992. "Alternate treatment

Methods for BPH". 11. Visiting Professor, Beth Israel Hospital - Mt. Sinai School of Medicine, New York, NY,

November 5-6, 1992. "Practical Urodynamics", "Drug Treatment of Voiding Dysfunction", case discussions.

12. Course Director, "Non-Prosthetic Management of Erectile Dysfunction; Benign Prostatic

Hyperplasia Management", University of Pennsylvania, November 14, 1992. 13. Residency Review Committee for Urology meeting (Vice-Chairman), Longboat Key, FL.,

December 3-4, 1992. 14. Visiting Professor, Bowman Gray School of Medicine, Winston-Salem, NC, January 21-23,

1993. "Neurologic Disease and Voiding Dysfunction", "Practical Urodynamics", "Pathophysiology of Urinary Incontinence in the Female", case management and evaluation.


190

15. American Board of Urology (Trustee) meeting and Part I ABU exam administration, Dearborn, Ml, Feburary 24-28, 1993.

16. Clinical Society of Genitourinary Surgeons, annual meeting, New York, NY, March 11-14, 1993. 17. Interstitial Cystitis Database Steering Committee meeting (Chairman Steering Committee,

Principal Investigator, Penn Group), Washington, DC, March 26-27, 1993. 18. AUA Update Editorial Board meeting, Phoenix, AZ, April 13-14, 1993. 19. Invited speaker, Harvard Medical School course on "Urinary Incontinence in the Elderly -

Evaluation and Treatment for the Specialist". Wakefield, MA, May 8, 1993. "Pharmacologic Treatment of Urinary Incontinence in the Elderly".

20. Annual meeting of Urodynamics Society and American Urological Association, San Antonio,

TX, May 14-20, 1993.

a) Meeting of Executive Committee, Urodynamics Society. b) Urodynamics Society Symposium - "Common Shortcomings of Studies on Drug

Treatment of Voiding Dysfunction". c) Meeting of Editorial Board of Neurourology and Urodynamics. d) Course Director, Postgraduate Course on "Practical Urodynamics". e) Presentations: "Introduction: The "Rules"; "Cystometry: Filling and Voiding; Pressure

Flow Studies", "Prostatism, Smooth Sphincter Dyssynergia, Neurogenic Bladder and Neurogenic Bladder, Low Pressure, Low Flow".

f) Meeting of Editorial Board of Urology (Associate Editor). g) Meeting of Editorial Board, Investigative Section, Journal of Urology (Associate Editor). h) Co-moderator of Podium Session. Topic: Urinary Continence and Bladder Dysfunction.

PRESENTATIONS:

i) Visual laser assisted prostatectomy (VLAP) using Urolase right angle fiber: preliminary results with 60 watts protocol with J. Kabalin, Gill, G. Leach, K. Ganabathi, L. Sirls, R. Cowles, G. Broderick.

j) KTP-532 laser ablation of urethral strictures: long term response rates with D. Carbone, P. Turek, V. Carpiniello, T. Malloy.

k) Neurourological consequences of traumatic conus medullaris lesions with H. Wessells, G. Broderick, M. Perrigot.

l) Combined abdominal and vaginal approach for bladder neck closure and permanent suprapubic tube urinary diversion in the neurologically impaired female with J. Levy, J. Jacobs.

m) Effect of partial outlet obstruction of the male rabbit bladder on ryanodine binding with R. Levin, S. Levin, S. Zderic.

n) Comparative metabolism of bladder smooth muscle and mucosa with J. Hypolite, N. Haugaard, P. Longhurst, J. Briscoe, R. Levin.

o) Comparative studies on the contractile and relaxant responses to field stimulation in the urethra of the male and female rabbit with Lee, R. Levin.

p) Developmental aspects of excitation contraction coupling in rabbit urinary bladder smooth muscle with S. Zderic, U. Sillen, G. Liu, Snyder, J. Duckett, R. Levin.

q) Laparoscopic lymphadenectomy - Is a unilateral dissection adequate for staging prostate cancer? with K. Van Arsdalen, G. Broderick, Bruce Malkowicz.


191

r) A novel modification of the canine BPH model yielding partial outlet obstruction with G. Broderick, P. Juniewicz, R. Kaira, R. Levin.

s) Comparison study of transurethral ultrasonic aspiration versus transurethral resection of prostate for bladder obstruction with T. Malloy, Carpiniello.

21. Invited faculty, American Uralogical Association course on Basic Science in Urology,

Charlottesville, VA, June 16, 1993. "Physiology and Pharmacology of the Lower Urinary Tract", "The Neurourologic and Urodynamic Evaluation", "Classification of Voiding Dysfunction", "Correlation of Neurologic Disease with Voiding Dysfunction", "Pharmacologic Management of Voiding Dysfunction".

22. J. Hartwell Harrison Visiting Professor, Harvard Medical School, Boston, MA, June 17-19, 1993.

"Pharmacologic Management of Voiding Dysfunction", "Evaluation and Management of BPH - New Perspectives" (Countway Grand Rounds), operative demonstration, case management and evaluation.

23. Residency Review Commitee for Urology meeting (Vice Chairman), Washington, DC, June 24-

25, 1993. 24. Interstitial Cystitis Database Steering Committee meeting (Chairman and Principal Investigator,

Penn Group), Washington, DC, June 25-26, 1993.


192

ACADEMIC ACTIVITIES - 1993-1994 1. Course Director, Urology 300 (Surgery). 2. Course Director, regional subject oriented seminar (American Urological Association Office of

Education), San Francisco, CA, July 16-18, 1993. "Pathophysiology and Categorization of Voiding Dysfunction: A Simple System"; "Fluoroscopic Evaluation"; "Sphincteric Incontinence; Overview; Conservative Treatment, Retropubic Suspension Surgery"; "Urodynamics: Correlation of Neuropathology with Voiding Dysfunction; Sensory Disorders"; "Detrusor Incontinence Overview; Conservative Treatment"' "Watchful Waiting and Drug Therapy".

3. American Board of Urology meeting (Trustee), August 7-12, 1993, Newport, RI. 4. Lecture, Urology Grand Rounds, University of Pennsylvania, August 21-22, 1993. "Physiology

and Pharmacology of the Lower Urinary Tract"; "Pathophysiology of Voiding Dysfunction; Urodynamics; Evaluation of Voiding Dysfunction".

5. International Continence Society, annual meeting, September 8-11, 1993 Rome, Italy. 6. Mid-Atlantic Section American Urological Association annual meeting, September 19-22, 1993

Palm Beach, FL. Program Committee Chairman; Moderator, Session 1, Prostate Cancer. PRESENTATIONS:

a) Endorectal coil MRI staging for clinically localized prostate cancer: clinical/pathological correlation. R. Harkaway, J. Levy, S.B. Malkowicz, Tomaszewski, M. Schnall, A. Wein.

b) FDG-Positron emission tomography in genitourinary tumors. S.B. Malkowicz, A. Wein, A. Alavi.

c) Correlation of extravasation and irregularity in the postop VCUG with bladder neck contracture following radical prostatectomy. J. Levy, J.W. Berlin, P. Ramchandani, G. Broderick, A. Wein.

d) Loss of heterozygosity analysis of chromosome 9 in transitional cell carcinoma demonstrates two regions of deletion. S.B. Malkowicz, Pressler, J. Tomaszewski, A. Wein, V. Carpiniello, T. Malloy, Linnenbach.

e) Effectiveness of urine cytology in the diagnosis of transitional cell carcinoma. D. Carbone, A. Wein, S.B. Malkowicz.

7. Interstitial Cystitis Database Steering Committee meeting, October 7, 1993, Orlando, FL

(Chairperson). 8. Invited Lecture, Interstitial Cystitis Association, Annual Seminar, October 8-10, 1993, Orlando,

FL. "An Overview of Treatments for Interstitial Cystitis", panel discussion. 9. American Foundation of Urologic Diseases Research Committee, Scientific Study Section

meeting. Boston, MA, October 30, 1993. 10. Visiting Professor, Department of Urology, University of Miami School of Medicine, November

18-19, 1993, Miami, FL. Presentations: Practical Urodynamics; Correlation of Voiding Dysfunction with Neurologic Disesase. Case discussions.


193

11. Moderator and Faculty Member, Videoteleconference on Advances in the Management of Intrinsic Sphincter Deficiency, Chicago, IL, November 10, 1993 (Sponsored by C.R. Bard). Presentation: Pathophysiology of Urinary Incontinence; Moderator of program; case discussions and questions and answers.

12. Residency Review Committee in Urology, Semi-annual meeting (Vice Chairman), Naples, FL

December 2-3, 1993. 13. Invited faculty, regional subject oriented seminar, Pelvic Reconstruction and Voiding

Dysfunction, Washington, DC, March 4-6, 1994. Presentations: Pathophysiology of Female Voiding Dysfunction; Interstitial Cystitis; Detrusor Hyperactivity; Conservative Therapy of Sphincteric Incontinence; Abdominal Suspensions for Sphincteric Incontinence; Abdominal Repair of Vesicovaginal Fistula; The Use of the Omentum in Reconstructive Surgery. Faculty Breakout Sessions.

14. Host and organizer, Clinical Society of Genitourinary Surgeons annual meeting, March 10-12,

1994, Philadelphia, PA. 15. Co-chairperson 1994 Symposium on Women's Urological Health Research sponsored by the

Women's Urological Health Program NIDDK, NIH and the Office of Research on Women's Health, NIH. March 11-13, 1994, Bethesda, MD.

16. Editorial Board meeting, Campbell's Urology (7th edition), Columbus Isle, Bahamas, March 19-

26, 1994. 17. American Surgical Association, annual meeting, San Antonio, TX, April 7-9, 1994 (inductee). 18. Muscle Matrix and Bladder Function, meeting sponsored by Division of Urology, University of

Pennsylvania and Children's Hospital of Philadelphia, April 15-16, 1994. Planning Committee, Moderator, session on Bladder Outlet Obstruction, Overview (April 15).

19. Invited lecture, Collagen Injection Therapy for Urinary Incontinence. American Urological

Association Allied, Delaware Valley Chapter, Philadelphia, PA. April 21, 1994. 20. AUA Update Editorial Board meeting. Boca Raton, FL, April 25-27, 1994. 21. American Association of Genitourinary Surgeons annual meeting, Boca Raton, FL, April 28-May

1, 1994. Presentation: Acute and Chronic Effects of Ethanol on Corporal Cavernosal Function. 22. Annual meeting of Urodynamics Society and American Urological Association, San Francisco,

CA, May 13-18, 1994. a) Meeting of Executive Committee, Urodynamics Society Urodynamics b) Society Symposium - Neurogenic bladder c) International BPH Conference, Subcommittee for Evaluation of Clinical Trials in BPH,

Product Evaluator. d) Meeting, Editorial Board, Neurourology and Urodynamics e) Course Director, Postgraduate Course on Practical Urodynamics. Presentations;

Introduction: A Simple Way to Conceptualize Urodynamics; Simple-Minded but Useful Rules. Bladder and Urethral Pressures; Urethral Profilometry, 3 1/2 hour course.

f) Representative of Bladder Health Council at AFUD Board of Directors meeting. g) Meeting, Editorial Board, Urology.


194

h) Meeting, Editorial Board, Investigative Urology. i) Ad Hoc meeting, Interstitial Cystitis Database Steering Committee, Chairman. j) Annual luncheon, American Board of Urology k) Co-Moderator Poster Session, Bladder Physiology Research l) Meeting, Editorial Board, Investigative Urology (Associate Editor) m) Bladder Health Council meeting, Co-chairman n) NIDDK/AFUD Physician and Scientist Training Program in Urologic Research - Pilot

Program, Co-Chairman o) Meeting, Editorial Board, Campbell's Urology, 7th Edition.

PRESENTATIONS:

p) Visual laser assisted prostatectomy using Urolase right angle fiber: multicenter 60 watt protocol. G. Leach, R. Dmochowski, K. Ganabathi,Broderick, A. Wein, R. Cowles, J. Kabalin, H. Gill.

q) Combined hormone radiation therapy for lymph node positive adenocarcinoma of the prostate. R. Whittington, S. Malkowicz, G. Broderick, Barnes, A. Wein.

r) Patterns of seminal vesicle invasion in radical prostatectomy specimens and their association with clinical parameters. T. Cangiano, S. Malkowicz, A. Wein, J. Tomaszewski.

s) Effects of the peptide leukotriene receptor antagonist ICI 198, 615 on the in vivo and in vitro changes in guinea pig bladder function which occur after sensitization with ovalbumin. J. Lee, R. Levin, Wein, P. Longhurst.

t) The role of the Sertoli cell in active immunosuppression in the testis. Turek, S. Malkowicz, J. Tomaszewski, A. Wein, D. Peehl.

u) Vesicourethral healing following radical prostatectomy: Is it related to surgical approach? J. Levy, J. Berlin, P. Ramchandani, C. Broderick, Wein.

v) Evidence for urothelial hyperplasia following partial outlet obstruction of rabbit urinary bladders. R. Levin, A. Wein, F. Monson.

w) Developmental changes in pharmacologic and field stimulated response of the fetal bovine bladder. H. Koo, E. Macarak, J. Duckett, H. Snyder, A. Wein, R. Levin.

x) Strategy for prostate rebiopsy in patients with previously diagnosed prostatic intraepithelial neoplasia. E. Rovner, J. Langer, J. Tomaszewski, S. Malkowicz, A. Wein.

y) Cell saver and radical retropubic prostatectomy: analysis of cost effectiveness. J. Gilbert, S. Malkowicz, A. Wein.

z) Effect of mucosal removal on the response of the feline bladder to pharmacological stimulation. L. Krasnopolsky, A. Wein, R. Levin, Atta, G. Ghoniem.

aa) Effect of partial urinary outlet obstruction in the rabbit on the activities of mitochondrial enzymes in the bladder. N. Haugaard, A. Wein, B. Chandy, R. Levin.

bb) High resolution 3 dimensional imaging of prostates by transrectal ultrasound. C. Sehgal, G. Broderick, A. Wein, P. Arger.

23. Invited faculty member, American Urological Association Office of Education, Basic Science

Course, Charlottesville, VA, June 22, 1994. Neurophysiology and Neuropharmacology of the Lower Urinary Tract; The Neurourologic Evaluation; Urodynamic Evaluation of Voiding Dysfunction; Classification of Voiding Dysfunction; Voiding Dysfunction Seen with Various Neurologic Diseases; Pharmacologic Management of Voiding Dysfunction.

24. Residency Review Committee semi-annual meeting (Vice-Chairman), Washington, DC, June

23-24, 1994.


195

25. Interstitial Cystitis Database Steering Committee meeting (Chairman), NIH Campus, Bethesda, MD, June 24, 1994.


196

ACADEMIC ACTIVITIES - 1994-1995 1. Course Director, Urology 300 (Surgery). 2. Invited Faculty Regional Subject Oriented Seminar on Incontinence/Voiding Dysfunction

sponsored by the American Urological Association Office of Education. Talks delivered: Lower Urinary Tract Dysfunction: Pathophysiology and Classification; Spinal Cord and Root Lesions; Lower Motor Neuron and Peripheral Lesions; Interstitial Cystitis Syndromes; Sensory Urge Incontinence; Conservative Management of Urinary Incontinence; Treatment of the Intractable Bladder by Augmentation Cystoplasty. Three breakout sessions with attendees (questions and answers). Orlando, FL, July 17-18, 1994.

3. American Board of Urology, annual summer meeting, July 30-August 5, 1994, Asheville, NC

(Vice President). 4. American Urological Association Update, Editorial Board meeting, Nevis West Indies, August

11-13, 1994. 5. Interstitial Cystitis Database Steering Committee meeting (Chairman), Bethesda, MD,

September 23, 1994. 6. Invited lecturer, New York Section American Urological Association annual meeting. London,

England, October 1-8, 1994, "Urodynamic Evaluation of BPH”; Moderator, section on pelvic and reconstructive surgery.

7. Invited lecturer lnterventional Radiology and Vascular Imaging 194 Conference, University of

Pennsylvania, Department of Radiology, Philadelphia, PA, October 12, 1994. "Therapeutic Alternatives for BPH".

8. Invited lecturer Rose Kline Oncology Lectureship, Mercer Medical Center, Trenton, New Jersey,

October 18, 1994. "Role of Prostatectomy and Cryosurgery in the Treatment of Early Stage Prostate Cancer".

9. Residency Review Committee for Urology (Vice Chairman), Washington, DC, December 8-9,

1994. 10. Invited lecturer: Urodynamics, Voiding Dysfunction, Incontinence: Update 1995, sponsored by

the Paralyzed Veterans Association and the VA Medical Center, Miami, FL, January 6-9, 1995. "Pharmacologic Treatment of Voiding Dysfunction - What Works and What Doesn't", "Urodynamics in the Spinal Cord Injury Patient; Factors Involved in Deciding Management", Case presentations and discussion.

11. Bladder Health Council, American Foundation for Urologic Disease, (Co-Chairman), meeting,

January 14, 1995. 12. ACGME meeting (attending as Chairman, Residency Review Committee for Urology), Chicago,

IL, February 13, 1995. 13. American Board of Urology winter meeting and Board examination, Dallas, TX, February 14-19,

1995.


197

14. Clinical Society of Genitourinary Surgeons (Secretary-Treasurer), annual meeting, Los Angeles, CA, March 9-11, 1995.

15. Course Director, Urinary Incontinence; Practical Evaluation and Management. March 25, 1995,

Philadelphia, PA. Talks: "Introductions, Definitions, Pathophysiology"; Drug Treatment of Urinary Incontinence, Pelvic Floor Exercises, Bladder Retraining and Biofeedback"; round table discussions.

16. Residency Review, University of Pennsylvania, March 29, 1995. 17. Invited lecture, Neurology Grand Rounds, Hospital of the University of Pennsylvania, March 30,

1995, "Voiding Dysfunction Associated with Neurologic Disease". 18. American Urological Association Update Series Editorial Board meeting; Annual meeting

American Association of Genitourinary Surgeons, Santa FE, NM, April 4-8, 1995. 19. Urodynamics Society annual meeting, American Urological Association annual meeting, Las

Vegas, NV, April 22-27, 1995. a) Meeting, Urodynamics Society Executive Committee b) Meeting, Urodynamics Society c) Speaker, Spanish Urology Program, "Pharmacologic Treatment of Voiding Dysfunction" d) Meeting, AFUD Board of Trustees e) Session Moderator, Urodynamics Society f) Meeting, Clinical Trials for BPH Subcommittee, Product Evaluator g) Meeting, Editorial Board, Neurourology and Urodynamics h) Bladder Health Awareness Week Press Conference i) Meeting, AUA Today Editorial Board meeting "Think Tank" j) Meeting, Bladder Health Council k) Meeting, Editorial Committee, Urological Survey l) Meeting, Practice Parameters, Guidelines & Standards Committee m) Moderator, Practical Urodynamics, Postgraduate Course n) Moderator, Poster Session, "Bladder Physiology & Pharmacology II” o) Take Home Message, American Urological Association

PRESENTATIONS:

p) Effect of partial outlet obstruction (rabbit) on calcium metabolism, D. Rohrmann, Alan J. Wein, Robert M. Levin.

q) A multivariate analysis of clinical and pathological factors which predict for prostate specific antigen failure after radical prostatectomy for prostate cancer. A. D'Amico, R. Whittington, S. B. Malkowicz, Schnall, J.E. Tomaszewski, D. Schultz, A. Wein.

r) Mitogenic effects of pharmacologic agents on cultured rabbit detrusor smooth muscle cells. S. Malkowicz, J. Thomas, A. Wein, R. Levin.

s) Erectile dysfunction following therapy for localized prostate cancer: the role of the penile blood flow study. G. Broderick, S. B. Malkowicz, Van Arsdalen, A. J. Wein.

t) Detection of stress gene mRNAs in bladder biopsies, exfoliated cells in urine, and cells in bladder barbotage obtained from interstitial cystitis patients. Y Zhao, K. Whitmore, D. Gordon, A. Wein, R. Levin.

u) Progressive phenotypic transitions induced by partial outlet obstruction in the rabbit urinary bladder. M. Roelofs, G. Passerini-Glazel, Sartore, A. Wein, F. Monson, R. Levin.


198

20. Interstitial Cystitis Database Steering Committee (Chair) meeting, Philadelphia, PA, May 12,

1995. 21. American Urological Association Office of Education Basic Science Course, invited lecturer,

Charlottesville, VA, June 14, 1995. Physiology of Micturition; Evaluation of Voiding Dysfunction; Classificaton of Voiding Dysfunction; Neurologic Diseases and Voiding Dysfunction; Pharmacologic Treatment of Voiding Dysfunction.

22. Residency Review Committee for Urology (Chair), Washington, DC, June 23-24, 1995.


199

ACADEMIC ACTIVITIES - 1995-1996 1. Course Director, Urology 300 (Surgery). 2. Interstitial Cystitis Database Steering Committee conference call, centered at National

Institutes of Health, July 28, 1995. 3. American Foundation for Urologic Diseases/National Institutes of Health review of

Physician Scientist Training Awards (presentations), National Institutes of Health, Bethesda, MD, July 28, 1995.

4. Program Committee meeting, American Urological Association (for annual meeting),

Chicago, IL, August 5, 1995. 5. Mid-Atlantic Section meeting, American Urological Association, Southampton, Bermuda,

September 16-19, 1995. a) Executive Committee meeting. b) Moderator, session on Neurogenic Bladder and Incontinence.

PRESENTATIONS:

c) Clinicopathologic stratification of radical prostatectomy specimens in patients treated preoperatively with three months or less of LHRH agonists. T. Cangiano, S. Malkowicz, K. Montone, A. D'Amico, A. Wein, J. Tomaszewski.

d) Impotence following minimally invasive treatments for prostate cancer. Chaikin, M.D., G. Broderick, M.D., S. Malkowicz, T. Malloy, A. Wein.

e) The role of biofeedback therapy in urinary continence after radical retropubic prostatectomy. M. Hagg, S. Malkowicz, G. Broderick, English, A. Wein.

f) Cellular basis for contractile dysfunction following chronic partial outlet obstruction (in rabbits). D. Nigro, N. Haugaard, A. Wein, R. Levin.

g) MRI in preoperative assessment and postoperative follow up of patients undergoing nephron-sparing surgery. P. Ramchandani, T. Cangiano, M. Banner, S. Malkowicz, A. Wein, B. Soyupak, M. Schnell.

6. ACGME meeting (Chair, Residency Review Committee for Urology), Amelia Island, FL, December 7-8, 1995. 7. Bladder Health Council Meeting, (Co-Chair), American Foundation for Urologic Disease, January 13, 1996, Baltimore, MD. 8. Interstitial Cystitis Database (NIH) meeting (Chair, Steering Committee), Philadelphia, PA, January 26, 1996. 9. ACGME meeting (Chair, Residency Review Committee for Urology), Chicago, IL, February 12, 1996. 10. American Board of Urology winter meeting (Vice President), Examiner, part II Qualifying Examination. Dallas, TX February 22-25, 1996.


200

11. Clinical Society of Genitourinary Surgeons (Secretary-Treasurer) annual meeting, Cleveland, OH, March 21-24, 1996. 12. Director, annual postgraduate seminar, American Urological Association Office of Education, (Also delivered portions on Physiology and Pharmacology of the Lower Urinary Tract, Pathophysiology of Voiding Dysfunction, Voiding Dysfunction in Neurologic Injury and Disease), Philadelphia, PA March 29-31, 1996. 13. American Urological Association AUA Update Editorial Board meeting; American Association of Genitourinary Surgeons annual meeting. Sea Island, GA, April 16 -20, 1996. 14. Urodynamics Society, American Urological Association annual meeting, Orlando, FL, May 3-8, 1996. a. Executive Committee meeting, Urodynamics Society, (Membership Committee Chair, Past President). b. Annual meeting, Urodynamics Society. A. Moderator, two meeting sessions: “Voiding dysfunction, BPH”, Voiding dysfunction, bladder neck obstruction, external sphincter dyssynergia.” c. Meeting, Editorial Board, Neurourology and Urodynamics. d. Meeting, AUA/AFUD Research Committee. e. Meeting, American Foundation for Urologic Disease. f. Meeting, Editorial Board, Family Urology g. Meeting, AUA Education Council. h. Moderator, Practical Urodynamics Postgraduate Course. i. Interstitial Cystitis Podium session. j. Meeting, Editorial Board, Urology k. Meeting, Editorial Board, Journal of Urology l. Moderator, Poster Session, “Bladder Dysfunction, Research and Clinical”. m. Meeting, Bladder Health Council. n. Invited Lecturer, Ramon Guiteras Lecture, “Male and Female Incontinence: What the Urologist of the Future Needs to Know”. o. Award ceremony, F. Brantley Scott Award presented by AFUD and the Bladder Health Council. p. Take Home Messages, American Urological Association. PRESENTATIONS: q. The passive mechanics of obstructed and de-obstructed rat urinary bladders (Society for Urology and Engineering, Inc.) M. Damaser, R. Levin, A. Wein, P. Longhurst. r. Home care interventions for postsurgical prostate cancer patients. D. Adler, M. Cooley, M. Clark, L. Robinson, M. Pickett, A. Wein, S. Malkowicz, R. McCorkle. s. Improved urinary continence without pathologic compromise by urethral preservation during radical prostatectomy. M. Hagg, S. Malkowicz, G. Broderick, A. Wein.


201

t. Template analysis of N+ status on survival in radical cystectomy patients. B. Soyupak, S. Malkowicz, A. Wein. u. Effect of ischemia of the rabbit bladder on Ca-Mg activated ATP-ase activity. B. Soyupak, A. Wein, R. Levin, N. Haugaard. v. Contractile responses and calcium mobiliation induced by muscarinic agents: effects of age. H-J Yu, A. Wein, R. Levin. w. Vascular impotence following radical retropubic prostatectomy. D. Blander, G. Broderick, S. Malkowicz, K. Van Arsdalen, A. Wein. x. Associations among cystoscopic and urodynamic findings for women enrolled in the interstitial cystitis database (ICDB). A. Wein, D. Nigro, M. Foy, C. Parsons, M. Williams, L. Nyberg, J. Landis, Y. Matthews, L. Simon, ICDB Study Group. y. Hematuria patient urograms with ureteral segment nonvisualization. I. Schwartz, M. Banner, P. Ramchandani, A. Wein. z. Transurethral biopsy of the prostate for persistently elevated or rising PSA following multiple negative transrectal biopsies. E. Rovner, F. Schanne, S. Malkowicz, A. Wein. aa. Regulation of bladder function by calcium. R. Levin, K-B Kim, P. Longhurst, A. Wein, M. Damaser. bb. P21waf1/cip1 and p53 expression in superficial and invasive transitional cell carcinoma. S. Malkowicz, J. Tomaszewski, A. Linnenbach, A. Wein, T. Cangiano, T. McGarvey. 15. Interstitial Cystitis Database Steering Committee (NIH) meeting (Chair), Bethesda, MD, May 31, 1996. 16. Visiting Professor, Temple University Department of Urology, Philadelphia, PA, June 3- 4, 1996. Presentations, (“Physiology and Pharmacology of the Lower Urinary Tract”, “Practical Urodynamics”, “Voiding Dysfunction in Neurologic Injury and Disease”), Case discussions. 17. Residency Review Committee for Urology (Chair), Boston, June 6-7, 1996. 18. Basic Science Course, American Urological Association Office of Education, Invited Faculty, Charlottesville, VA, June 12, 1996. Presentations: “Physiology and Pharmacology of the Lower Urinary Tract”; “Evaluation of Voiding Dysfunction”; “Classification of Voiding Dysfunction”; “Voiding Dysfunction in Neurologic Injury and Disease”; Pharmacologic Treatment of Voiding Dysfunction”. 19. ACGME meeting (Chair, Residency Review Committee for Urology), Chicago, IL, June 17, 1996.


202


1. Course Director, Urology 300 (Surgery). 2. ACGME Meeting (Chair, Residency Review Committee, Urology), Chicago, IL, September 16, 1996. 3. Interstitial Cystitis Database Steering Committee (Chair) meeting (NIH). Bethesda, MD, September 27, 1996. 4. Visiting Professor, Johns Hopkins University Hospital Department of Urology, Baltimore, MD, September 29-October 1, 1996. Presentations: “Practical Urodynamics”; “Voiding Dysfunction and Neurologic Injury and Disease”; Case presentations and discussions, operative demonstrations. 5. Invited Faculty, Urotrend 2000 meeting, Monte Carlo, October 3-5, 1996. Presentations: “Non-surgical Management of Urinary Incontinence”; “Current Management of Benign Prostatic Hyperplasia”; “Current Management of Urinary Incontinence”. 6. Annual meeting, New York Section American Urological Association, October 6-11, 1996, Paris, France. Presentation: “Pathophysiology and Classification of Voiding Dysfunction in Males and Females”; Debate: “The Place of Pressure Flow Studies in the Evaluation of Benign Prostatic Hyperplasia (Negative side); Panel Discussions: “Current Evaluation Therapy for BPH”; “Current Evaluation and Therapy for Urinary Incontinence”. 7. Executive Committee meeting, Mid-Atlantic Section, American Urological Association. Washington, DC, October 27, 1996. 8. Bladder Health Council, American Foundation for Urologic Disease (Co-Chair), meeting, Philadelphia, PA November 16, 1996. 9. Lewis Werkersheimer Visiting Professor, Columbia University Department of Urology, New York, NY November 21-22, 1996. Presentations: “Voiding Dysfunction in Neurologic Injury and Disease”; “Practical Urodynamics”; “Academic Urology Practice in the Future”; Case discussions, Urology, Uroradiology, Uropathology. 10. Residency Review Committee for Urology (Chair) meeting, Washington, DC., December 5-6, 1996. 11. Course Co-Director, Lasers in Urology, University of Pennsylvania/Pennsylvania Hospital, Philadelphia, PA , December 7-8, 1996.


203

12. Visiting Professor, Northwestern University School of Medicine Department of Urology, January 22-24, 1997. Presentations: “Physiology and Pharmacology of the Lower Urinary Tract”; “Practical Urodynamics”; “Voiding Dysfunction in Neurologic Injury and Disease”; Case presentations/discussions. 13. Interstitial Cystitis Database Steering Committee (Chair) meeting. January 31, 1997. Ft. Lauderdale, FL. 14. American Board of Urology, examiner, Part II, Certifying process. February 20-23, l997. 15. American Urological Association Office of Education AUA Update Editorial Board meeting, American Association of Genitourinary Surgeons annual meeting, March 25-29, 1997, Palm Spring, CA. Presentation: “Valsalva Leak Point Pressure to Predict Efficacy of Collagen Treatment for Post-prostatectomy Incontinence”. 16. Urodynamics Society, American Urological Association annual meeting, April 11-17, 1997, New Orleans, LA. a. Awards ceremony, recipient of Hugh Hampton Young Award. b. Meeting, American Foundation of Urologic Disease Board of Trustees. c. Meeting, Pharmacia/Upjohn International Advisory Board. d. Meeting, AUA Voiding Dysfunction Committee. e. Moderator, Practical Urodynamics Postgraduate Course. f. Meeting, Editorial Board, Urology g. Meeting, Editorial Board, Investigative Urology h. Meeting, Bladder Health Council. i. Merck Consultant Group, round table discussions. j. Co-Moderator Poster Session, “Surgical Treatment of Lower Urinary Tract Problems in Males”. k. Take Home Messages, American Urological Association. PRESENTATIONS: l. Magnetic resonance imaging in nephron sparing surgery. T. Cangiano, P. Ramchandani, M. Banner, S. Pertorius, S. Malkowicz, B. Soyupak, A. Wein, M. Schnall. m. Molecular mechanism for contractile dysfunction in the detrusor following outlet obstruction: expression of caldesmon, a protein that regulates actin- myosin interaction in smooth muscle. C. Menon, Y-M Zheng, M. Di Santo, D. Nigro, J. Hypolite, A. Wein, S. Chacko. n. Alexander Randall and the Department of Urology at the University of Pennsylvania. D. Chaikin, S. Malkowicz, J. Duckett, A. Wein. o. Collagen therapy for post-prostatectomy incontinence: the role of the Valsalva leak point pressure. D. Chaikin, G. Broderick, D. Blander, R. Sanchez-Ortiz, S. Malkowicz, A. Wein.


204

p. Correlation of clinical and pathologic staging of capsular involvement in prostate cancer using endorectal coil magnetic resonance imaging. M. Bernstein, S. Malkowicz, A. Wein. q. Paclitaxel plus carboplatin in advanced carcinoma of the urothelium: an active outpatient regimen. D. Vaughn, S. Malkowicz, B. Zoltick, P. Ramchandani, R. Mick, A. Wein, Penn Cancer Clinical Trials Group. r. Changing in penile length after radical prostatectomy. K. Lessans, D. Blander, J. Roth, G. Broderick, S. Malkowicz, A. Wein.

s. Molecular basis of erectile function: expression of myosin isoforms in smooth muscle cells in corpus cavernosum penis. M. Di Santo, S. Chacko, J. Hypolite, G. Broderick, A. Wein, T. Chacko. 17. American Surgical Association annual meeting, April 18-20, 1997, Quebec, Canada. 18. Clinical Society of Genitourinary Surgeons (Secretary-Treasurer), annual meeting, May 1-4, 1997, Boston, MA. 19. Interstitial Cystitis Database meeting, Chairman, Steering Committee. May 30, 1997, Bethesda, MD. 20. Invited lecturer, American Urological Association Basic Science Course, June 10 -11, 1997. Neurophysiology and Neuropharmacology of the Lower Urinary Tract; Pathophysiology of Voiding Dysfunction; The Neurourologic Evaluation; Classification of Voiding Dysfunction; Voiding Dysfunction Associated with Neurologic Disease; Pharmacologic Management of Voiding Dysfunction. Charlottesville, VA. 21. Course director, American Urological Association subject oriented seminar - Female Urology and Incontinence. Introduction, Objectives; Pathophysiology of Urinary Incontinence; Overview of Treatment; Non-hormonal Medical Therapy; Occlusive Devices; Panel moderator - Therapy after Conservative Treatment Failure (corrective surgery, bulking agents, prosthetics, denervation, augmentation); June 19-22, 1997, Dallas, TX. 22. Co-chairman, Consensus Conference - The Overactive Bladder: From Basic Science to Clinical Management. June 28-30, 1997, London, England.


205


1. Course Director, Urology 300 (Surgery). 2. Committee Co-Chairman, Committee on Obstruction and Aging. Fourth Annual International Consultation on BPH -- “Pathophysiology of Bladder Obstruction in Aging.” Sponsored by World Health Organization Union Against Cancer, Monaco. July 1-5, 1997. 3. Invited lecturer, Philadelphia Urologic Residents Educational Consortium, “Physiology and Pharmacology of the Lower Urinary Tract.” Philadelphia, PA. July 19, 1997. 4. Invited lecturer, Philadelphia Urologic Educational Consortium: “Practical Urodynamics”. Philadelphia, PA. August 16, 1997 5. Honorary American Urological Association Société Internationale d’Urologie Association lecturer, Triannual meeting, “The Overactive Bladder: Etiology, Evaluation, Management Montreal, Canada, September 6-10, 1997. 6. Invited speaker, University of Pennsylvania Cancer Center Course: New Developments in Urologic Cancer. Invited presentation: “Surgical Treatrment of Localized Prostate Cancer”; panel discussion. Philadelphia, PA. September 12, 1997. 7. Executive Committee meeting, Mid-Atlantic Section American Urological Association Hot Springs, VA. September 27, 1997 8. Society of University Urologists, annual meeting (Counselor). Invited moderator, “Urogynecology: How Should Urology Respond?”, Chicago, IL October 16-18, 1997. 9. Co-Chair Symposium on Interstitial Cystitis, sponsored by NIH (NIDDK) and Interstitial Cystitis Association; moderator session, “Treatment of IC; Review and Overview”, Crystal City, VA. October 30/Nov. 1, 1997 10. Co-chairman Bladder Health Council American Foundation for Urologic Disease, biannual meeting, Philadelphia, PA. November 15, 1997. 11. Pharmacia & Upjohn Medical Advisory Board meeting (member), Zürs, Austria. January 15-18, 1998. 12. Invited Lecturer: Society of Urologic Nurses and Associates, “Interstitial Cystitis: Epidemiology, Pathophysiology, Diagnosis and Management”, Philadelphia, PA. February 17, 1998 13. Invited Lecturer, Food and Drug Administration Symposium on Establishing Outcome,

Guidelines for Studies on Urinary Incontinence. “Urinary Incontinence - Epidemiology, Pathophysiology, Evaluation, Management, Outcome Measurements. Rockville, MD. February 26, 1998


206

14. Course Director -- Annual postgraduate seminar, AmericanUrological Association Office of Education; presentations: “Physiology and Pharmacology of the Lower Urinary Tract”; “Pathophysiology of Voiding Dysfunction”; “Voiding Dysfunction Associated with Neurologic Disease”. Dallas TX. March 5-8, 1998. 15. Annual Meeting, Clinical Society of Genitourinary Surgeons, Los Angeles, CA, March 12- 15, 1998. 16. Annual meeting, American Surgical Association, Palm Beach, FL, April 2-5, 1998. 17. Invited Lecturer -- Paralyzed Veterans Association of Florida, 9th Annual Urodynamics, Voiding Dysfunction, Incontinence: Update ‘98. “Non-Surgical Management of Voiding Dysfunction;”; “Voiding Dysfunction Associated with Neurologic Disease”. Miami, FL (University of Miami), April 4, 1998. 18. Meeting, American Urological Association Upate Series (Editorial Board member), Williamsurg, VA, April 14-15, 1998. 19. Annual Meeting, American Association of Genitourinary Surgeons, Wiliamsburg, VA, April 16-19, 1998. 20. Invited Lecturer, New Jersey Academy of Family Physicians, “The Overactive Bladder”, Philadelphia, PA, May 16, 1998. 21. Annual meeting, Urodynamics Society and American Urological Association, San Diego, CA, May 29-June 3, 1998. a. Urodynamics Society Executive Committee meeting. b. Modertor Point/Counterpoint session, Urodynamics Society meeting, Management of Detrusor Instability.

c. Pharmacia/Upjohn Symposium: Introduction, Definition of Overactive Bladder, Summation. d. Invited speaker, Society of Urologic Nurses and Associates, “Clinical Uses for tolterodine (Detrol) in the Treatment of Urge Incontinence.” e. Invited speaker, Spanish speaking members of the AUA, “Treatment of Voiding Dysfunction”. f. Meeting, Scientific Advisory Board, Influence, Inc. g. Editorial Board meeting, Neurourology and Urodynamics. h. Advisory Board Meeting, ContiMed, Inc. i. Meeting, women’s issues in Urology, invited participant. j. Meeting, Bladder Health Council/Pediatric Urology Health Council combined meeting. k. Panel moderator, Plenary session: “Female Urology: Medical Management of Stress Incontinence. “ l. Meeting, ICI ‘98 subcommittees, Co-chair m. Meeting, editors of Campbell’s Urology n. Moderator, Practical Urodynamics Course.


207

PRESENTATIONS:

o. The effect of the bowman-birk inhibitor (a soy protein) on invitro bladder neck/urethral and penile corporal smooth muscle activity. S. B. Malkowicz, S-P Liu, G.A. Broderick, R.M. Levin, A.J. Wein, A.R. Kennedy. p. Regional variations in the composition of myosin isoforms and light chain phosphorylation at the resting tone in rabbit bladder smooth muscle. J.A. Hypolite, M.E. DiSanto, A.J. Wein,S. Chacko. q. Linked roles of protein kinase C and Na+pump activities in diminished bladder contractility in diabetes. D. Koo, A.J. Wein, S. Gupta. r. Bladder outlet obstruction induces the expression of a myosin isoform which has a low actin-activated ATPase activity. M. DiSanto, J.A. Hypolite, D. Nigro, A.J. Wein, s. Modification of clinical presentation in early onset, family history positive prostate cancer by CYP3A4 genotype. T. Rebbeck, J. Jaffe, A. Walker, A.H. Wein, S. B.Malkowicz. t. Magnetic resonance imaging in the evaluation of indeterminate cystic renal masses. M.R. Bernstein, E.S. Rovner, S.B. Malkowicz, M. Banner, M. Schnall, K. Van Arsdalen, A. J. Wein. u. Possible mechanisms underlying ATP-induced relaxation of corpus cavernosum smooth muscle. G. Broderick, J. Hypolite, A. Wein, S. Gupta.

22. Invited Faculty, Basic Science Course sponsored by the American Urological Association Office of Education, Lecture: “Physiology and Pharmacology of the Lower Urinary Tract”, “Evaluation of Voiding Dysfunction”, “Classification of Voiding Dysfunction”, Voiding Dysfunction associated with Neurologic Disease”, “Management of Voiding Dysfunction”, Charlottesville, VA June 12, 1998. 23. Invited Lecturer, annual meeting Canadian Urologic Society, “The Overactive Bladder”. Halifax, NS, June 20-22, 1998. 24. Co-Chair, First International Consultation on Incontinence (World Health Organization), Monaco, June 29-July 2, 1998.


208


1. Course Director, Urology 300 (Surgery). 2. American Urological Association Program Committee meeting, 1998-1999, Chicago, IL, August 8, 1998. 3. Guest Speaker, Reading Urological Society: “Finasteride and Benign Prostatic Hyperplasia”, Reading, PA August 21, 1998. 4. TAP Pharmaceuticals Consultant’s meeting, Chicago, IL, August 26, 1998. 5. Invited lecturer, Society for Incontinence and Singapore Urological Association: “Management of Overactive Bladder in the USA -- New Treatment Options”, Singapore, September 28, 1998. 6. Invited visiting professor, Shinshu University, Matsumoto, Japan: “The Overactive Bladder: Current Thoughts and New Treatment Vistas”; case presentations and discussion, Matsumoto, Japan, September 30, 1998. 7. Moderator, CME Teleconference Series, “Management of Overactive Bladder by the Primary Care Physician”, Philadelphia, PA, October 14, 1998. 8. Invited Course Director, American College of Surgeons: “Urinary Incontinence: Advances in Therapy”. Annual meeting American College of Surgeons, Orlando, FL, October 29, 1998. 9. Executive Committee annual meeting, Society of University Urologists. Orlando, FL, October 29, 1998. 10. Invited Speaker, Society of University Urologists Annual meeting. Session on Fellowships in Urology, “Fellowship Funding”, Orlando, FL, October 29, 1998. 11. Victor Marshall Visiting Professor, New York Hospital/Cornell Medical Center: “Physiology and Pharmacology of the Lower Urinary Tract with Clinical Correlations”, “Pharmacologic Management of Lower Urinary Tract Dysfunction”, “Practical Urodynamics”, Case presentations and discussion. New York, NY, December 4-6, 1998. 12. Course Director, American Urological Association Annual Review Course, Female Urology and Incontinence. Presentations: Introduction, “Pathophysiology of Urinary Incontinence: Overview of Treatment”; “Non-Hormonal Medical Therapy”; “Occlusive Devices”; breakout sessions. Washington, DC, December 11-13, 1998. 13. Invited Lecturer, World Foundation for Medical Studies in Female Health, 4th Annual Clinical Conference. “The Overactive Bladder - An Overview for Primary Health Care Providers”. New York, NY, December 19, 1998.


209

14. International Medical Advisory Board meeting (member), Pharmacia & Upjohn, Zürs, Austria. January 13-17, 1999. 15. Visiting Lecturer, State-of-the-Art Urology, UCLA School of Medicine. “Pharmacologic Management of Voiding Dysfunction in 1999”; “The Overactive Bladder”; “Update on Interstitial Cystitis”; Panel discussion and case presentation. Marina del Rey, CA February 12-14, 1999. 16. Director American Urological Association Annual Review Course. Lecture: “Neurourology and Incontinence”. Dallas, TX March 11-14, 1999. 17. Editorial Board meeting, Campbell’s Urology. Columbus Isle, San Salvador, March 22-26, 1999. 18. Annual meeting, AUA Update Series Editorial Board, Naples, FL, April 11-13, 1999. 19. Annual meeting, American Association of Genitourinary Surgeons, Naples, FL, April 14-16, 1999. 20. Annual meeting, Society for Urodynamics and Female Urology and American Urological Association, Dallas, TX, April 30-May 4, 1999.

A. Course Chairman session on evaluating clinical relevance in overactive bladder. “Welcome and introduction”, “Review of clinical experience with tolterodine”, panel discussion. B. Executive Committee meeting, Society for Urodynamics and Female Urology. C. Committee meeting, 2nd International Consultation on Prostate Cancer. D. Society for Urodynamics and Female Urology meeting; Moderator Session III, “Sensory Bladder Disorders”. E. Podium participant, “Tolterodine is effective and well tolerated during long term uses in patients with overactive bladder”. F. Editorial Board meeting, Neurourology and Urodynamics G. Medical Advisory Board meeting, ContiMed , Inc. H. Advisory Board meeting, Pharmacia/Upjohn I. Bladder Health Council meeting J. AUA Voiding Dysfunction Committee meeting. K. Moderator, Plenary session, “Operative Management of Stress Urinary Incontinence”. L. HCFA Health Policy meeting. M. Meeting, Editorial Board, Campbell’s Urology N. Meeting, Editorial Board, Urology O. Meeting, AUA Nominating Committee, Mid-Atlantic AUA representative P. Course Moderator, “Advanced Urodynamics with Case Studies of Voiding Dysfunction and Incontinence.


210

PRESENTATIONS:

Q. Tolterodine is effective and well tolerated during long-term use in patients with overactive bladder. AJ Wein, P Abrams, R Appell, HP Drutz. R. Estrogen modulates the expression of contractile proteins in the detrusor smooth muscle. RF Sanchez-Ortiz, Z Wang, C Menon, AJ Wein, S. Chacko. S. Glutathione-S-Transferase (GSTMI and (GSTTI) genotype in the etiology of prostate cancer. TR Rebbeck, JM Jaffe, AH Walker, DI White, AJ Wein, SB Malkowicz. T. Do alterations in the composition of isoforms of myosin, the molecular motor for muscle contraction, in aging corpora cavernosa favor contraction over relaxation? ME DiSanto, GA Broderick, JA Hypolite, Y Zheng, AJ Wein, S. Chacko. U. Sustained contraction of detrusor muscle in outlet obstruction is associated with an increase in myosin isoform SM-A that is present in tonic smooth muscle. J Hypolite, M DiSanto, C Gomes, Y Zheng, AJ Wein, S. Chacko. V. Overexpression of calponin, a thin-filament associated protein in smooth muscle that decreases maximal shortening velocity, in response to urinary bladder outlet obstruction. M DiSanto, C Gomes, JA Hypolite, AJ Wein, S. Chacko. W. Phase I study of oral bowman-birk inhibitor concentrate, (BBIC), a soy protein, on patients with lower urinary tract symptoms. SB Malkowicz, GA Broderick, B Zoltick, SHF Marks, J Treat, J Tomaszewski, K Propert, AJ Wein, AR Kennedy.

21. Invited Lecturer, Urology Pinnacle Program, “Clinical Update on Overactive Bladder: The Disease and New Treatment Modalities”. Cincinnati, OH, May 15, 1999. 22. Invited Speaker, American College of Obstetrics and Gynecology Symposium: Lower Urinary Tract Disorders in Perspective: A Focus on Overactive Bladder. Presentation: “Successful Management of Overactive Bladder”. Philadelphia, PA, May 16, 1999. 23. Invited Lecturer, University of Pennsylvania Cancer Center: “Incontinence Following Treatment for Prostate Cancer, Philadelphia, PA, May 18, 1999. 24. Invited Faculty, Basic Science Course sponsored by the American Urological Association Office of Education. Lecture: “Physiology and Pharmacology of the Lower Urinary Tract”, “Evaluation of Voiding Dysfunction”, “Classification of Voiding Dysfunction”, “Voiding Dysfunction Associated with Neurologic Disease”, “Management of Voiding Dysfunction”, Charlottesville, VA June 9, 1999. 25. Invited Lecturer, National Congress of the Italian Society of Urology. “Overactive Bladder: A Widespread But Treatable Condition”. Rome, Italy, June 22, 1999. 26. British Journal of Urology Guest Lecturer, Annual Meeting British Association of Urological Surgeons: “The Overactive Bladder”. Co-chair session, Incontinence/Bladder Dysfunction. Glasgow, Scotland, June 22-24, 1999. 27. Committee Member (Diagnosis and Staging of Prostate Cancer), 2nd International Consultation on Prostate Cancer, Paris, France, June 27-29, 1999.


211

ACADEMIC ACTIVITIES 1999-2000 1. Course Director, Urology 300 (Surgery), School of Medicine. 2. Invited Lecturer, German Urology Thought Leaders. “Overactive Bladder: Status, Problems, Pharmacologic Opportunities”. Frankfurt, Germany, July 2, 1999. 3. Co-Chair, Symposium on Overactive Bladder and Its Treatments. Opening remarks, summary, closing remarks. London, England, July 3-4, 1999. 4. Visiting Professor, University of Alabama Urology Seminar. “Practical Urodynamics”, “Overactive Bladder”, Questions and Answers, Destin, FL, July 17, 1999. 5. Visiting Professor, Distinguished Visiting Professor Lecture Series, SUNY at Stony Brook Hospital and Medical Center. “The Overactive Bladder”. Stony Brook, New York, August 6, 1999. 6. Invited Lecturer, Grand Rounds, Division of Urology, Hospital of the University of Pennsylvania. “The Overactive Bladder”. Philadelphia, PA, August 12, 1999. 7. International Continence Society annual meeting. Invited State of the Art Lecture, “Drug Treatment of Urinary Incontinence”, Denver, CO, August 24, 1999. 8. International Continence Society annual meeting. Standardization/Terminology Committee and Workshop; Chair session on “Drug Treatment of Incontinence”; Chair symposium on “Overactive Bladder, a Patient Oriented Approach”. Denver, CO, August 22-26, 1999. 9. Course Director, American Urological Association Annual Review Course, Female Urology and Incontinence. Presentations: Introduction, “Pathophysiology of Urinary Incontinence: Overview of Treatment”; “Non-Hormonal Medical Therapy”; “Occlusive Devices”; breakout sessions. Fort Lauderdale, FL, September 17-19, 1999. 10. Clinical Society of Genitourinary Surgeons annual meeting, (Nominating Committee), New Haven, CT, October 21-24, 1999. 11. Invited lecture, Wissahickon Hospice Luncheon, “Urinary Incontinence in Women”. Philadelphia, PA . October 29, 1999. 12. Visiting Professor, Mayo Clinic Jacksonville, Millie A. Berg Lectureship. “The Overactive Bladder”, case discussions. Jacksonville, FL, November 4, 1999. 13. Invited Lecturer, American Society of Nephrology Annual Meeting. “Urinary Incontinence”. Miami FL, November 4-7, 1999. 14. Interstitial Cystitis Clinical Trials Group, study session and meeting. Bethesda, MD, November 18-19,1999. 15. Chairman, Conference on “Overactive Bladder: The Burden of Disease”. Lecture: “Definitions, Urodynamics and Symptoms”. New York, NY December 11-12, 1999. 16. Global Advisory Board, Pharmacia Corporation. Zürs, Switzerland, January 20-23, 2000.


212

17. Invited lecture, “Incontinence: Etiology, Pathophysiology, Outcome Measurement, Rationale for Therapy”. Philadelphia, PA (Sponsored by Neotonus Corp.), March 1, 2000. 18. Co-Chairman American Urological Association Annual Postgraduate Seminar. Chair responsibilities; Lecture “Physiology of Micturition”, “Pathophysiology of Voiding Dysfunction”, Voiding Dysfunction in Neurologic Disease and Injury”. Dallas, TX March 9-12, 2000. 19. Invited lecture, course on “Pelvic Floor Dysfunction. “Drug Therapy for Voiding Dysfunction”. Long Island, NY, April 1, 2000 (Center for Biomedical Communication). 20. Editorial Board Meeting, American Urological Association, AUA Update Series, San Antonio, TX, April 3-5, 2000. 21. Annual meeting, American Association of Genitourinary Surgeons, San Antonio, TX, April 6-9, 2000. 22. Society of University Urologists annual meeting, (President-Elect). Chairman and program organizer. Atlanta, GA April 28, 2000. 23. Annual meeting Society for Urodynamics and Female Urology, American Urological Association, Atlanta, GA April 28-May 3, 2000.

A. Executive Committee meeting, Society of University Urologists. B. Society of University Urologists meeting. Moderator session on Calculating Productivity and Compensation: Clinical, Academic, Administrative Aspects and session on What is the Future Academic Department Going to Look Like? C. Executive Committee meeting, Society for Urodynamics and Female Urology. D. WHO 5th International Consultation on BPH. E. Society for Urodynamics and Female Urology annual meeting. Co-moderator session on Neuromodulation and the Management of Voiding Dysfunction. F. Symposium on Overactive Bladder, Additional Discussion of New Clinical Data. G. Editorial Board meeting, Neurourology and Urodynamics. H. Editorial Board meeting, Campbell’s Urology (editor). I. Global Advisory Board Meeting, Pharmacia Corporation. J. Moderator discussion, Approaches to Evaluation and Management, SUI. K. Course Participant, Advanced Urodynamics with Case Studies of Voiding Dysfunction and Incontinence. L. Editorial Board meeting, Urology. M. Poster presentation, Abstract 2512, A Comparison of the Efficacy Response Profile of Tolterodine and Oxybutynin. N. Bladder Health Council meeting.

PRESENTATIONS:

O. Non-invasive outcome measures for urinary incontinence: a multicenter study of voiding diaries and pad tests. A Groutz, J Blaivas, D Chaikin, N Resnick, K Engleman, A Wein. P. Mechanism for the diabetes-induced decrease in detrusor contractility involves translocation of protein kinase C isoforms. J Earley, C Gomes, M DiSanto, A. Wein, S Chacko. Q. Erectile function and health-related quality of life after interstitial radiation therapy for Prostate cancer: Data from Capsure™. R.Sanche-Ortiz, E Rovner, G Broderick, R Whittington, A. Wein, S. Malkowicz.


213

R. Decompensated detrusor smooth muscle in partial bladder outlet obstruction shows an Overexpression of myosin isoform SM-A which utilizes less ATP during actin myosin interaction and force generation. M DiSanto, Y Zheng, R Stein, S Zderic, A Wein, S Chacko. S. Comparison of the efficacy response profile of tolterodine and oxybutynin. A Wein. T. A novel intravesical device for optimal drug delivery. R. Appell, A Diokno, C Parsons, Zupkas P, Nickel J, Lopez M, Wein A. U. Mechanisms for urinary incontinence: a correlation between smooth muscle myosin Isoform and shortening velocity in different layers of rabbit urethra. D Xu, M DiSanto, J. Hypolite, R Barsotti, A Wein, S Chacko.

24. Invited lecture, Neurosurgery Grand Rounds, University of Pennsylvania Health System. “Voiding Dysfunction in Neurologic Injury and Disease”. Philadelphia, PA June 8, 2000. 25. Invited lecture, Urology Pinnacle Program. “The Overactive Bladder: New Concepts and Therapies”. Cincinnati, OH, June 10, 2000. 26. Merck Medical Hour, radio station WPEN. “Benign Prostatic Hyperplasia). Philadelphia, PA, June 11, 2000. 27. Invited Faculty, Basic Science Course sponsored by the American Urological Association Office of Education. Lecture: “Physiology and Pharmacology of the Lower Urinary Tract”, “Evaluation of Voiding Dysfunction”, “Classification of Voiding Dysfunction”, “Voiding Dysfunction Associated with Neurologic Disease”, “Management of Voiding Dysfunction”. Charlottesville, VA June 14, 2000. 28. World Health Organization International Consultation on BPH. Committee on Initial Evaluation of BPH. Paris, France, June 24-27, 2000.


214

ACADEMIC ACTIVITIES 2000-2001 1. Course Director, Urology 300 (Surgery) , School of Medicine. 2. Lecture, Philadelphia Urology Residents Educational Consortium. “Physiology and Pharma- cology of Lower Urinary Tract Function”, “Voiding Dysfunction Associated with Neurologic Disease”. Philadelphia, PA, July 15, 2000. 3. Lecture, Philadelphia Urology Residents Educational Consortium. “Urodynamics”. Philadelphia, PA, August 19, 2000. 4. Visiting Professor, Tennessee Urologic Society. Lecture: “The Overactive Bladder”, discussions. July 29, 2000. 5. Urology Residency Review, ACGME, Philadelphia, PA, August 23, 2000. 6. International Continence Society annual meeting. Terminology Committee; Chair symposium on the overactive bladder; invited lecture Korean and Japanese delegations, “The Overactive Bladder”. Tempere, Finland, August 26-30, 2000. 7. Visiting Professor, Presidential Lecture South Central Section American Urological Association Montreal, Canada, September 9-10, 2000. 8. Interstitial Cystitis Clinical Trials Group (NIH sponsored) meeting. Minneapolis, MN October 18-19, 2000. 9. Visiting Professor, Loyola University. Lectures: “Physiology and Pharmacology of the Lower Urinary Tract”, “Urodynamics”, “Drug Treatment of Voiding Dysfunction”, case presentations and Discussions. Chicago, IL October 19-20, 2000. 10. Invited Course Director, American College of Surgeons annual meeting. “Current Advances in the Treatment of Urinary Incontinence”, “Pharmacologic Therapy”. Chicago, IL October 23, 2000. 11. Annual meeting Clinical Society of Genitourinary Surgeons (Chairman Nominating Committee). Chicago, IL November 16-18, 2000. 12. Visiting Professor and Benjamin Peng Lecturer, New York University School of Medicine. “State of the Art: Drug Therapy of Urinary Incontinence”, “The Overactive Bladder: Definition, Epide- miology, Pathophysiology, Evaluation and Therapy”. New York, NY. December 7-9, 2000. 13. Terminology Committee Meeting, International Continence Society, London, UK, January 20-23, 2001. 14. Editorial Board meeting, British Journal of Urology International, London, UK, January 22, 2001. 15. Examiner, Part II (oral), American Board of Urology Certifying Examination process. Dallas, TX, February 15-17, 2001. 16. National Overactive Bladder Evaluation Study, Medical Advisory Board and Date Review Meeting. San Francisco, CA March 12-13, 2001.


215

17. Editorial Board Meeting, American Urological Association AUA Update Series, San Francisco, CA, April 16-18, 2001. 18. Annual meeting, American Association of Genitourinary Surgeons, San Francisco, CA, April 18- 21, 2001. 19. Annual meeting Society for Urodynamics and Female Urology, American Urological Association, Anaheim, CA May 31-June 5, 2001.

A. Executive Committee meeting, Society of University Urologists. B. Annual meeting, Society of University Urologists, President. C. Executive Committee meeting, Society for Urodynamics and Female Urology. D. Annual meeting, Society for Urodynamics and Female Urology; Co-moderator panel on BPH. E. Editorial Committee meeting, Urological Survey of the Journal of Urology. F. WHO 2nd International Consultation on Incontinence preparatory meeting. G. Symposium, Pharmacologic Management of the Overactive Bladder. H. Editorial Board meeting, Neurourology and Urodynamics. I. Invited speaker, SUNA meeting: Current Pharmacologic Treatments for Lower Urinary Tract Disorders. J. Meeting, AUA Education Council. K. Co-moderator podium session, Urodynamics/Incontinence/Female Urology: Incontinence: Evaluation. L. Roundtable discussion, presentation, Overactive Bladder. M. Bladder Health Council meeting. N. Editorial Board meeting, Campbell’s Urology. O. Urology Editorial Board meeting. P. Panel member, postgraduate course, Advanced Urodynamics with Case Studies of Voiding Dysfunction and Incontinence.

PRESENTATIONS:

A. A prolonged interval between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. R. Sanchez-Ortiz, K.Van Arsdalen, A. Wein, S. Malkowicz, W. Huang.

B. Pharmacokinetic evaluation of intravesical oxybutynin: bolus and continuous delivery. T. Boone, R. Appell, M. Lopez, A. Diokno, M. Chancellor, A. Wein, C. Parsons. C. Changes in myosin isoform expression after partial bladder outlet obstruction and reversal: correlation with functional outcome in an experimental study. R. Stein, J. Thüroff, M. dissent, S. Zderic, J. Hutcheson, D. Canning, A. Wein, S. Chacko. D. Overexpression of non-muscle isoform of caldesmon, a protein associated with stress fibers, in detrusor remodeling following outlet obstruction. E. Zhang, R. Stein, S. Zderic, A. Wein, S. Chacko. E. Induction of free radicals and activation of aldose reductase, markers for detrusor contractile dysfunction in diabetes. A. Changolkar, J. Hypolite, M. DiSanto, S. Chacko, A. Wein. F. The effect of bladder outlet obstruction on rabbit corpus cavernosum smooth muscle contractility. S. Change, J. Hypolite, A. Wein, S. Chacko, M. DiSanto. G. Osteopontin expression in rabbit urinary bladder: remodeling-associated osteopontin downregulation in response to partial bladder outlet obstruction. H. Arafat, S. Zderic, A. Wein S. Chacko. H. Diagnosis and reconstruction of the circumferential urethral diverticulum. E. Rovner, M. Banner, P. Ramchandani, A. Wein.


216

I. Low affinity neurotrophic receptor (P75NTR) in normal and hydronephrotic rabbit kidney. H. Arafat, S. Zderic, A. Wein, S. Chacko. J. Bladder function in diabetes: decreased detrusor contractility is accompanied by underexpression of nerve growth factor (NGF) receptor. J. Hypolite, H. Arafat, A. Changolkar, A. Wein, S. Chacko. K. Establishment of a phenotypically stable bladder myocyte cell line from hypertrophied detrusor smooth muscle. Y. Zheng, W. Weber, S. Wang, A. Wein, S. Chacko, M. DiSanto. L. Osteopontin overexpression in ovarectomized rabbit bladder. H. Arafat, R. Sanchez- Ortiz, M. DiSanto, A. Wein, S. Chacko. M. The Bladder Health questionnaire (BHQ): the first clinically validated instrument to identify overactive bladder. C. Payne, W. Steward, J. VanRooyen, A. Wein on behalf of the NOBLE Research Team, Peapack, NJ. N. Invited presentation on the latest developments in the pharmacologic management of overactive bladder.

20. Invited visiting professor, Canadian Urological Association annual meeting, Toronto, Canada. June 24-26, 2001. 21. Invited educational seminar participant (Definition, epidemiology, quality of life effects, pathophysiology of overactive bladder; case presentations and discussions); invited lecture: The Overactive Bladder. Canadian Urological Association, Toronto, Canada, June 14-26, 2001. 22. 2nd International Consultation on Incontinence, Co-chair, Paris, France. June 30-July 4, 2001.


217

ACADEMIC ACTIVITIES 2001-2002 1. Course Director, Urology 300 (Surgery), School of Medicine. 2. Invited Lecture, Urology Grand Rounds, University of Pennsylvania Health System. “Voiding Dysfunction in Neurologic Injury and Disease”. July 26, 2001, Philadelphia, PA. 3. Invited co-chair, The Overactive Bladder: Eastern and Western Treatment Approaches. Introductory remarks; “New Approaches to the Pharmacotherapeutic Management of

Overactive Bladder”. Seoul, Korea, September 20, 2001. Cancelled because of 9-11-01 tragedy.

4. International Continence Society, Terminology Committee member, symposium chair,

moderator session on voiding function/dysfunction. Cancelled because of 9-11-01 tragedy. (Scheduled September 16-19, 2001 Seoul, Korea).

5. Residency Review Committee for Urology, Review Panel (Member), Chicago, Illinois, October

4, 2001. 6. American Urological Association Education Council Fall meeting, Chairman. Houston, TX, October 4, 2001. 7. Visiting Professor, Puerto Rico Urological Association annual meeting, San Juan, Puerto Rico.

Dr. Luis A. Sanjurjo Lecture – “The Overactive Bladder”; Pharmacologic Management of Urinary Incontinence in the Female”. Judge pyelogram conference and case presentations and presentation of original papers. November 9-10, 2001.

8. Visiting Professor, Strong Memorial Hospital/University of Rochester School of Medicine. “Pharmacologic Management of Urinary Incontinence”; case discussions. Rochester, NY, November 14, 2001. 9. Invited Panel Participant, Conversation in Neurology (UPHS CME Activity) New York City, January 11, 2002. 10. Interstitial Cystitis Clinical Trials Group, study session and meeting. Bethesda, MD, February

8, 2002. 11. 1st International Consultation on Nocturia, Co-Chairman., Presentation: “Nocturia in Men”. London, England, February 22, 2002. 12. Invited Lectures, XVII Congress of the European Association of Urology. State of the Art Lecture – AUA Lecture, “Urinary Incontinence”; Symposium participant, “Antimuscarinic Treatment for Overactive Bladder in the Elderly”; panel discussion and summary. Birmingham, England. February 22-25, 2002. 13. Invited co-chair, New Perspectives on the Overactive Bladder. Introduction; Definition and Epidemiology of Overactive Bladder; Discussions; Closing Remarks; Consensus Discussion. Boston, MA, March 7-8, 2002. 14. Invited Faculty, Annual Postgraduate Seminar, American Urological Association, Inc.,

Chicago, IL, March 21, 2002: “Neurophysiology and Neuropharmacology of the Lower Urinary Tract”; “Pathophysiology of Voiding Dysfunction”; “Voiding Dysfunction Associated with Neurologic Disease and Injury”.


218

15. Invited Faculty, First Annual International Seminar on Female Urology and Urogynecology. Las Vegas, NV, April 4-7, 2002. “Pathophysiology and Classification of Lower Urinary Tract Dysfunction”; “The Overactive Bladder”.

16. Meeting, Mid-Atlantic AUA Executive Committee, (President Elect) President, April 8, 2002, Washington, D.C. 17. Invited Charles J. Robson Visiting Professorship, University of Toronto Division of Urology, April 11-12, 2002, Toronto, Canada. Lectures: “Physiology and

Pharmacology of Lower Urinary Tract Function with Clinical Correlation”; “Thoughts about the Refractory Overactive Bladder and Future Perspectives for Pharmacologic Therapy”; Judge University of Toronto Robson Research Day; Case presentation and discussions.

18. Meeting. Editorial Board (Member), American Urological Association Update Series, Kiawah Island, SC. April 15-16, 2002.

19. Annual meeting, American Association of Genitourinary Surgeons, Kiawah Island, SC, April

17-20, 2002. 20. Annual Meeting, American Surgical Association. Hot Springs, VA, April 25-27, 2002. 21. Annual Meeting, American Urological Association, Orlando, FL, May 23 – 29, 2002. A. Annual Meeting, SUU (Society of University Urologists), Executive Committee Meeting at the American Urological Association Annual Meeting, Orlando, FL, May 23-24, 2002. B. Moderator, SUFU Prize Winning Essays and Poster Award Winners, SUFU

(Society for Female Urology & Urodynamics), Meeting, May 25, 2002. C. Urology Survey Editorial Committee Meeting, May 25, 2002. D. Invited Lecturer, Spanish speaking urologists, “Overactive Bladder”, May 25, 2002. E. Meeting, Editorial of Campbell’s Urology, May 25, 2002. F. Editorial Board Meeting, Neurourology and Urodynamics, May 26, 2002.

G. O’Brien Center Grant Meeting, May 26, 2002. H. Invited State-of-the-Art Lecture: Past, Present & Future Perspectives of Surgery to Correct Urinary Incontinence in, May 27, 2002. I. Urology Editorial Board Meeting, May 23 – 28, 2002. J. AUA Education Council Meeting, May 28, 2002. K. Bladder Health Council Meeting, May 28, 2002. L. Course Director, “New Pharmacologic Therapy for the Overactive Bladder”, May 28,

2002. 22. International Consultation on Prostate Cancer (sponsored by World Health Organization). Committee Member, Paris, June 22-23, 2002.


219

ACADEMIC ACTIVITIES 2002 - 2003 1. Course Director, Urology 300, (Surgery), School of Medicine.

2. Invited lecture, Forum on Incontinence, “New Ideas in the Treatment of Incontinence”, Philadelphia, July 9, 2002.

3. Invited lecture, Urological Association of Pennsylvania Annual Meeting, July 13, 2002,

Absecon, NJ, “The Overactive Bladder”.

4. Educational Lecture, Urology Grand Rounds, “Practical Urodynamics”, August 1, 2002.

5. Visiting Professor, Vanderbilt University, “Pharmacologic Management of the Overactive Bladder, Including the Refractory Patient”, August 5, 2002.

6. Invited Lecturer, National Multiple Sclerosis Society, “Lower Urinary Tract and Sexual Difficulties in Men with Multiple Sclerosis”, August 21, 2002,

7. International Continence Society Meeting, Heidelberg, Germany, August 26-30, 2002.

A. Satellite Symposium, Invited Faculty, Key Issues in the Treatment of Overactive Bladder, Lecture: “The Use of Combinations of Different Treatment Modalities for Overactive Bladder”

B. Symposium, Invited Faculty, Evolving Research in Overactive Bladder Management – A Global Perspective - Opening Remarks, Clinical Effectiveness as an Outcome Measure in Overactive Bladder.

C. SUFU Executive Committee Meeting, and TT Medical and Global Management Conf – at der Europaische Hof Hotel, Stadthalle Heidelberg, Germany, August 26-30, 2002.

8. Société Internationale d’Urologie Meeting, Stockholm, Sweden, September 8-11, 2002,

Invited Faculty Member “Lower Urinary Tract Symptoms 2002 – An Update on Storage and Voiding Symptoms”, Lecture “Diagnosis and Management of Overactive Bladder”.

9. Invited Faculty / Professor CME Course “New Techniques in Urinary Incontinence and

Female Urology”, October 4-5, 2002, St. Louis. Presentations: “Uroquotes on Urinary Incontinence and its Treatment” (Faculty, Residents, and Medical Students”, October 4, 2002); Pharmacologic Therapy of Urinary Incontinence: Past, Present and Future”, October 5, 2002.

10. Mid-Atlantic Section Meeting, American Urological Association, October 6-9, 2002 Baltimore, MD. A. Invited Presenter: Past, Present and Future Perspectives on Surgery for Stress Incontinence. B. Moderator, Panel on Surgery for Stress Incontinence in the Female. C. Inauguration as President of the Society. 11. Annual Meeting, Clinical Society of GU Surgeons, October 18, 19, Ann Arbor, MI.


220

12. Invited Faculty, University of Pennsylvania Cancer Center, Course on Prostate Cancer, Philadelphia, PA, March 28, 2003, Lecture: “Incontinence Following Radical Prostatectomy”, Case and Panel Discussion. 13. Mid-Atlantic Section of the American Urological Association Executive Committee/Board of Directors Meeting, March 31, 2003, Washington (President) Meeting, American Urological Association. 14. American Urological Association Update Editorial Board, April 1-2, 2003, Tuscon, AZ. (Member, Board of Editors). 15. Annual Meeting, American Association of Genitorurinary Surgeons (active member), April 3-5, 2003, Tuscon, AZ. 16. Annual Meeting, American Urological Association, April 24-30, 2003, Chicago, IL.

a. Executive Committee Meeting, Society of University Urologists b. Society of University Urologists Annual Scientific Meeting c. Invited Lecturer Symposium on The Future of Overactive Bladder Treatment

Addressing Obstacles to Successful Patient Outcomes: “An Overview of OAB and its Treatment.”

d. Society for Urodynamics and Female Urology Executive Committee Meeting e. Urological Survey Editorial Committee Meeting f. Society for Urodynamics and Female Urology Annual Meeting g. British Journal of Urology International Editorial Board Meeting h. Editorial Board Meeting, Neurourology and Urodynamics i. Campbell’s Urology Editorial Board Meeting j. American Urological Association Education Council Meeting (Chairperson) k. American Foundation of Urologic Disease Board Meeting l. American Board of Urology and Society for Urodynamics and Female Urology

Meeting m. American College of Surgeons 2003 Interim Meeting of the Advisory Council. n. Urology Editorial Board Meeting o. Plenary Sessions (Moderator): “Cause of Nocturia and Treatment” p. Bladder Health Council Meeting (Chairperson) q. Course Director, New Pharmacologic Therapy for the Overactive Bladder

PRESENTATIONS:

a. Stretch-induced upregulation of endothelin-1/rho-kinase pathway in bladder

smooth Muscle cells. S. Chang, E.J. Macarak, Y. Zheng, A.J. Wein, S. Chacko, M.E. DiSanto.

b. Transfection and bethanechol exposure induce over-expression of H-caldesmon and filament assembly in bladder smooth muscle cells. A.R. Shukla, T. Nguyen, Y. Zheng, M. DiSanto, A.J. Wein, S. A. Zderic, S. Chacko.

c. Establishment of a phenotypically stable contractile smooth muscle cell line from human corpus cavernosum. Y. Zheng, T. R. Malloy, W.T. Weber, S. Wang, S. Chang, A.J. Wein, S. Chacko, M.E. DiSanto.

d. Nitric oxide and nitric oxide synthase activity are decreased in corpus cavernosum smooth muscle from rabbits with partial bladder outlet obstruction. S. Chang, J.A. Hypolite, S.A. Zderic, A.J. Wein, S. Chacko, M.E. DiSanto.


221

e. Regional variations in the expression of myosin II isoforms, the molecular motor for smooth muscle contraction, in response to partial bladder outlet obstruction. A. Mannikarottu, M.E. DiSanto, S.A. Zderic, A.J. Wein, S. Chacko.

f. Myocytes in hypertrophied urinary bladder smooth muscle overexpress calponin and tropomyosin. A.S. Mannikarottu, M.E. DiSanto, Y. Zheng, S.A. Zderic, A.J. Wein, S. Chacko.

g. Effect of a 7F transurethral catheter on valsalva leak point pressure measurement in men with post-prostatectomy incontinentce. V.J. Ferlise, A.J. Wein, P. Ramchandani, M. P. Banner, E.S. Rovner.

17. Invited Faculty/Lecture, Foundation for Better Health Care. North American Women’s Healthcare Forum, June 14, 2003, Philadelphia, PA.

18. Invited Faculty, Wound Ostomy and Continence Nurses Society, 35th Annual

Conference, Lecture, “Overactive Bladder: Evaluation and Management,” June 17, 2003, Cincinnati, OH.


222


1. Course Director, Urology 300 (Surgery), School of Medicine.

2. Co-Chair, International Panel on Consensus for Minimal Necessary Evaluation of Stress Urinary Incontinence. Galliard Education, London, August 2-3, 2003. 3. Invited Keynote Speaker, 10th Annual Japanese Neurogenic Bladder Society Meeting, Tokyo, Japan. “Demystifying LUTS: New Aspects of Etiology and Pharmacologic Treatment,” questions and discussion. 4. Visiting Professor, Shinshu University, Matsumoto, Japan. “New Aspects of Etiology and Pharmacologic Treatment of Urgency and BPO”, discussion. 5. Visiting Professor, Keio and Tokyo University, Tokyo, Japan. “Demystifying LUTS: New Aspects of the Etiology and Pharmacologic Treatment of Urgency,” discussion. 6. Visiting Professor, Osaka University, Osaka, Japan. “New Aspects of the Etiology and Pharmologic Treatment of Urgency,” discussion. 7. International Continence Society Meeting, October 3-11, 2003, Florence, Italy.

A. Canada Consultants Meeting. B. ICI Chairs Meeting and Scientific Committee. C. Society for Urodynamics and Female Urology Executive Committee Meeting. D. Neurourology and Urodynamics Editorial Board Meeting (Chairperson).

8. Mid-Atlantic Sectional Meeting, American Urological Association, Presidential Duties, October 25-29, 2003, Boca Raton, FL. 9. Invited Keynote Lecture, NIH Sponsored Symposium on Research Insights into Interstitial Cystitis, A Basic Clinical Science Symposium, October 30-November 1, 2003, Alexandria, VA. 10. Annual Meeting, Society of Pelvic Surgeons. Invited Discussion: Transurethral Microwave Thermotherapy using the Thermatrix TMX-2000. 11. Invited Lecture, “Overactive Bladder: Definition, Epidemiology, Evaluation and Management”, CME seminar sponsored by Logic Healthworks, Los Angeles, CA, January 30-31, 2004. 12. Organizational Meeting, Campbells Urology, 9th Edition (Editor-in-Chief), Elsevier Press, Boca Raton, FL, February 10-15, 2004. 13. Mid-Atlantic Section, American Urological Association, Executive Committee Meeting (Past President), Washington, DC, March 15, 2004. 14. European Association of Urology Annual Meeting, Invited Symposia Participant and Lecturer, Vienna, Austria, March 22-26, 2004.

A. Quality of Life Considerations in Overactive Bladder B. M3 Selectivity in the Treatment of Overactive Bladder C. Co-Chair: Symposium on Overactive Bladder: The Role of Urgency


223

15. Invited Participant and Lecturer, Seminar on the Role of Afferent Signaling, Vienna, Austria, March 27, 2004. 16. Meetings, Editorial Board, American Urological Association, AUA Update Series; Annual Meeting, American Association of Genitourinary Surgeons, Amelia Island, FL, April 12-17, 2004. 17. Annual Meeting, American Urological Association, May 6-13, 2004, San Francisco, CA

A. Executive Committee Meeting, Society of University Urologists

Chairperson, Residency Standards B. Invited Lecturer Symposium on Antimuscarinics and Other Therapies in the

Treatment of Overactive Bladder C. Society for Urodynamics and Female Urology Executive Committee Meeting D. Invited Lecturer Symposium on Bridging the Gap in the Management of Overactive Bladder: The Importance of Targeting Urgency E. Urological Survey Editorial Committee Meeting F. Society for Urodynamics and Female Urology CME Meeting: Interstitial Cystitis and Chronic Pelvic Pain G. Editorial Meeting, International Consultation on Incontinence H. International Consultation on Incontinence Committee Meeting I. Editorial Board Meeting, Neurourology and Urodynamics J. American Urological Association Education Council Meeting K. American College of Surgeons 2004 Interim Meeting of the Advisory Council. L. Course Chair, Gaining Control: Treating the Spectrum of Overactive Bladder Symptomatology M. Society for Urodynamics and Female Urology/American Board of Urology Meeting N. American Foundation of Urological Diseases Bladder Advisory Council Meeting O. Invited Lecturer, Japanese Urology Contingent: “Demystifying Overactive

Bladder: Urgency” PRESENTATIONS:

(1) Transection of bladder smooth muscle cells with telokin alters their smooth muscle phenotype. Hyun, G., Chang, S., Zderic, S.A., Wein, A.J., Chacko, S., DiSanto, M.E. (2) Upregulation of rho-kinase in a human corpus cavernosum smooth muscle cell line in response to hypoxia. Zheng, Y., Chang, S., Wein, A.J., Chacko, S., DiSanto, M.

(3) Decreased CGMP-dependent protein kinase-1 (PKG-1) expression and activity in the corpus cavernosum of alloxan-induced diabetic rabbits. Chang, S., Hypolite, J.A., Changolkar, A.K., Wein, A.J., Chacko, S., DiSanto, M.E.

(3) Downregulation of telokin, a smooth muscle-specific protein associated with myosin filament formation and calcium desensitization, in response to partial bladder outlet obstruction. DiSanto, M.E., Dave, R., Zderic, S.A., Wein, A.J., Chacko, S.

(4) Obstruction-induced changes in the “fine tuning” of regulation of detrusor smooth muscle contraction through alternative splicing of myosin phosphatase

targeting subunit. Chang, S., Hypolite, J.A., Zderic, S.A., DiSanto, M.E., Wein, A.J., Chacko, S.


224

(5) The decreased force in the detrusor smooth muscle in diabetes is associated with the overexpression of thin filament-associated regulatory proteins. Mannikarottu, A.S., Hypolite, J.A., Changolkar, A.K., Gomes, C.M., San Paolo, Brazil; DiSanto, M.E., Wein, A.J., Chacko, S.

(6) Alterations in the expression of enzymes that modulate corpus cavernosum

smooth muscle contraction in men with erectile dysfunction. Chang, S., Malloy, T.R., Malkowicz, S.B., Wein, A.J., Chacko, S., DiSanto, M.E.

18. Invited Roundtable Discussion, Supplement Planning Meeting, Overactive Bladder, Santa Monica, CA, June 10-12, 2004. 19. Lecture, Philadelphia Urologic Residents Educational Consortium, “Practical Urodynamics”, Philadelphia, PA, June 19, 2004. 20. Stress Urinary Expert Panel Meeting, Sponsored by Gailliard Medical, “Update on Recent Developments in Incontinence”, “Injectable Agents – Examining the Evidence: Efficacy”, London, June 25, 2004. 21. Third International Consultation on Incontinence (ICI) Co-Chairman; Moderator, Committee Reports 21, 10, 14, 12 (Painful Bladder, Drug Treatment, Adult Conservative Management, Neurogenic Patients); Executive Committee and Chairs Working Sessions, Monte Carlo, June 26-30, 2004.


225


1. Course Director, Urology 300 (Surgery), School of Medicine. 2. Invited Speaker, American College of Osteopathic Surgeons, “Overactive Bladder Over 55+”, July 11, 2004, Cambridge, Maryland. 3. Visiting Professor, University of California, Irvine College of Medicine, Irvine, CA. Lectures: “Practical Urodynamics”; “Physiology and Pharmacology of the Lower Urinary Tract”; “Pharmacologic Therapy of Urinary Incontinence”; “On Life (or How Did I Get Here?)”; Case presentations and discussions. 4. Societe Internationale d’Urologie Meeting, October 3-7, 2004, Honolulu, Hawaii.

A. Invited Faculty, “Symposium on Urgency: Ideas and Opinions”. Presentation: “Urgency: Terminology, Epidemiology and Methods of Assessment”. B. Faculty Co-Chair, Symposium: “Storage and Voiding Symptoms of LUTS: Current Concepts and Therapeutic Options”, Questions and Answers, Discussion. Presentation: “OAB Syndrome: A Disorder of the Bladder Storage Phase”, Questions and Answers, Discussion. C. Report from the International Continence Society: “Guidelines for the Management of Urinary Incontinence”. Presentations: “Neurogenic Urinary Incontinence: International Consultation on Incontinence Summary”. Questions and Answers, Discussion. D. Presentation: “Outcome Parameters for Evaluation of Treatment Results for Overactive Bladder”. Presentation: “What Determines Success in the Treatment of OAB”? Questions and Answers, Discussion.

E. Invited Faculty Member, course on “Current Management of Female Incontinence”. Presentation: “The Overactive Bladder: Pathophysiology, Evaluation and Management”. Questions and Answers, Discussion.

5. Advisory Council and Board of Governors Meeting, American College of Surgeons (Annual Meeting), New Orleans, LA, October 12-13, 2004. 6. Visiting Professor, University of Maryland, Department of Urology, Baltimore, MD, October 21, 2004, “Pharmacologic Management of Urinary Incontinence”. 7. Co-Chair, Annual Advances in Genitourinary Health, CME Program (sponsored by Johns Hopkins), Chicago, IL, October 22-24, 2004. A. State of Art Lecture: Overactive Bladder: Epidemiology, Pathophysiology, Diagnosis and Pharmacologic Treatment.

B. LUTS in the Male Patient: Lectures, Questions and Answers. (1) Medical Management of Male Lower Urinary Tract Symptoms (2) Management of Refractory Overactive Bladder in the Male Patient. (3) Moderator: Advances in Prostatectomy; Management of Post- prostatectomy Complications; External Beam and Brachytherapy; Case Presentations and Discussion, Questions and Answers. C. Guidelines for Managing Urologic Cancer: Moderator of all sessions, Panel Discussions, Questions and Answers. D. The Male Patient in Primary Care (1) Benign Prostatic Hyperplasia in Primary Care: What you need to know.

E. Closing Remarks.


226

8. Annual Meeting, Clinical Society of Genitourinary Surgeons, Charlottesville, VA,

November 4-7, 2004.

9. Invited Lecture, Urology Grand Rounds, Baylor University (Methodist Hospital), “The Ideal Antimuscarinic”, December 8, 2004.

10. Chair, CME Course (University of Pennsylvania), “Pro-OAB”. Lectures: “Overactive Bladder – Overview”; “The Ideal Antimuscarinic”; “OAB and BPO – A Discussion of the Facts”; Case Presentations and Discussions, December 11, 2004.

11. Course Director, Urology 300 (Surgery), School of Medicine. 12. Visiting Professor, Medical University of South Carolina, February 3, 2005. “Overactive

Bladder: Pathophysiology, Evaluation and Management”. Society for Urodynamics and Female Urology, Orlando, FL, February 24-27, 2005, Executive Committee Meeting; Presentation: “Comparing Data Using Antimuscarinic Drugs as an Example”.

Invited Lecture, Department of Neurosurgery, University of Pennsylvania, Grand Rounds,

March 3, 2005. “Voiding Dysfunction in Neurologic Injury and Disease”.

Editorial Board Meeting American Urological Association Update Series, Newport Beach, CA, April 4-6, 2005,

Annual meeting, American Association of Genitourinary Surgeons, Newport Beach, CA, April 7-10, 2005. Invited Lecture, American College of Physicians Annual Meeting, San Francisco, CA, April 14, 2005. “Overactive Bladder: Terminology, Epidemiology, Pathophysiology, Evaluation, and Treatment”. Visiting Professor, Division of Urology, State University of New York at Stony Brook. Lecture: Evaluating Comparative Data Using Overactive Bladder as an Example), Case Presentations and Discussions, April 20, 2005

Visiting Professor, Division of Urology, George Washington School of Medicine. Lecture: “Antimuscarinics for the Treatment of Overactive Bladder; Evaluating Comparative Data Using Antimuscarinics for Overactive Bladder as an Example.” Case Presentations and Discussions, April 27, 2005 Invited Lecture: Society of Urologic Nurses and Associates. Lecture: “Overactive Bladder: Definition, Epidemiology, Evaluation, Management”. May 12, 2005. Annual Meeting, American Urological Association, May 19-25, 2005, San Antonio, TX MEETINGS AND PRESENTATIONS

1. Society of University Urologists (SUU), Executive Committee Meeting, Residency Standards

Report 2. Society of University Urologists/Society for Urology Chairpersons and Program Directors’

Meeting (SUU/SUCPD) Match Problems Report 3. Society of Urodynamics and Female Urology (SUFU) Annual Meeting


227

4. Board Meeting, SUFU Liaison Committee to American Board of Urology 5. Urological Survey Editorial Committee Meeting 6. Sixth International Consultation of New Developments in Prostate Cancer and Prostate

Diseases, 2nd Preparatory Meeting 7. Franco-American Urology Meeting. Invited Lecturer: New Drugs for the Treatment of Female

Voiding Dysfunction 8. American Foundation of Urological Diseases Bladder Advisory Council Meeting 9. Campbell-Walsh Editors’ Meeting 10. ICA Medical Advisory Board Meeting 11. American College of Surgeons Advisory Council for Urology 12. Urology Editorial Board Meeting 13. American Board of Urology Annual Trustees Meeting 14. Seminar (Q&A). The New Science of the Urothelium and Data Reconciliation in Overactive

Bladder 15. Symposium (Co-Chair)

a. Overactive Bladder and Lower Urinary Tract Symptoms in Men: Shifting the Treatment Paradigm

b. Overactive Bladder: Overview and Epidemiology 16. Podium Session Moderator. Incontinence Evaluation & Therapy 17. Point-Counterpoint Plenary Session (Moderator) Management of Incontinence After Sling

Program: Surgery v. Drugs 18. Prous Science Interview / Timely Topics in Medicine / Urology: Overactive Bladder 19. Visiting Professor, State University of New York, Upstate Medical Center at Syracuse.

Lectures/Case Discussions – “Overactive Bladder: Definitions, Epidemiology, Pathophysiology, Evaluation, Management”: “Comparing Data Using Antimuscarinic Therapy for Overactive Bladder as an Example”. June 1-2, 2005

20. International Consultation on Prostate Diseases (Member Task Force on Initial Evaluation and Symptomatology). Paris, France, June 23-26, 2005

21. Evidence-Based Urology Task Force Committee, Invited Member: Paris, France, June 23, 2005.


228


1. Course Director, Urology 300 (Surgery), School of Medicine, July 2005 2. Invited Keynote Lecture: Urological Association of Pennsylvania, Baltimore, MD Lecture: “Efficacy, Tolerability and Safety of Antimuscarinic Agents for Overactive Bladder:

Comparing and Contrasting Data”, July 16, 2005

3. International Continence Society, 35th Annual Meeting, Montreal, Canada August 27-September 1, 2005

MEETINGS AND PRESENTATIONS:

1. Society of Urodynamics and Female Urology Executive Committee Interim Meeting; Invited Moderator: “Stress and Mixed Urinary

Incontinence (SMUI); Sub-Committee Discussion: SUNA/SUFU UDS Course; Executive Committee Dinner Meeting

2. ICS Workshops: Invited Faculty Workshop #17: “Managing Older Adults with Incontinence: An International

Perspective”. “Pharmacologic Therapy for Incontinence: Special Considerations in “The Elderly”.

3. ICS Symposium Chairperson: “Patient Choice or Physician Choice – Which Comes First? – A Debate on SUI”; Slide Review Meeting: Symposium – “The New Science of OAB”;

Satellite Symposia (Co-Chair): “The New Science of OAB: Understanding the Role of the Urothelium and Antimuscarinic Effects”; Discussion: “New Ideas on the Pathophysiology of OAB”

4. Honorary Ph.D. bestowed by University of Patras, Patras, Greece, September 29, 2005. Thesis presentation: “Pathophysiology of Urinary Urgency”. 5. Invited Opening Lecture, Hellenic Urological Association Meeting, Congress of Urodynamics, Neurourology and Female Urology, Athens, Greece. September 29 -October 1, 2005. Presentation: “The Ideal Antimuscarinic”. 6. American College of Surgeons Annual Meeting, Advisory Council for Urology. San Francisco, CA October 16-19, 2005.

7. Visiting Professor, Wake Forest University School of Medicine, Department of Urology. Practical Urodynamic Studies: Clinical Relevant Physiology and Pharmacology of the Lower Urinary Tract: Overactive Bladder – Definition, epidemiology, pathophysiology, evaluation and management. Case presentations and discussion. November 1-3, 2005.

8. Invited Faculty. The Evolving Role of Botulinum Toxin: Application, Rationale and Techniques in the Management of Voiding Dysfunction (CME). “Current State of Pharmacologic, Neuromodulation and Surgical Approaches for Overactive Bladder”; “Botulinum Toxin: Mechanism of Action and Pharmacologic Rationale for Use in Lower Urinary Tract Applications”. Sponsored by University of Nebraska Medical Center, Philadelphia, PA, November 19, 2005. 9. Invited Faculty, 3rd Annual University of Pennsylvania Conference on Urogynecology and Pelvic Floor Dysfunction (CME). John Mikuta Lecture: “Newer Medications for Overactive Bladder: A Critical Approach”. Philadelphia, PA December 9, 2005.


229

10. Board of Regents (Member), Mercersburg Academy. Meeting, January 19-21, 2006, Washington, DC.

11. Invited Visiting Professor (Grand Rounds), University of Miami, “Pathophysiology of

Overactive Bladder: The ideal antimuscarinic,” Miami, Florida. February 16, 2006.

12. Society for Urodynamics and Female Urology (SUFU), Annual Meeting, Grand Bahamas, February 23-27, 2006

a. Executive Committee Meeting (Member) (Chair, Membership Committee) b. Moderator, Session on Selection of Equipment for Office Benign Prostatic

Hypertrophy (BPH) Therapy c. Session on Pharmacologic Management of Urinary Incontinence, “Current Therapeutic

Alternatives”

13. Invited Lecture, Atlanta Urology, “Comparing Data for Overactive Bladder Management”, Atlanta, Georgia - March 22, 2006

14. European Association of Urology, Annual Meeting. Invited Chair, Symposium on Patient Selective Overactive Bladder Therapy. Introduction, Summary, Questions and Answers. Rehearsal and Symposium. Paris. April 4-8, 2006

15. Combined American Urological Association (AUA) – European Association of Urology (EAU) Combined Task Force on Evidence Based Urology (EB Uro) (Member). Paris. April 8, 2006

16. Editorial Board Meeting, American Urological Association Update Series (Member), Boca

Raton, Florida – April 17-19, 2006

17. American Association of Genitourinary Surgeons (AAGUS), Annual Meeting. Report of Representative to American College of Surgeons (ACS), Boca Raton, Florida, April 20-23, 2006.

18. Invited Faculty, Continence Education Program: “Pathophysiology of Overactive Bladder; Rationale for the Use of Antimuscarinics.” Henderson, Nevada, April 28-30, 2006.

19. Mercersburg Academy, Board of Regents Meetings; Mercersburg, PA, May 11-13, 2006.

20. American Urological Association (AUA) Annual Meeting, Atlanta, Georgia May 18-25, 2006 MEETINGS, PRESENTATIONS AND SOCIAL RESPONSIBILITIES

A. Botox Trial Protocol Advisory Meeting B. Society of University Urologists (SUU)

a. Board Meeting b. SUU Annual Meeting

C. Society of Urology Chairs and Program Directors (SUCPD) Annual Meeting D. AUA Symposium Presentation: (Chair) Diagnosis and Treatment of LUTS in Men: Separating

Myth from Reality E. Society of Urodynamics and Female Urology (SUFU)

a. SUFU Executive Committee Meeting b. SUFU Annual Meeting – Presenter: “Pharmacology of the bladder neck and urethra”

F. Urological Survey Editorial Committee, The Journal of Urology G. Nature Clinical Practice Urology Advisory Board – Editorial Board H. AUA Education Council Meeting


230

I. Societé Internationale d’Urologie (SIU) U.S. Chapter Business Meeting J. Campbell-Walsh Urology Editorial Board Meeting K. Elsevier Editors’ Breakfast Meeting – May 22 2006 L. Elsevier Urology Editorial Board Breakfast Meeting – May 23 2006 M. American College of Surgeons Advisory Council for Urology N. Urology Technology Assessment Committee Meeting O. American Board of Urology Annual Trustees Luncheon Meeting P. AUA ACCME Poster Session #MP18 on Urodynamic Testing (Moderator) Q. Interstitial Cystitis Association Executive Committee Breakfast Meeting R. Penn Urology Dinner (host) S. Penn Alumni Evening Event (co-host)

21. Visiting Professor, Mater Misericordia Hospital Center, Department of Urology, Dublin, Ireland, June 15-17, 2006. “Pathophysiology of Overactive Bladder; Rationale for the Use of Antimuscarinics; Comparisons of Data: Fact vs. Well, Whatever”.

22. Invited Speaker, Network of Excellence in Urologic Science, Dublin, Ireland, June 16-18,

2006. “Antimuscarinic Treatment of OAB Symptoms in the Male Patient – Evidence to Date, Management of Male Patients with LUTS Including OAB Symptoms of Urgency and Frequency.”


231


1. Course Director Urology 300 (Surgery) July 2006

2. Male Overactive White Paper Working Group (Contributing Member). W Hotel, New York City, July 15, 2006

3. ACGME Residency Review and Pediatric Fellowship Review with Site Visitor, Philadelphia,

PA, July 26-27, 2006

4. Focus on Prostate Cancer Program sponsored by University of Pennsylvania Cancer Center. Chairperson: Overview: of Prostate Cancer; Rationale for Surgery for Cure of Prostate Cancer; Retropubic and Perineal Approach, Philadelphia, PA, July 28, 2006

5. Academic Visit to Intuitive Surgical for Department of Surgery/Medical Center, Sunnyvale, CA,

August 17-19, 2006

6. Society Urodynamics and Female Urology Executive Committee Meeting, Chicago, IL, August 24-25, 2006

7. Invited Visiting Professor, University of Wisconsin, Department of Urology and Milwaukee

Urologic Society. “The Ideal Antimuscarinic”, “Pathophysiology of Overactive Bladder, Rationale for the Use of Antimuscarinics”, case discussions. Milwaukee, Wisconsin, August 30-September 1, 2006

8. Urology Technology Assessment Group Meeting. New York, New York, September 8, 2006

9. Visiting Professor, University of Nebraska School of Medicine, Department of Urology.

“Pathophysiology of Overactive Bladder, Rationale(s) for the Use of Antimuscarinics, Comparative Evaluations: Fact vs Well, Whatever”, Case Presentations and Discussions. Omaha, Nebraska, September 20-21, 2006.

10. American College of Surgeons, 92nd Annual Clinical Congress, October 8-11, 2006.

A. Board of Governors Meeting B. Urology Advisory Council Meeting

11. Invited Lecturer, Tampa Urologic Society. “Pathophysiology of Overactive Bladder, Rationale

for the Use of Antimuscarinics, Comparisons of Data: Fact vs. Well, Whatever.” Tampa, Florida, October 11, 2006.

12. Invited Chair, PROAB CME Course (The Wright Resource). “Overactive Bladder: Overview,

Terminology, Epidemiology, Economics”: Moderator, all sessions(5). New York, New York, October 13-14, 2006.

13. Invited Visiting Professor, Annual Meeting New York Section, American Urological

Association, Oct 27-Nov 5, 2006, India (New Delhi, Agra, Jaipur) A. Indian TV Session (their version of CNN): Incontinence, Overactive Bladder and

Urinary Tract Infection (1 hour), October 2006. B. Debate: In Favor of Minimal Initial Evaluation of Overactive Bladder with Minimally

Invasive Therapy, October 2006. C. Drug Therapy of Overactive Bladder: Comparisons of Data. October 2006.


232

14. Co-Chair, CME Program, “PROAB’06”(Organizers: thewrightresource.com), Marina Del Ray, California, November 17-18, 2006.

Presentations: A. Welcome and Introductions B. Overactive Bladder (OAB): Terminology, Epidemiology, and Economic Considerations C. Physiology and Pathophysiology of OAB D. Introduction to Pharmacologic Therapy E. Rationale for Antimuscarinics F. Panel Discussions, Questions and Answers

15. International Continence Society (ICS) Annual Meeting, Christchurch, New Zealand, November 26 - December 1, 2006.

A. Invited Lecturer to the Japanese Delegation: Overactive Bladder in Men: The State of the Art.

B. Invited Faculty, Symposium on “LUTS in Men” Presentation: Evidence for the Safety of Antimuscarinic Therapy in Men with LUTS

16. Society of Urodynamics and Female Urology Annual Meeting, February 21-24, 2007,

San Diego, California A. Executive Committee Meeting B. Membership Committee Report (Chairman) C. Moderator, Session on Drugs, Devices and Reconstructive Procedures D. Presenter, Lifetime Achievement Award

17. University of Pennsylvania Fund Raising Event, Palm Beach, Florida, March 5-7, 2007

“Prostate Cancer”, “BPH”, “Erectile Dysfunction” 18. Sleep (Study and Overactive Bladder) Advisory Committee Meeting, Philadelphia, PA,

March 10, 2007

19. European Association of Urology (EAU) 22nd Annual Congress, Berlin, Germany, March 19-24, 2007

A. Seminar on Male Overactive Bladder. “Current Evidence on Antimuscarinic Safety in the Treatment of Overactive Bladder Symptoms in Men”, Questions and Answers.

B. Advisory Committee, EPIC-LUTS Study, Meeting C. Co-Chairs Organizational Meeting for International Consultation on Incontinence, 2008 D. Manuscript Commission, Nature Urology (Board of Advisors) E. Organizational/Editorial Meeting: Fast Facts, Bladder Disorders

20. Urology Congress, San Francisco, California, April 4-7, 2007 Invited Faculty Member: Lectures: “Overactive Bladder – Outcomes and Study Comparability” and “Overactive Bladder – Terminology, Epidemiology, Pathophysiology, Economics”

21. Symposium on Cardiovascular Issues in Overactive Bladder Treatment with Antimuscarinic

Agents. Invited Lecturer: “The Pathophysiology of Overactive Bladder and the Principles of Pharmacologic Management”, Friday, April 27, 2007

22. Lecture: Penn Primary Care Urology Update (CME Program presented by the Division of Urology): Prostate Cancer: Overview. Saturday, April 28, 2007

23. Annual Meeting of the American Urological Association (AUA), May 17-25, 2007, Anaheim, California


233

A. Society of University Urologists (SUU) Executive Committee Meeting: Report of the Residency Standards Committee (Chair)

B. SUU Annual Meeting C. Invited Lecturer: Annenberg Center Educational Program – Comparing Data for OAB

Drugs, Emerging Cardiovascular Considerations for OAB Management: Questions and Answers

D. Society of University Chairpersons and Program Directors (SUCPD) Meeting E. Society of Urodynamics and Female Urology (SUFU) Executive Meeting (Membership

Chairman) F. Urological Survey Editorial Board Meeting G. SUFU Annual Meeting H. Nature Clinical Practice Urology Meeting I. Urological Health Foundation Meeting J. Campbell-Walsh Urology Editorial Board Meeting K. Penn Medicine Alumni Reception (Co-Host) L. Interstitial Cystitis Association (ICA) Medical Advisory Board Meeting M. AUA Moderated Poster Presentations (Co-Moderator) N. The Bob Krane British Journal of Urology International Prize Ceremony O. UROLOGY Editorial Board Meeting P. Invited Lecturer: Office of Female Urology and Demystifying Urodynamics Course:

“Practical Urodynamics” Q. Lunch With The Experts: Invited Expert R. Penn Urology Dinner (Host)

24. Visiting Professor/Invited O.R. Observation (only): “Practical Urodynamics”, Questions

and Answers. University of Washington, Department of Urology, Seattle, Washington, June 20-21, 2007


234


1. Visiting Professor Lectureship: “Comparing Data in the Management of Overactive Bladder”, Questions and Answers. Urology Attending and Resident Staff, William Beaumont Hospital, Troy, Michigan, July 11, 2007

2. Visiting Professor Lectureship: Grand Rounds: “Pathophysiology of Overactive Bladder:

Rationale for the Use of Antimuscarinics: Comparing Data: Questions and Answers. Attending and Resident Staff, Botsford Hospital, Farmington Hills, Michigan, July 12, 2007

3. Visiting Professor Lectureship: Urology Grand Rounds: “Pathophysiology of Overactive

Bladder: Rationale for the Use of Antimuscarinics: Comparing Data: Facts, Fables, and Whatever”, Questions and Answers. Harper Hospital, Wayne State University School of Medicine, July 12, 2007

4. International Continence Society (ICS) Annual Meeting, Aug 20-24, 2007,

Rotterdam, The Netherlands A) Invited Speaker: Symposium “OAB – Many Patients – One Diagnosis?”

Presentation: “The Many Faces of OAB”, Moderation, Questions and Answers

B) Invited Speaker: Symposium “OAB With Cardiovascular Safety: Next Steps in Patient Care” Presentation: “Clinical Uroselectivity: What Does It Mean?” Panel Discussion: Questions and Answers

C) Preliminary Meeting, Chairperson: International Consultation on Incontinence

(ICI) 2008

5. 29th Congress of the Société Internationale de Urologie (SIU) Meeting, September 3-5, 2007, Paris, France. Presentation: Overactive Bladder: Patient Evaluation and Medical Treatment

6. Invited Faculty Presenter, Urology Journal Circle: An Online Forum for Expert Opinions and

Journal Reviews (CME). Presentation: “Outcome Measures”. September 10, 2007

7. American College of Surgeons Annual Meeting, October 6-10, 2007. New Orleans, Louisiana A. Board of Governors Meeting (Member) B. Advisory Council for Urology Meeting (Member) C. Invited Moderator: Video-session on Urology

8. Invited Visiting Professor, Ohio State University School of Medicine, Department of Urology,

Columbus, Ohio. Lectures: “New Aspects of Pathophysiology of Overactive Bladder”; “Rationale for the Use of Antimuscarinics“; Comparing Data”; Practical Urodynamics”; Case Presentations and Discussions. October 10-12, 2007, Columbus, Ohio.

9. Invited Faculty: Symposium on Urinary Incontinence Southern Medical Association.

Presentations: “Overactive Bladder” and “Overflow Incontinence”; Case Presentations and Discussions. November 15-16, 2007, New Orleans, Louisiana

10. Invited speaker, NIH State-of-the-Science Conference. Prevention of Fecal and Urinary

Incontinence in Adults. Topics: “Pathophysiology of Urinary Incontinence”; Questions and Answers. Discussion; “Iatrogenic Disorders, Drug Side Effects and the Development of Urinary and Fecal Incontinence”; Questions and Answers. Discussion. December 10-12, 2007, Bethesda, Maryland.


235

11. Editorial Board Meeting, British Journal of Urology International (Associate Editor), February 7-10, 2008, Boca Raton, Florida 12. Editorial Board Organizational Meeting for Tenth Edition of Campbell-Walsh Urology (Editor-in-Chief), February 14-18,2008, Boca Raton, Florida 13. Society for Urodynamics and Female Urology Annual Meeting; Executive Committee Meeting, February 28-March 2, 2008, Miami, Florida.

A) Presentation: Analysis of Data From A Non-Naïve Study

on Antimuscarinics for Overactive Bladder B) Recipient: 2008 Distinguished Service Award

14. Lecturer: Urology Grand Rounds: Pathophysiology of Urinary Incontinence University of Pennsylvania School of Medicine. February 21, 2008 15. Invited Examiner: American Board of Urology, Part II Certification Examination:

Dallas, Texas, February 22-23, 2008 16. Lecturer: Urology Grand Rounds, University of Pennsylvania School of Medicine: LUTS Dysfunction in Neurologic Injury and Disease, March 13, 2008 17. 23rd Annual European Association of Urology (EAU) Congress, March 26-29, 2008

A) Presentation: The Prevalence, Bother and Overlap of LUTS in the United States, B) United Kingdom and Sweden: EpiLUTS (EpiLUTS Team) C) ICI - International Consultation on Incontinence Organizational Meeting D) (Co-Chair) with Saad Khoury, Paul Abrams, Committee Chairs E) Scientific Meeting: Future of Overactive Bladder Therapy F) Meeting with Senior Editor of Springer Publishing regarding two new authorships G) Committee on Evidence Based Medicine, International Consultation on

Incontinence 18. Urology’08 Congress, Philadelphia, PA – April 25-26, 2008

A) Invited Planning Committee, Member and Session Chair: Voiding Function and Dysfunction

B) Lecturer: Overactive Bladder 2008, Questions and Answers and Panel

19. Invited Lecturer: Resident Rounds, University of Southern California, Los Angeles, CA May 1, 2008. “Lower Urinary Tract Physiology and Pharmacology; Lower Urinary Tract Dysfunction Secondary to Neurologic Disease or Injury”

20. Invited Visiting Professor, Department of Gynecology and Obstetrics, North Shore Long Island

Jewish Hospital, Long Island, NY. May 7, 2008: Lecture: Questions and Answers “Overactive Bladder 2008”

21. Wharton School of Business – University of Pennsylvania Executive Training Course,

Philadelphia, PA - February 1-2, 2008; March 7-8, 2008; April 4-5, 2008; May 9-10, 2008

22. Men’s Prostate Event, Abramson Cancer Center/University of Pennsylvania Health System Fund Raising Dinner and Silent Auction. Moderator and Remarks, May 12, 2008


236

23. American Urological Association (AUA) 103rd Annual Meeting, Orlando, Florida, May 2008

a. Society of University Urologists (SUU) Executive Committee Meeting i. Chair, Residency Standards Committee

b. SUU Annual Meeting c. Society of Urology Chairs and Program Directors (SUCPD) d. Society of Urodynamics and Female Urology (SUFU) Executive Committee Meeting

i. Chair, Membership Committee e. Urological Survey Editorial Committee Meeting f. SUFU Basic Science Program Committee g. SUFU Meeting at AUA h. Nature Clinical Practice Urology Advisory Board Meeting i. Interstitial Cystitis Association, Medical Advisory Board Meeting j. AUA Education Council, Member k. SUFU/American Board of Urology Meeting l. Penn Urology Alumni Reception (co-host) m. Springer Publications Meeting (Textbooks on OAB & BPH) n. Meeting with David Penson, MD (discussion: Penn Urology Faculty Position) o. J Urology Editorial Board & Reviewers Awards p. BJU International - Bob Krane Award Presentation q. UROLOGY Editors Meeting and UROLOGY Board Meeting r. American Board of Urology Reception & Luncheon s. ACS Advisory Council for Urology (Interim Meeting) t. American Association of Clinical Urologists (AACU) u. Socioeconomics Forum & Charles Hoffman Lecture v. AUA Education Program Poster Sessions

i. Co-Moderator for Urodynamics/Incontinence/Female Urology: Evaluation & Therapy III

w. Host: Penn Urology Dinner & Surprise Roast featuring Terrence R. Malloy MD x. Science Liaisons Meeting

24. Visiting Professor, Beaumont Hospital, Royal Oak, Michigan; June 26, 2008 “Evolution and

Current Concepts of Nocturia”, Questions and Answers.

25. Visiting Professor, Columbia University Medical Center, New York, NY, 2008

26. Visiting Professor, Massachusetts General Hospital, Harvard Medical School, Boston, 2008


237


1. Co-Chair, 4th International Consultation on Incontinence, sponsored by ICUD, SIU, WHO, July 5-9, 2008, Paris, France

a. Executive Committee, Moderator; Presentations from Committee 13, 14, 15; Moderator, Best of Awarded Presentations; Co-Chair, Editorial Committee for the Summary of the Recommendations

2. Lecturer: Urology Grand Rounds, University of Pennsylvania School of Medicine:

Practical Urodynamics, August 14, 2008

3. Faculty Member – Penn Urology Robotic Course, Improving Efficiency in Robotic Surgery, Introduction and Welcome Remarks, October 10, 2008, University of Pennsylvania School of Medicine

4. American College of Surgeons 94th Annual Clinical Congress, October 12-16, 2008, San Francisco, California

a. Board of Governors Annual Business Meeting b. Combined Meeting: Nominating Committee of the Board of Governors;

Nominating Committee of Fellows and Advisors Committee on Nomination of Board of Regents

c. ACS Advisory Council for Urology d. Board of Governors Adjourned Meeting e. Board of Governors Executive Committee Meeting f. Annual Business Meeting of “Members” (formerly “Fellows”)

5. The Schneider Visiting Professorship, Massachusetts General Hospital, Harvard

Medical School, Boston, MA. October 30-31, 2008. Lectures, Case Presentations, Discussions – “Physiology and Pharmacology of the Lower Urinary Tract”; “Overactive Bladder 2008: What’s New?”; “Evaluating Pharmacologic Agents for Therapy

6. Visiting Professor, New York University, Department of Urology - Surgical, Pharmacological and Technical Advances in Urology, New York, NY. December 4-6, 2008. Lecture: “Overactive Bladder”

7. Examiner, American Board of Urology Annual Oral Examination Process, Dallas, Texas, February 19-22, 2009.

8. Annual Meeting of the Society for Urodynamics and Female Urology (SUFU), Lake

Las Vegas, Nevada, February 25-28, 2009.

a. Executive Committee Meeting, (Membership Chairman) b. Invited Moderator, Session on “Panel Discussion: The Meeting with the

Editors; What Makes An Ideal Manuscript; The Review Process; Conflict of Interest; Discussion and Questions & Answers.

9. Annual Meeting of the American Urological Association (AUA), Society of University

Urologists (SUU), Society for Urodynamics and Female Urology (SUFU), Society of Urologic Oncology (SUO), April 23-30, 2009


238

a. SUU Executive Committee Annual Meeting (Chairman, Residency Standards

Committee and President-Elect) b. SUU Annual Meeting (Chairman, Residency Standards Committee,

President-Elect) c. Society of Urologic Chairpersons and Program Directors (SUCPD) Annual

Meeting d. AUA-TCL Institute CME Program (sponsored by Astellas Pharmaceuticals):

Assessing Bladder Sensation and Urgency - Invited Faculty. Presentation: Urgency: What it is - What it Isn’t, Metrics, Caution.

e. SUFU Executive Committee Dinner and Meeting f. Urological Survey Editorial Board Meeting g. Campbell-Walsh Urology 10th Edition – Meeting of the Board of Editors

(Editor-in-Chief) h. SUFU Annual Didactic Meeting i. Meeting of the Editorial Board of Nature Urology j. Meeting of the Medical Advisory Committee of the Interstitial Cystitis

Association k. Editorial Meeting , Fast Facts – Bladder Disorders l. International Society of Urology , US Chapter (Member) Annual Business

Meeting m. British Journal of Urology International (BJUI) Reception and Awards

Presentation (Associate Editor) n. Editorial Board Meeting: Therapeutic Advances in Urology o. Invited Moderator, moderated Poster Session:

Urodynamics/Incontinence/Female Urology/Neurogenic Voiding Dysfunction p. Reception in honor of AUA President q. Editorial Board Meeting: UROLOGY (Associate Editor) r. Reception and Luncheon, American Board of Urology Trustees (Emeritus

Trustee)

10. International Consultation on Incontinence – Research Society, 1st Meeting, Bristol, U.K., May 20-22, 2009. Steering Committee, Moderator, Facilitator: “Neurological Patients Need EBM”.


239


1. Lecturer: Urology Grand Rounds, University of Pennsylvania School of Medicine: The Six Competencies, July 9, 2009.

2. Lecturer: Urology Grand Rounds, University of Pennsylvania School of Medicine: “Physiology/Pharmacology of LUTS, July 30, 2009.

3. International Continence Society (ICS) Meeting, San Francisco, CA – Organizing Committee Member, September 29-October 3, 2009.

4. Invited Lecturer: EAU Section of Oncological Urology (ESOU), Annual Meeting, Vienna Austria. January 15-17, 2010. “Post Radical Prostatectomy Urinary Incontinence: Myths, Facts and a Stepwise Approach to Treatment”.

5. Invited Keynote Address, Overactive Bladder Training Course, Phoenix, Arizona, Feb 4-5, 2010. “Overactive Bladder - A Detailed Overview”. Sponsored by Pfizer, Inc., Approved by Penn Legal Department.

6. Invited Examiner, American Board of Urology Certifying Examination, Dallas, Texas, February18-20, 2010.

7. Society for Urodynamics and Female Urology, St. Petersburg, Florida, February 23-27, 2010 a. Invited Moderator, Basic Science Poster Session b. Executive Committee Meeting (Chairman of the Membership Committee) c. Invited Director, Session on Overactive Bladder: Symptom and Syndrome

8. Invited Participant and Lecturer, NOCTURIA MANAGEMENT CONSENSUS

CONFERENCE, New England Research Institute, Boston, MA, April 10-11, 2010: “Effects on Nocturia of Agents Used for the Treatment of BPH and Overactive Bladder”, Question and Answer, Consensus Discussion.

9. Invited Chairman, Symposium on “Neuromodulation - Its Place Within The Algorithms of Therapy for Filling/Storage and Emptying Disorders”. Program Organizer and Moderator of all session, New York City, NY, March 5-6, 2010

10. Invited Chairman, “Young Leaders in Urology Symposium”. Lectures: “Overactive Bladder, What’s Really New?”, “Managing Relationships with Industry”, “Funding Opportunities in Urology at the NIH”. Dallas, TX, March 12-13, 2010.

11. Annual Meeting of the Genitourinary Surgeons, Santa Ana, Pueblo, New Mexico, May 5-8, 2010.

12. Invited: Andrew C. Novick Visiting Professor, Cleveland Clinic, Glickman Urological & Kidney Institute, May 12-14, 2010. Lectures: “Overactive Bladder - A Detailed Overview and Physiology and Pharmacology of the Lower Urinary Tract Function”; Practical Urodynamics; Case Presentation s and Discussions; Research Presentations by the Residents with Discussions.


240

13. Invited Visiting Professor/Lecturer, Russian Institute of Urology; Russian-American Scientific Meeting. Lecture: “Postprostatectomy Incontinence”; Case Presentations and Discussions Centering on Individual Approach to Patients with Prostate Cancer”. Moscow, Russia, May 15-19, 2010.

14. Invited Committee Member, World Health Organization, ICD-11 Revision, Topic Advisory Group (TAG), Urogenital/Reproductive 2010.

15. Annual Meeting of the American Urological Association (AUA), Society of University Urologists (SUU), Society of Urodynamics and Female Urology (SUFU), Society of Urologic Oncology (SUO), May 29, June 2, 2010.

a. Society of Urologic Chairpersons and Program Directors (SUCPD) Executive Committee Annual Meeting

b. President-Elect , Society of University Urologists (SUU) Executive Committee Annual Meeting Moderator: “Matching: How Did We Get Where We Are? Is There A Reason To Change?” Moderator: “Are We Ready For Subspecialization in Urology?” Speaker: “What Do Program Directors and Applicants Think?

c. Society of Urodynamics and Female Urology (SUFU) – Speaker: “State of the Art: The Terminology of Male Voiding Dysfunction”, Questions and Answers.

d. Urological Survey Editorial Committee Meeting (Journal of Urology) e. Society of Urologic Oncology/Society of Basic Urological Research (SUO/SBUR)

Annual Meeting f. Campbell-Walsh Urology, 10th edition, Editorial Board Meeting g. AUA Plenary Session (Moderator: “Painful Bladder Syndrome: What Happened

to Interstitial Cystitis”.) h. AUA Nominating Committee Meeting i. AUA Urodynamics Guidelines Panel Meeting j. Therapeutic Advances in Urology Business Meeting k. AUA Poster Session – Co-Moderator: Urodynamics/Incontinence/Female

16. The International Consultation on Incontinence Research Society, held in Bristol,

England, June 16-18, 2010.

a. Steering Committee

b. Moderator of the following sessions: Modelling the Urinary Tract; What’s Next for Drug Treatment of SUI, BPO and OAB?; Understanding the Pathophysiology of the Outflow Tract; Are Tissue Engineering and Biomaterials the Future for LUTD/POP?; Setting Research Priorities and Planning for the Future

c. Session Chair: Plenary Session #1; Plenary Session #3; Plenary Session #4

17. Committee Member, Stress Urinary Incontinence Measures Development Panel Meeting (representative of the American College of Surgery) Linthicum, Maryland, (sponsored by American Urological Association and the American College of Obstetrics and Gynecology, June 28, 2010.


241


1. Society of Urodynamics and Female Urology, Executive Committee Meeting (Membership Chair), Linthicum, MD., Aug 6, 2010.

2. Invited Keynote Address: AUA Foundation/Society of Basic Urologic Research Summer Research Conference: Integrating Basic and Clinical Research Perspectives; Linthicum , MD., Aug 7-8, 2010. "Urinary Incontinence: What We Know, What we Don't Know, What We Would Like To Know".

3. Invited Chair, Annual Meeting of the International Continence Society and International Urogynecological Association, Toronto, Canada, August 23-27, 2010 - Session on Quality of Life and Miscellaneous.

4. Invited Faculty, Annual Meeting of the International Continence Society/International Urogynecological Association, August 23-27, 2010 - Symposium on Nocturia, “Therapy of Nocturia with Agents for BPH and Overactive Bladder.

5. Invited Chair, moderated poster session on “Overactive Bladder”; Chair, Symposium on

“Opening the Door to Individualized Care” (Overactive Bladder); “The Progression of Antimuscarinic Therapy”, Questions and Answers. Société Internationale D’Urologie (SIU) World Meeting 2010, Marrakech, Morocco, October 13-16, 2010.

6. Invited Guest/Speaker, Penn Medicine in Palm Beach – “Living Longer, Living Better”, March 1, 2011; Introductory Remarks: New Frontiers in Prostate Cancer Treatment.

7. Society For Urodynamics and Female Urology Annual Meeting, Tuesday-Saturday, March 1-5, 2011, Phoenix, Arizona

a. Executive Committee Meeting (Chairman of the Membership Committee) b. Invited Speaker: “Case Presentations in Voiding Dysfunction and Incontinence”

8. Invited Lecturer: Canadian Urologic Forum (Accredited Group Learning by the Royal

College of Physicians and Surgeons of Canada and the Canadian Urologic Association). “Symptom-Based Diagnosis of Overactive Bladder: An Overview”; Panel Discussion, Overactive Bladder, Questions and Answers. Toronto, Canada, April 2, 2011

9. Ferdinand C. Valentine Award Presentation and Invited Lecturer, New York Academy of

Medicine. Lecture: “The Development of the Simpleminded and User-Friendly Classification System Applicable to All Types of Lower Urinary Tract Dysfunction”. Wednesday, April 6, 2011

10. Invited Visiting Professor, Beth Israel Medical Center, New York City, New York. Lectures, Questions and Answers, Case Presentations (Physiology and Pharmacology of the Lower Urinary Tract; Overactive Bladder: A Detailed Overview). Thursday-Friday, April 7-8, 2011.

11. The American Association of Genitourinary Surgeons Annual Meeting, Charleston, South Carolina. (by-election only society, attendance required). Wednesday-Saturday, April 13-16, 2011


242

12. Annual Meeting of the American Urological Association (AUA), Society of University Urologists (SUU), Society of Urodynamics and Female Urology (SUFU), Society of Urologic Oncology (SUO), May 12 – June 18, 2011

a. Society of Urologic Chairpersons and Program Directors (SUCPD) Executive Committee Meeting; and Annual Meeting

b. President, Society of University Urologists (SUU) Executive Committee Meeting

c. Chair, SUU Annual Membership Meeting

1. Moderator: Task Force Report on Residency Match Process 2. Moderator: Introduction and Key Points from Previous Discussions (Q&A)

d. Urological Survey Editorial Committee Meeting (Journal of Urology)

e. Joint Mtg - AUA Core Curriculum Cmte & Campbell-Walsh Urology Ed.10 Ed. Bd.

f. Society of Urodynamics and Female Urology (SUFU) – Speaker: “State of the Art: What We Know and What We Don’t Know About Urinary Incontinence.

g. F. Brantley Scott Physician Academy Recognition Awards Ceremony honoring Terrence R. Malloy MD (Invited: Introductory Remarks)

h. AUA Nominating Committee Meeting (member)

i. AUA Podium Session 45 – Urodynamics/Incontinence/Female Urology-I (moderator)

j. American Board of Urology Annual Trustees Meeting

k. UROLOGY Editorial Board Meeting

l. AUA Urodynamics Guidelines Panel Meeting

m. Nocturia Think Tank (TT) Meeting (member)

n. Society of Urologic Oncology/Society of Basic Urological Research (SUO/SBUR) Annual Meeting

o. BJU International Annual Meeting

p. Campbell-Walsh Urology, 10th Edition, Editorial Board Meeting

q. AUA Education Council Meeting (member)

r. Friends of Israel Urological (FOIU) Chairmen’s Meeting (Scientific Symposium 2012)

s. Penn Urology Alumni Reception (co-host with Terrence Malloy MD)

t. Invited Speaker: Pharmacotherapy of OAB


243

13. Invited Lecture and Participation: Incomb-Trust-SEA-EAU Joint Symposium on “Urinary

Incontinence – From Basic Science to Clinical Practice” (sponsored by: Karolinska Institute), June 8-11, 2011, Stockholm, Sweden

a. Lecture: Nocturia: Clinical and Pathophysiologic Factors

14. The International Consultation on Incontinence Research Society, Bristol, England. Co-Chair, Annual Meeting, and Moderator: Think Tank on Nocturia and Think Tank on CPPS/BPS, June 13-15, 2011


244

ACADEMIC ACTIVITIES 2011 - 2012

15. Executive Committee Meeting, Society for Urodynamic and Female Urology, Cleveland, Ohio, August 18-19, 2011 (Membership Chairman, Executive Committee Member).

16. International Continence Society (ICS) Meeting, Glasgow Scotland, August 29-September 2, 2011.

a. Invited Speaker:

Symposium on Nocturia: State of the Art in New Directions, August 30, 2011, “State of the Art – Causes, Consequences and Therapeutic Options”.

Panel: Questions and Answers, Discussion

b. Editorial Board Meeting, Neurourology and Urodynamics

c. ICS, Urodynamics Committee Meeting

17. Focus on Urology in Primary Care at the Second Annual Fall CME Conference of the New Jersey Association of Osteopathic Physicians and Surgeons (NJAOPS) in Mount Laurel, New Jersey, November 19, 2011.

a. Invited Co-Chair: Morning Session - Urological Issues in Men b. Invited Speaker: “Nocturia”

18. January 16-17, 2012: Preparation and Readiness: ACGME Urology Residency Site

Review & Visit, University of Pennsylvania, Philadelphia, PA.

19. January 20-21, 2012: Board of Regents, Mercersburg Academy, Philadelphia, PA.

20. February 22-25, 2012: Executive Committee Meeting, International Consultation on Incontinence, (Co-Chair) and (Moderator for Committees), Paris, France

a. EAU Programme, Special Session: “Reports of the Committees of the ICUD-EAU ICI (5th ICI) 2012”: Moderator for Committees:

Committee 2: Cell biology Committee 3: Neural control Committee 5: Assessment Committee 7: Imaging and other tests Committee 12: Conservative management Committee 21: Continence promotion Committee 22: Economics

b. EAU Section Meetings, Meeting of the EAU Section of Female and Functional

Urology (ESFFU) – “From international recommendations to clinical practice” Moderator for Committees:

Committee 8: Pharmacology Committee 10: Neurogenic patients


245

21. February 29-March 3, 2012: Society of Urodynamics and Female Urology Annual Meeting, Executive Committee Meeting (Membership Chairman); (Feb 29) Moderator, Session on Neurogenic Lower Urinary Tract Dysfunction (Mar 3).

22. March 24, 2012: Invited Lecturer, Nocturia: Current Status of Epidemiology,

Pathophysiology, University of Pennsylvania, Pennsylvania Hospital Urology Saturday Conference.

23. The American Association of Genitourinary Surgeons (AAGUS) Annual Meeting, La Jolla, California. (by-election only society, attendance required). Wednesday-Saturday, April 25-28, 2012. (Awarded the Edward L. Keyes Medal 2012)

24. Annual Meeting of the American Urological Association (AUA), Society of University Urologists (SUU), Society of Urodynamics and Female Urology (SUFU), Society of Urologic Oncology (SUO) in Atlanta, Georgia, May 19-23,2012.

a. Society of University Urologists (SUU) Executive Committee Meeting and Annual Meeting Moderator: Nominating Committee Report

b. Society of Urologic Chairpersons and Program Directors (SUCPD) Executive Committee Meeting; and Annual Meeting Moderator: Nominating Committee Report

c. Urological Survey Editorial Committee Meeting d. Society Basic Urology Research & Society Urologic Oncologists (SBUR/SUO)

Joint Meeting e. Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction f. Sexual Medicine Society of North America (SMSNA) Annual Meeting g. Campbell-Walsh Urology Editors’ Meeting h. AUA Plenary II: Critical Discussion: Panelist: Expanding the Role of APN/PA in

Urology Practice i. AUA Podium Session: Moderator: Bladder and Urethra: Anatomy, Physiology

and Pharmacology II j. AUA Foundation Scholar Awards Program k. AUA Education Council Meeting l. AUA/UroToday Press Room Interview with Karen Roberts m. AUA/Urological Society of Australia & New Zealand Meeting (USANZ) n. AUA/Penn Urology Alumni Annual Reception (host) o. AUA Annual Nominating Committee Meeting p. AUA/American Board of Urology Board of Trustees Annual Meeting

25. Invited Speaker and Consensus Committee Member (Best Practices in Nocturia

Management and Treatment), New England Research Institute (NERI) Boston (Cambridge) Mass, “Antimuscarinic Treatment of Nocturia “, Discussions (manuscript to follow). June 2-3, 2012


246

26. Invited Speaker, George M. O’Brien Urology Research Center Mini Symposium, Epithelial and Neuronal Signaling on Lower Urinary Tract, University of Pennsylvania, Philadelphia “Overactive Bladder and Bladder Outlet Obstruction: What Needs to be Translated”. June 22, 2012

27. Invited Course Director, Chairman and Moderator, AUA (American Urological Association) Teaching Course at the British Association of Urologic Surgeons (BAUS) Meeting, Glasgow, Scotland; and “Nocturia: Clinical and Pathophysiologic Factors”, Discussion. June 25-28, 2012.

28. Visiting Professor, Department of Urology, Case Western Reserve School of Medicine, Cleveland, Ohio. Lectures: Case Discussions, Q and A. “Overactive Bladder: The Good, The Bad, The Ugly”; “The Physiology and Pharmacology of the Lower Urinary Tract”. September 27-28, 2012.


247

ACADEMIC ACTIVITIES 2012-2013 1) Society of Urodynamics and Female Pelvic Medicine & Urogenital Reconstruction -

SUFU (formerly, Society of Urodynamics and Female Urology). Executive Committee Meeting/Member. August 24, 2012., Chicago, Illinois

2) Invited Lecturer, SUFU (see above) Course in Female Urology and Voiding Dysfunction , Resident Preceptorship Program, “The Physiology and Pharmacology of the Lower Urinary Tract”; Invited Panelist, “Management of Neurogenic Bladder with Case Presentations”, August 25-26, 2012, Chicago, Illinois

3) International Continence Society (ICS) Annual Meeting, October 15-19, 2012, Beijing, China a) Neurourology & Urodynamics Committee (Member): Meeting, October 16

b) Invited Participant: The Norman R. Zinner Debate: The ICS Standardization of

OAB, DO Terminology 10 years on: Are We Barking Up the Wrong Tree? Talk: OAB:, The Good, The Bad, The Ugly; Rebuttal 4) Invited Panel Member, “The Future of Research in Academic Urology Departments” at the Clinical Society of Genitourinary Surgeons (CSGUS) Annual Meeting, Chicago, Illinois, October 25-27, 2012 (Membership in CSGUS is by election-only) 5) Co-Chair and Invited Presentation, Burden of Nocturia, ICI-RS Nocturia Think Tank Workshop, November 17, 2012, Miami, FL. “Management of Nocturia: A Benefit-Risk Assessment of Presently Available Treatments”, Moderated Discussions. 6) Invited Lecturer: Bristol Urological Institute, 19th Annual Scientific Meeting, Benign

Disease of the Lower Urinary Tract. Lecture: “Overactive Bladder: The Good, The Bad and The Ugly”, Questions and Answers, Discussions, November 26-29, 2012.

Invited Participant: International Consultation on Incontinence-Research Society (ICI-RS), Workshop on Unanswered Questions in Urinary Incontinence: What Are The Needs? November 26, 2012.

Documents

Alan J. Wein, M.D. Ph.D.(hon.) · Royal Society of Medicine Sexual Medicine Society of North America, Inc. Sigma Xi Simon Foundation Société Internationale d’Urologie Société